Athene Holding (ATH-PD) 10-K 25 Feb 22 2021 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2021	Jan. 31, 2022	Jun. 30, 2021
Document Information [Line Items]
Entity Incorporation, State or Country Code	D0
Entity Registrant Name	ATHENE HOLDING LTD
Entity Address, Address Line One	Second Floor, Washington House
Entity Address, City or Town	Hamilton
Entity Address, Postal Zip Code	HM 11
Entity Address, Country	BM
City Area Code	441
Local Phone Number	279-8400
Entity Interactive Data Current	Yes
Entity Central Index Key	0001527469
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	001-37963
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Shell Company	false
Entity Public Float			$ 9
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		205,316,918
Entity Tax Identification Number	98-0630022
ICFR Auditor Attestation Flag	true
Entity Address, Address Line Two	16 Church Street
Auditor Name	PricewaterhouseCoopers LLP
Auditor Firm ID	238
Auditor Location	Des Moines, Iowa
Series A Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Share, Series A
Trading Symbol	ATHPrA
Security Exchange Name	NYSE
Series B Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	5.625% Fixed-Rate Perpetual Non-Cumulative Preference Share, Series B
Trading Symbol	ATHPrB
Security Exchange Name	NYSE
Series C Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	6.375% Fixed-Rate Reset Perpetual Non-Cumulative Preference Share, Series C
Trading Symbol	ATHPrC
Security Exchange Name	NYSE
Series D Preferred Stock
Document Information [Line Items]
Title of 12(b) Security	4.875% Fixed-Rate Perpetual Non-Cumulative Preference Share, Series D
Trading Symbol	ATHPrD
Security Exchange Name	NYSE

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	Des Moines, Iowa
Auditor Firm ID	238

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets
Fair Value	$ 110,561	$ 89,373
Mortgage Loans on Real Estate, Commercial and Consumer, Net	24,148	15,938
Investment funds	9,866	6,087
Derivative assets	4,387	3,523
Cash and Cash Equivalents, at Carrying Value	9,633	7,704
Restricted Cash and Cash Equivalents	796	738
Accrued Investment Income Receivable	968	905
Reinsurance recoverable	4,594	4,848
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits	5,362	4,906
Other Assets	1,283	1,249
Assets, Total	235,149	202,771
Liabilities
Interest Sensitive Contract Liabilities	156,325	144,566
Future Policy Benefits	42,488	29,258
Other Policyholder Funds	138	130
Policyholder Dividends Payable	101	110
Long-term Debt	2,964	1,976
Derivative liabilities	472	298
Investment-related Liabilities	7,044	3,801
Funds withheld liability	439	452
Other Liabilities	2,997	2,040
Liabilities, Total	212,968	182,631
Commitments and Contingencies (Note 15)
Equity
Additional Paid in Capital	6,667	6,613
Retained Earnings (Accumulated Deficit)	11,033	8,073
Accumulated other comprehensive income (loss)	2,430	3,971
Stockholders' Equity Attributable to Parent, Total	20,130	18,657
Stockholders' Equity Attributable to Noncontrolling Interest	2,051	1,483
Equity	22,181	20,140
Liabilities and Equity, Total	235,149	202,771
Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	100,159	82,853
Trading securities	2,056	2,093
Equity Securities, FV-NI	1,170
Equity Securities, FV-NI and without Readily Determinable Fair Value		532
Mortgage Loans on Real Estate, Commercial and Consumer, Net	22,557	15,264
Investment funds	1,407	803
Loans, Gross, Insurance Policy	312	369
Funds withheld at interest	43,907	48,612
Derivative assets	4,387	3,523
Short-term investments, at fair value	139	222
Other investments	1,473	572
Investments, Total	177,567	154,843
Related Party
Assets
Fair Value	10,402	6,520
Trading securities	1,781	1,529
Equity Securities, FV-NI	284	72
Mortgage Loans on Real Estate, Commercial and Consumer, Net	1,591	674
Investment funds	8,459	5,284
Funds withheld at interest	12,207	13,030
Other investments	222	469
Accrued Investment Income Receivable	54	38
Liabilities
Interest Sensitive Contract Liabilities	12,948	14,150
Future Policy Benefits	1,853	1,610
Other Liabilities	936	112
Equity
Accumulated other comprehensive income (loss)	33	59
Series A Preferred Stock [Member]
Equity
Preferred Stock, Value, Outstanding	0	0
Series B Preferred Stock [Member]
Equity
Preferred Stock, Value, Outstanding	0	0
Series C Preferred Stock [Member]
Equity
Preferred Stock, Value, Outstanding	0	0
Series D Preferred Stock
Equity
Preferred Stock, Value, Outstanding	0	0
Class A
Equity
Common Stock, Value, Issued	$ 0	$ 0

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale, Allowance for Credit Loss	$ 123	$ 104
Debt Securities, Available-for-sale, Amortized Cost	106,859	82,544
Mortgage Loans on Real Estate, Commercial and Consumer, Net	24,148	15,938
Financing Receivable, Allowance for Credit Loss	237	253
Investment funds	9,866	6,087
Cash and Cash Equivalents, at Carrying Value	9,633	7,704
Accrued Investment Income Receivable	968	905
Reinsurance recoverable	4,594	4,848
Other Assets	1,283	1,249
Interest Sensitive Contract Liabilities	156,325	144,566
Future Policy Benefits	42,488	29,258
Other Policyholder Funds	138	130
Funds withheld liability	439	452
Other Liabilities	2,997	2,040
Accumulated other comprehensive income (loss)	$ 2,430	$ 3,971
Series A Preferred Stock [Member]
Preferred Stock, Shares Issued	34,500	0
Preferred Stock, Shares Authorized	34,500	0
Preferred Stock, Shares Outstanding	34,500	0
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Liquidation Preference, Value	$ 863	$ 863
Series B Preferred Stock [Member]
Preferred Stock, Shares Issued	13,800	0
Preferred Stock, Shares Authorized	13,800	0
Preferred Stock, Shares Outstanding	13,800	0
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Liquidation Preference, Value	$ 345	$ 345
Series C Preferred Stock [Member]
Preferred Stock, Shares Issued	24,000	0
Preferred Stock, Shares Authorized	24,000	0
Preferred Stock, Shares Outstanding	24,000	0
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Liquidation Preference, Value	$ 600	$ 600
Series D Preferred Stock
Preferred Stock, Shares Issued	23,000	0
Preferred Stock, Shares Authorized	23,000	0
Preferred Stock, Shares Outstanding	23,000	0
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Liquidation Preference, Value	$ 575	$ 575
Class A
Common stock outstanding (in shares)	192,200,000	191,500,000
Common stock issued (in shares)	192,200,000	191,500,000
Common stock, par value (in USD per share)	$ 0.001	$ 0.001
Common stock authorized (in shares)	425,000,000	425,000,000
Class B
Common stock outstanding (in shares)	0	0
Class M-1
Common stock outstanding (in shares)	0	0
Class M-2
Common stock outstanding (in shares)	0	0
Class M-3
Common stock outstanding (in shares)	0	0
Class M-4
Common stock outstanding (in shares)	0	0
Fair Value
Interest Sensitive Contract Liabilities	$ 108,621	$ 98,945
Funds withheld liability	394	393
Fair Value | Recurring
Reinsurance recoverable	1,991	2,100
Interest Sensitive Contract Liabilities	16,142	14,181
Future Policy Benefits	2,262	2,376
Funds withheld liability	45	59
Variable Interest Entities
Cash and Cash Equivalents, at Carrying Value	154	0
Other Assets	26	1
Other Liabilities	461	134
Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss	123	103
Debt Securities, Available-for-sale, Amortized Cost	96,458	76,100
Trading securities	2,056	2,093
Equity Securities, FV-NI	1,170
Mortgage Loans on Real Estate, Commercial and Consumer, Net	22,557	15,264
Financing Receivable, Allowance for Credit Loss	232	232
Investment funds	1,407	803
Investment funds	412	161
Funds withheld at interest	43,907	48,612
Short-term investments, at fair value	139	222
Other investments	1,473	572
Other Investments, Allowance for Credit Loss	0	3
Consolidated Entity Excluding Affiliated Entity | Fair Value
Mortgage Loans on Real Estate, Commercial and Consumer, Net	23,059	15,811
Investment funds	995	642
Funds withheld at interest	43,125	46,668
Other investments	1,343	471
Consolidated Entity Excluding Affiliated Entity | Fair Value | Recurring
Equity securities	1,170	330
Trading securities	2,056	2,093
Mortgage Loans on Real Estate, Commercial and Consumer, Net	17	19
Investment funds	412	161
Funds withheld at interest	782	1,944
Short-term investments, at fair value	139	222
Other investments	130	105
Variable Interest Entity, Primary Beneficiary, Excluding Affiliated Entity
Mortgage Loans on Real Estate, Commercial and Consumer, Net	1,809	1,880
Investment funds	229	0
Variable Interest Entity, Primary Beneficiary, Affiliated Entity
Mortgage Loans on Real Estate, Commercial and Consumer, Net	231	0
Investment funds	1,068	0
Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	1
Debt Securities, Available-for-sale, Amortized Cost	10,401	6,444
Trading securities	1,781	1,529
Equity Securities, FV-NI	284	72
Mortgage Loans on Real Estate, Commercial and Consumer, Net	1,591	674
Financing Receivable, Allowance for Credit Loss	5	14
Investment funds	8,459	5,284
Investment funds	4,026	2,119
Funds withheld at interest	12,207	13,030
Other investments	222	469
Other Investments, Allowance for Credit Loss	0	4
Accrued Investment Income Receivable	54	38
Interest Sensitive Contract Liabilities	12,948	14,150
Future Policy Benefits	1,853	1,610
Other Liabilities	936	112
Accumulated other comprehensive income (loss)	33	59
Related Party | Fair Value
Mortgage Loans on Real Estate, Commercial and Consumer, Net	1,600	694
Investment funds	4,433	3,165
Funds withheld at interest	11,629	12,168
Other investments	223	499
Related Party | Fair Value | Recurring
Equity securities	284	72
Trading securities	1,781	1,529
Investment funds	4,026	2,119
Funds withheld at interest	$ 578	$ 862

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues [Abstract]
Net investment income	$ 7,177	$ 4,885	$ 4,596
Other Income	72	36	37
Revenues, Total	26,320	14,764	16,258
Premiums Earned, Net	14,262	5,963	6,382
Insurance Commissions and Fees	621	571	524
Gain (Loss) on Investments	4,188	3,309	4,719
Benefits, Losses and Expenses [Abstract]
Interest Sensitive Contract Benefits Expense	4,442	3,891	4,557
Deferred Sales Inducement Cost, Amortization Expense	198	66	74
Policyholder Benefits and Claims Incurred, Net	15,734	7,187	7,587
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Amortization	632	521	958
Policyholder Dividends, Expense	27	38	36
Other Cost and Expense, Operating	1,101	855	744
Benefits, Losses and Expenses, Total	22,134	12,558	13,956
Income before income taxes	4,186	2,206	2,302
Income tax expense	386	285	117
Net income	3,800	1,921	2,185
Less: Net income (loss) attributable to noncontrolling interests	(59)	380	13
Net income available to Athene Holding Ltd. shareholders	3,859	1,541	2,172
Less: Preferred stock dividends	141	95	36
Net Income (Loss) Available to Common Stockholders, Basic	(3,718)	(1,446)	(2,136)
Related Party
Revenues [Abstract]
Premiums Earned, Net	298	322	243
Insurance Commissions and Fees	43	51	54
Gain (Loss) on Investments	252	702	1,009
Benefits, Losses and Expenses [Abstract]
Interest Sensitive Contract Benefits Expense	392	295	511
Policyholder Benefits and Claims Incurred, Net	365	405	365
Other Cost and Expense, Operating	51	53	45
Class A
Benefits, Losses and Expenses [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic	$ (3,718)	$ (1,573)	$ (1,760)
Earnings (loss) per share
Basic (in USD per share)	$ 19.40	$ 8.51	$ 11.44
Diluted (in USD per share)	$ 18.71	$ 8.34	$ 11.41
Class B
Benefits, Losses and Expenses [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic		$ 98	$ (291)
Earnings (loss) per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 11.44
Class M-1
Benefits, Losses and Expenses [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic		$ 13	$ (38)
Earnings (loss) per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 11.44
Class M-2
Benefits, Losses and Expenses [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic		$ 3	$ (10)
Earnings (loss) per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 11.44
Class M-3
Benefits, Losses and Expenses [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic		$ 4	$ (11)
Earnings (loss) per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 11.44
Class M-4
Benefits, Losses and Expenses [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic		$ 9	$ (26)
Earnings (loss) per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 9.94

Consolidated Statements of In_2

Consolidated Statements of Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Premiums	$ 14,262	$ 5,963	$ 6,382
Product charges	621	571	524
Investment income	7,786	5,389	5,031
Investment expense	609	504	435
Gain (Loss) on Investments	4,188	3,309	4,719
Interest Sensitive Contract Benefits Expense	4,442	3,891	4,557
Future policy and other policy benefits	15,734	7,187	7,587
Net investment income	7,177	4,885	4,596
Policy and other operating expenses	1,101	855	744
Variable Interest Entities
Gain (Loss) on Investments	(27)	22	5
Net investment income	77	51	74
Related Party
Premiums	298	322	243
Product charges	43	51	54
Investment income	2,498	1,101	779
Investment expense	592	490	426
Gain (Loss) on Investments	252	702	1,009
Interest Sensitive Contract Benefits Expense	392	295	511
Future policy and other policy benefits	365	405	365
Policy and other operating expenses	$ 51	$ 53	$ 45

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 3,800	$ 1,921	$ 2,185
Other comprehensive income (loss), before tax
Unrealized investment gains (losses) on available-for-sale securities, net of offsets	(2,283)	2,358	3,438
Unrealized gains (losses) on hedging instruments	232	(106)	29
Foreign currency translation and other adjustments	(10)	18	1
Other comprehensive income (loss), before tax	(2,061)	2,270	3,468
Income tax expense (benefit) related to other comprehensive income (loss)	(371)	413	698
Other comprehensive loss	(1,690)	1,857	2,770
Comprehensive income	2,110	3,778	4,955
Less: Comprehensive income (loss) attributable to noncontrolling interests	(208)	541	(4)
Comprehensive income (loss) available to Athene Holding Ltd. shareholders	$ 2,318	$ 3,237	$ 4,959

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Retained earnings	Retained earningsCumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)	Accumulated other comprehensive income (loss)Cumulative Effect, Period of Adoption, Adjustment	Total Athene Holding Ltd. shareholders’ equity	Total Athene Holding Ltd. shareholders’ equityCumulative Effect, Period of Adoption, Adjustment	Noncontrolling interests	Noncontrolling interestsCumulative Effect, Period of Adoption, Adjustment	Preferred stock	Preferred stock	Preferred stockAdditional paid-in capital	Preferred stockTotal Athene Holding Ltd. shareholders’ equity	Common stock	Common stockAdditional paid-in capital	Common stockTotal Athene Holding Ltd. shareholders’ equity
Beginning Balance at Dec. 31, 2018	$ 8,276		$ 0	$ 3,462	$ 5,286		$ (472)		$ 8,276		$ 0		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,185				2,172				2,172		13
Other comprehensive loss	2,770						2,787		2,787		(17)
Issuance of common shares, net of expenses														$ 1,172	$ 1,172	$ 1,172	$ 3	$ 3	$ 3
Stock-based compensation	28			28					28
Retirement or repurchase of shares	(832)			(349)	(483)				(832)
Preferred stock dividends	(36)				(36)				(36)
Other changes in equity of noncontrolling interests	575			(145)			(34)		(179)		754
Ending Balance at Dec. 31, 2019	14,141	$ (125)	0	4,171	6,939	$ (117)	2,281	$ (6)	13,391	$ (123)	750	$ (2)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,921				1,541				1,541		380
Other comprehensive loss	1,857						1,696		1,696		161
Issuance of common shares, net of expenses														$ 1,140	$ 1,140	$ 1,140	1,510	1,510	1,510
Stock-based compensation	25			25					25
Retirement or repurchase of shares	(428)			(233)	(195)				(428)
Preferred stock dividends	(95)				(95)				(95)
Other changes in equity of noncontrolling interests	240										240
Ending Balance at Dec. 31, 2020	20,140		0	6,613	8,073		3,971		18,657		1,483		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(46)										(46)
Net income	3,800				3,859				3,859		(59)
Other comprehensive loss	(1,690)						(1,541)		(1,541)		(149)
Issuance of common shares, net of expenses																	$ 11	$ 11	$ 11
Stock-based compensation	43			43					43
Retirement or repurchase of shares	(8)			0	(8)				(8)
Preferred stock dividends	(141)				(141)				(141)
Dividends, Common Stock, Cash	(750)				(750)				(750)
Other changes in equity of noncontrolling interests	758			0			0		0		758
Ending Balance at Dec. 31, 2021	22,181		$ 0	$ 6,667	$ 11,033		$ 2,430		$ 20,130		2,051		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders											0
Subsidiary issuance of equity interests	$ 18										$ 18

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net income		$ 3,800	$ 1,921	$ 2,185
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Amortization		632	521	958
Deferred Sales Inducement Cost, Amortization Expense		198	66	74
Net accretion of net investment premiums, discounts and other		(192)	(203)	(94)
Net investments (income) loss		(1,493)	(395)	(167)
Net recognized (gains) losses on investments and derivatives		(3,632)	(687)	(2,484)
Deferred Policy Acquisition Cost, Capitalization		(698)	(633)	(645)
Increase (Decrease) in Operating Capital [Abstract]
Increase (Decrease) in Accrued Investment Income Receivable		(63)	(130)	(128)
Increase (Decrease) in Interest Sensitive Contract Liabilities		3,357	3,347	4,003
Increase (Decrease) in Insurance Liabilities		8,742	3,246	1,171
Increase (Decrease) in Funds Held under Reinsurance Agreements		(646)	(2,241)	(2,582)
Increase (Decrease) in Other Operating Assets and Liabilities, Net		287	65	365
Net cash provided by operating activities		10,292	4,154	2,656
Proceeds from Sale, Maturity and Collection of Investments [Abstract]
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale		28,620	11,384	12,762
Proceeds from Sale and Maturity of Debt and Equity Securities, FV-NI, Held-for-investment		201	170	309
Proceeds from Sale and Collection of Mortgage Notes Receivable		2,900	2,162	2,070
Proceeds from Investment Funds		1,823	788	429
Proceeds from Derivative Instrument, Investing Activities		5,185	2,505	1,503
Proceeds from Sale, Maturity and Collection of Short-term Investments		3,125	883	398
Payments to Acquire Investments [Abstract]
Payments to Acquire Debt Securities, Available-for-sale		(47,181)	(23,404)	(17,237)
Payments to Acquire Trading Securities Held-for-investment		(489)	(341)	(495)
Payments to Acquire Mortgage Notes Receivable		(11,131)	(4,091)	(6,391)
Payments to Acquire Investment Funds		(3,807)	(1,536)	(1,012)
Payments for Derivative Instrument, Investing Activities		(3,636)	(1,879)	(1,299)
Payments to Acquire Short-term Investments		(3,045)	(617)	(802)
Payments for (Proceeds from) Other Investing Activities		225	(299)	(45)
Net cash provided by (used in) investing activities		(27,932)	(14,817)	(9,956)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Proceeds from Short-term Debt		0	0	475
Repayments of Notes Payable		0	(75)	0
Proceeds from Issuance of Long-term Debt		997	992	0
Proceeds from Annuities and Investment Certificates		21,447	18,836	11,569
Repayments of Annuities and Investment Certificates		(7,042)	(7,067)	(6,548)
Payments for coinsurance agreements on investment-type contracts, net		(9)	(27)	(44)
Payments for (Proceeds from) Derivative Instrument, Financing Activities		3,243	546	2,286
Proceeds from Issuance of Preferred Stock and Preference Stock		0	1,140	1,172
Payments of Ordinary Dividends, Preferred Stock and Preference Stock		(141)	(95)	(36)
Payments for Repurchase of Common Stock		8	428	832
Proceeds from Noncontrolling Interests		758	240	575
Proceeds from (Payments for) Other Financing Activities		373	122	(80)
Net cash provided by financing activities		19,629	14,489	8,537
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents		(2)	(26)	0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total		1,987	3,800	1,237
Cash and cash equivalents at beginning of year	[1]	8,442	4,642	3,405
Cash and cash equivalents at end of year	[1]	10,429	8,442	4,642
Supplementary information
Income Taxes Paid, Net		192	168	36
Cash paid for interest		125	99	49
Noncash Investing and Financing Items [Abstract]
Reinsurance Agreements, Deposits on Investment Policies and Contracts		2,103	30,172	782
Reinsurance Agreements, Withdrawals on Investment Policies and Contracts		8,098	5,010	3,393
Assets contributed to consolidated VIEs		169	0	0
Ceding commission on reinsurance agreements settled in investments		0	723	0
Proceeds from sale of equity securities		209	820	305
Payments to acquire equity securities		(931)	(1,362)	(451)
Proceeds from Issuance of Common Stock		11	351	0
Payments to Noncontrolling Interests		0	(46)	0
Federal Home Loan Bank of Des Moines | Federal Home Loan Bank, Advances, Convertible Option
Noncash Investing and Financing Items [Abstract]
Increase (Decrease) in Loans from Federal Home Loan Banks		0	400	0
Related Party
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Net investments (income) loss		(1,380)	(363)	(171)
Net recognized (gains) losses on investments and derivatives		(180)	(27)	(16)
Increase (Decrease) in Operating Capital [Abstract]
Increase (Decrease) in Accrued Investment Income Receivable		(16)	(13)	(2)
Increase (Decrease) in Interest Sensitive Contract Liabilities		398	276	471
Increase (Decrease) in Insurance Liabilities		246	291	295
Increase (Decrease) in Funds Held under Reinsurance Agreements		(419)	(902)	(1,317)
Proceeds from Sale, Maturity and Collection of Investments [Abstract]
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale		2,040	282	252
Proceeds from Sale and Maturity of Debt and Equity Securities, FV-NI, Held-for-investment		76	31	74
Proceeds from Sale and Collection of Mortgage Notes Receivable		16	12	4
Proceeds from Investment Funds		1,433	691	296
Proceeds from Derivative Instrument, Investing Activities		330	0	0
Proceeds from Sale, Maturity and Collection of Short-term Investments		2,732	28	0
Payments to Acquire Investments [Abstract]
Payments to Acquire Debt Securities, Available-for-sale		(6,057)	(3,127)	(2,897)
Payments to Acquire Trading Securities Held-for-investment		(267)	(278)	(6)
Payments to Acquire Mortgage Notes Receivable		(918)	(61)	(366)
Payments to Acquire Investment Funds		(3,140)	(1,372)	(838)
Payments for Derivative Instrument, Investing Activities		(75)	0	(100)
Payments to Acquire Short-term Investments		(2,734)	(28)	0
Net Cash Provided by (Used in) Financing Activities [Abstract]
Proceeds from Annuities and Investment Certificates		82	86	146
Repayments of Annuities and Investment Certificates		(420)	(382)	(455)
Noncash Investing and Financing Items [Abstract]
Reinsurance Agreements, Deposits on Investment Policies and Contracts		330	344	217
Reinsurance Agreements, Withdrawals on Investment Policies and Contracts		1,532	1,435	1,753
Transfer from Investments		139	0	0
Proceeds from sale of equity securities		12	5	123
Payments to acquire equity securities		(216)	(19)	(262)
Reinsurance Settlements [Member]
Noncash Investing and Financing Items [Abstract]
Transfer to Investments		124	53	56
Reinsurance Settlements [Member] | Related Party
Noncash Investing and Financing Items [Abstract]
Transfer to Investments		41	0	149
Pension Risk Transfer Premiums [Member]
Noncash Investing and Financing Items [Abstract]
Transfer to Investments		4,971	2,364	5,235
Investment funds | Related Party
Noncash Investing and Financing Items [Abstract]
Transfer to Investments		0	1,147	0
Reinsurance agreement | Related Party
Noncash Investing and Financing Items [Abstract]
Transfer from Investments		0	0	320
Reinsurance Recapture
Noncash Investing and Financing Items [Abstract]
Transfer from Investments		0	4,298	0
Investment funds | Trading securities | Related Party
Noncash Investing and Financing Items [Abstract]
Transfer to Investments		$ 0	$ 516	$ 0
[1]	1 Includes cash and cash equivalents and restricted cash.

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net investments (income) loss	$ (1,493)	$ (395)	$ (167)
Net recognized (gains) losses on investments and derivatives	(3,632)	(687)	(2,484)
Increase (Decrease) in Accrued Investment Income Receivable	(63)	(130)	(128)
Interest sensitive contract liabilities	3,357	3,347	4,003
Increase (Decrease) in Insurance Liabilities	8,742	3,246	1,171
Increase (Decrease) in Funds Held under Reinsurance Agreements	(646)	(2,241)	(2,582)
Proceeds from Sale, Maturity and Collection of Investments [Abstract]
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	28,620	11,384	12,762
Trading securities	201	170	309
Proceeds from sale of equity securities	209	820	305
Proceeds from Sale and Collection of Mortgage Notes Receivable	2,900	2,162	2,070
Investment funds	1,823	788	429
Proceeds from Derivative Instrument, Investing Activities	5,185	2,505	1,503
Short-term investments	3,125	883	398
Payments to Acquire Investments [Abstract]
Payments to Acquire Debt Securities, Available-for-sale	(47,181)	(23,404)	(17,237)
Payments to Acquire Mortgage Notes Receivable	(11,131)	(4,091)	(6,391)
Trading securities	(489)	(341)	(495)
Payments to acquire equity securities	(931)	(1,362)	(451)
Investment funds	(3,807)	(1,536)	(1,012)
Payments for Derivative Instrument, Investing Activities	(3,636)	(1,879)	(1,299)
Short-term investments	(3,045)	(617)	(802)
Proceeds from Annuities and Investment Certificates	21,447	18,836	11,569
Repayments of Annuities and Investment Certificates	(7,042)	(7,067)	(6,548)
Reinsurance Agreements, Deposits on Investment Policies and Contracts	2,103	30,172	782
Reinsurance Agreements, Withdrawals on Investment Policies and Contracts	8,098	5,010	3,393
Related Party
Net investments (income) loss	(1,380)	(363)	(171)
Net recognized (gains) losses on investments and derivatives	(180)	(27)	(16)
Increase (Decrease) in Accrued Investment Income Receivable	(16)	(13)	(2)
Interest sensitive contract liabilities	398	276	471
Increase (Decrease) in Insurance Liabilities	246	291	295
Increase (Decrease) in Funds Held under Reinsurance Agreements	(419)	(902)	(1,317)
Proceeds from Sale, Maturity and Collection of Investments [Abstract]
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	2,040	282	252
Trading securities	76	31	74
Proceeds from sale of equity securities	12	5	123
Proceeds from Sale and Collection of Mortgage Notes Receivable	16	12	4
Investment funds	1,433	691	296
Proceeds from Derivative Instrument, Investing Activities	330	0	0
Short-term investments	2,732	28	0
Payments to Acquire Investments [Abstract]
Payments to Acquire Debt Securities, Available-for-sale	(6,057)	(3,127)	(2,897)
Payments to Acquire Mortgage Notes Receivable	(918)	(61)	(366)
Trading securities	(267)	(278)	(6)
Payments to acquire equity securities	(216)	(19)	(262)
Investment funds	(3,140)	(1,372)	(838)
Payments for Derivative Instrument, Investing Activities	(75)	0	(100)
Short-term investments	(2,734)	(28)	0
Transfer from Investments	139	0	0
Proceeds from Annuities and Investment Certificates	82	86	146
Repayments of Annuities and Investment Certificates	(420)	(382)	(455)
Reinsurance Agreements, Deposits on Investment Policies and Contracts	330	344	217
Reinsurance Agreements, Withdrawals on Investment Policies and Contracts	$ 1,532	$ 1,435	$ 1,753

Business, Basis of Presentation

Business, Basis of Presentation, and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Business, Basis of Presentation, and Significant Accounting Policies	1. Business, Basis of Presentation and Significant Accounting Policies Athene Holding Ltd. (AHL), a Bermuda exempted company, together with its subsidiaries (collectively, Athene, we, our, us, or the Company), is a leading financial services company specializing in retirement services that issues, reinsures and acquires retirement savings products in the United States (US) and internationally. We conduct business primarily through the following consolidated subsidiaries: • Our non-US reinsurance subsidiaries, to which AHL’s other insurance subsidiaries and third-party ceding companies directly and indirectly reinsure a portion of their liabilities, including Athene Life Re Ltd. (ALRe), a Bermuda exempted company, and Athene Life Re International Ltd. (ALReI); and • Athene USA Corporation, an Iowa corporation (together with its subsidiaries, AUSA). Consolidation and Basis of Presentation —Our consolidated financial statements include our wholly owned subsidiaries and investees in which we hold a controlling financial interest, including variable interest entities (VIEs). Investees in which we do not hold a controlling financial interest, but have the ability to exercise significant influence over operating and financing decisions, other than investments for which we have elected the fair value option, are accounted for under the equity method. Intercompany balances and transactions have been eliminated. For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the consolidated financial statements. We report investments in related parties separately, as further described in the accounting policies that follow. We have prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP), which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period. Actual experience could materially differ from these estimates and assumptions. Our principal estimates impact: • fair value of investments; • impairment of investments and allowances for expected credit losses; • derivatives valuation, including embedded derivatives; • deferred acquisition costs (DAC), deferred sales inducements (DSI) and value of business acquired (VOBA); • future policy benefit reserves; and • valuation allowances on deferred tax assets. Additional details around these principal estimates and assumptions are discussed in the significant accounting policies that follow and the related footnote disclosures. Merger —On March 8, 2021, we entered into an Agreement and Plan of Merger (Merger Agreement), by and among the Company, Apollo Global Management, Inc., a Delaware corporation (AGM, and together with its subsidiaries other than us or our subsidiaries, Apollo), Tango Holdings, Inc., a Delaware corporation and a direct wholly owned subsidiary of AGM (HoldCo), Blue Merger Sub, Ltd., a Bermuda exempted company and a direct wholly owned subsidiary of HoldCo (AHL Merger Sub), and Green Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of HoldCo (AGM Merger Sub). The Company and AGM agreed, subject to the terms and conditions of the Merger Agreement, to effect an all-stock merger transaction to combine our respective businesses by: (1) AGM merging with AGM Merger Sub, with AGM surviving such merger as a direct wholly owned subsidiary of HoldCo (AGM Merger), (2) the Company merging with AHL Merger Sub, with the Company surviving such merger as a direct wholly owned subsidiary of HoldCo (AHL Merger and, together with the AGM Merger, Mergers), and (3) as of the effective time of the Mergers, changing the name of HoldCo to be Apollo Global Management, Inc. On January 1, 2022, the Mergers were completed. The total preliminary purchase price for the transaction was approximately $12.2 billion, subject to completion of the purchase accounting analysis. The preliminary purchase price was calculated based on AGM’s December 31, 2021 closing share price multiplied by the AGM common shares issued in the exchange, as well as the fair value of stock-based compensation awards acquired, fair value of warrants converted to AGM common shares and other equity consideration. At the closing of the Mergers, we became a direct wholly owned subsidiary of AGM. Each issued and outstanding AHL Class A common share (other than AHL Class A common shares held by AHL Merger Sub, the Apollo Operating Group (AOG) or the respective direct or indirect wholly owned subsidiaries of Athene or the AOG) was converted automatically into 1.149 shares of AGM common shares and any cash paid in lieu of fractional AGM common shares. In connection with the Mergers, AGM issued to AHL Class A common shareholders 158.2 million AGM common shares in exchange for 137.6 million AHL Class A common shares that were issued and outstanding as of the acquisition date, exclusive of the 54.6 million shares previously held by AGM immediately before the acquisition date. Summary of Significant Accounting Policies Investments Fixed Maturity Securities – Fixed maturity securities includes bonds, collateralized loan obligations (CLO), asset-backed securities (ABS), residential mortgage-backed securities (RMBS), commercial mortgage-backed securities (CMBS) and redeemable preferred stock. We classify fixed maturity securities as available-for-sale (AFS) or trading at the time of purchase and subsequently carry them at fair value. Fair value hierarchy and valuation methodologies are discussed in Note 5 – Fair Value . Classification is dependent on a variety of factors including our expected holding period, election of the fair value option and asset and liability matching. AFS Securities – AFS securities are held at fair value on the consolidated balance sheets with unrealized gains and losses, net of allowances for expected credit losses, tax and adjustments to DAC, DSI, VOBA and future policy benefits, if applicable, generally reflected in accumulated other comprehensive income (loss) (AOCI) on the consolidated balance sheets. Unrealized gains or losses relating to identified risks within AFS securities in fair value hedging relationships are reflected in investment related gains (losses) on the consolidated statements of income. Trading Securities – We elected the fair value option for certain fixed maturity securities. These fixed maturity securities are classified as trading, with changes to fair value included in investment related gains (losses) on the consolidated statements of income. Although the securities are classified as trading, the trading activity related to these investments is primarily focused on asset and liability matching activities and is not intended to be an income strategy based on active trading. As such, the activity related to these investments on the consolidated statements of cash flows is classified as investing activities. We generally record security transactions on a trade date basis, with any unsettled trades recorded in other assets or other liabilities on the consolidated balance sheets. Bank loans, private placements and investment funds are recorded on settlement date basis. Equity Securities – Equity securities includes common stock, mutual funds and non-redeemable preferred stock. Equity securities with readily determinable fair values are carried at fair value with subsequent changes in fair value recognized in net income. We have elected to account for certain equity securities without readily determinable fair values that do not qualify for the practical expedient to estimate fair values based on net asset value (NAV) per share (or its equivalent) at cost less impairment, subject to adjustments based on observable price changes in orderly transactions for identical or similar investments of the same issuer. Purchased Credit Deteriorated (PCD) Investments – We purchase certain structured securities, primarily RMBS, and re-performing mortgage loans having experienced a more-than-insignificant deterioration in credit quality since their origination which upon our assessment have been determined to meet the definition of PCD investments. Additionally, structured securities classified as beneficial interests follow the initial measurement guidance for PCD investments if there is a significant difference between contractual cash flows adjusted for expected prepayments and expected cash flows at the date of recognition. The initial allowance for credit losses for PCD investments is recorded through a gross-up adjustment to the initial amortized cost. For mortgage loans, the initial allowance is determined using the methodology described in the Credit Losses – Assets Held at Amortized Cost and Off-Balance Sheet Credit Exposures section. For structured securities classified as beneficial interests, the initial allowance is calculated as the present value of the difference between contractual cash flows adjusted for expected prepayments and expected cash flows at the date of recognition. The non-credit purchase discount or premium is amortized into investment income using the effective interest method. The credit discount, represented by the allowance for expected credit losses, is remeasured each period following the policies for measuring credit losses described in the Credit Losses – Assets Held at Amortized Cost and Off-Balance Sheet Credit Exposures and Credit Losses – Available-for-Sale Securities sections below. Purchased Credit Impaired (PCI) Investments – Prior to January 1, 2020, certain securities purchased with deterioration in credit quality since their issuance were accounted for as PCI investments. The difference between the undiscounted expected future cash flows of the PCI investment and the recorded investment represented the initial accretable yield, which was accreted into investment income, net of related expenses, over its remaining life on a level-yield basis. The difference between the contractually required payments on the PCI investment and the undiscounted expected future cash flows represented the non-accretable difference at acquisition. Over time, based on actual payments received and changes in estimates of undiscounted expected future cash flows, the accretable yield and the non-accretable difference could change. PCI investments are presented on the consolidated financial statements consistent with AFS securities or mortgage loans depending on the underlying investment. Quarterly, we evaluated the undiscounted expected future cash flows associated with PCI investments based on updates to key assumptions. Mortgage Loans – Mortgage loans are primarily stated at unpaid principal balance, adjusted for any unamortized premium or discount, and net of allowances for expected credit losses. Interest income is accrued on the principal amount of the loan based on its contractual interest rate. We record amortization of premiums and discounts using the effective yield method and contractual cash flows on the underlying loan. We accrue interest on loans until it is probable we will not receive interest or the loan is 90 days past due. Interest income, amortization of premiums and discounts, and prepayment fees are reported in net investment income on the consolidated statements of income. We have also elected the fair value option on a portion of our mortgage loans. Investment Funds – We invest in certain non-fixed income, alternative investments in the form of limited partnerships or similar legal structures (investment funds). For investment funds in which we do not hold a controlling financial interest, and therefore are not required to consolidate, we typically account for these investments using the equity method, where the cost is recorded as an investment in the fund, or we have elected the fair value option. Adjustments to the carrying amount reflect our pro rata ownership percentage of the operating results as indicated by NAV in the investment fund financial statements, which can be on a lag of up to three months when investee information is not received in a timely manner. We record our proportionate share of investment fund income within net investment income on the consolidated statements of income. Contributions paid or distributions received by us are recorded directly to the investment fund balance as an increase to carrying value or as a return of capital, respectively. Policy Loans – Policy loans are funds provided to policyholders in return for a claim on the policyholder’s account balance. The funds provided are limited to a specified percentage of the account balance. The majority of policy loans do not have a stated maturity and the balances and accrued interest are repaid with proceeds from the policyholder’s account balance. Policy loans are reported at the unpaid principal balance. Interest income is recorded as earned using the contract interest rate and is reported in net investment income on the consolidated statements of income. Funds Withheld at Interest – Funds withheld at interest represents a receivable for amounts contractually withheld by ceding companies in accordance with funds withheld coinsurance (funds withheld) and modified coinsurance (modco) reinsurance agreements in which we are the reinsurer. Generally, assets equal to statutory reserves are withheld and legally owned by the ceding company, and any excess or shortfall is settled periodically. The underlying agreements contain embedded derivatives as discussed below. Short-term Investments – Short-term investments consists of financial instruments with maturities of greater than three months but less than twelve months when purchased. Short-term debt securities are accounted for as trading or AFS consistent with our policies for those investments. Short-term loans are carried at amortized cost. Fair values are determined consistent with methodologies described in Note 5 – Fair Value for the respective investment type. Other Investments – Other investments includes, but is not limited to, term loans collateralized by mortgages on residential and commercial real estate. Mortgage collateralized term loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and net of allowances for expected credit losses. Interest income is accrued on the principal amount of the loan based on its contractual interest rate. We record amortization of premiums and discounts using the effective interest method and contractual cash flows on the underlying loan. We accrue interest on loans until it is probable we will not receive interest or the loan is 90 days past due. Interest income, amortization of premiums and discounts, and prepayment and other fees are reported in net investment income on the consolidated statements of income. Securities Repurchase and Reverse Repurchase Agreements – Securities repurchase and reverse repurchase transactions involve the temporary exchange of securities for cash or other collateral of equivalent value, with agreement to redeliver a like quantity of the same or similar securities at a future date and at a fixed and determinable price. We evaluate transfers of securities under these agreements to repurchase or resell to determine whether they satisfy the criteria for accounting treatment as secured borrowing or lending arrangements. Agreements not meeting the criteria would require recognition of the transferred securities as sales or purchases, with related forward repurchase or resale commitments. All of our securities repurchase transactions are accounted for as secured borrowings and are included in payables for collateral on derivatives and securities to repurchase on the consolidated balance sheets. Earnings from investing activities related to the cash received under our securities repurchase arrangements are included in net investment income on the consolidated statements of income. The associated borrowing cost is included in policy and other operating expenses on the consolidated statements of income. The investments purchased in reverse repurchase agreements, which represent collateral on a secured lending arrangement, are not reflected in our consolidated balance sheets; however, the secured lending arrangement is recorded as a short-term investment for the principal amount loaned under the agreement. Investment Income – We recognize investment income as it accrues or is legally due, net of investment management and custody fees. Investment income on fixed maturity securities includes coupon interest, as well as the amortization of any premium and the accretion of any discount. Investment income on equity securities represents dividend income and preferred coupons interest. Realized gains and losses on sales of investments are included in investment related gains (losses) on the consolidated statements of income. Realized gains and losses on investments sold are determined based on a first-in first-out method. Credit Losses – Assets Held at Amortized Cost and Off-Balance Sheet Credit Exposures – We establish an allowance for expected credit losses at the time of purchase for assets held at amortized cost, which primarily includes our residential and commercial mortgage loan portfolios, but also includes certain other loans and reinsurance assets. The allowance for expected credit losses represents the portion of the asset's amortized cost basis that we do not expect to collect due to credit losses over the asset's contractual life, considering past events, current conditions, and reasonable and supportable forecasts of future economic conditions or macroeconomic forecasts. We use a quantitative probability of default and loss given default methodology to develop our estimate of expected credit loss. We develop the estimate on a collective basis factoring in the risk characteristics of the assets in the portfolio. If an asset does not share similar risk characteristics with other assets, the asset is individually assessed. Allowance estimates are highly dependent on expectations of future economic conditions and macroeconomic forecasts, which involve significant judgment and subjectivity. We use quantitative modeling to develop the allowance for expected credit losses. Key inputs into the model include data pertaining to the characteristics of the assets, historical losses and current market conditions. Additionally, the model incorporates management’s expectations around future economic conditions and macroeconomic forecasts over a reasonable and supportable forecast period, after which the model reverts to historical averages. These inputs, the reasonable and supportable forecast period, and reversion to historical average technique are subject to a formal governance and review process by management. Additionally, management considers qualitative adjustments to the model output to the extent that any relevant information regarding the collectability of the asset is available and not already considered in the quantitative model. If we determine that a financial asset has become collateral dependent, which we determine to be the point at which foreclosure is probable, the allowance is measured as the difference between amortized cost and the fair value of the collateral, less any expected costs to sell. The initial allowance for invested assets held at amortized cost other than for PCD investments, and subsequent changes in the allowance including PCD investments, are recorded through a charge to credit loss expense within investment related gains (losses) on the consolidated statements of income. Credit loss expense for reinsurance assets held at amortized cost is recorded through policy and other operating expenses on the consolidated statements of income. We limit accrued interest income on loans to 90 days of interest. Once a loan becomes 90 days past due, the loan is put on non-accrual status and any accrued interest is written off. Once a loan is on non-accrual status, we first apply any payments received to the principal of the loan, and once the principal is repaid, we include amounts received in net investment income. We have elected to present accrued interest receivable separately in accrued investment income on the consolidated balance sheets. We have also elected the practical expedient to exclude the accrued interest receivable from the amortized cost balance used to calculate the allowance given our policy to write off such balances in a timely manner. Any write-off of accrued interest is recorded through a reversal of net investment income on the consolidated statements of income. Upon determining that all or a portion of the amortized cost of an asset is uncollectible, which is generally when all efforts for collection are exhausted, the amortized cost is written off against the existing allowance. Any write off in excess of the existing allowance is recorded through credit loss expense within investment related gains (losses) on the consolidated statements of income. We also have certain off-balance sheet credit exposures for which we establish a liability for expected credit losses. These exposures primarily relate to commitments to fund commercial or residential mortgage loans that are not unconditionally cancellable. The methodology for estimating the liability for these credit exposures is consistent with that described above, with the additional consideration pertaining to the probability of funding. At the time the commitment expires or is funded, the liability is reversed and an allowance for expected credit losses is established, as applicable. The liability for off-balance sheet credit exposures is included in other liabilities on the consolidated balance sheets. The establishment of the initial liability and all subsequent changes are recorded through credit loss expense within investment related gains (losses) on the consolidated statements of income. Credit Losses – Available-for-Sale Securities – We evaluate AFS securities with a fair value that has declined below amortized cost to determine how the decline in fair value should be recognized. If we determine, based on the facts and circumstances related to the specific security, that we intend to sell a security or it is more likely than not that we would be required to sell a security before the recovery of its amortized cost, any existing allowance for expected credit losses is reversed and the amortized cost of the security is written down to fair value. If neither of these conditions exist, we evaluate whether the decline in fair value has resulted from a credit loss or other factors. For non-structured AFS securities, we qualitatively consider relevant facts and circumstances in evaluating whether a decline below fair value is credit - related. Relevant facts and circumstances include but are not limited to: (1) the extent to which the fair value is less than amortized cost; (2) changes in agency credit ratings, (3) adverse conditions related to the security’s industry or geographical area, (4) failure to make scheduled payments, and (5) other known changes in the financial condition of the issuer or quality of any underlying collateral or credit enhancements. For structured AFS securities meeting the definition of beneficial interests, the qualitative assessment is bypassed, and any securities having experienced a decline in fair value below amortized cost move directly to a quantitative analysis. If upon completion of this analysis it is determined that a potential credit loss exists, an allowance for expected credit losses is established equal to the amount by which the present value of expected cash flows is less than amortized cost, limited by the amount by which fair value is less than amortized cost. A non-structured security’s cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using security-specific facts and circumstances including timing, security interests and loss severity. A structured security’s cash flow estimates are based on security-specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayments and structural support, including subordination and guarantees. The expected cash flows are discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete a structured security. For securities with a contractual interest rate that varies based on changes in an independent factor, such as an index or rate, the effective interest rate is calculated based on the factor as it changes over the life of the security. Inherently under the discounted cash flow model, both the timing and amount of expected cash flows affect the measurement of the allowance for expected credit losses. The allowance for expected credit losses is remeasured each period for the passage of time, any change in expected cash flows, and changes in the fair value of the security. All impairments, whether intent or requirement to sell or credit-related, are recorded through a charge to credit loss expense within investment related gains (losses) on the consolidated statements of income. All changes in the allowance for expected credit losses are recorded through credit loss expense within investment related gains (losses) on the consolidated statements of income. We have elected to present accrued interest receivable separately in accrued investment income on the consolidated balance sheets. We have also elected the practical expedient to exclude the accrued interest receivable from the amortized cost balance used to calculate the allowance for expected credit losses, as we have a policy to write off such balances in a timely manner, when they become 90 days past due. Any write-off of accrued interest is recorded through a reversal of net investment income on the consolidated statements of income. Upon determining that all or a portion of the amortized cost of an asset is uncollectible, which is generally when all efforts for collection are exhausted, the amortized cost is written off against the existing allowance. Any write off in excess of the existing allowance is recorded through credit loss expense within investment related gains (losses) on the consolidated statements of income. Derivative Instruments —We invest in derivatives to hedge the risks experienced in our ongoing operations, such as equity, interest rate and cash flow risks, or for other risk management purposes, which primarily involve managing liability risks associated with our indexed annuity products and reinsurance agreements. Derivatives are financial instruments with values that are derived from interest rates, foreign exchange rates, financial indices or other combinations of an underlying and notional. Derivative assets and liabilities are carried at fair value on the consolidated balance sheets. We elect to present any derivatives subject to master netting provisions as a gross asset or liability and gross of collateral. Disclosures regarding balance sheet presentation of derivatives subject to master netting agreements are discussed in Note 3 – Derivative Instruments . We may designate derivatives as cash flow, fair value or net investment hedges. Hedge Documentation and Hedge Effectiveness – To qualify for hedge accounting, at the inception of the hedging relationship, we formally document our designation of the hedge as a cash flow, fair value or net investment hedge and our risk management objective and strategy for undertaking the hedging transaction. In this documentation, we identify how the hedging instrument is expected to hedge the designated risks related to the hedged item and the method that will be used to retrospectively and prospectively assess the hedge effectiveness and the method which will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and periodically throughout the life of the hedge accounting relationship. For a cash flow hedge, all changes in the fair value of the hedging derivative are reported within AOCI and the related gains or losses on the derivative are reclassified into the consolidated statements of income when the cash flows of the hedged item affect earnings. For a fair value hedge, changes in the fair value of the hedging derivative and changes in the fair value of the hedged item related to the designated risk being hedged are reported on the consolidated statements of income according to the nature of the risk being hedged. Additionally, changes in the fair value of amounts excluded from the assessment of effectiveness are recorded in AOCI and amortized into income over the life of the hedge accounting relationship. For a net investment hedge, changes in the fair value of the hedging derivative are reported within AOCI to offset the translation adjustments for subsidiaries with functional currencies other than US dollar. We discontinue hedge accounting prospectively when: (1) we determine the derivative is no longer highly effective in offsetting changes in the estimated cash flows or fair value of a hedged item; (2) the derivative expires, is sold, terminated, or exercised; or (3) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued, the derivative continues to be carried on the consolidated balance sheets at fair value, with changes in fair value recognized in investment related gains (losses) on the consolidated statements of income. For a derivative not designated as a hedge, changes in the derivative’s fair value and any income received or paid on derivatives at the settlement date are included in investment related gains (losses) on the consolidated statements of income. Embedded Derivatives – We issue and reinsure products, primarily fixed indexed annuity products, or purchase investments that contain embedded derivatives. If we determine the embedded derivative has economic characteristics not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract and accounted for separately, unless the fair value option is elected on the host contract. Under the fair value option, bifurcation of the embedded derivative is not necessary as the entire contract is carried at fair value with all related gains and losses recognized in investment related gains (losses) on the consolidated statements of income. Embedded derivatives are carried on the consolidated balance sheets at fair value in the same line item as the host contract. Fixed indexed annuity, index-linked variable annuity and indexed universal life insurance contracts allow the policyholder to elect a fixed interest rate return or an equity market component for which interest credited is based on the performance of certain stock market indices. The equity market option is an embedded derivative. The benefit reserve is equal to the sum of the fair value of the embedded derivative and the host (or guaranteed) component of the contracts. The fair value of the embedded derivatives is computed as the present value of benefits attributable to the excess of the projected policy contract values over the projected minimum guaranteed contract values. The projections of policy contract values are based on assumptions for future policy growth, which include assumptions for expected index credits on the next policy anniversary date, future equity option costs, volatility, interest rates and policyholder behavior assumptions including lapses and the use of benefit riders. The projections of minimum guaranteed contract values include the same assumptions for policyholder behavior as were used to project policy contract values. The embedded derivative cash flows are discounted using a rate that reflects our own credit rating. The host contract is established at contract inception as the initial account value less the initial fair value of the embedded derivative and accreted over the policy’s life. The host contract accretion rate

Investments

Investments	12 Months Ended
	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Investments	2. Investments AFS Securities — The following table represents the amortized cost, allowance for credit losses, gross unrealized gains and losses and fair value of our AFS investments by asset type: December 31, 2021 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 231 $ — $ 2 $ (10) $ 223 US state, municipal and political subdivisions 1,081 — 134 (2) 1,213 Foreign governments 1,110 — 35 (17) 1,128 Corporate 62,817 — 4,060 (651) 66,226 CLO 13,793 — 44 (185) 13,652 ABS 8,890 (17) 151 (35) 8,989 CMBS 2,764 (3) 56 (59) 2,758 RMBS 5,772 (103) 326 (25) 5,970 Total AFS securities 96,458 (123) 4,808 (984) 100,159 AFS securities – related party Corporate 842 — 19 (2) 859 CLO 2,573 — 5 (29) 2,549 ABS 6,986 — 61 (53) 6,994 Total AFS securities – related party 10,401 — 85 (84) 10,402 Total AFS securities including related party $ 106,859 $ (123) $ 4,893 $ (1,068) $ 110,561 December 31, 2020 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 349 $ — $ 3 $ (1) $ 351 US state, municipal and political subdivisions 864 — 169 — 1,033 Foreign governments 330 — 38 — 368 Corporate 51,934 (6) 6,368 (116) 58,180 CLO 9,631 (1) 145 (206) 9,569 ABS 4,259 (6) 140 (123) 4,270 CMBS 2,165 (10) 85 (71) 2,169 RMBS 6,568 (80) 447 (22) 6,913 Total AFS securities 76,100 (103) 7,395 (539) 82,853 AFS securities – related party Corporate 213 — 2 — 215 CLO 1,511 (1) 23 (13) 1,520 ABS 4,720 — 95 (30) 4,785 Total AFS securities – related party 6,444 (1) 120 (43) 6,520 Total AFS securities including related party $ 82,544 $ (104) $ 7,515 $ (582) $ 89,373 The amortized cost and fair value of AFS securities, including related party, are shown by contractual maturity below: December 31, 2021 (In millions) Amortized Cost Fair Value AFS securities Due in one year or less $ 958 $ 968 Due after one year through five years 9,374 9,622 Due after five years through ten years 17,411 17,858 Due after ten years 37,496 40,342 CLO, ABS, CMBS and RMBS 31,219 31,369 Total AFS securities 96,458 100,159 AFS securities – related party Due after one year through five years 23 24 Due after five years through ten years 673 687 Due after ten years 146 148 CLO and ABS 9,559 9,543 Total AFS securities – related party 10,401 10,402 Total AFS securities including related party $ 106,859 $ 110,561 Actual maturities can differ from contractual maturities as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Unrealized Losses on AFS Securities — The following summarizes the fair value and gross unrealized losses for AFS securities, including related party, for which an allowance for credit losses has not been recorded, aggregated by asset type and length of time the fair value has remained below amortized cost: December 31, 2021 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Fair Value Gross Fair Value Gross AFS securities US government and agencies $ 164 $ (8) $ 22 $ (2) $ 186 $ (10) US state, municipal and political subdivisions 122 (2) 1 — 123 (2) Foreign governments 387 (17) 1 — 388 (17) Corporate 18,995 (523) 863 (59) 19,858 (582) CLO 7,685 (124) 1,537 (35) 9,222 (159) ABS 4,038 (16) 165 (12) 4,203 (28) CMBS 880 (29) 177 (22) 1,057 (51) RMBS 437 (9) 274 (5) 711 (14) Total AFS securities 32,708 (728) 3,040 (135) 35,748 (863) AFS securities – related party Corporate 313 (2) — — 313 (2) CLO 1,245 (20) 163 (3) 1,408 (23) ABS 3,801 (52) 13 (1) 3,814 (53) Total AFS securities – related party 5,359 (74) 176 (4) 5,535 (78) Total AFS securities including related party $ 38,067 $ (802) $ 3,216 $ (139) $ 41,283 $ (941) December 31, 2020 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 31 $ (1) $ — $ — $ 31 $ (1) US state, municipal and political subdivisions 9 — 6 — 15 — Foreign governments 2 — — — 2 — Corporate 2,218 (66) 248 (24) 2,466 (90) CLO 1,649 (33) 3,179 (167) 4,828 (200) ABS 1,169 (73) 84 (18) 1,253 (91) CMBS 710 (37) 48 (13) 758 (50) RMBS 548 (11) 37 (2) 585 (13) Total AFS securities 6,336 (221) 3,602 (224) 9,938 (445) AFS securities – related party CLO 336 (3) 232 (10) 568 (13) ABS 1,012 (30) — — 1,012 (30) Total AFS securities – related party 1,348 (33) 232 (10) 1,580 (43) Total AFS securities including related party $ 7,684 $ (254) $ 3,834 $ (234) $ 11,518 $ (488) The following summarizes the number of AFS securities that were in an unrealized loss position, including related party, for which an allowance for credit losses has not been recorded: December 31, 2021 Unrealized loss position Unrealized loss position 12 months or more AFS securities 4,104 435 AFS securities – related party 78 9 The unrealized losses on AFS securities can primarily be attributed to changes in market interest rates since acquisition. We did not recognize the unrealized losses in income as we intend to hold these securities and it is not more likely than not we will be required to sell a security before the recovery of its amortized cost. Allowance for Credit Losses — The following table summarizes the activity in the allowance for credit losses for AFS securities by asset type: Year ended December 31, 2021 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending Balance AFS securities Corporate $ 6 $ 3 $ — $ (7) $ (2) $ — CLO 1 7 — (1) (7) — ABS 6 5 — (2) 8 17 CMBS 10 4 — — (11) 3 RMBS 80 2 25 (20) 16 103 Total AFS securities 103 21 25 (30) 4 123 AFS securities – related party, CLO 1 5 — (1) (5) — Total AFS securities including related party $ 104 $ 26 $ 25 $ (31) $ (1) $ 123 Year ended December 31, 2020 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending Balance AFS securities Corporate $ — $ 44 $ — $ (14) $ (24) $ 6 CLO — 1 — — — 1 ABS — 7 — — (1) 6 CMBS — 24 — (1) (13) 10 RMBS 17 51 66 (17) (37) 80 Total AFS securities 17 127 66 (32) (75) 103 AFS securities – related party, CLO — 2 — (1) — 1 Total AFS securities including related party $ 17 $ 129 $ 66 $ (33) $ (75) $ 104 Net Investment Income —Net investment income by asset class consists of the following: Years ended December 31, (In millions) 2021 2020 2019 AFS securities $ 3,668 $ 3,225 $ 3,088 Trading securities 260 192 189 Equity securities 19 14 16 Mortgage loans 875 742 670 Investment funds 1,912 721 382 Funds withheld at interest 781 269 527 Other 271 226 159 Investment revenue 7,786 5,389 5,031 Investment expenses (609) (504) (435) Net investment income $ 7,177 $ 4,885 $ 4,596 Investment Related Gains (Losses) —Investment related gains (losses) by asset class consists of the following: Years ended December 31, (In millions) 2021 2020 2019 AFS securities Gross realized gains on investment activity $ 936 $ 602 $ 178 Gross realized losses on investment activity (633) (415) (56) Net realized investment gains on AFS securities 303 187 122 Net recognized investment gains (losses) on trading securities (70) 33 151 Net recognized investment gains (losses) on equity securities 237 (218) 25 Derivative gains 3,525 3,430 4,443 Provision for credit losses (5) (69) — Other gains (losses) 198 (54) (22) Investment related gains (losses) $ 4,188 $ 3,309 $ 4,719 Proceeds from sales of AFS securities were $11,092 million, $7,911 million and $6,886 million for the years ended December 31, 2021, 2020 and 2019, respectively. The following table summarizes the change in unrealized gains (losses) on trading and equity securities, including related party and consolidated VIEs, we held as of the respective year end: Years ended December 31, (In millions) 2021 2020 2019 Trading securities $ (78) $ 130 $ 193 Trading securities – related party 56 (37) (18) Equity securities 213 (9) 19 Equity securities – related party 9 — (18) Purchased Financial Assets with Credit Deterioration —The following table summarizes our PCD investment purchases with the following amounts at the time of purchase: Year ended December 31, 2021 (In millions) Fixed maturity securities Mortgage loans Purchase price $ 35 $ 335 Allowance for credit losses at acquisition 25 6 Discount (premiums) attributable to other factors (3) (26) Par value $ 57 $ 315 Repurchase Agreements —The following table summarizes the maturities of our repurchase agreements: December 31, 2021 Remaining Contractual Maturity (In millions) Overnight and continuous Less than 30 days 30–90 days 91 days to 1 year Greater than 1 year Total Payables for repurchase agreements 1 $ — $ 2,512 $ — $ — $ 598 $ 3,110 1 Included in payables for collateral on derivatives and securities to repurchase on the consolidated balance sheets. December 31, 2020 Remaining Contractual Maturity (In millions) Overnight and continuous Less than 30 days 30–90 days 91 days to 1 year Greater than 1 year Total Payables for repurchase agreements 1 $ — $ — $ — $ — $ 598 $ 598 1 Included in payables for collateral on derivatives and securities to repurchase on the consolidated balance sheets. The following table summarizes the securities pledged as collateral for repurchase agreements: December 31, 2021 2020 (In millions) Amortized cost Fair value Amortized cost Fair value AFS securities – Corporate $ 2,923 $ 3,208 $ 559 $ 644 Mortgage Loans, including related party —Mortgage loans, net of allowances, consists of the following: December 31, (In millions) 2021 2020 Commercial mortgage loans $ 16,565 $ 11,383 Commercial mortgage loans under development 499 232 Total commercial mortgage loans 17,064 11,615 Allowance for credit losses on commercial mortgage loans (167) (167) Commercial mortgage loans, net of allowances 16,897 11,448 Residential mortgage loans 7,321 4,569 Allowance for credit losses on residential mortgage loans (70) (79) Residential mortgage loans, net of allowances 7,251 4,490 Mortgage loans, net of allowances $ 24,148 $ 15,938 We primarily invest in commercial mortgage loans on income producing properties including office and retail buildings, apartments, hotels, and industrial properties. We diversify the commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. We evaluate mortgage loans based on relevant current information to confirm if properties are performing at a consistent and acceptable level to secure the related debt. The distribution of commercial mortgage loans, including those under development, net of allowances, by property type and geographic region, is as follows: December 31, 2021 2020 (In millions, except for percentages) Net carrying value Percentage of total Net carrying value Percentage of total Property type Office building $ 4,870 28.8 % $ 3,589 31.4 % Retail 2,022 12.0 % 2,083 18.2 % Apartment 4,626 27.4 % 2,441 21.3 % Hotels 1,727 10.2 % 1,294 11.3 % Industrial 2,336 13.8 % 1,362 11.9 % Other commercial 1,316 7.8 % 679 5.9 % Total commercial mortgage loans $ 16,897 100.0 % $ 11,448 100.0 % US region East North Central $ 1,697 10.0 % $ 1,209 10.5 % East South Central 470 2.8 % 402 3.5 % Middle Atlantic 3,637 21.5 % 3,069 26.8 % Mountain 460 2.7 % 487 4.2 % New England 453 2.7 % 350 3.1 % Pacific 3,994 23.6 % 2,746 24.0 % South Atlantic 2,817 16.7 % 1,773 15.5 % West North Central 271 1.6 % 145 1.3 % West South Central 997 5.9 % 640 5.6 % Total US region 14,796 87.5 % 10,821 94.5 % International region United Kingdom 1,279 7.6 % — — % Other International 1 822 4.9 % 627 5.5 % Total International region 2,101 12.5 % 627 5.5 % Total commercial mortgage loans $ 16,897 100.0 % $ 11,448 100.0 % 1 Represents all other countries, with each individual country comprising less than 5% of the portfolio. Our residential mortgage loan portfolio includes first lien residential mortgage loans collateralized by properties in various geographic locations and is summarized by proportion of the portfolio in the following table: December 31, 2021 2020 US states California 28.4 % 24.8 % Florida 11.4 % 13.3 % New York 4.8 % 6.2 % New Jersey 5.1 % 4.0 % Other 1 38.5 % 37.1 % Total US residential mortgage loan percentage 88.2 % 85.4 % International Ireland 6.4 % 12.9 % Other 2 5.4 % 1.7 % Total International residential mortgage loan percentage 11.8 % 14.6 % Total residential mortgage loan percentage 100.0 % 100.0 % 1 Represents all other states, with each individual state comprising less than 5% of the portfolio. 2 Represents all other countries, with each individual country comprising less than 5% of the portfolio. Loan Valuation Allowance — The allowances for our mortgage loan portfolio and other loans are summarized as follows: Year ended December 31, 2021 (In millions) Commercial mortgage Residential mortgage Other investments Total Beginning balance $ 167 $ 79 $ 7 $ 253 Provision (reversal) for expected credit losses — (14) (7) (21) Initial credit losses on PCD loans — 6 — 6 Loans charged-off — (1) — (1) Ending balance $ 167 $ 70 $ — $ 237 Year ended December 31, 2020 (In millions) Commercial mortgage Residential mortgage Other investments Total Beginning balance $ 10 $ 1 $ — $ 11 Adoption of accounting standard 167 43 11 221 Provision (reversal) for expected credit losses (10) 29 (4) 15 Initial credit losses on PCD loans — 7 — 7 Loans charged-off — (1) — (1) Ending balance $ 167 $ 79 $ 7 $ 253 Commercial mortgage loans – Our allowance model for commercial mortgage loans is based on the characteristics of the loans in our portfolio, historical economic data and loss information, and current and forecasted economic conditions. Key loan characteristics affecting the estimate include, among others: time to maturity, delinquency status, loan-to-value ratios, debt service coverage ratios, etc. Key macroeconomic variables include unemployment rates, London Inter-bank Offered Rate (LIBOR), commercial real estate price index, and market liquidity score. Management reviews and approves forecasted macroeconomic variables, along with the reasonable and supportable forecast period and mean reversion technique. Management also evaluates assumptions from independent third parties and these assumptions have a high degree of subjectivity. The mean reversion technique varies by macroeconomic variable and may vary by geographic location. As of December 31, 2021, our reasonable and supportable forecast period was one year, after which we revert to the 20-year or greater historical average over one year. Residential mortgage loans – Our allowance model for residential mortgage loans is based on the characteristics of the loans in our portfolio, historical economic data and loss information, and current and forecasted economic conditions. Key loan characteristics affecting the estimate include, among others: time to maturity, delinquency status, original credit scores and loan-to-value ratios. Key macroeconomic variables include unemployment rates and the housing price index. Management reviews and approves forecasted macroeconomic variables, along with the reasonable and supportable forecast period and mean reversion technique. Management also evaluates assumptions from independent third parties and these assumptions have a high degree of subjectivity. The mean reversion technique varies by macroeconomic variable and may vary by geographic location. As of December 31, 2021, our reasonable and supportable forecast period was one year, after which we revert to the 30-year or greater historical average over a period of up to one year and then continue at those averages through the contractual life of the loan. Other investments – The allowance model for the loans included in other investments and related party other investments derives an estimate based on historical loss data available for similarly rated unsecured corporate debt obligations, while also incorporating management’s expectations around prepayment. See Note 14 – Related Parties for further information on the related party loans. Credit Quality Indicators Residential mortgage loans – The underwriting process for our residential mortgage loans includes an evaluation of relevant credit information including past loan performance, credit scores, loan-to-value and other relevant information. Subsequent to purchase or origination, we closely monitor economic conditions and loan performance to manage and evaluate our exposure to credit risk in our residential mortgage loan portfolio. The primary credit quality indicator monitored for residential mortgage loans is loan performance. Nonperforming residential mortgage loans are 90 days or more past due and/or are in non-accrual status. The following represents our residential loan portfolio by origination year and performance status: December 31, 2021 (In millions) 2021 2020 2019 2018 2017 Prior Total Current (less than 30 days past due) $ 2,398 $ 319 $ 37 $ 383 $ 54 $ 2,568 $ 5,759 30 to 59 days past due 100 37 3 3 6 223 372 60 to 89 days past due 36 16 3 2 7 136 200 90 days or more past due 1 27 133 82 87 141 520 990 Total residential mortgages $ 2,561 $ 505 $ 125 $ 475 $ 208 $ 3,447 $ 7,321 1 Includes $856 million of residential mortgage loans that are guaranteed by US government-sponsored agencies. December 31, 2020 1 (In millions) 2020 2019 2018 2017 2016 Prior Total Current (less than 30 days past due) $ 274 $ 68 $ 845 $ 72 $ 7 $ 2,993 $ 4,259 30 to 59 days past due 28 1 3 — — 121 153 60 to 89 days past due 2 — 1 — — 47 50 90 days or more past due — 8 5 — — 94 107 Total residential mortgages $ 304 $ 77 $ 854 $ 72 $ 7 $ 3,255 $ 4,569 1 Previously reported amounts have been revised to correct a misstatement, which was not material, in the classification of residential mortgage loans by origination year. As of December 31, 2021 and 2020, we had $856 million and $0 million, respectively, of residential mortgage loans that were 90 days or more past due and are accruing interest. The following represents our residential loan portfolio in non-accrual status: December 31, (In millions) 2021 2020 Beginning amortized cost of residential mortgage loans in non-accrual status $ 107 $ 67 Ending amortized cost of residential mortgage loans in non-accrual status 134 107 Amortized cost of residential mortgage loans in non-accrual status without a related allowance for credit losses 76 13 During the years ended December 31, 2021 and 2020, we recognized $8 million and $5 million, respectively, of interest income on residential mortgage loans in non-accrual status. Commercial mortgage loans – The following represents our commercial mortgage loan portfolio by origination year and loan performance status: December 31, 2021 (In millions) 2021 2020 2019 2018 2017 Prior Total Current (less than 30 days past due) $ 6,003 $ 1,852 $ 4,129 $ 2,731 $ 952 $ 1,255 $ 16,922 30 to 59 days past due 52 — — — 90 — 142 Total commercial mortgages $ 6,055 $ 1,852 $ 4,129 $ 2,731 $ 1,042 $ 1,255 $ 17,064 December 31, 2020 (In millions) 2020 2019 2018 2017 2016 Prior Total Current (less than 30 days past due) $ 1,913 $ 4,400 $ 2,617 $ 987 $ 130 $ 1,452 $ 11,499 30 to 59 days past due — 20 45 25 — 5 95 90 days or more past due — — — — — 21 21 Total commercial mortgages $ 1,913 $ 4,420 $ 2,662 $ 1,012 $ 130 $ 1,478 $ 11,615 The following represents our commercial mortgage loan portfolio in non-accrual status: December 31, (In millions) 2021 2020 Beginning amortized cost of commercial mortgage loans in non-accrual status $ 38 $ — Ending amortized cost of commercial mortgage loans in non-accrual status 62 38 Amortized cost of commercial mortgage loans in non-accrual status without a related allowance for credit losses — — During the years ended December 31, 2021 and 2020, no interest income was recognized on commercial mortgage loans in non-accrual status. Loan-to-value and debt service coverage ratios are measures we use to assess the risk and quality of commercial mortgage loans other than those under development. Loans under development are not evaluated using these ratios as the properties underlying these loans are generally not yet income-producing and the value of the underlying property significantly fluctuates based on the progress of construction. Therefore, the risk and quality of loans under development are evaluated based on the aging and geographical distribution of such loans as shown above. The loan-to-value ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A loan-to-value ratio in excess of 100% indicates the unpaid loan amount exceeds the value of the underlying collateral. Loan-to-value information is updated annually as part of the re-underwriting process supporting the National Association of Insurance Commissioners (NAIC) risk-based capital rating criteria. The following represents the loan-to-value ratio of the commercial mortgage loan portfolio, excluding those under development, by origination year: December 31, 2021 (In millions) 2021 2020 2019 2018 2017 Prior Total Less than 50% $ 491 $ 211 $ 633 $ 293 $ 166 $ 957 $ 2,751 50% to 59% 2,127 566 1,275 629 381 191 5,169 60% to 69% 1,748 544 1,786 1,326 369 71 5,844 70% to 79% 1,442 417 360 420 101 — 2,740 80% to 99% — — — — 25 — 25 100% or greater — — — — — 36 36 Commercial mortgage loans $ 5,808 $ 1,738 $ 4,054 $ 2,668 $ 1,042 $ 1,255 $ 16,565 December 31, 2020 (In millions) 2020 2019 2018 2017 2016 Prior Total Less than 50% $ 431 $ 600 $ 201 $ 152 $ 44 $ 1,153 $ 2,581 50% to 59% 315 1,320 765 300 40 147 2,887 60% to 69% 583 1,988 1,222 440 46 106 4,385 70% to 79% 478 485 375 95 — 13 1,446 80% to 99% — — — 25 — 21 46 100% or greater — — — — — 38 38 Commercial mortgage loans $ 1,807 $ 4,393 $ 2,563 $ 1,012 $ 130 $ 1,478 $ 11,383 The debt service coverage ratio is expressed as a percentage of a property’s net operating income to its debt service payments. A debt service ratio of less than 1.0 indicates a property’s operations do not generate enough income to cover debt payments. Debt service coverage ratios are updated as more recent financial statements become available, at least annually or as frequently as quarterly in some cases. The following represents the debt service coverage ratio of the commercial mortgage loan portfolio, excluding those under development, by origination year: December 31, 2021 (In millions) 2021 2020 2019 2018 2017 Prior Total Greater than 1.20x $ 4,370 $ 1,123 $ 2,216 $ 2,163 $ 860 $ 1,095 $ 11,827 1.00x – 1.20x 1,018 496 1,429 66 — 82 3,091 Less than 1.00x 420 119 409 439 182 78 1,647 Commercial mortgage loans $ 5,808 $ 1,738 $ 4,054 $ 2,668 $ 1,042 $ 1,255 $ 16,565 December 31, 2020 (In millions) 2020 2019 2018 2017 2016 Prior Total Greater than 1.20x $ 1,274 $ 2,964 $ 2,440 $ 846 $ 129 $ 1,369 $ 9,022 1.00x – 1.20x 533 1,122 36 70 1 101 1,863 Less than 1.00x — 307 87 96 — 8 498 Commercial mortgage loans $ 1,807 $ 4,393 $ 2,563 $ 1,012 $ 130 $ 1,478 $ 11,383 Investment Funds —Our investment fund portfolio consists of funds that employ various strategies and include investments in real estate, real assets, credit , equity and natural resources. Investment funds can meet the definition of VIEs, which are discussed further in Note 4 – Variable Interest Entities . Our investment funds do not specify timing of distributions on the funds’ underlying assets. The following summarizes our investment funds, including related party: December 31, 2021 2020 (In millions, except for percentages) Carrying value Percent of total Carrying value Percent of total Investment funds Real estate $ 856 60.8 % $ 348 43.3 % Credit funds 86 6.1 % 107 13.3 % Private equity 343 24.4 % 267 33.3 % Real assets 122 8.7 % 81 10.1 % Total investment funds 1,407 100.0 % 803 100.0 % Investment funds – related parties Differentiated investments Athora Holding Ltd. (Athora) 1 743 8.8 % 709 13.4 % Athene Freedom Holdings LP 1 700 8.3 % — — % Catalina Holdings Ltd. (Catalina) 441 5.2 % 334 6.3 % Venerable Holdings, Inc. (Venerable) 1 219 2.6 % 123 2.3 % A-A Mortgage Opportunities, L.P. (A-A Mortgage) 1 26 0.3 % 444 8.4 % Other 433 5.1 % 279 5.3 % Total differentiated investments 2,562 30.3 % 1,889 35.7 % Real estate 1,507 17.8 % 828 15.7 % Credit funds 1,198 14.1 % 375 7.1 % Private equity 751 8.9 % 473 8.9 % Natural resources 172 2.0 % 113 2.1 % Real assets 157 1.9 % 172 3.3 % Public equities — — % 110 2.1 % Investment in Apollo 1 2,112 25.0 % 1,324 25.1 % Total investment funds – related parties 8,459 100.0 % 5,284 100.0 % Total investment funds including related party $ 9,866 $ 6,087 1 Our Venerable investment is in its parent company, VA Capital Company LLC (VA Capital). See further discussion on this investment and our investments in Apollo, Athora, A-A Mortgage and Athene Freedom Holdings LP in Note 14 – Related Parties. Summarized Ownership of Investment Funds —The following is the aggregated summarized financial information of equity method investees, including those for which we elected the fair value option and would otherwise be accounted for as an equity method investment, and may be presented on a lag due to the availability of financial information from the investee: December 31, (In millions) 2021 2020 Assets $ 142,045 $ 130,807 Liabilities 108,525 109,654 Equity 33,520 21,153 Years ended December 31, (In millions) 2021 2020 2019 Net income $ 6,335 $ 2,196 $ 817 The following table presents the carrying value by ownership percentage of equity method investment funds, including related party investment funds: December 31, (In millions) 2021 2020 Ownership Percentage 100% $ 649 $ 717 50% – 99% 2,111 678 3% – 49% 2,668 2,412 Equity method investment funds $ 5,428 $ 3,807 The following table presents the carrying value by ownership percentage of investment funds held at fair value, either due to election of the fair value option or requirement, including related party investment funds: December 31, (In millions) 2021 2020 Ownership Percentage 100% $ 229 $ — 50% – 99% 201 28 3% – 49% 3,697 2,109 Less than 3% 311 143 Fair value investment funds $ 4,438 $ 2,280 Non-Consolidated Securities and Investment Funds Fixed maturity securities – We invest in securitization entities as a debt holder or an investor in the residual interest of the securitization vehicle. These entities are deemed VIEs due to insufficient equity within the structure and lack of control by the equity investors over the activities that significantly impact the economics of the entity. In general, we are a debt investor within these entities and, as such, hold a variable interest; however, due to the debt holders’ lack of ability to control the decisions within the trust that significantly impact the entity, and the fact the debt holders are protected from losses due to the subordination of the equity tranche, the debt holders are not deemed the primary beneficiary. Securitization vehicles in which we hold the residual tranche are not consolidated because we do not unilaterally have substantive rights to remove the general partner, or when assessing related party interests, we are not under common control, as defined by GAAP, with the related party, nor are substantially all of the activities conducted on our behalf; therefore, we are not deemed the primary beneficiary. Debt investments and investments in the residual tranche of securitization entities are considered debt instruments and are held at fair value on the balance sheet and classified as AFS or trading. Investment funds – Investment funds include non-fixed income, alternative investments in the form of limited partnerships or similar legal structures. Equity securities – We invest in preferred equity securities issued by entities deemed to be VIEs due to insufficient equity within the structure. Our risk of loss associated with our non-consolidated investments depends on the investment. Investment funds, equity securities and trading securities are limited to the carrying value plus unfunded commitments. AFS securities are limited to amortized cost plus unfunded commitments. The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: December 31, 2021 2020 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 1,407 $ 2,225 $ 803 $ 1,265 Investment in related parties – investment funds 8,459 12,136 5,284 7,989 Investment in fixed maturity securities 31,769 31,622 23,325 23,027 Investment in related parties – fixed maturity securities 11,324 12,681 7,834 8,126 Investment in related parties – equity securities 284 284 72 72 Total non-consolidated investments $ 53,243 $ 58,948 $ 37,318 $ 40,479

Derivative Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	3. Derivative Instruments We use a variety of derivative instruments to manage risks, primarily equity, interest rate, credit, foreign currency and market volatility. See Note 1 – Business, Basis of Presentation and Significant Accounting Policies for a description of our accounting policies for derivatives and Note 5 – Fair Value for information about the fair value hierarchy for derivatives. The following table presents the notional amount and fair value of derivative instruments: December 31, 2021 2020 Notional Amount Fair Value Notional Amount Fair Value (In millions) Assets Liabilities Assets Liabilities Derivatives designated as hedges Foreign currency hedges Swaps 6,371 $ 281 $ 56 4,417 $ 134 $ 181 Forwards 6,395 189 2 2,038 3 9 Interest rate swaps 2,783 — 173 — — — Forwards on net investments 231 — 4 173 — 2 Interest rate swaps 500 — 1 — — — Total derivatives designated as hedges 470 236 137 192 Derivatives not designated as hedges Equity options 57,890 3,629 115 53,666 3,209 22 Futures 33 67 — 24 58 2 Total return swaps 231 10 — 97 6 — Foreign currency swaps 2,592 57 19 1,510 96 — Interest rate swaps 483 78 1 803 — 34 Credit default swaps 10 — 3 10 — 4 Foreign currency forwards 7,382 76 98 3,595 17 44 Embedded derivatives Funds withheld including related party 1,360 45 2,806 59 Interest sensitive contract liabilities — 14,907 — 12,873 Total derivatives not designated as hedges 5,277 15,188 6,192 13,038 Total derivatives $ 5,747 $ 15,424 $ 6,329 $ 13,230 Derivatives Designated as Hedges Cash Flow Hedges – We use foreign currency swaps to convert foreign currency denominated cash flows of investments or liabilities to US dollars to reduce cash flow fluctuations due to changes in currency exchange rates. These swaps will expire by March 2052. The following is a summary of the gains (losses) related to cash flow hedges: Years ended December 31, (In millions) 2021 2020 2019 Foreign currency swaps – Other comprehensive income (loss) $ 254 $ (106) $ 29 Foreign currency swaps – Investment related gains (losses) 14 — — There were no amounts deemed ineffective during the years ended December 31, 2021 , 2020 or 2019. As of December 31, 2021, no amounts are expected to be reclassified to income within the next 12 months. Fair Value Hedges – We use foreign currency forward contracts, foreign currency interest rate swaps and interest rate swaps that are designated and accounted for as fair value hedges to hedge certain exposures to foreign currency risk and interest rate risk. The foreign currency forward price is agreed upon at the time of the contract and payment is made at a specified future date. The following represents the carrying amount and the cumulative fair value hedging adjustments included in the hedged assets or liabilities: December 31, 2021 December 31, 2020 (In millions) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) AFS securities – Foreign currency forwards $ 4,224 $ (136) $ 1,932 $ 117 Mortgage loans – Foreign currency forwards 1,686 (44) — — Interest sensitive contract liabilities Foreign currency forwards — — 65 (1) Foreign currency interest rate swaps 2,773 121 — — Interest rate swaps 500 — — — 1 The carrying amount disclosed for AFS securities is amortized cost. The following is a summary of the gains (losses) related to the derivatives and related hedged items in fair value hedge relationships: Amounts Excluded (In millions) Derivatives Hedged Items Net Recognized in income through amortization approach Recognized in income through changes in fair value Year ended December 31, 2021 Investment related gains (losses) Foreign currency forwards $ 420 $ (440) $ (20) $ 21 $ 16 Foreign currency interest rate swaps (102) 99 (3) — — Interest rate swaps (1) 1 — — — Interest sensitive contract benefits Foreign currency interest rate swaps 23 (21) 2 — — Year ended December 31, 2020 Investment related gains (losses) – Foreign currency forwards (118) 116 (2) — — Interest sensitive contract benefits – Foreign currency forwards 1 (1) — — — Year ended December 31, 2019 Investment related gains (losses) – Foreign currency forwards 2 — 2 — — Foreign currency forward gains and losses excluded from the assessment of hedge effectiveness that were recognized in OCI were losses of $22 million, $0 million and $0 million for the years ended December 31, 2021, 2020 and 2019, respectively. Net Investment Hedges – We use foreign currency forwards to hedge the foreign currency exchange rate risk of our investments in subsidiaries that have a reporting currency other than the US dollar. We assess hedge effectiveness based on the changes in forward rates. During the years ended December 31, 2021, 2020 and 2019, these derivatives had gains of $1 million and $2 million and losses of $2 million, respectively. These derivatives are included in foreign currency translation and other adjustments on the consolidated statements of comprehensive income. As of December 31, 2021 and 2020, the cumulative foreign currency translation recorded in AOCI related to these net investment hedges were gains of $1 million and $0 million, respectively. There were no amounts deemed ineffective for the years ended December 31, 2021, 2020 and 2019. Derivatives Not Designated as Hedges Equity options – We use equity indexed options to economically hedge fixed indexed annuity products that guarantee the return of principal to the policyholder and credit interest based on a percentage of the gain in a specified market index, primarily the S&P 500. To hedge against adverse changes in equity indices, we enter into contracts to buy equity indexed options. The contracts are net settled in cash based on differentials in the indices at the time of exercise and the strike price. Futures – Futures contracts are purchased to hedge the growth in interest credited to the customer as a direct result of increases in the related indices. We enter into exchange-traded futures with regulated futures commission clearing brokers who are members of a trading exchange. Under exchange-traded futures contracts, we agree to purchase a specified number of contracts with other parties and to post variation margin on a daily basis in an amount equal to the difference in the daily fair values of those contracts. Total return swaps – We purchase total rate of return swaps to gain exposure and benefit from a reference asset or index without ownership. Total rate of return swaps are contracts in which one party makes payments based on a set rate, either fixed or variable, while the other party makes payments based on the return of the underlying asset or index, which includes both the income it generates and any capital gains. Interest rate swaps – We use interest rate swaps to reduce market risks from interest rate changes and to alter interest rate exposure arising from duration mismatches between assets and liabilities. With an interest rate swap, we agree with another party to exchange the difference between fixed-rate and floating-rate interest amounts tied to an agreed-upon notional principal amount at specified intervals. Credit default swaps – Credit default swaps provide a measure of protection against the default of an issuer or allow us to gain credit exposure to an issuer or traded index. We use credit default swaps coupled with a bond to synthetically create the characteristics of a reference bond. These transactions have a lower cost and are generally more liquid relative to the cash market. We receive a periodic premium for these transactions as compensation for accepting credit risk. Hedging credit risk involves buying protection for existing credit risk. The exposure resulting from the agreements, which is usually the notional amount, is equal to the maximum proceeds that must be paid by a counterparty for a defaulted security. If a credit event occurs on a reference entity, then a counterparty who sold protection is required to pay the buyer the trade notional amount less any recovery value of the security. Embedded derivatives – We have embedded derivatives which are required to be separated from their host contracts and reported as derivatives. Host contracts include reinsurance agreements structured on modco or funds withheld basis and indexed annuity products. The following is a summary of the gains (losses) related to derivatives not designated as hedges: Years ended December 31, (In millions) 2021 2020 2019 Equity options $ 2,452 $ 819 $ 2,169 Futures 81 123 (13) Swaps 15 82 43 Foreign currency forwards 37 (127) (2) Embedded derivatives on funds withheld 572 2,651 2,246 Amounts recognized in investment related gains (losses) 3,157 3,548 4,443 Embedded derivatives in indexed annuity products 1 (1,451) (1,384) (2,526) Total net gains on derivatives not designated as hedges $ 1,706 $ 2,164 $ 1,917 1 Included in interest sensitive contract benefits on the consolidated statements of income. Credit Risk —We may be exposed to credit-related losses in the event of counterparty nonperformance on derivative financial instruments. Generally, the current credit exposure of our derivative contracts is the fair value at the reporting date less any collateral received from the counterparty. We manage credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties. Where possible, we maintain collateral arrangements and use master netting agreements that provide for a single net payment from one counterparty to another at each due date and upon termination. We have also established counterparty exposure limits, where possible, in order to evaluate if there is sufficient collateral to support the net exposure. Collateral arrangements typically require the posting of collateral in connection with its derivative instruments. Collateral agreements often contain posting thresholds, some of which may vary depending on the posting party’s financial strength ratings. Additionally, a decrease in our financial strength rating to a specified level can result in settlement of the derivative position. The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral December 31, 2021 Derivative assets $ 4,387 $ (430) $ (3,934) $ 23 $ — $ 23 Derivative liabilities (472) 430 32 (10) — (10) December 31, 2020 Derivative assets $ 3,523 $ (165) $ (3,196) $ 162 $ (46) $ 116 Derivative liabilities (298) 165 144 11 — 11 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the consolidated balance sheets. As of December 31, 2021 and 2020, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received. Certain derivative instruments contain provisions for credit-related events, such as downgrades in our credit ratings or for a negative credit event of a credit default swap’s reference entity. If a credit event were to occur, we may be required to settle an outstanding liability. The following is a summary of our exposure to credit-related events: December 31, (In millions) 2021 2020 Fair value of derivative liabilities with credit related provisions $ 3 $ 4 Maximum exposure for credit default swaps 10 10 As of December 31, 2021 and 2020, no additional collateral would be required if a default or termination event were to occur.

Variable Interest Entities

Variable Interest Entities	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	4. Variable Interest Entities As of December 31, 2021, we consolidate the following primary VIEs: • Hamlet Securitization Trust 2020-CRE1 (Hamlet) • A-A Debt Euro Investment Fund (Lux) SCSP and A-A Euro Investment Fund (Lux) SCSP (collectively, A-A Euro) • AOP Finance Partners, LP (AOP) • NNN AGP Opportunities Fund, L.P., NNN AGP Opportunities Fund II, L.P., and NNN AGP Opportunities Fund III, L.P. (collectively, NNN AGP Opportunities) • A-A SPN-9 (ASREII - ACRASP), L.P. and A-A SPN-9 (ASREII - ALRESP), L.P. (collectively, A-A SPN-9) • A-A Offshore 2021-1 (Java), L.P. (Java) The following summarizes the investments of these consolidated VIEs: December 31, (In millions) 2021 2020 Mortgage loans Hamlet $ 1,793 $ 1,880 A-A Euro 231 — Other 16 — Investment funds AOP 747 — NNN AGP Opportunities 264 — A-A SPN-9 194 — Java 35 — A-A Euro 57 — Hamlet was formed to securitize a portion of our commercial mortgage loan portfolio as CMBS securities held by AHL subsidiaries and third-party cedant portfolios. Securitization of these commercial mortgage loans allows retention of the full economics of these assets while being able to pledge these assets as collateral to the Federal Home Loan Bank (FHLB) under the funding agreement program. As substantially all of the activities and economics of Hamlet are conducted on our behalf, we are the primary beneficiary. Additionally, as Hamlet is in the form of a trust, the commercial mortgage loan assets are included in the pledged assets and funds in trust table in Note 15 – Commitments and Contingencies . A-A Euro are investment funds formed to purchase investments in European real estate. We are both the general partner and a limited partner in the entities and receive a significant portion of their economic benefits and losses. As the general partner, we hired an Apollo affiliate as the related party investment manager who receives management fees and service fees, as applicable. As we control these entities and receive a significant portion of the economic benefits and losses, we are deemed to be the primary beneficiary of the VIE. AOP is an investment fund formed to participate in a platform that originates loans. We are a limited partner in this entity and receive a significant portion of its economic benefits and losses, other than management fees and carried interest, as applicable, paid to the general partner, which is an Apollo affiliate and related party. We do not have any direct voting rights as a limited partner, but we do have a unilateral ability to dissolve the entity; therefore, we are deemed to be the primary beneficiary of the VIE. NNN AGP Opportunities are investment funds formed to purchase US-based net lease properties. We are both the general partner and a limited partner of the funds. As the general partner, we hired an Apollo affiliate as the related party investment manager who receives management fees and service fees, as applicable. As we control these entities and receive a significant portion of the economic benefits and losses, we are deemed to be the primary beneficiary of the VIEs. A-A SPN-9 is comprised of limited partnership entities that invest in an underlying investment fund. We are a limited partner in these entities and receive a significant portion of the economic benefits and losses, other than management fees and carried interest, as applicable, paid to the general partner in each entity, which are Apollo affiliates and related parties. We do not have any direct voting rights as a limited partner at the A-A SPN-9 level, but we do have an ability to dissolve the underlying investment that results in dissolution of the entities. Therefore, as we have a unilateral ability to ultimately dissolve the entities and also receive a significant portion of the economics of each of the entities, we are deemed to be the primary beneficiary of the VIEs. Java is an investment fund. We are both the general partner and the only limited partner in this investment fund and receive all of the economic benefits and losses. As the general partner, we hired an Apollo affiliate as the related party investment manager who receives management fees and service fees, as applicable. We hold both the power, as a general partner, and significant economics, as a limited partner, satisfying the primary beneficiary criteria. No arrangement exists requiring us to provide additional funding in excess of our committed capital investment, liquidity, or the funding of losses or an increase to our loss exposure in excess of our investment in any of the consolidated VIEs. We consolidated the following VIEs during the year ended December 31, 2019: • AAA Investments (Co-Invest VI), L.P. (CoInvest VI); • AAA Investments (Co-Invest VII), L.P. (CoInvest VII); • AAA Investments (Other), L.P. (CoInvest Other); • ALR Aircraft Investment Ireland Limited (ALR) and • Entities included under our agreement to purchase funds managed by Apollo entities (Strategic Partnership). See Note 14 – Related Parties for further discussion on the Strategic Partnership. We were the only limited partner or holder of profit participating notes in these investment funds and received all of the economic benefits and losses, other than management fees and carried interest, as applicable, paid to the general partner in each entity, or a related entity, which are related parties. We did not have any voting rights as limited partner and, as the limited partner or holder of profit participating notes, did not solely satisfy the power criteria to direct the activities that significantly impact the economics of the VIE. However, the criteria for the primary beneficiary were satisfied by our related party group and, because substantially all of the activities were conducted on our behalf, we consolidated the investment funds. CoInvest VI, CoInvest VII and CoInvest Other were formed to make investments, including co-investments alongside private equity funds sponsored by Apollo. Investments held by CoInvest VI, CoInvest VII and CoInvest Other were related party investments because Apollo affiliates exercised significant influence over the management or operations of the investees. We received our interests in CoInvest VI, CoInvest VII and CoInvest Other as part of a contribution agreement in 2012 with AAA Guarantor – Athene, L.P. and its subsidiary, Apollo Life Re Ltd., in order to provide a capital base to support future acquisitions. During 2020, as a result of the AGM share transaction discussed further in Note 14 – Related Parties , we reassessed the consolidation conclusions for the following VIEs, which are managed by Apollo affiliates: • CoInvest VI; • CoInvest VII; • CoInvest Other; and • Entities included under the Strategic Partnership. Following the AGM share transaction, we determined that we are no longer the primary beneficiary of CoInvest VI, CoInvest VII, CoInvest Other and the Strategic Partnership, as a result of Apollo receiving significant economics of these entities through their increased economic ownership in us. We did not recognize a gain or loss upon deconsolidation of these previously consolidated VIEs, as the deconsolidated VIEs accounted for their assets and liabilities at fair value. The investments remaining from the deconsolidated VIEs are included at NAV in related party investment funds on the consolidated balance sheets. ALR was formed to invest in a joint venture that provides airplane lease financing to a major commercial airline. During 2020, we received final payment on the profit participating notes and no longer consolidate ALR.

Fair Value

Fair Value	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value	5. Fair Value Fair value is the price we would receive to sell an asset or pay to transfer a liability (exit price) in an orderly transaction between market participants. We determine fair value based on the following fair value hierarchy: Level 1 – Unadjusted quoted prices for identical assets or liabilities in an active market. Level 2 – Quoted prices for inactive markets or valuation techniques that require observable direct or indirect inputs for substantially the full term of the asset or liability. Level 2 inputs include the following: • Quoted prices for similar assets or liabilities in active markets, • Observable inputs other than quoted market prices, and • Observable inputs derived principally from market data through correlation or other means. Level 3 – Prices or valuation techniques with unobservable inputs significant to the overall fair value estimate. These valuations use critical assumptions not readily available to market participants. Level 3 valuations are based on market standard valuation methodologies, including discounted cash flows, matrix pricing or other similar techniques. NAV – Investment funds are typically measured using NAV as a practical expedient in determining fair value and are not classified in the fair value hierarchy. Our carrying value reflects our pro rata ownership percentage as indicated by NAV in the investment fund financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. The underlying investments of the investment funds may have significant unobservable inputs, which may include but are not limited to, comparable multiples and weighted average cost of capital rates applied in valuation models or a discounted cash flow model. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the instrument’s fair value measurement. We use a number of valuation sources to determine fair values. Valuation sources can include quoted market prices; third-party commercial pricing services; third-party brokers; industry-standard, vendor modeling software that uses market observable inputs; and other internal modeling techniques based on projected cash flows. We periodically review the assumptions and inputs of third-party commercial pricing services through internal valuation price variance reviews, comparisons to internal pricing models, back testing to recent trades, or monitoring trading volumes. The following represents the hierarchy for our assets and liabilities measured at fair value on a recurring basis: December 31, 2021 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 223 $ — $ 214 $ 9 $ — US state, municipal and political subdivisions 1,213 — — 1,213 — Foreign governments 1,128 — — 1,126 2 Corporate 66,226 — — 64,887 1,339 CLO 13,652 — — 13,638 14 ABS 8,989 — — 5,370 3,619 CMBS 2,758 — — 2,715 43 RMBS 5,970 — — 5,970 — Total AFS securities 100,159 — 214 94,928 5,017 Trading securities US government and agencies 6 — 3 3 — US state, municipal and political subdivisions 101 — — 101 — Foreign governments 19 — — 19 — Corporate 1,530 — — 1,530 — CLO 11 — — 6 5 ABS 141 — — 96 45 CMBS 94 — — 94 — RMBS 154 — — 135 19 Total trading securities 2,056 — 3 1,984 69 Equity securities 1,170 — 86 655 429 Mortgage loans 17 — — — 17 Investment funds 412 165 — — 247 Funds withheld at interest – embedded derivative 782 — — — 782 Derivative assets 4,387 — 67 4,320 — Short-term investments 139 — 49 61 29 Other investments 130 — — 130 — Cash and cash equivalents 9,633 — 9,633 — — Restricted cash 796 — 796 — — Investments in related parties AFS securities Corporate 859 — — 189 670 CLO 2,549 — — 2,347 202 ABS 6,994 — — 549 6,445 Total AFS securities – related party 10,402 — — 3,085 7,317 Trading securities CLO 52 — — 10 42 ABS 1,729 — — — 1,729 Total trading securities – related party 1,781 — — 10 1,771 Equity securities 284 — — — 284 Investment funds 4,026 103 — — 3,923 Funds withheld at interest – embedded derivative 578 — — — 578 Reinsurance recoverable 1,991 — — — 1,991 Total assets measured at fair value $ 138,743 $ 268 $ 10,848 $ 105,173 $ 22,454 (Continued) December 31, 2021 (In millions) Total NAV Level 1 Level 2 Level 3 Liabilities Interest sensitive contract liabilities Embedded derivative $ 14,907 $ — $ — $ — $ 14,907 Universal life benefits 1,235 — — — 1,235 Future policy benefits AmerUs Closed Block 1,520 — — — 1,520 ILICO Closed Block and life benefits 742 — — — 742 Derivative liabilities 472 — — 469 3 Funds withheld liability – embedded derivative 45 — — 45 — Total liabilities measured at fair value $ 18,921 $ — $ — $ 514 $ 18,407 (Concluded) December 31, 2020 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 351 $ — $ 332 $ 19 $ — US state, municipal and political subdivisions 1,033 — — 999 34 Foreign governments 368 — — 366 2 Corporate 58,180 — — 57,402 778 CLO 9,569 — — 9,361 208 ABS 4,270 — — 3,470 800 CMBS 2,169 — — 2,126 43 RMBS 6,913 — — 6,913 — Total AFS securities 82,853 — 332 80,656 1,865 Trading securities US government and agencies 6 — 3 3 — US state, municipal and political subdivisions 106 — — 106 — Corporate 1,577 — — 1,577 — CLO 4 — — — 4 ABS 128 — — 93 35 CMBS 52 — — 52 — RMBS 220 — — 173 47 Total trading securities 2,093 — 3 2,004 86 Equity securities 330 — 57 262 11 Mortgage loans 19 — — — 19 Investment funds 161 144 — — 17 Funds withheld at interest – embedded derivative 1,944 — — — 1,944 Derivative assets 3,523 — 58 3,465 — Short-term investments 222 — 146 74 2 Other investments 105 — — 105 — Cash and cash equivalents 7,704 — 7,704 — — Restricted cash 738 — 738 — — (Continued) December 31, 2020 (In millions) Total NAV Level 1 Level 2 Level 3 Investments in related parties AFS securities Corporate 215 — — 20 195 CLO 1,520 — — 1,520 — ABS 4,785 — — 676 4,109 Total AFS securities – related party 6,520 — — 2,216 4,304 Trading securities CLO 54 — — 4 50 ABS 1,475 — — — 1,475 Total trading securities – related party 1,529 — — 4 1,525 Equity securities 72 — — — 72 Investment funds 2,119 86 — — 2,033 Funds withheld at interest – embedded derivative 862 — — — 862 Reinsurance recoverable 2,100 — — — 2,100 Total assets measured at fair value $ 112,894 $ 230 $ 9,038 $ 88,786 $ 14,840 Liabilities Interest sensitive contract liabilities Embedded derivative $ 12,873 $ — $ — $ — $ 12,873 Universal life benefits 1,308 — — — 1,308 Future policy benefits AmerUs Closed Block 1,600 — — — 1,600 ILICO Closed Block and life benefits 776 — — — 776 Derivative liabilities 298 — 2 292 4 Funds withheld liability – embedded derivative 59 — — 59 — Total liabilities measured at fair value $ 16,914 $ — $ 2 $ 351 $ 16,561 (Concluded) Fair Value Valuation Methods —We used the following valuation methods and assumptions to estimate fair value: AFS and trading securities – We obtain the fair value for most marketable securities without an active market from several commercial pricing services. These are classified as Level 2 assets. The pricing services incorporate a variety of market observable information in their valuation techniques, including benchmark yields, trading activity, credit quality, issuer spreads, bids, offers and other reference data. This category typically includes US and non-US corporate bonds, US agency and government guaranteed securities, CLO, ABS, CMBS and RMBS. We also have fixed maturity securities priced based on indicative broker quotes or by employing market accepted valuation models. For certain fixed maturity securities, the valuation model uses significant unobservable inputs and are included in Level 3 in our fair value hierarchy. Significant unobservable inputs used include: discount rates, issue specific credit adjustments, material non-public financial information, estimation of future earnings and cash flows, default rate assumptions, liquidity assumptions and indicative quotes from market makers. These inputs are usually considered unobservable, as not all market participants have access to this data. We value privately placed fixed maturity securities based on the credit quality and duration of comparable marketable securities, which may be securities of another issuer with similar characteristics. In some instances, we use a matrix-based pricing model. These models consider the current level of risk-free interest rates, corporate spreads, credit quality of the issuer and cash flow characteristics of the security. We also consider additional factors such as net worth of the borrower, value of collateral, capital structure of the borrower, presence of guarantees and our evaluation of the borrower’s ability to compete in its relevant market. Privately placed fixed maturity securities are classified as Level 2 or 3. Equity securities – Fair values of publicly traded equity securities are based on quoted market prices and classified as Level 1. Other equity securities, typically private equities or equity securities not traded on an exchange, we value based on other sources, such as commercial pricing services or brokers, and are classified as Level 2 or 3. Mortgage loans – Mortgage loans for which we have elected the fair value option or those held for sale are carried at fair value. We estimate fair value on a monthly basis using discounted cash flow analysis and rates being offered for similar loans to borrowers with similar credit ratings. Loans with similar characteristics are aggregated for purposes of the calculations. The discounted cash flow model uses unobservable inputs, including estimates of discount rates and loan prepayments. Mortgage loans are classified as Level 3. Investment funds – Certain investment funds for which we elected the fair value option are included in Level 3 and are priced based on market accepted valuation models. The valuation models use significant unobservable inputs, which include material non-public financial information, estimation of future distributable earnings and demographic assumptions. These inputs are usually considered unobservable, as not all market participants have access to this data. Funds withheld at interest embedded derivative – We estimate the fair value of the embedded derivative based on the change in the fair value of the assets supporting the funds withheld payable under modco and funds withheld reinsurance agreements. As a result, the fair value of the embedded derivative is classified as Level 2 or 3 based on the valuation methods used for the assets held supporting the reinsurance agreements. Derivatives – Derivative contracts can be exchange traded or over-the-counter. Exchange-traded derivatives typically fall within Level 1 of the fair value hierarchy depending on trading activity. Over-the-counter derivatives are valued using valuation models or an income approach using third-party broker valuations. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit curves, measures of volatility, prepayment rates and correlation of the inputs. We consider and incorporate counterparty credit risk in the valuation process through counterparty credit rating requirements and monitoring of overall exposure. We also evaluate and include our own nonperformance risk in valuing derivatives. The majority of our derivatives trade in liquid markets; therefore, we can verify model inputs and model selection does not involve significant management judgment. These are typically classified within Level 2 of the fair value hierarchy. Cash and cash equivalents, including restricted cash – The carrying amount for cash equals fair value. We estimate the fair value for cash equivalents based on quoted market prices. These assets are classified as Level 1. Interest sensitive contract liabilities embedded derivative – Embedded derivatives related to interest sensitive contract liabilities with fixed indexed annuity products are classified as Level 3. The valuations include significant unobservable inputs associated with economic assumptions and actuarial assumptions for policyholder behavior. AmerUs Closed Block – We elected the fair value option for the future policy benefits liability in the AmerUs Closed Block. Our valuation technique is to set the fair value of policyholder liabilities equal to the fair value of assets. There is an additional component which captures the fair value of the open block’s obligations to the closed block business. This component is the present value of the projected release of required capital and future earnings before income taxes on required capital supporting the AmerUs Closed Block, discounted at a rate which represents a market participant’s required rate of return, less the initial required capital. Unobservable inputs include estimates for these items. The AmerUs Closed Block policyholder liabilities and any corresponding reinsurance recoverable are classified as Level 3. ILICO Closed Block – We elected the fair value option for the ILICO Closed Block. Our valuation technique is to set the fair value of policyholder liabilities equal to the fair value of assets. There is an additional component which captures the fair value of the open block’s obligations to the closed block business. This component uses the present value of future cash flows which include commissions, administrative expenses, reinsurance premiums and benefits, and an explicit cost of capital. The discount rate includes a margin to reflect the business and nonperformance risk. Unobservable inputs include estimates for these items. The ILICO Closed Block policyholder liabilities and corresponding reinsurance recoverable are classified as Level 3. Universal life liabilities and other life benefits – We elected the fair value option for certain blocks of universal and other life business ceded to Global Atlantic. We use a present value of liability cash flows. Unobservable inputs include estimates of mortality, persistency, expenses, premium payments and a risk margin used in the discount rates that reflects the riskiness of the business. These universal life policyholder liabilities and corresponding reinsurance recoverable are classified as Level 3. Fair Value Option — The following represents the gains (losses) recorded for instruments for which we have elected the fair value option, including related parties: Years ended December 31, (In millions) 2021 2020 2019 Trading securities $ (70) $ 33 $ 151 Investment funds 826 295 (3) Future policy benefits 80 (54) (103) Total gains (losses) $ 836 $ 274 $ 45 Gains and losses on trading securities are recorded in investment related gains (losses) on the consolidated statements of income. For fair valu e option mortgage loans, we record interest income in net investment income and subsequent changes in fair value in investment related gains (losses) on the consolidated statements of income. Gains and losses related to investment funds, including related party investment funds, are recorded in net investment income on the consolidated statements of income. We record the change in fair value of future policy benefits to future policy and other policy benefits on the consolidated statements of income. The following summarizes information for fair value option mortgage loans: December 31, (In millions) 2021 2020 Unpaid principal balance $ 15 $ 17 Mark to fair value 2 2 Fair value $ 17 $ 19 There were no fair value option mortgage loans 90 days or more past due as of December 31, 2021 and 2020. Level 3 Financial Instruments — The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. All transfers in and out of Level 3 are based on changes in the availability of pricing sources, as described in the valuation methods above. Year ended December 31, 2021 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities US state, municipal and political subdivisions $ 34 $ — $ — $ — $ (34) $ — $ — $ — Foreign governments 2 — — — — 2 — — Corporate 778 6 27 428 100 1,339 — 27 CLO 208 — 1 (37) (158) 14 — 1 ABS 800 (17) 45 2,958 (167) 3,619 — 45 CMBS 43 2 6 (11) 3 43 — 6 Trading securities CLO 4 — — 1 — 5 — — ABS 35 (1) — — 11 45 (1) — RMBS 47 (10) — — (18) 19 (4) — Equity securities 11 16 — 402 — 429 16 — Mortgage loans 19 — — (2) — 17 — — Investment funds 17 (27) — 148 109 247 (27) — Funds withheld at interest – embedded derivative 1,944 (1,162) — — — 782 — — Short-term investments 2 — — 27 — 29 — — Investments in related parties AFS securities Corporate 195 2 7 661 (195) 670 — 7 CLO — — — 202 — 202 — — ABS 4,109 (6) (44) 2,386 — 6,445 — (44) Trading securities CLO 50 (7) — 9 (10) 42 — — ABS 1,475 27 — 227 — 1,729 40 — Equity securities 72 8 — 204 — 284 8 — Investment funds 2,033 853 — 1,037 — 3,923 853 — Funds withheld at interest – embedded derivative 862 (284) — — — 578 — — Reinsurance recoverable 2,100 (109) — — — 1,991 — — Total Level 3 assets $ 14,840 $ (709) $ 42 $ 8,640 $ (359) $ 22,454 $ 885 $ 42 Liabilities Interest sensitive contract liabilities Embedded derivative $ (12,873) $ (1,451) $ — $ (583) $ — $ (14,907) $ — $ — Universal life benefits (1,308) 73 — — — (1,235) — — Future policy benefits AmerUs Closed Block (1,600) 80 — — — (1,520) — — ILICO Closed Block and life benefits (776) 34 — — — (742) — — Derivative liabilities (4) 1 — — — (3) — — Total Level 3 liabilities $ (16,561) $ (1,263) $ — $ (583) $ — $ (18,407) $ — $ — 1 Related to instruments held at end of period. Year ended December 31, 2020 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities US state, municipal and political subdivisions $ 40 $ — $ — $ (6) $ — $ 34 $ — $ — Foreign governments — — — 2 — 2 — — Corporate 725 10 5 10 28 778 — 5 CLO 121 — — 109 (22) 208 — — ABS 1,374 20 (48) (282) (264) 800 — (47) CMBS 46 (4) (5) (5) 11 43 — (4) Trading securities CLO 6 (2) — — — 4 — — ABS 16 — — 19 — 35 — — RMBS 52 (9) — — 4 47 2 — Equity securities 3 3 — 5 — 11 3 — Mortgage loans 27 — — (8) — 19 — — Investment funds 22 (5) — — — 17 (5) — Funds withheld at interest – embedded derivative 801 1,143 — — — 1,944 — — Short-term investments 41 — — (39) — 2 — — Investments in related parties AFS securities Corporate — — — 195 — 195 — — ABS 2,324 24 37 1,889 (165) 4,109 — 37 Trading securities CLO 38 (13) — 14 11 50 (9) — ABS 711 (13) — 777 — 1,475 (14) — Equity securities 64 1 — 12 (5) 72 1 — Investment funds 132 298 — 1,603 — 2,033 122 — Funds withheld at interest – embedded derivative 594 268 — — — 862 — — Reinsurance recoverable 1,821 279 — — — 2,100 — — Total Level 3 assets $ 8,958 $ 2,000 $ (11) $ 4,295 $ (402) $ 14,840 $ 100 $ (9) Liabilities Interest sensitive contract liabilities Embedded derivative $ (10,942) $ (1,384) $ — $ (547) $ — $ (12,873) $ — $ — Universal life benefits (1,050) (258) — — — (1,308) — — Future policy benefits AmerUs Closed Block (1,546) (54) — — — (1,600) — — ILICO Closed Block and life benefits (755) (21) — — — (776) — — Derivative liabilities (3) (1) — — — (4) (1) — Total Level 3 liabilities $ (14,296) $ (1,718) $ — $ (547) $ — $ (16,561) $ (1) $ — 1 Related to instruments held at end of period. The following represents the gross components of purchases, issuances, sales and settlements, net, and net transfers in (out) shown above: Year ended December 31, 2021 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities US state, municipal and political subdivisions $ — $ — $ — $ — $ — $ — $ (34) $ (34) Foreign governments 1 — — (1) — — — — Corporate 636 — (96) (112) 428 228 (128) 100 CLO — — — (37) (37) — (158) (158) ABS 4,455 — (1,001) (496) 2,958 160 (327) (167) CMBS — — (10) (1) (11) 43 (40) 3 Trading securities CLO 5 — (4) — 1 — — — ABS — — — — — 11 — 11 RMBS — — — — — 4 (22) (18) Equity securities 402 — — — 402 — — — Mortgage loans — — — (2) (2) — — — Investment funds 285 — (137) — 148 109 — 109 Short-term investments 30 — (3) — 27 — — — Investments in related parties AFS securities Corporate 661 — — — 661 — (195) (195) CLO 202 — — — 202 — — — ABS 3,679 — (212) (1,081) 2,386 — — — Trading securities CLO 18 — (2) (7) 9 — (10) (10) ABS 404 — (115) (62) 227 — — — Equity securities 213 — — (9) 204 — — — Investment funds 1,037 — — — 1,037 — — — Total Level 3 assets $ 12,028 $ — $ (1,580) $ (1,808) $ 8,640 $ 555 $ (914) $ (359) Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (1,474) $ — $ 891 $ (583) $ — $ — $ — Total Level 3 liabilities $ — $ (1,474) $ — $ 891 $ (583) $ — $ — $ — Year ended December 31, 2020 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities US state, municipal and political subdivisions $ — $ — $ (5) $ (1) $ (6) $ — $ — $ — Foreign governments 2 — — — 2 — — — Corporate 177 — — (167) 10 69 (41) 28 CLO 145 — (8) (28) 109 — (22) (22) ABS 128 — — (410) (282) 7 (271) (264) CMBS — — (4) (1) (5) 11 — 11 Trading securities ABS 35 — (16) — 19 — — — RMBS — — — — — 5 (1) 4 Equity securities 11 — — (6) 5 — — — Mortgage loans — — — (8) (8) — — — Short-term investments 3 — (7) (35) (39) — — — Investments in related parties AFS securities Corporate 195 — — — 195 — — — ABS 2,156 — (5) (262) 1,889 — (165) (165) Trading securities CLO 27 — (13) — 14 15 (4) 11 ABS 802 — (11) (14) 777 — — — Equity securities 18 — (1) (5) 12 — (5) (5) Investment funds 1,678 — (75) — 1,603 — — — Total Level 3 assets $ 5,377 $ — $ (145) $ (937) $ 4,295 $ 107 $ (509) $ (402) Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (1,188) $ — $ 641 $ (547) $ — $ — $ — Total Level 3 liabilities $ — $ (1,188) $ — $ 641 $ (547) $ — $ — $ — Significant Unobservable Inputs — Significant unobservable inputs occur when we could not obtain or corroborate the quantitative detail of the inputs. This applies to fixed maturity securities, equity securities, mortgage loans and certain derivatives, as well as embedded derivatives in liabilities. Additional significant unobservable inputs are described below. AFS and trading securities – For certain fixed maturity securities, discounted cash flow models are used to calculate the fair value. The discount rate is a significant unobservable input because the credit spread includes adjustments made to the base rate. The base rate represents a market comparable rate for securities with similar characteristics. This excludes assets for which fair value is provided by independent broker quotes, but includes assets for which fair value is provided by affiliated quotes. Interest sensitive contract liabilities – embedded derivative – Significant unobservable inputs we use in the fixed indexed annuities embedded derivative of the interest sensitive contract liabilities valuation include: 1. Nonperformance risk – For contracts we issue, we use the credit spread, relative to the US Department of the Treasury (Treasury) curve based on our public credit rating as of the valuation date. This represents our credit risk for use in the estimate of the fair value of embedded derivatives. 2. Option budget – We assume future hedge costs in the derivative’s fair value estimate. The level of option budgets determines the future costs of the options and impacts future policyholder account value growth. 3. Policyholder behavior – We regularly review the lapse and withdrawal assumptions (surrender rate). These are based on our initial pricing assumptions updated for actual experience. Actual experience may be limited for recently issued products. The following summarizes the unobservable inputs for AFS and trading securities and the embedded derivatives of fixed indexed annuities: December 31, 2021 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS and trading securities $ 10,167 Discounted cash flow Discount rate 1.4 % 19.4 % 5.2 % 1 Decrease Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives $ 14,907 Option budget method Nonperformance risk 0.1 % 1.0 % 0.6 % 2 Decrease Option budget 0.4 % 3.4 % 1.9 % 3 Increase Surrender rate 5.9 % 10.7 % 8.0 % 4 Decrease December 31, 2020 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS and trading securities $ 5,858 Discounted cash flow Discount rate 1.7 % 35.0 % 4.6 % 1 Decrease Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives $ 12,873 Option budget method Nonperformance risk 0.0 % 1.1 % 0.5 % 2 Decrease Option budget 0.6 % 3.5 % 1.9 % 3 Increase Surrender rate 5.3 % 9.5 % 7.1 % 4 Decrease 1 The discount rate weighted average is calculated based on the relative fair values of the securities. 2 The nonperformance risk weighted average is based on the projected excess benefits of reserves used in the calculation of the embedded derivative. 3 The option budget weighted average is calculated based on the indexed account values. 4 The surrender rate weighted average is calculated based on projected account values. Financial Instruments Without Readily Determinable Fair Values —We had elected the measurement alternative for certain equity securities that did not have a readily determinable fair value. The equity securities were held at cost less impairment. As of December 31, 2021, these equity securities no longer qualified for the measurement alternative and are measured at fair value. As of December 31, 2020, the carrying amount of the equity securities was $202 million, with a cumulative impairment of $231 million. Fair Value of Financial Instruments Not Carried at Fair Value — The following represents our financial instruments not carried at fair value on the consolidated balance sheets: December 31, 2021 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Mortgage loans $ 22,540 $ 23,059 $ — $ — $ — $ 23,059 Investment funds 995 995 995 — — — Policy loans 312 312 — — 312 — Funds withheld at interest 43,125 43,125 — — — 43,125 Other investments 1,343 1,343 — — — 1,343 Investments in related parties Mortgage loans 1,591 1,600 — — — 1,600 Investment funds 4,433 4,433 4,433 — — — Funds withheld at interest 11,629 11,629 — — — 11,629 Other investments 222 223 — — — 223 Total financial assets not carried at fair value $ 86,190 $ 86,719 $ 5,428 $ — $ 312 $ 80,979 Financial liabilities Interest sensitive contract liabilities $ 105,293 $ 108,621 $ — $ — $ — $ 108,621 Long-term debt 2,964 3,295 — — 3,295 — Securities to repurchase 3,110 3,110 — — 3,110 — Funds withheld liability 394 394 — — 394 — Total financial liabilities not carried at fair value $ 111,761 $ 115,420 $ — $ — $ 6,799 $ 108,621 December 31, 2020 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Mortgage loans $ 15,245 $ 15,811 $ — $ — $ — $ 15,811 Investment funds 642 642 642 — — — Policy loans 369 369 — — 369 — Funds withheld at interest 46,668 46,668 — — — 46,668 Other investments 467 471 — — — 471 Investments in related parties Mortgage loans 674 694 — — — 694 Investment funds 3,165 3,165 3,165 — — — Funds withheld at interest 12,168 12,168 — — — 12,168 Other investments 469 499 — — — 499 Total financial assets not carried at fair value $ 79,867 $ 80,487 $ 3,807 $ — $ 369 $ 76,311 Financial liabilities Interest sensitive contract liabilities $ 94,685 $ 98,945 $ — $ — $ — $ 98,945 Long-term debt 1,976 2,259 — — 2,259 — Securities to repurchase 598 598 — — 598 — Funds withheld liability 393 393 — — 393 — Total financial liabilities not carried at fair value $ 97,652 $ 102,195 $ — $ — $ 3,250 $ 98,945 We estimate the fair value for financial instruments not carried at fair value using the same methods and assumptions as those we carry at fair value. The financial instruments presented above are reported at carrying value on the consolidated balance sheets; however, in the case of policy loans, funds withheld at interest and liability, short-term investments, short-term debt and securities to repurchase, the carrying amount approximates fair value. Other investments – The fair value of other investments is determined using a discounted cash flow model using discount rates for similar investments. Interest sensitive contract liabilities – The carrying and fair value of interest sensitive contract liabilities above includes fixed indexed and traditional fixed annuities without mortality or morbidity risks, funding agreements and payout annuities without life contingencies. The embedded derivatives within fixed indexed annuities without mortality or morbidity risks are excluded, as they are carried at fair value. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates, adding a spread to reflect our nonperformance risk and subtracting a risk margin to reflect uncertainty inherent in the projected cash flows. Long-term debt – We obtain the fair value of long-term debt from commercial pricing services. These are classified as Level 2. The pricing services incorporate a variety of market observable information in their valuation techniques, including benchmark yields, trading activity, credit quality, issuer spreads, bids, offers and other reference data.

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2021
Insurance [Abstract]
Reinsurance	6. Reinsurance The following summarizes the effect of reinsurance on premiums and future policy and other policy benefits on the consolidated statements of income: Years ended December 31, (In millions) 2021 2020 2019 Premiums Direct $ 13,989 $ 5,691 $ 5,449 Reinsurance assumed 388 413 1,092 Reinsurance ceded (115) (141) (159) Total premiums $ 14,262 $ 5,963 $ 6,382 Future policy and other policy benefits Direct $ 15,482 $ 7,016 $ 6,697 Reinsurance assumed 503 522 1,223 Reinsurance ceded (251) (351) (333) Total future policy and other policy benefits $ 15,734 $ 7,187 $ 7,587 Reinsurance typically provides for recapture rights on the part of the ceding company for certain events of default. Additionally, some agreements require us to place assets in trust accounts for the benefit of the ceding entity. The required minimum assets are equal to or greater than statutory reserves, as defined by the agreement, and were $6,380 million and $6,538 million as of December 31, 2021 and 2020 , respectively. Although we own the assets placed in trust, their use is restricted based on the trust agreement terms. If the statutory book value of the assets, or in certain cases fair value, in a trust declines because of impairments or other reasons, we may be required to contribute additional assets to the trust. In addition, the assets within a trust may be subject to a pledge in favor of the applicable reinsurance company. Reinsurance transactions We have entered into various coinsurance and modco agreements to reinsure blocks of fixed deferred and fixed indexed and pension group annuities. The following summarizes those agreements at inception: Years ended December 31, (In millions) 2020 2019 Liabilities assumed $ 27,439 $ 791 Less: Assets received 28,805 818 Net cost of reinsurance $ (1,366) $ (27) Unearned revenue reserve 1 $ (1,366) $ — Deferred profit liability 2 — (27) Net cost of reinsurance $ (1,366) $ (27) 1 Included within interest sensitive contract liabilities on the consolidated balance sheets. 2 Included within future policy benefits on the consolidated balance sheets. Unearned revenue reserve balances are amortized over the life of the reinsurance agreements on a basis consistent with our DAC amortization policy. The deferred profit liability balance is amortized over the life of the reinsurance agreement on a constant relationship to the benefit reserves. Effective July 1, 2020, we restructured our reinsurance agreement with Mass Mutual Life Insurance Company (MassMutual). MassMutual recaptured the existing coinsurance agreement and we immediately entered into a new funds withheld coinsurance agreement with our ALRe subsidiary. As a result, we recorded a $5,021 million increase in funds withheld at interest and a corresponding decrease in assets, primarily consisting of investments and cash. Global Atlantic – We have a 100% coinsurance and assumption agreement with Global Atlantic. The agreement ceded all existing open block life insurance business issued by Athene Annuity and Life Company (AAIA), with the exception of enhanced guarantee universal life insurance products. We also entered into a 100% coinsurance agreement with Global Atlantic to cede all policy liabilities of the ILICO Closed Block. The ILICO Closed Block consists primarily of participating whole life insurance policies. We also have an excess of loss arrangement with Global Atlantic to reimburse us for any payments required from our general assets to meet the contractual obligations of the AmerUs Closed Block not covered by existing reinsurance through Athene Re USA IV. The AmerUs Closed Block consists primarily of participating whole life insurance policies. Since all liabilities were covered by the existing reinsurance at close, no reinsurance premiums were ceded. The assets backing the AmerUs Closed Block are managed, on AAIA’s behalf, by Goldman Sachs Asset Management. As of December 31, 2021 and 2020 , Global Atlantic maintained a series of trust and custody accounts under the terms of these agreements with assets equal to or greater than a required aggregate statutory balance of $2,854 million and $3,022 million, respectively. Protective Life Insurance Company (Protective) – We reinsured substantially all of the existing life and health business of Athene Annuity & Life Assurance Company (AADE) to Protective under a coinsurance agreement in 2011. As of December 31, 2021 and 2020 , Protective maintained a trust for our benefit with assets having a fair value of $1,624 million and $1,722 million, respectively. Reinsurance Recoverables —The following summarizes our reinsurance recoverable from the following: December 31, (In millions) 2021 2020 Global Atlantic $ 2,916 $ 3,108 Protective 1,515 1,558 Other 1 163 182 Reinsurance recoverable $ 4,594 $ 4,848 1 Represents all other reinsurers, with no single reinsurer having a carrying value in excess of 5% of total recoverable.

Deferred Acquisition Costs, Def

Deferred Acquisition Costs, Deferred Sales Inducements, and Value of Business Acquired	12 Months Ended
	Dec. 31, 2021
Insurance [Abstract]
Deferred Acquisition Costs, Deferred Sales Inducements, and Value of Business Acquired	7. Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired The following represents a rollforward of DAC, DSI and VOBA: (In millions) DAC DSI VOBA Total Balance at December 31, 2018 $ 3,921 $ 799 $ 1,187 $ 5,907 Additions 645 226 — 871 Unlocking (117) (9) (24) (150) Amortization (749) (65) (68) (882) Impact of unrealized investment (gains) losses (426) (131) (181) (738) Balance at December 31, 2019 3,274 820 914 5,008 Adoption of accounting standard 12 5 5 22 Additions 633 178 — 811 Unlocking (36) (13) (11) (60) Amortization (414) (53) (60) (527) Impact of unrealized investment (gains) losses (233) (80) (35) (348) Balance at December 31, 2020 3,236 857 813 4,906 Additions 698 265 — 963 Unlocking (18) (16) 24 (10) Amortization (483) (182) (155) (820) Impact of unrealized investment (gains) losses 182 54 87 323 Balance at December 31, 2021 $ 3,615 $ 978 $ 769 $ 5,362 The expected amortization of VOBA for the next five years is as follows: (In millions) Expected Amortization 2022 $ 59 2023 62 2024 64 2025 62 2026 59

Closed Block

Closed Block	12 Months Ended
	Dec. 31, 2021
Insurance [Abstract]
Closed Block	8. Closed Block We pay guaranteed benefits under all policies included in the Closed Blocks. In the event the performance of the Closed Blocks’ assets is insufficient to maintain dividend scales and interest credits, we may reduce the policyholder dividend scales. In the event dividends have been reduced to zero and the Closed Blocks’ assets remain insufficient to fund the Closed Blocks’ guaranteed benefits, we would use assets supporting open block policies or surplus to meet the contractual benefits of the Closed Blocks’ policyholders. The ILICO Closed Block has been ceded to Global Atlantic. Therefore, Global Atlantic would be required to provide funding for any asset insufficiency related to the ILICO Closed Block. Additionally, the AmerUs Closed Block has a letter of credit and tail risk reinsurance agreement in place that limits our exposure to potential asset insufficiency. We elected the fair value option for the AmerUs Closed Block. The fair value of liabilities of the AmerUs Closed Block was derived at election as the sum of the fair value of the AmerUs Closed Block assets plus our cost of capital in the AmerUs Closed Block. The cost of capital was then determined to be the present value of the projected release of required capital and future after tax earnings on required capital supporting the AmerUs Closed Block, discounted at a rate which represents a market participant’s required rate of return, less the initial required capital. At each reporting period, we record the fair value of the AmerUs Closed Block by adjusting the change in liabilities, exclusive of the cost of capital, to equal the change in assets. We do not record additional policyholder dividend obligations, as there are no future GAAP earnings available to the policyholders. The excess of the fair value of the liabilities over the fair value of the assets represents our cost of capital in the AmerUs Closed Block. The maximum amount of future earnings from the assets and liabilities of the AmerUs Closed Block is represented by the reduction in the cost of capital in future years based on the operations of the AmerUs Closed Block and recalculation of the cost of capital each reporting period. Summarized financial information of the AmerUs Closed Block is presented below. December 31, (In millions) 2021 2020 Liabilities Future policy benefits $ 1,520 $ 1,600 Other policy claims and benefits 16 15 Dividends payable to policyholders 75 84 Total liabilities 1,611 1,699 Assets Trading securities 1,321 1,431 Mortgage loans, net of allowances 17 19 Policy loans 108 124 Total investments 1,446 1,574 Cash and cash equivalents 63 35 Accrued investment income 46 44 Reinsurance recoverable 14 16 Other assets 10 2 Total assets 1,579 1,671 Maximum future earnings to be recognized from AmerUs Closed Block $ 32 $ 28 The following represents the contribution from AmerUs Closed Block. Years ended December 31, (In millions) 2021 2020 2019 Revenues Premiums $ 42 $ 48 $ 54 Net investment income 68 71 74 Investment related gains (losses) (61) 99 147 Total revenues 49 218 275 Benefits and Expenses Future policy and other policy benefits 24 177 234 Dividends to policyholders 27 38 36 Total benefits and expenses 51 215 270 Contribution (to) from AmerUs Closed Block before income taxes (2) 3 5 Income tax expense (benefit) 2 1 (1) Contribution (to) from AmerUs Closed Block, net of income taxes $ (4) $ 2 $ 6

Debt

Debt	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Debt	9. Debt Credit Facility —We have a revolving credit agreement with Citibank, N.A. as administrative agent, which matures on December 3, 2024, subject to up to two one-year extensions (Credit Facility). The borrowing capacity under the Credit Facility is $1.25 billion, with potential increases up to $1.75 billion. In connection with the Credit Facility, AHL and AUSA guaranteed all of the obligations of AHL, ALRe, Athene Annuity Re Ltd. (AARe) and AUSA under this facility, and ALRe and AARe guaranteed certain of the obligations of AHL, ALRe, AARe and AUSA under this facility. The Credit Facility contains various standard covenants with which we must comply, including the following: 1. Consolidated debt to capitalization ratio of not greater than 35%; 2. Minimum consolidated net worth of no less than $7.3 billion; and 3. Restrictions on our ability to incur debt and liens, in each case with certain exceptions. As of December 31, 2021 and 2020, we had no amounts outstanding under the Credit Facility and were in compliance with all covenants under the facility. Interest accrues on outstanding borrowings at either the Eurodollar Rate (as defined in the Credit Facility) plus a margin or a base rate plus a margin, with the applicable margin varying based on AHL’s Debt Rating (as defined in the Credit Facility). The Credit Facility has a commitment fee that is determined by reference to AHL’s Debt Rating, and ranges from 0.10% to 0.30% of the undrawn commitment. As of December 31, 2021 and 2020, the commitment fee was 0.15% of the undrawn commitment. Senior Notes —The following is a summary of our senior notes as of December 31, 2021: 2028 Notes 2030 Notes 2031 Notes 2051 Notes 2052 Notes Issue date January 12, 2018 April 3, 2020 October 8, 2020 May 25, 2021 December 13, 2021 Principal balance (in millions) $ 1,000 $ 500 $ 500 $ 500 $ 500 Outstanding balance (in millions) $ 994 $ 495 $ 490 $ 491 $ 494 Interest rate 4.125 % 6.150 % 3.500 % 3.950 % 3.450 % Maturity date January 12, 2028 April 3, 2030 January 15, 2031 May 25, 2051 May 15, 2052 The senior unsecured notes are callable by AHL at any time. If called prior to three months before the scheduled maturity date, the price is equal to the greater of (1) 100% of the principal and any accrued and unpaid interest and (2) an amount equal to the sum of the present values of remaining scheduled payments, discounted from the scheduled payment date to the redemption date treasury rate plus a spread as defined in the applicable prospectus supplement and any accrued and unpaid interest. Interest expense on long-term debt was $105 million, $69 million and $42 million for the years ended December 31, 2021, 2020 and 2019, respectively.

Equity

Equity	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Common Stock	10. Equity Preferred Stock— We have four series of preferred stock: 6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, Series A (Series A); 5.625% Fixed-Rate Perpetual Non-Cumulative Preference Shares, Series B (Series B); 6.375% Fixed-Rate Reset Perpetual Non-Cumulative Preference Shares, Series C (Series C); and 4.875% Fixed-Rate Perpetual Non-Cumulative Preference Shares, Series D (Series D) as summarized below: Series A Series B Series C Series D Issue date June 10, 2019 September 19, 2019 June 11, 2020 December 18, 2020 Authorized, issued and outstanding 34,500 13,800 24,000 23,000 Liquidation preference per share $ 25,000 $ 25,000 $ 25,000 $ 25,000 The following summarizes dividends declared and paid per preferred stock share by series: Years ended December 31, (Per share) 2021 2020 2019 Series A $ 1,587.50 $ 1,587.51 $ 881.95 Series B 1,406.25 1,406.25 394.53 Series C 1,593.75 880.99 — Series D 1,259.38 — — The following summarizes dividends declared and paid in the aggregate on the preferred stock by series: Years ended December 31, (In millions) 2021 2020 2019 Series A $ 55 $ 55 $ 31 Series B 19 19 5 Series C 38 21 — Series D 29 — — Total dividends declared and paid $ 141 $ 95 $ 36 Preferred stock dividends are payable on a non-cumulative basis only when, as and if declared, quarterly in arrears on the 30 th day of March, June, September and December of each year. Preferred stock ranks senior to our common stock with respect to dividends, to the extent declared, and in liquidation, to the extent of the liquidation preference. Common Stock— Prior to the closing of our merger with AGM, o ur bye-laws placed certain restrictions on Class A shares such that a holder of Class A shares, except for shareholders permitted by our board of directors, which include members of the Apollo Group, as defined in our bye-laws, could not control greater than 9.9% of the total outstanding vote and if a holder of Class A shares were to control greater than 9.9%, then such holder’s voting power is automatically reduced to 9.9% and the other holders of Class A shares would vote the remainder on a prorated basis. During the first quarter of 2020, shareholders approved amendments to our bye-laws which eliminated our multi-class share structure at the closing of the share transaction with AGM. See Note 14 – Related Parties for further information on this transaction. Class B shares outstanding were converted to Class A shares on a one-to-one basis. Class M shares outstanding were converted to Class A shares representing 5% of the Class M value and warrants representing 95% of the Class M value. The warrants were issued with substantially the same terms, including the same economic terms, as the Class M shares. As of December 31, 2021, we had 8.1 million warrants outstanding with a weighted average conversion price of $18.40. Upon closing of our merger with AGM, the outstanding warrants were converted to AGM common stock. Prior to the share transaction with AGM in the first quarter of 2020, we had six classes of common stock: Class A, Class B, Class M-1, Class M-2, Class M-3 and Class M-4. The Class M-1, Class M-2, Class M-3 and Class M-4 shares were collectively referred to as Class M shares. Class A shares collectively represented 55% of the total voting power of the Company. Class B shares collectively represented the remaining 45% of the total voting power of the Company, and were beneficially owned by shareholders who were members of the Apollo Group, as defined in our bye-laws. Class B shares were convertible to Class A shares on a one-to-one basis at any time upon notice to us. Class M shares were restricted, non-voting shares previously issued under equity incentive plans. Class M shares functioned similar to options in that they were exchangeable into Class A shares upon payment of a conversion price and satisfaction of other conditions, including vesting conditions. Share Repurchase Authorizations Our board of directors previously approved authorizations of $1,567 million for the repurchase of our Class A shares under our repurchase program; however, the program was terminated following the closing of our merger with AGM. The following summarizes the activity on our share repurchase authorizations: Years ended December 31, (In millions) 2021 2020 2019 Beginning balance $ 221 $ 640 $ 150 Authorizations — — 1,317 Repurchases — (419) (827) Ending balance $ 221 $ 221 $ 640 As of December 31, 2021, we had $406,810 aggregate par value of authorized but undesignated shares (equivalent to 406.8 million shares if designated as Class A common shares). Dividends Declared Our board of directors declared common stock cash dividends of $750 million on December 31, 2021, payable to holders of the Company’s Class A shares with a record date and payment date following the completion of our merger with AGM. The dividend payable was included in related party other liabilities on the consolidated balance sheets as of December 31, 2021. The dividend was paid on January 4, 2022. The table below shows the changes in each class of shares issued and outstanding: Years ended December 31, (In millions) 2021 2020 2019 Class A Beginning balance 191.5 143.2 162.4 Issued shares 0.9 36.0 0.7 Forfeited shares (0.2) (0.1) (0.1) Repurchased shares — (13.3) (19.8) Converted from Class B shares — 25.4 — Converted from Class M — 0.3 — Ending balance 192.2 191.5 143.2 Class B Beginning balance — 25.4 25.4 Converted to Class A shares — (25.4) — Ending balance — — 25.4 Class M-1 Beginning balance — 3.3 3.4 Converted to Class A shares — (0.2) (0.1) Converted to warrants — (3.1) — Ending balance — — 3.3 Class M-2 Beginning balance — 0.8 0.8 Converted to Class A shares — 0.0 — Converted to warrants — (0.8) — Ending balance — — 0.8 Class M-3 Beginning balance — 1.0 1.0 Converted to Class A shares — 0.0 — Converted to warrants — (1.0) — Ending balance — — 1.0 Class M-4 Beginning balance — 4.0 4.1 Converted to Class A shares — (0.1) (0.1) Converted to warrants — (3.6) — Repurchased shares — (0.3) — Ending balance — — 4.0 Acc umulated Other Comprehensive Income (Loss)— The following provides the details and changes in AOCI: (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance 2 Unrealized investment gains (losses) on AFS securities with a credit allowance 2 DAC, DSI, VOBA and future policy benefits adjustments on AFS securities Unrealized gains (losses) on hedging instruments Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at December 31, 2018 $ (628) $ — $ 121 $ 39 $ (4) $ (472) Other comprehensive income (loss) before reclassifications 4,929 — (1,322) 29 1 3,637 Less: Reclassification adjustments for gains (losses) realized in net income 1 225 — (56) — — 169 Less: Income tax expense (benefit) 958 — (266) 6 — 698 Less: Other comprehensive income attributable to NCI, net of subsidiary issuance of equity interests and tax 16 — — 1 — 17 Balance at December 31, 2019 3,102 — (879) 61 (3) 2,281 Adoption of accounting standards 4 (4) (6) — — (6) Other comprehensive income (loss) before reclassifications 3,312 (61) (634) (106) 18 2,529 Less: Reclassification adjustments for gains (losses) realized in net income 1 353 — (94) — — 259 Less: Income tax expense (benefit) 566 (12) (115) (26) — 413 Less: Other comprehensive income attributable to NCI 147 — — 7 7 161 Balance at December 31, 2020 5,352 (53) (1,310) (26) 8 3,971 Other comprehensive income (loss) before reclassifications (2,988) 52 605 246 (10) (2,095) Less: Reclassification adjustments for gains (losses) realized in net income 1 (65) — 17 14 — (34) Less: Income tax expense (benefit) (558) 10 123 54 — (371) Less: Other comprehensive income (loss) attributable to NCI (154) — — 6 (1) (149) Balance at December 31, 2021 $ 3,141 $ (11) $ (845) $ 146 $ (1) $ 2,430 1 Recognized in investment related gains (losses) on the consolidated statements of income. 2 Previously reported amounts for the year ending December 31, 2020 have been revised to correct a misstatement, which was not material, in the classification of balances and changes attributable to AFS securities with and without credit allowances.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share	11. Earnings Per Share The following represents our basic and diluted EPS calculations: Year ended December 31, 2021 (In millions, except per share data) Class A Net income available to Athene Holding Ltd. common shareholders – basic and diluted $ 3,718 Basic weighted average shares outstanding 191.6 Dilutive effect of stock compensation plans and warrants 7.1 Diluted weighted average shares outstanding 198.7 Earnings per share Basic $ 19.40 Diluted $ 18.71 Year ended December 31, 2020 (In millions, except per share data) Class A Class B Class M-1 Class M-2 Class M-3 Class M-4 Net income (loss) available to Athene Holding Ltd. common shareholders – basic and diluted $ 1,573 $ (98) $ (13) $ (3) $ (4) $ (9) Basic weighted average shares outstanding 184.9 25.4 3.3 0.8 1.0 2.4 Dilutive effect of stock compensation plans and warrants 3.7 — — — — — Diluted weighted average shares outstanding 188.6 25.4 3.3 0.8 1.0 2.4 Earnings (loss) per share Basic $ 8.51 $ (3.87) $ (3.87) $ (3.87) $ (3.87) $ (3.87) Diluted $ 8.34 $ (3.87) $ (3.87) $ (3.87) $ (3.87) $ (3.87) Year ended December 31, 2019 (In millions, except per share data) Class A Class B Class M-1 Class M-2 Class M-3 Class M-4 Net income available to Athene Holding Ltd. common shareholders – basic and diluted $ 1,760 $ 291 $ 38 $ 10 $ 11 $ 26 Basic weighted average shares outstanding 153.9 25.4 3.3 0.8 1.0 2.2 Dilutive effect of stock compensation plans 0.4 — — — — 0.3 Diluted weighted average shares outstanding 154.3 25.4 3.3 0.8 1.0 2.5 Earnings per share Basic $ 11.44 $ 11.44 $ 11.44 $ 11.44 $ 11.44 $ 11.44 Diluted $ 11.41 $ 11.44 $ 11.44 $ 11.44 $ 11.44 $ 9.94 For the periods in which we had multiple classes of stock participating in earnings, we used the two-class method for allocating net income available to Athene Holding Ltd. common shareholders to each class of our common stock. During the first quarter of 2020, as a result of the closing of the share transaction discussed further in Note 14 – Related Parties , we converted outstanding Class B shares to Class A shares and Class M shares were converted to Class A shares and warrants. As a result, the EPS calculation for the year ended December 31, 2020 allocated all net income for the second, third and fourth quarters to Class A shares and, for the first quarter of 2020, used only the weighted average shares for the first quarter to allocate first quarter net loss to Class B and Class M shares. However, for Class B and Class M shares, the weighted average shares outstanding represented only that period of time that the shares were outstanding. The warrants issued as part of the conversion of the Class M shares are included within the dilutive effect of stock compensation plans and warrants above if dilutive. Dilutive shares are calculated using the treasury stock method. For Class A shares, this method takes into account shares that can be settled into Class A shares, net of a conversion price. As of December 31, 2021, 2020 and 2019, the diluted EPS calculations for Class A shares excluded 0.8 million, 1.8 million and 31.9 million shares, respectively.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes Income tax expense consists of the following: Years ended December 31, (In millions) 2021 2020 2019 Current $ 410 $ 107 $ 53 Deferred (24) 178 64 Income tax expense $ 386 $ 285 $ 117 Income tax expense was calculated based on the following income (loss) before income taxes by jurisdiction: Years ended December 31, (In millions) 2021 2020 2019 Bermuda $ 2,780 $ 903 $ 1,895 US 1,559 1,083 528 United Kingdom (153) 220 (121) Income before income taxes $ 4,186 $ 2,206 $ 2,302 The expected tax provision computed on pre-tax income at the weighted average tax rate has been calculated as the sum of the pre-tax income in each jurisdiction multiplied by that jurisdiction’s applicable statutory tax rate. Statutory tax rates of 0%, 21% and 19% have been used for Bermuda, the US and the United Kingdom (UK), respectively, for the years ended December 31, 2021, 2020 and 2019. A reconciliation of the difference between the expected tax provision at the weighted average tax rate and income tax expense is as follows: Years ended December 31, (In millions, except for percentages) 2021 2020 2019 Expected tax provision computed on pre-tax income at weighted average income tax rate $ 299 $ 268 $ 88 Increase in income taxes resulting from: Deferred tax valuation allowance (2) 8 16 Non-deductible expenses 19 5 17 Prior year true-up 4 (4) 2 Corporate owned life insurance 52 (6) (6) Stock compensation expense 2 — 2 State taxes and other 12 14 (2) Income tax expense $ 386 $ 285 $ 117 Effective tax rate 9 % 13 % 5 % During the third quarter of 2021, we recorded an out-of-period adjustment that affected the consolidated statements of income. The adjustment related to the correction of errors in jurisdictional income, which resulted in the misstatement of income tax expense. The adjustment understated income tax expense for the year ended December 31, 2021 by $63 million. We evaluated the out-of-period adjustment and determined it was not material to the consolidated financial statements for the year ended December 31, 2021, or any other previously reported period. Total income taxes were as follows: Years ended December 31, (In millions) 2021 2020 2019 Income tax expense $ 386 $ 285 $ 117 Income tax expense (benefit) from OCI (371) 413 698 Total income tax expense $ 15 $ 698 $ 815 Current income tax recoverable and deferred tax assets are included in other assets on the consolidated balance sheets, and current income tax payable and deferred tax liabilities are included in other liabilities on the consolidated balance sheets. Current and deferred income tax assets and liabilities were as follows: December 31, (In millions) 2021 2020 Current income tax recoverable $ 2 $ 55 Current income tax payable 169 — Net current income tax recoverable (payable) $ (167) $ 55 Deferred tax assets $ — $ — Deferred tax liabilities 576 972 Net deferred tax liabilities $ (576) $ (972) Deferred income tax assets and liabilities consisted of the following: December 31, (In millions) 2021 2020 Deferred tax assets Insurance liabilities $ 2,169 $ 1,723 Net operating and capital loss carryforwards 60 86 Employee benefits 22 20 Other 39 36 Total deferred tax assets 2,290 1,865 Valuation allowance (66) (74) Deferred tax assets, net of valuation allowance 2,224 1,791 Deferred tax liabilities Investments, including derivatives 974 998 Net unrealized gains on AFS 626 997 DAC, DSI and VOBA 1,026 767 Other 174 1 Total deferred tax liabilities 2,800 2,763 Net deferred tax liabilities $ (576) $ (972) As of December 31, 2021, we have gross deferred tax assets associated with US federal and state net operating losses of $421 million, which will begin to expire in 2022. The valuation allowance consists of the following: December 31, (In millions) 2021 2020 US federal and state net operating losses and other deferred tax assets $ 30 $ 50 UK net operating losses and other deferred tax assets 36 24 Total valuation allowance $ 66 $ 74 AHL and its Bermuda subsidiaries file protective US income tax returns and its US subsidiaries file income tax returns with the US federal government and various US state governments. AADE is not subject to US federal and state examinations by tax authorities for years prior to 2013, while Athene Annuity & Life Assurance Company of New York (AANY) is not subject to examinations for years prior to 2015. The Internal Revenue Service is currently auditing the 2013 consolidated tax return filed by AUSA, is conducting a limited scope audit of the 2015 consolidated tax return filed by AADE, and is auditing the 2017 consolidated tax return filed by AADE. No material adverse proposed adjustments have been issued with respect to any examination . Under current Bermuda law, we are not required to pay any taxes in Bermuda on either income or capital gains. We have received an undertaking from the Bermuda Minister of Finance that, in the event of any such taxes being imposed, we will be exempted from taxation until the year 2035. We expect that earnings from AHL’s US subsidiaries will not be subject to US dividend withholding tax under the benefits provided by the income tax treaty between the US and the UK. Any dividends remitted from ALRe are not subject to withholding tax.

Statutory Requirements

Statutory Requirements	12 Months Ended
	Dec. 31, 2021
Insurance [Abstract]
Insurance Disclosure [Text Block]	13. Statutory Requirements Our insurance and reinsurance subsidiaries are subject to insurance laws and regulations in the jurisdictions in which they operate including Bermuda and the US. Certain regulations include restrictions that limit the dividends or other distributions, such as loans or cash advances, available to shareholders without prior approval of the insurance regulatory authorities. The differences between financial statements prepared for insurance regulatory authorities and GAAP financial statements vary by jurisdiction. Bermuda statutory requirements —ALRe, AARe and Athene Co-Invest Reinsurance Affiliate 1A Ltd. (ACRA 1A) are each licensed by the Bermuda Monetary Authority (BMA) as long-term insurers and are subject to the Insurance Act 1978, as amended (Bermuda Insurance Act) and regulations promulgated thereunder. The BMA implemented the Economic Balance Sheet (EBS) framework into the Bermuda Solvency Capital Requirement (BSCR), which was granted equivalence to the European Union’s Directive (2009/138/EC) (Solvency II). Under the Bermuda Insurance Act, long-term insurers are required to maintain minimum statutory capital and surplus to meet the minimum margin of solvency (MMS) and minimum economic statutory capital and surplus (EBS capital and surplus) to meet the Enhanced Capital Requirement (ECR). For our Class C reinsurer, ACRA 1A, MMS is equal to the greater of $500,000, 1.5% of the total statutory assets or 25% of ECR. For our Class E reinsurers, ALRe and AARe, MMS is equal to the greater of $8 million, 2% of the first $500 million of statutory assets plus 1.5% of statutory assets above $500 million or 25% of ECR. For each class, the ECR is calculated based on a risk-based capital model where risk factor charges are applied to the EBS. The ECR is floored at the MMS. As of December 31, 2021, our Bermuda subsidiaries were in excess of the minimum levels required. For our Bermuda reinsurance subsidiaries, the ECR is the binding regulatory constraint. The following represents the EBS capital and surplus and BSCR ratios: EBS capital & surplus BSCR ratio December 31, December 31, (In millions) 2021 2020 2021 2020 ALRe $ 14,630 $ 17,168 209 % 254 % AARe 6,632 2,441 2,460 % 967 % ACRA 1A 3,872 2,945 183 % 236 % Under the EBS framework, statutory financial statements are generally equivalent to GAAP financial statements, with the exception of permitted practices granted by the BMA. Our Bermuda subsidiaries have permission in the statutory financial statements to use amortized cost instead of fair value as the basis for certain investments. Additionally, our Bermuda subsidiaries use US statutory reserving principles for the calculation of insurance reserves instead of GAAP, subject to the reserves being proved adequate based on cash flow testing. The following represents the effect of the permitted practices to the statutory financial statements: December 31, 2021 (In millions) ALRe AARe 1 ACRA 1A Decrease to capital and surplus due to permitted practices $ 3,963 $ (4,979) $ 980 Decrease to statutory net income due to permitted practices (635) 2,678 599 1 AARe has permission to use amortized cost instead of fair value as the basis for certain investments but does not produce GAAP financial statements. The effect of the permitted practices to the AARe statutory financial statements reflects the impact of the difference between amortized cost and fair value for certain investments. Under the Bermuda Insurance Act, our Bermuda subsidiaries are prohibited from paying a dividend in an amount exceeding 25% of the prior year’s statutory capital and surplus, unless at least two members of the companies’ respective board of directors and its principal representative in Bermuda sign and submit to the BMA an affidavit attesting that a dividend in excess of this amount would not cause the subsidiary to fail to meet its relevant margins. In certain instances, the Bermuda subsidiary would also be required to provide prior notice to the BMA in advance of the payment of dividends. In the event that such an affidavit is submitted to the BMA, and further subject to meeting the MMS and ECR requirements, a Bermuda subsidiary is permitted to distribute up to the sum of 100% of statutory surplus and an amount less than 15% of statutory capital. Distributions in excess of this amount require the approval of the BMA. The following represents the maximum distribution our Bermuda subsidiaries would be permitted to remit to its parent without the need for prior approval: December 31, (In millions) 2021 2020 ALRe $ 7,122 $ 9,971 AARe 165 1,096 ACRA 1A 1,759 1,592 US statutory requirements —Our regulated US subsidiaries and the corresponding insurance regulatory authorities are as follows: Subsidiary Regulatory Authority AADE Delaware Department of Insurance AAIA Iowa Insurance Division AANY New York Department of Financial Services Athene Re USA IV State of Vermont Department of Financial Regulation Each entity’s statutory statements are presented on the basis of accounting practices determined by the respective regulatory authority. The regulatory authority recognizes only statutory accounting practices prescribed or permitted by the corresponding state for determining and reporting the financial condition and results of operations of an insurance company and for determining its solvency under insurance law. The maximum dividend these subsidiaries can pay to shareholders, without prior approval of the respective state insurance department, is subject to restrictions relating to statutory surplus or net gain from operations. The maximum dividend payment over a twelve-month period may not, without prior approval, be paid from a source other than earned surplus and may not exceed the greater of (1) the prior year’s net gain from operations or (2) 10% of prior year’s policyholders’ surplus. Based on these restrictions, the maximum dividend AADE could pay to AUSA absent regulatory approval was $0 million and $170 million as of December 31, 2021 and 2020, respectively. Any dividends from AHL’s other US statutory entities in excess of the amounts allowed for AADE would not be able to be remitted to AUSA without regulatory approval from the Delaware Department of Insurance. As of December 31, 2021, our US subsidiaries’ solvency, liquidity and risk-based capital amounts were significantly in excess of the minimum levels required. In some instances, the states of domicile of our US subsidiaries have adopted prescribed accounting practices that differ from the required accounting outlined in NAIC Statutory Accounting Principles (SAP). These subsidiaries also have certain accounting practices permitted by the states of domicile that differ from those found in NAIC SAP. These prescribed and permitted practices are described as follows: AAIA – Among the products issued by AAIA are indexed universal life insurance and fixed indexed annuities. These products allow a portion of the premium to earn interest based on certain indices, primarily the S&P 500. We purchase call options, futures and variance swaps to hedge the growth in interest credited to the customer as a direct result of increases in the related index. The Iowa Insurance Division allows an insurer to elect (1) to use an amortized cost method to account for certain derivative instruments, such as call options, purchased to hedge the growth in interest credited to the customer on indexed insurance products and (2) to use an indexed annuity reserve calculation methodology under which call options associated with the current index interest crediting term are valued at zero. AAIA has elected to apply this option to its over-the-counter call options and reserve liabilities. As a result, AAIA’s statutory surplus decreased by $91 million and $84 million as of December 31, 2021 and 2020, respectively. Athene Re USA IV – AAIA has ceded the AmerUs Closed Block to Athene Re USA IV on a 100% funds withheld basis. A permitted practice in the State of Vermont allows Athene Re USA IV to include as admitted assets the face amount of all issued and outstanding letters of credit used to fund its reinsurance obligations to AAIA in its statutory financial statements. If Athene Re USA IV had not followed this permitted practice, then it would not have exceeded authorized control level risk based capital requirements. As of December 31, 2021 and 2020, Athene Re USA IV included as admitted assets $117 million and $134 million, respectively, related to the outstanding letters of credit. Statutory capital and surplus and net income (loss) —The following table presents, for each of our primary insurance subsidiaries, the statutory capital and surplus and the statutory net income (loss), based on the most recent statutory financial statements to be filed with insurance regulators: Statutory capital & surplus Statutory net income (loss) December 31, Years ended December 31, (In millions) 2021 2020 2021 2020 2019 ALRe $ 11,823 $ 13,518 $ 3,278 $ 1,544 $ 1,247 AARe 2,649 2,457 (3,703) 92 248 ACRA 1A 4,187 2,718 293 1,522 265 AADE 1,605 1,700 (70) 54 (86) AAIA 1,279 1,312 (182) (8) 241 AANY 304 320 (8) (25) 33

Related Parties

Related Parties	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Parties	14. Related Parties Apollo Fee structure – Substantially all of our investments are managed by Apollo. Apollo provides us a full suite of services that includes: direct investment management; asset sourcing and allocation; mergers and acquisition sourcing, execution and asset diligence; and strategic support and advice. Apollo also provides certain operational support services for our investment portfolio including investment compliance, tax, legal and risk management support. Apollo has extensive experience managing our investment portfolio and its knowledge of our liability profile enables it to tailor an asset management strategy to fit our specific needs. This strategy has proven responsive to changing market conditions and focuses on earning incremental yield by taking liquidity risk and complexity risk, rather than assuming solely credit risk. Our partnership has enabled us to take advantage of investment opportunities that would likely not otherwise have been available to us. Under our fee agreement with Apollo, we pay Apollo a base management fee of (1) 0.225% per year of the lesser of (A) the aggregate market value of substantially all of the assets in substantially all of the investment accounts of or relating to us (collectively, the Accounts) as of December 31, 2018 of $103.4 billion (Backbook Value) and (B) the aggregate market value of substantially all of the assets in the Accounts at the end of the respective month, plus (2) 0.15% per year of the amount, if any, by which the aggregate market value of substantially all of the assets in the Accounts at the end of the respective month exceeds the Backbook Value, subject to certain adjustments. Additionally, we pay a sub-allocation fee based on specified asset class tiers ranging from 0.065% to 0.70% of the market value, with the higher percentages in this range for asset classes that are designed to have more alpha generating abilities. For the years ended December 31, 2021, 2020 and 2019, we incurred management fees, inclusive of the base and sub-allocation fees, of $592 million, $490 million and $426 million, respectively. Management fees are included within net investment income on the consolidated statements of income. As of December 31, 2021 and 2020, management fees payable were $59 million and $41 million, respectively, and are included in other liabilities on the consolidated balance sheets. Such amounts include fees incurred attributable to ACRA including 100% of the noncontrolling interest in ACRA. In addition to the assets on our consolidated balance sheets managed by Apollo, Apollo manages the assets underlying our funds withheld receivable. For these assets, the third-party cedants pay Apollo fees based upon the same fee construct we have with Apollo. Such fees directly reduce the settlement payments that we receive from the third-party cedant and, as such, we indirectly pay those fees. Finally, Apollo charges management fees and carried interest on Apollo-managed funds and other entities in which we invest. Neither the fees paid by such third-party cedants nor the fees or carried interest paid by such Apollo-managed funds or other entities are included in the investment management fee amounts cited above. Investment management agreement (IMA) termination – Our bye-laws currently provide that, with respect to IMAs covering assets backing reserves and surplus in ACRA, whether from internal reinsurance, third-party reinsurance, or inorganic transactions, among us or any of our subsidiaries, on the one hand, and ISG, on the other hand, we will not terminate any such IMA with Apollo other than at specified termination dates and with relevant board approvals of independent directors and written notice. Governance – We have a management investment and asset liability committee, which includes members of our senior management and reports to the risk committee of our board of directors. The committee focuses on strategic decisions involving our investment portfolio, such as approving investment limits, new asset classes and our allocation strategy, reviewing large asset transactions, as well as monitoring our credit risk, and the management of our assets and liabilities. Prior to our merger with AGM on January 1, 2022, a significant voting interest in the Company was held by shareholders who are members of the Apollo Group. James Belardi, our Chief Executive Officer, also serves as a member of the board of directors and an executive officer of AGM, and, as Chief Executive Officer of ISG, receives compensation from ISG for services he provides. Mr. Belardi also owns a 5% profit interest in ISG and in connection with such interest receives a specified percentage of other fee streams earned by Apollo from us, including sub-allocation fees. Additionally, six of the sixteen members of our board of directors are employees of or consultants to Apollo (including Mr. Belardi). In order to protect against potential conflicts of interest resulting from transactions into which we have entered and will continue to enter into with the Apollo Group, our bye-laws require us to maintain a conflicts committee comprised solely of directors who are not general partners, directors (other than independent directors of AGM), managers, officers or employees of any member of the Apollo Group. The conflicts committee reviews and approves material transactions between us and the Apollo Group, subject to certain exceptions. Other related party transactions Athene Freedom Holdings LP – We have a limited partnership investment in Athene Freedom Holdings LP, for which an Apollo affiliate is the general partner. Athene Freedom Holdings LP indirectly invests in both Wheels, Inc. (Wheels) and Donlen, LLC (Donlen). Additionally, we own ABS and corporate debt securities issued by Wheels and Donlen, which are held as related party AFS securities on the consolidated balance sheets. The following summarizes these investments in Wheels/Donlen: (In millions) December 31, 2021 AFS securities $ 2,419 Investment fund 700 Total investment in Wheels/Donlen $ 3,119 A-A Mortgage – We have an equity method investment of $26 million and $444 million as of December 31, 2021 and 2020, respectively, in A-A Mortgage, which previously held an investment in AmeriHome. In 2021, Apollo and Athene sold AmeriHome to a subsidiary of Western Alliance Bancorporation and we recognized $182 million of revenue from the premium of the platform sale, net of carry and transaction expenses. We have a loan purchase agreement with AmeriHome, which survived the sale. The agreement allows us to purchase residential mortgage loans which AmeriHome has purchased from correspondent sellers and pooled for sale in the secondary market. AmeriHome retains the servicing rights to the sold loans. We purchased $0 million, $169 million and $411 million of residential mortgage loans under this agreement during the years ended December 31, 2021, 2020 and 2019, respectively. Additionally, as of December 31, 2020, we held $360 million of investments issued by AmeriHome or AmeriHome affiliates as related party AFS securities on the consolidated balance sheets. MidCap – We have multiple investments in MidCap including profit participating notes, senior unsecured notes and redeemable preferred stock, which are included in related party AFS or trading securities on the consolidated balance sheets. We also had advanced amounts to MidCap under a subordinated debt facility, which was included in related party other investments on the consolidated balance sheets. During the second quarter of 2021, the principal balance of the MidCap subordinated debt facility of $330 million was repaid and we received $19 million as a result of the early repayment. The following summarizes these investments in MidCap: December 31, (In millions) 2021 2020 Profit participating notes $ 635 $ 534 Senior unsecured notes 158 — Redeemable preferred stock 7 77 Subordinated debt facility — 328 Total investment in MidCap $ 800 $ 939 Additionally, we hold ABS and CLO securities issued by MidCap affiliates of $897 million and $630 million as of December 31, 2021 and 2020, respectively, which are included in related party AFS securities on the consolidated balance sheets. Athora – We have a cooperation agreement with Athora, pursuant to which, among other things, (1) for a period of 30 days from the receipt of notice of a cession, we have the right of first refusal to reinsure (a) up to 50% of the liabilities ceded from Athora’s reinsurance subsidiaries to Athora Life Re Ltd. and (b) up to 20% of the liabilities ceded from a third party to any of Athora’s insurance subsidiaries, subject to a limitation in the aggregate of 20% of Athora’s liabilities, (2) Athora agreed to cause its insurance subsidiaries to consider the purchase of certain funding agreements and/or other spread instruments issued by our insurance subsidiaries, subject to a limitation that the fair market value of such funding agreements purchased by any of Athora’s insurance subsidiaries may generally not exceed 3% of the fair market value of such subsidiary’s total assets, (3) we provide Athora with a right of first refusal to pursue acquisition and reinsurance transactions in Europe (other than the UK) and (4) Athora provides us and our subsidiaries with a right of first refusal to pursue acquisition and reinsurance transactions in North America and the UK. Notwithstanding the foregoing, pursuant to the cooperation agreement, Athora is only required to use its reasonable best efforts to cause its subsidiaries to adhere to the provisions set forth in the cooperation agreement and therefore Athora’s ability to cause its subsidiaries to act pursuant to the cooperation agreement may be limited by, among other things, legal prohibitions or the inability to obtain the approval of the board of directors or other applicable governing body of the applicable subsidiary, which approval is solely at the discretion of such governing body. As of December 31, 2021, we have not exercised our right of first refusal to reinsure liabilities ceded to Athora’s insurance or reinsurance subsidiaries. The following table summarizes our investments in Athora: December 31, (In millions) 2021 2020 Investment fund $ 743 $ 709 Non-redeemable preferred equity securities 171 — Total investment in Athora $ 914 $ 709 Additionally, as of December 31, 2021 and 2020, we had $63 million and $122 million, respectively, of funding agreements outstanding to Athora . We also have commitments to make additional investments in Athora of $512 million as of December 31, 2021. Venerable – We have coinsurance and modco agreements with Venerable Insurance and Annuity Company (VIAC). VIAC is a related party due to our minority equity investment in its holding company’s parent, VA Capital, which was $219 million and $123 million as of December 31, 2021 and 2020, respectively. The minority equity investment in VA Capital is included in related party investment funds on the consolidated balance sheets and accounted for as an equity method investment. VA Capital is owned by a consortium of investors, led by affiliates of AGM, Crestview Partners III Management , LLC (Crestview) and Reverence Capital Partners L.P. (Reverence), and is the parent of Venerable, which is the parent of VIAC. On June 1, 2021, Apollo Hybrid Value Fund, L.P., AA Direct, L.P. and certain entities affiliated with Athora, collectively through an acquisition vehicle, AP Violet, L.P. (AP Violet), along with Crestview and Reverence agreed to acquire a portion of the minority equity investment in VA Capital from us and Apollo. As a result, during the year ended December 31, 2021, we sold portions of our equity investment for $124 million, of which $25 million was deferred consideration, to Crestview, Reverence and AP Violet. We also have term loans receivable from Venerable due in 2033, which are included in related party other investments on the consolidated balance sheets. The loans are held at the principal balance less allowances and were $222 million and $145 million as of December 31, 2021 and 2020, respectively. While management views the overall transactions with Venerable as favorable to us, the stated interest rate of 6.257% on the initial term loan to Venerable represented a below-market interest rate, and management considered such rate as part of its evaluation and pricing of the reinsurance transactions. Strategic Partnership – We have an agreement pursuant to which we may invest up to $2.875 billion in funds managed by Apollo entities (Strategic Partnership). This arrangement is intended to permit us to invest across the Apollo alternatives platform into credit-oriented, strategic and other alternative investments in a manner and size that is consistent with our existing investment strategy. Fees for such investments payable by us to Apollo would be more favorable to us than market rates, and consistent with our existing alternative investments, investments made under the Strategic Partnership require approval of ISG and remain subject to our existing governance processes, including approval by our conflicts committee where applicable. As of December 31, 2021 and 2020, we had $415 million and $214 million, respectively, of investments under the Strategic Partnership and these investments are typically included in related party investment funds on the consolidated balance sheets. PK AirFinance – We have an investment in PK AirFinance (PK), an aviation lending business with a portfolio of loans (Aviation Loans). The Aviation Loans are generally fully secured by aircraft leases and aircraft. Apollo owns the PK loan origination platform, including personnel and systems and, pursuant to certain agreements entered into between us, Apollo, and certain entities managed by Apollo, the Aviation Loans are securitized by an SPV for which Apollo acts as ABS manager (ABS-SPV). The ABS-SPV issues tranches of senior notes and subordinated notes, which are secured by the Aviation Loans. As of December 31, 2021 and 2020, our investment in securitizations of loans originated by PK was $1,401 million and $1,373 million, respectively, and are included in related party AFS or trading securities on the consolidated balance sheets. We also have commitments to make additional investment in securitizations of loans originated by PK of $1,224 million as of December 31, 2021. Apollo/Athene Dedicated Investment Program (ADIP) – Our subsidiary, Athene Co-Invest Reinsurance Affiliate Holding Ltd. (together with its subsidiaries, ACRA) is partially owned by ADIP, which is managed by AGM. ALRe currently holds 36.55% of the economic interests in ACRA, with ADIP holding the remaining 63.45%. During the years ended December 31, 2021 and 2020, ACRA received capital contributions of $758 million and $240 million, respectively, from ADIP and paid dividends of $0 million and $46 million, respectively, to ADIP. Apollo Share Exchange and Related Transactions – On February 28, 2020, we closed a strategic transaction with AGM and certain affiliates of AGM which collectively comprise the AOG, pursuant to which we sold 27,959,184 newly issued Class A common shares to the AOG for an investment in Apollo of 29,154,519 newly issued AOG units valued at $1.1 billion and we sold 7,575,758 newly issued Class A common shares to the AOG for $350 million. As of December 31, 2021 and 2020, the investment in Apollo was $2,112 million and $1,324 million, respectively. Subsequent to our merger with AGM, our investment in Apollo was distributed to AGM. AA Infrastructure Fund 1 LLC (AA Infrastructure) – We have an investment in preferred shares of AA Infrastructure, which is a fund managed by ISG. As of December 31, 2021 and 2020, we held $113 million and $72 million, respectively, of preferred shares, which are included in related party equity securities on the consolidated balance sheets. In the fourth quarter of 2019, AA Infrastructure issued $267 million of ABS securities as a return of capital on the preferred shares. As of December 31, 2021 and 2020, we held AA Infrastructure ABS securities of $586 million and $420 million, respectively, which are included in related party trading securities on the consolidated balance sheets. We also have commitments to make additional investments in AA Infrastructure of $0 million as of December 31, 2021.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	15. Commitments and Contingencies Contingent Commitments —We had commitments to make investments, primarily capital contributions to investment funds, inclusive of related party commitments discussed previously, of $14,771 million a nd $7,472 million as of December 31, 2021 and 2020, respectively. We expect most of our current commitments will be invested over the next five years; however, these commitments could become due any time upon counterparty request. Funding Agreements —We are a member of the FHLB and, through membership, we have issued funding agreements to the FHLB in exchange for cash advances. As of December 31, 2021 and 2020, we had $2,751 million and $2,002 million, respectively, of FHLB funding agreements outstanding. We are required to provide collateral in excess of the funding agreement amounts outstanding, considering any discounts to the securities posted and prepayment penalties. We have a funding agreement backed notes (FABN) program, which allows Athene Global Funding, a special-purpose, unaffiliated statutory trust, to offer its senior secured medium-term notes. Athene Global Funding uses the net proceeds from each sale to purchase one or more funding agreements from us. As of December 31, 2021 and 2020 , we had $19,728 million and $8,822 million, respectively, of board-authorized FABN funding agreements outstanding. We had $5,183 million of board-authorized FABN capacity remaining as of December 31, 2021. During the third quarter of 2020, we established a secured funding agreement backed repurchase agreement (FABR) program, in which a special-purpose, unaffiliated entity entered into repurchase agreements with a bank and the proceeds of the repurchase agreements were used by the special-purpose entity to purchase funding agreements from us. As of December 31, 2021 and 2020, we had $1,000 million of FABR funding agreements outstanding. Pledged Assets and Funds in Trust (Restricted Assets)— The total restricted assets included on the consolidated balance sheets are as follows: December 31, (In millions) 2021 2020 AFS securities $ 9,111 $ 9,884 Trading securities 75 60 Equity securities 30 26 Mortgage loans 5,033 5,028 Investment funds 174 68 Derivative assets 96 107 Short-term investments — 52 Other investments 130 105 Restricted cash 796 738 Total restricted assets $ 15,445 $ 16,068 The restricted assets are primarily related to reinsurance trusts established in accordance with coinsurance agreements and the FHLB and FABR funding agreements described above. Letters of Credit —We have undrawn letters of credit totaling $1,375 million as of December 31, 2021. These letters of credit were issued for our reinsurance program and expire between May 22, 2023 and December 10, 2023. Litigation, Claims and Assessments Corporate-owned Life Insurance (COLI) Matter – In 2000 and 2001, two insurance companies which were subsequently merged into AAIA, purchased broad based variable COLI policies from American General Life Insurance Company (American General). In January 2012, the COLI policy administrator delivered to AAIA a supplement to the existing COLI policies and advised that American General and ZC Resource Investment Trust (ZC Trust) had unilaterally implemented changes set forth in the supplement that, if effective, would: (1) potentially negatively impact the crediting rate for the policies and (2) change the exit and surrender protocols set forth in the policies. In March 2013, AAIA filed suit against American General, ZC Trust, and ZC Resource LLC in Chancery Court in Delaware, seeking, among other relief, a declaration that the changes set forth in the supplement were ineffectual and in breach of the parties’ agreement. The parties filed cross motions for judgment as a matter of law, and the court granted defendants’ motion and dismissed without prejudice on ripeness grounds. The issue that negatively impacts the crediting rate for one of the COLI policies has subsequently been triggered and, on April 3, 2018, we filed suit against the same defendants in Chancery Court in Delaware seeking substantially similar relief. Defendants moved to dismiss and the court heard oral arguments on February 13, 2019. The court issued an opinion on July 31, 2019 that did not address the merits, but found that the Chancery Court did not have jurisdiction over our claims and directed us to either amend our complaint or transfer the matter to Delaware Superior Court. The matter has been transferred to the Delaware Superior Court. Defendants renewed their motion to dismiss and the Superior Court heard oral arguments on December 18, 2019. The Superior Court issued an opinion on May 18, 2020 in which it granted in part and denied in part defendants’ motion. The Superior Court denied defendants’ motion with respect to the issue that negatively impacts the crediting rate for one of the COLI policies, which issue proceeded to discovery. The Superior Court granted defendants’ motion and dismissed without prejudice on ripeness grounds claims related to the exit and surrender protocols set forth in the policies, and dismissed defendant ZC Resource LLC. If the supplement were to have been deemed effective, the purported changes to the policies could have impaired AAIA’s ability to access the value of guarantees associated with the policies. The parties engaged in discovery as well as discussions concerning whether the matter can be resolved without further litigation and, at the request of the parties, on August 11, 2021, the court entered an Amended Scheduling Order setting the trial date for June 2023. On December 27, 2021, the parties agreed in principle to a settlement, pursuant to which we will be able to surrender the policies at any time and receive proceeds within six months. During the year ended December 31, 2021, we recorded an impairment of the COLI asset of $53 million, and an adjustment to deferred tax liabilities of $47 million, to reflect the terms of the settlement. Regulatory Matters – From 2015 to 2018, our US insurance subsidiaries experienced increased complaints related to the conversion and administration of the block of life insurance business acquired in connection with our acquisition of Aviva USA and reinsured to affiliates of Global Atlantic. The life insurance policies included in this block have been and are currently being administered by AllianceOne Inc. (AllianceOne), a subsidiary of DXC Technology Company, which was retained by such Global Atlantic affiliates to provide third party administration services on such policies. AllianceOne also administers a small block of annuity policies that were on Aviva USA’s legacy policy administration systems that were also converted in connection with the acquisition of Aviva USA and have experienced some similar service and administration issues, but to a lesser degree. As a result of the difficulties experienced with respect to the administration of such policies, we have received notifications from several state regulators, including but not limited to New York State Department of Financial Services (NYSDFS), the California Department of Insurance (CDI) and the Texas Department of Insurance (TDI), indicating, in each case, that the respective regulator planned to undertake a market conduct examination or enforcement proceeding of the applicable US insurance subsidiary relating to the treatment of policyholders subject to our reinsurance agreements with affiliates of Global Atlantic and the conversion of the life and annuity policies, including the administration of such blocks by AllianceOne. We entered into consent orders with several state regulators, including the NYSDFS, the CDI and the TDI, to resolve underlying matters in the respective states. All fines and costs, including those associated with remediation plans, paid in connection with the consent orders are subject to indemnification by Global Atlantic or affiliates of Global Atlantic. Pursuant to the terms of the reinsurance agreements between us and the relevant affiliates of Global Atlantic, the applicable affiliates of Global Atlantic have financial responsibility for the ceded life block and are subject to significant administrative service requirements, including compliance with applicable law. The agreements also provide for indemnification to us, including for administration issues. In addition to the examinations and proceedings initiated to date, it is possible that other regulators may pursue similar formal examinations, inquiries or enforcement proceedings and that any examinations, inquiries and/or enforcement proceedings may result in fines, administrative penalties and payments to policyholders. While we do not expect the amount of any such fines, penalties or payments arising from these matters to be material to our financial condition, results of operations or cash flows, it is possible that such amounts could be material.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Segment Information	16. Segment Information We operate our core business strategies out of one reportable segment, Retirement Services. In addition to Retirement Services, we report certain other operations in Corporate and Other. Retirement Services —Retirement Services is comprised of our US and Bermuda operations, which issue and reinsure retirement savings products and institutional products. Retirement Services has retail operations, which provide annuity retirement solutions to our policyholders. Retirement Services also has reinsurance operations, which reinsure multi-year guaranteed annuities, fixed indexed annuities, traditional one-year guarantee fixed deferred annuities, immediate annuities and institutional products from our reinsurance partners. In addition, our institutional operations, including funding agreements and group annuities, are included in our Retirement Services segment. Corporate and Other —Corporate and Other includes certain other operations related to our corporate activities such as corporate allocated expenses, merger and acquisition costs, debt costs, preferred stock dividends, certain integration and restructuring costs, certain stock-based compensation and intersegment eliminations. In addition, we also hold capital in excess of the level of capital we hold in Retirement Services to support our operating strategy. Financial Measures —Segment adjusted operating income available to common shareholders and net investment earnings are internal measures used by the chief operating decision maker to evaluate and assess the results of our segments. Adjusted operating revenue is a component of adjusted operating income available to common shareholders and excludes market volatility and adjustments for other non-operating activity. Our adjusted operating revenue equals our total revenue, adjusted to eliminate the impact of the following non-operating adjustments: • Change in fair values of derivatives and embedded derivatives – index annuities, net of offsets; • Investment gains (losses), net of offsets; and • Noncontrolling interests, VIE expenses and other adjustments to revenues. The table below reconciles segment adjusted operating revenues to total revenues presented on the consolidated statements of income: Years ended December 31, (In millions) 2021 2020 2019 Retirement Services $ 14,903 $ 10,681 $ 11,460 Corporate and Other 1,152 266 117 Non-operating adjustments Change in fair values of derivatives and embedded derivatives – index annuities, net of offsets 2,507 868 2,346 Investment gains (losses), net of offsets (6) 720 1,685 Noncontrolling interests, VIE expenses and other adjustments to revenues 7,764 2,229 650 Total revenues $ 26,320 $ 14,764 $ 16,258 Adjusted operating income available to common shareholders is an internal measure used to evaluate our financial performance excluding market volatility and expenses related to integration, restructuring, stock compensation and certain other expenses. Our adjusted operating income available to common shareholders equals net income available to Athene Holding Ltd. common shareholders adjusted to eliminate the impact of the following non-operating adjustments: • Investment gains (losses), net of offsets; • Change in fair values of derivatives and embedded derivatives – index annuities, net of offsets; • Integration, restructuring and other non-operating expenses; • Stock-based compensation, excluding the long-term incentive plan (LTIP); and • Income tax (expense) benefit – non-operating. The table below reconciles segment adjusted operating income available to common shareholders to net income available to Athene Holding Ltd. common shareholders presented on the consolidated statements of income: Years ended December 31, (In millions) 2021 2020 2019 Retirement Services $ 2,423 $ 1,266 $ 1,322 Corporate and Other 643 (24) (33) Non-operating adjustments Investment gains (losses), net of offsets 160 508 994 Change in fair values of derivatives and embedded derivatives – index annuities, net of offsets 692 (235) (65) Integration, restructuring and other non-operating expenses (124) (10) (70) Stock-based compensation, excluding LTIP (2) (11) (12) Income tax expense – non-operating (74) (48) — Net income available to Athene Holding Ltd. common shareholders $ 3,718 $ 1,446 $ 2,136 Net investment earnings used to evaluate the performance of our segments is an internal measure that does not correspond to GAAP net investment income. Adjustments are made to GAAP net investment income to arrive at a net investment earnings measure that reflects the profitability of our core business. Accordingly, we adjust net investment income to include earnings from our consolidated VIEs and earnings on certain alternative investments (primarily CLOs) classified in investment related gains (losses) on the consolidated statements of income. Additionally, we adjust for impacts of reinsurance embedded derivatives and noncontrolling interests on net investment income. The table below reconciles segment net investment earnings to net investment income presented on the consolidated statements of income: Years ended December 31, (In millions) 2021 2020 2019 Retirement Services $ 6,791 $ 5,287 $ 5,062 Corporate and Other 288 41 117 Adjustments to net investment income Change in fair value of reinsurance assets (1,451) (1,408) (680) Alternative (gains) losses (144) 102 (1) Noncontrolling interests 943 559 61 Apollo investment gain 864 225 — Held for trading amortization and other (114) 79 37 Net investment income $ 7,177 $ 4,885 $ 4,596 Adjusted operating income available to common shareholders excludes the income tax impact of the taxable non-operating adjustments presented above. The income tax expense of non-operating income adjustments is comprised of the appropriate jurisdiction’s tax rate applied to the non-operating adjustments subject to income tax. The table below reconciles segment income taxes included in adjusted operating income to income tax expense presented on the consolidated statements of income: Years ended December 31, (In millions) 2021 2020 2019 Retirement Services $ 89 $ 164 $ 117 Corporate and Other 182 60 — Adjustments to income tax expense Noncontrolling interest tax expense 41 13 — Income tax expense – non-operating 74 48 — Income tax expense $ 386 $ 285 $ 117 The following represents total assets by segment: December 31, (In millions) 2021 2020 Retirement Services $ 228,835 $ 197,295 Corporate and Other 6,314 5,476 Total assets $ 235,149 $ 202,771 We market annuity products, primarily fixed rate and fixed indexed annuities. Deposits, which are generally not included in revenues on the consolidated statements of income, and premiums collected are as follows: Years ended December 31, (In millions) 2021 2020 2019 Fixed indexed annuities $ 8,408 $ 20,257 $ 7,304 Fixed rate annuities 2,662 20,433 3,192 Payouts without life contingencies 542 545 341 Funding agreements 11,852 7,679 1,301 Life and other deposits 2 2 (13) Total deposits 23,466 48,916 12,125 Payouts with life contingencies 14,217 5,911 6,332 Life and other premiums 45 52 50 Total premiums 14,262 5,963 6,382 Total premiums and deposits, net of ceded $ 37,728 $ 54,879 $ 18,507 Deposits and premiums by geographical location are as follows: Years ended December 31, (In millions) 2021 2020 1 2019 1 United States $ 25,380 $ 19,187 $ 16,614 Bermuda 12,348 35,692 1,893 Total premiums and deposits, net of ceded $ 37,728 $ 54,879 $ 18,507 1 Previously reported amounts have been revised to correct a misstatement, which was not material, in the classification between the United States and Bermuda geographical locations.

Schedule I Summary of Investmen

Schedule I Summary of Investments - Other Than Investments in Related Parties (Notes)	12 Months Ended
	Dec. 31, 2021
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Text Block]	December 31, 2021 (In millions) Cost or Amortized Cost Fair Value Amount Shown on Consolidated Balance Sheet AFS securities US government and agencies $ 231 $ 223 $ 223 US state, municipal and political subdivisions 1,081 1,213 1,213 Foreign governments 1,110 1,128 1,128 Public utilities 6,680 7,180 7,180 Redeemable preferred stock 325 335 335 Other corporate 55,812 58,711 58,711 CLO 13,793 13,652 13,652 ABS 8,890 8,989 8,989 CMBS 2,764 2,758 2,758 RMBS 5,772 5,970 5,970 Trading securities 1,824 2,056 2,056 Total fixed maturity securities 98,282 102,215 102,215 Equity securities Banks, trust and insurance companies common stock 180 365 365 Industrial, miscellaneous and all other common stock 498 517 517 Nonredeemable preferred stocks 277 288 288 Total equity securities 955 1,170 1,170 Mortgage loans, net of allowances 22,555 22,557 Investment funds 1,392 1,407 Policy loans 312 312 Funds withheld at interest 43,907 43,907 Derivative assets 4,377 4,387 Short-term investments 139 139 Other investments 1,443 1,473 Total investments $ 173,362 $ 177,567

Schedule II - Condensed Financi

Schedule II - Condensed Financial Information of Registrant Condensed Financial Information of Parent	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Condensed Financial Information of Parent Company Only Disclosure [Text Block]	December 31, (In millions, except per share data) 2021 2020 Assets Investments Available-for-sale securities, at fair value (amortized cost: 2021 – $71 and 2020 – $43) $ 78 $ 52 Cash and cash equivalents 1,186 342 Investments in related parties Equity securities, at fair value 171 — Investment funds 743 709 Other assets 19 43 Notes receivable from subsidiaries 83 1,393 Intercompany receivable 16 21 Investments in subsidiaries 21,773 18,133 Total assets $ 24,069 $ 20,693 Liabilities and Equity Liabilities Long-term debt $ 2,964 $ 1,976 Note payable to subsidiary 158 — Other liabilities (related party: 2021 – $754 and 2020 – $0) 811 57 Intercompany payable 6 3 Total liabilities 3,939 2,036 Equity Preferred stock Series A – par value $1 per share; $863 aggregate liquidation preference; authorized, issued and outstanding: 2021 and 2020 – 0.0 shares — — Series B – par value $1 per share; $345 aggregate liquidation preference; authorized, issued and outstanding: 2021 and 2020 – 0.0 shares — — Series C – par value $1 per share; $600 aggregate liquidation preference; authorized, issued and outstanding: 2021 and 2020 – 0.0 shares — — Series D – par value $1 per share; $575 aggregate liquidation preference; authorized, issued and outstanding: 2021 and 2020 – 0.0 shares — — Common stock Class A – par value $0.001 per share; authorized: 2021 and 2020 – 425.0 shares; issued and outstanding: 2021 – 192.2 and 2020 – 191.5 shares — — Additional paid-in capital 6,667 6,613 Retained earnings 11,033 8,073 Accumulated other comprehensive income 2,430 3,971 Total Athene Holding Ltd. shareholders’ equity 20,130 18,657 Total liabilities and equity $ 24,069 $ 20,693 See accompanying notes to condensed financial information of registrant (parent company only) Years ended December 31, (In millions) 2021 2020 2019 Revenue Net investment income (related party: 2021 – $44, 2020 – $146 and 2019 – $8) $ 39 $ 147 $ 15 Investment related gains (losses) (related party: 2021 – $0, 2020 – $0 and 2019 – $1) 58 (50) 6 Other revenues 7 — — Total revenues 104 97 21 Benefits and Expenses Operating expenses (related party: 2021 – $13, 2020 – $13 and 2019 – $11) 261 151 142 Total benefits and expenses 261 151 142 Loss before income taxes and equity earnings in subsidiaries (157) (54) (121) Income tax benefit (2) (2) — Equity earnings in subsidiaries 4,014 1,593 2,293 Net income available to Athene Holding Ltd. shareholders 3,859 1,541 2,172 Less: Preferred stock dividends 141 95 36 Net income available to Athene Holding Ltd. common shareholders $ 3,718 $ 1,446 $ 2,136 Net income available to Athene Holding Ltd. shareholders $ 3,859 $ 1,541 $ 2,172 Other comprehensive income (loss) attributable to Athene Holding Ltd. shareholders (1,541) 1,696 2,787 Comprehensive income attributable to Athene Holding Ltd. shareholders $ 2,318 $ 3,237 $ 4,959 See accompanying notes to condensed financial information of registrant (parent company only) Years ended December 31, (In millions) 2021 2020 2019 Net cash provided by (used in) operating activities $ 203 $ (145) $ (106) Cash flows from investing activities Capital contributions to subsidiary (330) (920) (70) Receipts on loans to subsidiaries 348 50 — Issuances of loans to subsidiaries (244) (237) — Sales, maturities and repayments of: Available-for-sale securities 2 17 4 Investment funds – related party — — 1 Purchases of: Available-for-sale securities (30) (3) (16) Equity securities – related party (170) — — Investment funds – related party (6) (455) (20) Other investing activities, net 66 (51) 27 Net cash used in investing activities (364) (1,599) (74) Cash flows from financing activities Issuance of common stock 11 351 — Proceeds from long-term debt 997 992 — Proceeds from note payable with subsidiary 238 740 108 Repayment of note payable with subsidiary (80) (778) (174) Issuance of preferred stock, net of expenses — 1,140 1,172 Preferred stock dividends (141) (95) (36) Repurchase of common stock (8) (428) (832) Other financing activities, net (12) (7) 1 Net cash provided by financing activities 1,005 1,915 239 Net increase in cash and cash equivalents 844 171 59 Cash and cash equivalents at beginning of year 342 171 112 Cash and cash equivalents at end of year $ 1,186 $ 342 $ 171 Supplementary information Cash paid for interest $ 98 $ 61 $ 46 Non-cash transactions Issuance of loan to subsidiary in exchange for Class A common shares and capital distribution — 1,206 — Investment interests received in exchange for extinguishment of loan from subsidiary 1,206 — — See accompanying notes to condensed financial information of registrant (parent company only) 1. Basis of Presentation The accompanying condensed financial statements of Athene Holding Ltd. (AHL) should be read in conjunction with the consolidated financial statements and notes of AHL and its subsidiaries (consolidated financial statements). For purposes of these condensed financial statements, AHL’s wholly owned and majority owned subsidiaries are presented under the equity method of accounting. Under this method, the assets and liabilities of subsidiaries are not consolidated. The investments in subsidiaries are recorded on the condensed balance sheets. The income from subsidiaries is reported on a net basis as equity earnings of subsidiaries on the condensed statements of income. 2. Intercompany Transactions Unsecured Revolving Notes Receivable — AHL has unsecured revolving notes receivable and an unsecured note receivable from subsidiaries Athene USA Corporation (AUSA), Athene Life Re Ltd. (ALRe) and Athene Life Re International Ltd. (ALReI). The unsecured revolving note receivable from AUSA has a borrowing capacity of $250 million and had an outstanding balance of $83 million and $187 million as of December 31, 2021 and 2020, respectively. Interest accrues at a fixed rate of 2.61% per year, and the balance is due on September 30, 2025, or earlier at AHL’s request. The unsecured revolving note receivable from ALRe has a borrowing capacity of $2,000 million and had no outstanding balance as of December 31, 2021 and 2020. Interest accrues at a fixed rate of 2.29% and has a maturity date of December 15, 2028, or earlier at AHL’s request. Additionally, AHL had an unsecured note receivable from ALRe, which was settled in December 2021. The unsecured note receivable had an outstanding balance of $1,206 million as of December 31, 2020. The unsecured revolving note receivable from ALReI has a borrowing capacity of $100 million and had no outstanding balance as of December 31, 2021 and 2020. Interest accrues at the US mid-term applicable federal rate per year and has a maturity date of December 5, 2024, or earlier at AHL’s request. Unsecured Revolving Note Payable — In addition to the unsecured revolving notes receivable described above, AHL has an unsecured revolving note payable with ALRe, which permits AHL to borrow up to $2,000 million with a fixed interest rate of 2.29% and a maturity date of December 15, 2028. As of December 31, 2021 and 2020, the revolving note payable had an outstanding balance of $158 million and $0 million, respectively. 3. Debt and Guarantees AHL has guaranteed certain of the obligations of AUSA, ALRe, and Athene Annuity Re Ltd. in connection with its revolving credit facility. Additionally, AHL has issued senior notes. See Note 9 – Debt to the consolidated financial statements for further discussion on the credit facility and senior notes. AHL has entered into capital maintenance agreements with each of its material US insurance subsidiaries, pursuant to which AHL agrees to provide capital to the subsidiary to the extent that the capital of the subsidiary falls below a specified threshold as set with the applicable subsidiary’s domestic regulator. In addition, on December 17, 2018, AHL entered into a capital maintenance agreement with its indirect subsidiary Athene London Assignment Corporation (Athene London) pursuant to which AHL agreed to contribute cash, cash equivalents, marketable securities, or other liquid assets so as to maintain capital in Athene London to ensure that it has the necessary funds to timely satisfy any obligations it has under any assumed settlement agreement. AHL does not anticipate making any capital infusions in Athene London pursuant to the capital maintenance agreement. 4. Dividends, Return of Capital and Capital Contributions During the years ended December 31, 2021, 2020 and 2019, AHL received $1,048 million, $0 million and $3 million, respectively, of dividends from subsidiaries. During the years ended December 31, 2021, 2020 and 2019, AHL contributed $330 million, $920 million and $70 million, respectively, to subsidiaries. See Note 13 – Statutory Requirements to the consolidated financial statements for additional information on subsidiary dividend restrictions. 5. Income Taxes AHL is a tax resident of the United Kingdom (UK). See Note 12 – Income Taxes to the consolidated financial statements for additional information on UK income taxes.

Schedule III - Supplementary In

Schedule III - Supplementary Insurance Information (Notes)	12 Months Ended
	Dec. 31, 2021
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Supplementary Insurance Information	(In millions) DAC, DSI and VOBA Future policy benefits, losses, claims and loss expenses 1 Other policy claims and benefits Premiums Net investment income Benefits, claims, losses and settlement expenses 2 Amortization of DAC and VOBA Policy and other operating expenses 2021 Retirement Services $ 5,362 $ 198,813 $ 138 $ 14,262 $ 6,025 $ 20,401 $ 632 $ 841 Corporate and other — — — — 1,152 — — 260 Total $ 5,362 $ 198,813 $ 138 $ 14,262 $ 7,177 $ 20,401 $ 632 $ 1,101 2020 Retirement Services $ 4,906 $ 173,824 $ 130 $ 5,963 $ 4,619 $ 11,182 $ 521 $ 705 Corporate and other — — — — 266 — — 150 Total $ 4,906 $ 173,824 $ 130 $ 5,963 $ 4,885 $ 11,182 $ 521 $ 855 2019 Retirement Services $ 5,008 $ 126,075 $ 138 $ 6,382 $ 4,479 $ 12,254 $ 958 $ 599 Corporate and other — — — — 117 — — 145 Total $ 5,008 $ 126,075 $ 138 $ 6,382 $ 4,596 $ 12,254 $ 958 $ 744 1 Represents interest sensitive contract liabilities and future policy benefits on the consolidated balance sheets. 2 Represents interest sensitive contract benefits, amortization of deferred sales inducements, future policy and other policy benefits, and dividends to policyholders on the consolidated statements of income.

Schedule IV - Reinsurance (Note

Schedule IV - Reinsurance (Notes)	12 Months Ended
	Dec. 31, 2021
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]
Reinsurance	(In millions, except for percentages) Gross amount Ceded to other companies Assumed from other companies Net amount Percentage of amount assumed to net Year ended December 31, 2021 Life insurance in force at end of year $ 26,858 $ 30,949 $ 5,518 $ 1,427 386.7 % Premiums 13,989 115 388 14,262 2.7 % Year ended December 31, 2020 Life insurance in force at end of year 29,527 35,088 6,863 1,302 527.1 % Premiums 5,691 141 413 5,963 6.9 % Year ended December 31, 2019 Life insurance in force at end of year 33,221 39,145 7,317 1,393 525.3 % Premiums 5,449 159 1,092 6,382 17.1 %

Schedule V - Valuation and Qual

Schedule V - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2021
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	(In millions) Additions Description Balance at beginning of year Charged to costs and expenses Assumed through acquisitions Deductions Balance at end of year Reserves deducted from assets to which they apply Year ended December 31, 2021 Valuation allowance on deferred tax assets $ 74 $ 12 $ — $ (20) $ 66 Year ended December 31, 2020 Valuation allowance on deferred tax assets 63 11 — — 74 Year ended December 31, 2019 Valuation allowance on deferred tax assets 52 31 — (20) 63

Business, Basis of Presentati_2

Business, Basis of Presentation, and Significant Accounting Policies (Policies)	Jan. 01, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Consolidation and Basis of Presentation		Our consolidated financial statements include our wholly owned subsidiaries and investees in which we hold a controlling financial interest, including variable interest entities (VIEs). Investees in which we do not hold a controlling financial interest, but have the ability to exercise significant influence over operating and financing decisions, other than investments for which we have elected the fair value option, are accounted for under the equity method. Intercompany balances and transactions have been eliminated. For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the consolidated financial statements. We report investments in related parties separately, as further described in the accounting policies that follow. We have prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP), which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period. Actual experience could materially differ from these estimates and assumptions. Our principal estimates impact: • fair value of investments; • impairment of investments and allowances for expected credit losses; • derivatives valuation, including embedded derivatives; • deferred acquisition costs (DAC), deferred sales inducements (DSI) and value of business acquired (VOBA); • future policy benefit reserves; and • valuation allowances on deferred tax assets. Additional details around these principal estimates and assumptions are discussed in the significant accounting policies that follow and the related footnote disclosures.
Basis of Presentation		We have prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP), which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period.
Use of Estimates		We have prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP), which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period. Actual experience could materially differ from these estimates and assumptions. Our principal estimates impact: • fair value of investments; • impairment of investments and allowances for expected credit losses; • derivatives valuation, including embedded derivatives; • deferred acquisition costs (DAC), deferred sales inducements (DSI) and value of business acquired (VOBA); • future policy benefit reserves; and • valuation allowances on deferred tax assets. Additional details around these principal estimates and assumptions are discussed in the significant accounting policies that follow and the related footnote disclosures.
Investments		Fixed Maturity Securities – Fixed maturity securities includes bonds, collateralized loan obligations (CLO), asset-backed securities (ABS), residential mortgage-backed securities (RMBS), commercial mortgage-backed securities (CMBS) and redeemable preferred stock. We classify fixed maturity securities as available-for-sale (AFS) or trading at the time of purchase and subsequently carry them at fair value. Fair value hierarchy and valuation methodologies are discussed in Note 5 – Fair Value . Classification is dependent on a variety of factors including our expected holding period, election of the fair value option and asset and liability matching. AFS Securities – AFS securities are held at fair value on the consolidated balance sheets with unrealized gains and losses, net of allowances for expected credit losses, tax and adjustments to DAC, DSI, VOBA and future policy benefits, if applicable, generally reflected in accumulated other comprehensive income (loss) (AOCI) on the consolidated balance sheets. Unrealized gains or losses relating to identified risks within AFS securities in fair value hedging relationships are reflected in investment related gains (losses) on the consolidated statements of income. Trading Securities – We elected the fair value option for certain fixed maturity securities. These fixed maturity securities are classified as trading, with changes to fair value included in investment related gains (losses) on the consolidated statements of income. Although the securities are classified as trading, the trading activity related to these investments is primarily focused on asset and liability matching activities and is not intended to be an income strategy based on active trading. As such, the activity related to these investments on the consolidated statements of cash flows is classified as investing activities. We generally record security transactions on a trade date basis, with any unsettled trades recorded in other assets or other liabilities on the consolidated balance sheets. Bank loans, private placements and investment funds are recorded on settlement date basis. Equity Securities – Equity securities includes common stock, mutual funds and non-redeemable preferred stock. Equity securities with readily determinable fair values are carried at fair value with subsequent changes in fair value recognized in net income. We have elected to account for certain equity securities without readily determinable fair values that do not qualify for the practical expedient to estimate fair values based on net asset value (NAV) per share (or its equivalent) at cost less impairment, subject to adjustments based on observable price changes in orderly transactions for identical or similar investments of the same issuer. Purchased Credit Deteriorated (PCD) Investments – We purchase certain structured securities, primarily RMBS, and re-performing mortgage loans having experienced a more-than-insignificant deterioration in credit quality since their origination which upon our assessment have been determined to meet the definition of PCD investments. Additionally, structured securities classified as beneficial interests follow the initial measurement guidance for PCD investments if there is a significant difference between contractual cash flows adjusted for expected prepayments and expected cash flows at the date of recognition. The initial allowance for credit losses for PCD investments is recorded through a gross-up adjustment to the initial amortized cost. For mortgage loans, the initial allowance is determined using the methodology described in the Credit Losses – Assets Held at Amortized Cost and Off-Balance Sheet Credit Exposures section. For structured securities classified as beneficial interests, the initial allowance is calculated as the present value of the difference between contractual cash flows adjusted for expected prepayments and expected cash flows at the date of recognition. The non-credit purchase discount or premium is amortized into investment income using the effective interest method. The credit discount, represented by the allowance for expected credit losses, is remeasured each period following the policies for measuring credit losses described in the Credit Losses – Assets Held at Amortized Cost and Off-Balance Sheet Credit Exposures and Credit Losses – Available-for-Sale Securities sections below. Purchased Credit Impaired (PCI) Investments – Prior to January 1, 2020, certain securities purchased with deterioration in credit quality since their issuance were accounted for as PCI investments. The difference between the undiscounted expected future cash flows of the PCI investment and the recorded investment represented the initial accretable yield, which was accreted into investment income, net of related expenses, over its remaining life on a level-yield basis. The difference between the contractually required payments on the PCI investment and the undiscounted expected future cash flows represented the non-accretable difference at acquisition. Over time, based on actual payments received and changes in estimates of undiscounted expected future cash flows, the accretable yield and the non-accretable difference could change. PCI investments are presented on the consolidated financial statements consistent with AFS securities or mortgage loans depending on the underlying investment. Quarterly, we evaluated the undiscounted expected future cash flows associated with PCI investments based on updates to key assumptions. Mortgage Loans – Mortgage loans are primarily stated at unpaid principal balance, adjusted for any unamortized premium or discount, and net of allowances for expected credit losses. Interest income is accrued on the principal amount of the loan based on its contractual interest rate. We record amortization of premiums and discounts using the effective yield method and contractual cash flows on the underlying loan. We accrue interest on loans until it is probable we will not receive interest or the loan is 90 days past due. Interest income, amortization of premiums and discounts, and prepayment fees are reported in net investment income on the consolidated statements of income. We have also elected the fair value option on a portion of our mortgage loans. Investment Funds – We invest in certain non-fixed income, alternative investments in the form of limited partnerships or similar legal structures (investment funds). For investment funds in which we do not hold a controlling financial interest, and therefore are not required to consolidate, we typically account for these investments using the equity method, where the cost is recorded as an investment in the fund, or we have elected the fair value option. Adjustments to the carrying amount reflect our pro rata ownership percentage of the operating results as indicated by NAV in the investment fund financial statements, which can be on a lag of up to three months when investee information is not received in a timely manner. We record our proportionate share of investment fund income within net investment income on the consolidated statements of income. Contributions paid or distributions received by us are recorded directly to the investment fund balance as an increase to carrying value or as a return of capital, respectively. Policy Loans – Policy loans are funds provided to policyholders in return for a claim on the policyholder’s account balance. The funds provided are limited to a specified percentage of the account balance. The majority of policy loans do not have a stated maturity and the balances and accrued interest are repaid with proceeds from the policyholder’s account balance. Policy loans are reported at the unpaid principal balance. Interest income is recorded as earned using the contract interest rate and is reported in net investment income on the consolidated statements of income. Funds Withheld at Interest – Funds withheld at interest represents a receivable for amounts contractually withheld by ceding companies in accordance with funds withheld coinsurance (funds withheld) and modified coinsurance (modco) reinsurance agreements in which we are the reinsurer. Generally, assets equal to statutory reserves are withheld and legally owned by the ceding company, and any excess or shortfall is settled periodically. The underlying agreements contain embedded derivatives as discussed below. Short-term Investments – Short-term investments consists of financial instruments with maturities of greater than three months but less than twelve months when purchased. Short-term debt securities are accounted for as trading or AFS consistent with our policies for those investments. Short-term loans are carried at amortized cost. Fair values are determined consistent with methodologies described in Note 5 – Fair Value for the respective investment type. Other Investments – Other investments includes, but is not limited to, term loans collateralized by mortgages on residential and commercial real estate. Mortgage collateralized term loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and net of allowances for expected credit losses. Interest income is accrued on the principal amount of the loan based on its contractual interest rate. We record amortization of premiums and discounts using the effective interest method and contractual cash flows on the underlying loan. We accrue interest on loans until it is probable we will not receive interest or the loan is 90 days past due. Interest income, amortization of premiums and discounts, and prepayment and other fees are reported in net investment income on the consolidated statements of income. Securities Repurchase and Reverse Repurchase Agreements – Securities repurchase and reverse repurchase transactions involve the temporary exchange of securities for cash or other collateral of equivalent value, with agreement to redeliver a like quantity of the same or similar securities at a future date and at a fixed and determinable price. We evaluate transfers of securities under these agreements to repurchase or resell to determine whether they satisfy the criteria for accounting treatment as secured borrowing or lending arrangements. Agreements not meeting the criteria would require recognition of the transferred securities as sales or purchases, with related forward repurchase or resale commitments. All of our securities repurchase transactions are accounted for as secured borrowings and are included in payables for collateral on derivatives and securities to repurchase on the consolidated balance sheets. Earnings from investing activities related to the cash received under our securities repurchase arrangements are included in net investment income on the consolidated statements of income. The associated borrowing cost is included in policy and other operating expenses on the consolidated statements of income. The investments purchased in reverse repurchase agreements, which represent collateral on a secured lending arrangement, are not reflected in our consolidated balance sheets; however, the secured lending arrangement is recorded as a short-term investment for the principal amount loaned under the agreement. Investment Income – We recognize investment income as it accrues or is legally due, net of investment management and custody fees. Investment income on fixed maturity securities includes coupon interest, as well as the amortization of any premium and the accretion of any discount. Investment income on equity securities represents dividend income and preferred coupons interest. Realized gains and losses on sales of investments are included in investment related gains (losses) on the consolidated statements of income. Realized gains and losses on investments sold are determined based on a first-in first-out method. Credit Losses – Assets Held at Amortized Cost and Off-Balance Sheet Credit Exposures – We establish an allowance for expected credit losses at the time of purchase for assets held at amortized cost, which primarily includes our residential and commercial mortgage loan portfolios, but also includes certain other loans and reinsurance assets. The allowance for expected credit losses represents the portion of the asset's amortized cost basis that we do not expect to collect due to credit losses over the asset's contractual life, considering past events, current conditions, and reasonable and supportable forecasts of future economic conditions or macroeconomic forecasts. We use a quantitative probability of default and loss given default methodology to develop our estimate of expected credit loss. We develop the estimate on a collective basis factoring in the risk characteristics of the assets in the portfolio. If an asset does not share similar risk characteristics with other assets, the asset is individually assessed. Allowance estimates are highly dependent on expectations of future economic conditions and macroeconomic forecasts, which involve significant judgment and subjectivity. We use quantitative modeling to develop the allowance for expected credit losses. Key inputs into the model include data pertaining to the characteristics of the assets, historical losses and current market conditions. Additionally, the model incorporates management’s expectations around future economic conditions and macroeconomic forecasts over a reasonable and supportable forecast period, after which the model reverts to historical averages. These inputs, the reasonable and supportable forecast period, and reversion to historical average technique are subject to a formal governance and review process by management. Additionally, management considers qualitative adjustments to the model output to the extent that any relevant information regarding the collectability of the asset is available and not already considered in the quantitative model. If we determine that a financial asset has become collateral dependent, which we determine to be the point at which foreclosure is probable, the allowance is measured as the difference between amortized cost and the fair value of the collateral, less any expected costs to sell. The initial allowance for invested assets held at amortized cost other than for PCD investments, and subsequent changes in the allowance including PCD investments, are recorded through a charge to credit loss expense within investment related gains (losses) on the consolidated statements of income. Credit loss expense for reinsurance assets held at amortized cost is recorded through policy and other operating expenses on the consolidated statements of income. We limit accrued interest income on loans to 90 days of interest. Once a loan becomes 90 days past due, the loan is put on non-accrual status and any accrued interest is written off. Once a loan is on non-accrual status, we first apply any payments received to the principal of the loan, and once the principal is repaid, we include amounts received in net investment income. We have elected to present accrued interest receivable separately in accrued investment income on the consolidated balance sheets. We have also elected the practical expedient to exclude the accrued interest receivable from the amortized cost balance used to calculate the allowance given our policy to write off such balances in a timely manner. Any write-off of accrued interest is recorded through a reversal of net investment income on the consolidated statements of income. Upon determining that all or a portion of the amortized cost of an asset is uncollectible, which is generally when all efforts for collection are exhausted, the amortized cost is written off against the existing allowance. Any write off in excess of the existing allowance is recorded through credit loss expense within investment related gains (losses) on the consolidated statements of income. We also have certain off-balance sheet credit exposures for which we establish a liability for expected credit losses. These exposures primarily relate to commitments to fund commercial or residential mortgage loans that are not unconditionally cancellable. The methodology for estimating the liability for these credit exposures is consistent with that described above, with the additional consideration pertaining to the probability of funding. At the time the commitment expires or is funded, the liability is reversed and an allowance for expected credit losses is established, as applicable. The liability for off-balance sheet credit exposures is included in other liabilities on the consolidated balance sheets. The establishment of the initial liability and all subsequent changes are recorded through credit loss expense within investment related gains (losses) on the consolidated statements of income. Credit Losses – Available-for-Sale Securities – We evaluate AFS securities with a fair value that has declined below amortized cost to determine how the decline in fair value should be recognized. If we determine, based on the facts and circumstances related to the specific security, that we intend to sell a security or it is more likely than not that we would be required to sell a security before the recovery of its amortized cost, any existing allowance for expected credit losses is reversed and the amortized cost of the security is written down to fair value. If neither of these conditions exist, we evaluate whether the decline in fair value has resulted from a credit loss or other factors. For non-structured AFS securities, we qualitatively consider relevant facts and circumstances in evaluating whether a decline below fair value is credit - related. Relevant facts and circumstances include but are not limited to: (1) the extent to which the fair value is less than amortized cost; (2) changes in agency credit ratings, (3) adverse conditions related to the security’s industry or geographical area, (4) failure to make scheduled payments, and (5) other known changes in the financial condition of the issuer or quality of any underlying collateral or credit enhancements. For structured AFS securities meeting the definition of beneficial interests, the qualitative assessment is bypassed, and any securities having experienced a decline in fair value below amortized cost move directly to a quantitative analysis. If upon completion of this analysis it is determined that a potential credit loss exists, an allowance for expected credit losses is established equal to the amount by which the present value of expected cash flows is less than amortized cost, limited by the amount by which fair value is less than amortized cost. A non-structured security’s cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using security-specific facts and circumstances including timing, security interests and loss severity. A structured security’s cash flow estimates are based on security-specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayments and structural support, including subordination and guarantees. The expected cash flows are discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete a structured security. For securities with a contractual interest rate that varies based on changes in an independent factor, such as an index or rate, the effective interest rate is calculated based on the factor as it changes over the life of the security. Inherently under the discounted cash flow model, both the timing and amount of expected cash flows affect the measurement of the allowance for expected credit losses. The allowance for expected credit losses is remeasured each period for the passage of time, any change in expected cash flows, and changes in the fair value of the security. All impairments, whether intent or requirement to sell or credit-related, are recorded through a charge to credit loss expense within investment related gains (losses) on the consolidated statements of income. All changes in the allowance for expected credit losses are recorded through credit loss expense within investment related gains (losses) on the consolidated statements of income. We have elected to present accrued interest receivable separately in accrued investment income on the consolidated balance sheets. We have also elected the practical expedient to exclude the accrued interest receivable from the amortized cost balance used to calculate the allowance for expected credit losses, as we have a policy to write off such balances in a timely manner, when they become 90 days past due. Any write-off of accrued interest is recorded through a reversal of net investment income on the consolidated statements of income. Upon determining that all or a portion of the amortized cost of an asset is uncollectible, which is generally when all efforts for collection are exhausted, the amortized cost is written off against the existing allowance. Any write off in excess of the existing allowance is recorded through credit loss expense within investment related gains (losses) on the consolidated statements of income.
Derivative Instruments		We invest in derivatives to hedge the risks experienced in our ongoing operations, such as equity, interest rate and cash flow risks, or for other risk management purposes, which primarily involve managing liability risks associated with our indexed annuity products and reinsurance agreements. Derivatives are financial instruments with values that are derived from interest rates, foreign exchange rates, financial indices or other combinations of an underlying and notional. Derivative assets and liabilities are carried at fair value on the consolidated balance sheets. We elect to present any derivatives subject to master netting provisions as a gross asset or liability and gross of collateral. Disclosures regarding balance sheet presentation of derivatives subject to master netting agreements are discussed in Note 3 – Derivative Instruments . We may designate derivatives as cash flow, fair value or net investment hedges. Hedge Documentation and Hedge Effectiveness – To qualify for hedge accounting, at the inception of the hedging relationship, we formally document our designation of the hedge as a cash flow, fair value or net investment hedge and our risk management objective and strategy for undertaking the hedging transaction. In this documentation, we identify how the hedging instrument is expected to hedge the designated risks related to the hedged item and the method that will be used to retrospectively and prospectively assess the hedge effectiveness and the method which will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and periodically throughout the life of the hedge accounting relationship. For a cash flow hedge, all changes in the fair value of the hedging derivative are reported within AOCI and the related gains or losses on the derivative are reclassified into the consolidated statements of income when the cash flows of the hedged item affect earnings. For a fair value hedge, changes in the fair value of the hedging derivative and changes in the fair value of the hedged item related to the designated risk being hedged are reported on the consolidated statements of income according to the nature of the risk being hedged. Additionally, changes in the fair value of amounts excluded from the assessment of effectiveness are recorded in AOCI and amortized into income over the life of the hedge accounting relationship. For a net investment hedge, changes in the fair value of the hedging derivative are reported within AOCI to offset the translation adjustments for subsidiaries with functional currencies other than US dollar. We discontinue hedge accounting prospectively when: (1) we determine the derivative is no longer highly effective in offsetting changes in the estimated cash flows or fair value of a hedged item; (2) the derivative expires, is sold, terminated, or exercised; or (3) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued, the derivative continues to be carried on the consolidated balance sheets at fair value, with changes in fair value recognized in investment related gains (losses) on the consolidated statements of income. For a derivative not designated as a hedge, changes in the derivative’s fair value and any income received or paid on derivatives at the settlement date are included in investment related gains (losses) on the consolidated statements of income. Embedded Derivatives – We issue and reinsure products, primarily fixed indexed annuity products, or purchase investments that contain embedded derivatives. If we determine the embedded derivative has economic characteristics not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract and accounted for separately, unless the fair value option is elected on the host contract. Under the fair value option, bifurcation of the embedded derivative is not necessary as the entire contract is carried at fair value with all related gains and losses recognized in investment related gains (losses) on the consolidated statements of income. Embedded derivatives are carried on the consolidated balance sheets at fair value in the same line item as the host contract. Fixed indexed annuity, index-linked variable annuity and indexed universal life insurance contracts allow the policyholder to elect a fixed interest rate return or an equity market component for which interest credited is based on the performance of certain stock market indices. The equity market option is an embedded derivative. The benefit reserve is equal to the sum of the fair value of the embedded derivative and the host (or guaranteed) component of the contracts. The fair value of the embedded derivatives is computed as the present value of benefits attributable to the excess of the projected policy contract values over the projected minimum guaranteed contract values. The projections of policy contract values are based on assumptions for future policy growth, which include assumptions for expected index credits on the next policy anniversary date, future equity option costs, volatility, interest rates and policyholder behavior assumptions including lapses and the use of benefit riders. The projections of minimum guaranteed contract values include the same assumptions for policyholder behavior as were used to project policy contract values. The embedded derivative cash flows are discounted using a rate that reflects our own credit rating. The host contract is established at contract inception as the initial account value less the initial fair value of the embedded derivative and accreted over the policy’s life. The host contract accretion rate is updated each quarter so that the present value of actual and expected guaranteed cash flows is equal to the initial host value. Changes in the fair value of embedded derivatives associated with fixed indexed annuities, index-linked variable annuities and indexed universal life insurance contracts are included in interest sensitive contract benefits on the consolidated statements of income. Additionally, reinsurance agreements written on a funds withheld or modco basis contain embedded derivatives. We have determined that the right to receive or obligation to pay the total return on the assets supporting the funds withheld at interest or funds withheld liability, respectively, represents a total return swap with a floating rate leg. The fair value of embedded derivatives on funds withheld and modco agreements is computed as the unrealized gain (loss) on the underlying assets and is included within funds withheld at interest and funds withheld liability on the consolidated balance sheets for assumed and ceded agreements, respectively. The change in the fair value of the embedded derivatives is recorded in investment related gains (losses) on the consolidated statements of income. Assumed and ceded earnings from funds withheld at interest, funds withheld liability and changes in the fair value of embedded derivatives are reported in operating activities on the consolidated statements of cash flows. Contributions to and withdrawals from funds withheld at interest and funds withheld liability are reported in operating activities on the consolidated statements of cash flows.
Variable Interest Entities		An entity that does not have sufficient equity to finance its activities without additional financial support, or in which the equity investors, as a group, do not have the characteristics typically afforded to common shareholders is a VIE. The determination as to whether an entity qualifies as a VIE depends on the facts and circumstances surrounding each entity and may require significant judgment. Our investment funds typically qualify as VIEs and are evaluated for consolidation under the VIE model. We are required to consolidate a VIE if we are the primary beneficiary, defined as the variable interest holder with both the power to direct the activities that most significantly impact the VIE’s economic performance and rights to receive benefits or obligations to absorb losses that could be potentially significant to the VIE. We determine whether we are the primary beneficiary of an entity based on a qualitative assessment of the VIE’s capital structure, contractual terms, nature of the VIE’s operations and purpose and our relative exposure to the related risks of the VIE. Since affiliates of AGM, a related party, are the decision makers in certain of the investment funds, we and a member of our related party group may together have the characteristics of the primary beneficiary of an investment fund. In this situation, we have concluded we are not under common control, as defined by GAAP, with the related party, and therefore we do not consolidate because the related party, whom is the decision maker, holds a significant indirect financial interest in the investee through its ownership interest in us. We reassess the VIE and primary beneficiary determinations on an ongoing basis. For entities that we do not consolidate but can exercise significant influence over the entities’ operating and financing decisions, we record our investment under the equity method. If we do not consolidate and do not have significant influence, generally on investment funds in which we own a less than 3% interest, we elect the fair value option.
Reinsurance		We assume and cede insurance and investment contracts under coinsurance, funds withheld and modco. We follow reinsurance accounting for transactions that provide indemnification against loss or liability relating to insurance risk (risk transfer). To meet risk transfer requirements, a reinsurance agreement must transfer insurance risk arising from uncertainties about both underwriting and timing risks. Cessions under reinsurance do not discharge our obligations as the primary insurer, unless the requirements of assumption reinsurance have been met. We generally have the right of offset on reinsurance contracts, but have elected to present reinsurance settlement amounts due to and from us on a gross basis. Assets and liabilities assumed or ceded under coinsurance, funds withheld, or modco are presented gross on the consolidated balance sheets. For investment contracts, the change in assumed and ceded reserves are presented net in interest sensitive contract benefits on the consolidated statements of income. For insurance contracts, the change in assumed and ceded reserves and benefits are presented net in future policy and other policy benefits on the consolidated statements of income. Assumed or ceded premiums are included in premiums on the consolidated statements of income. Accounting for reinsurance requires the use of assumptions, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. We attempt to minimize our counterparty credit risk through the structuring of the terms of our reinsurance agreements, including the use of trusts, and we monitor credit ratings of counterparties for signs of declining credit quality. When a ceding company does not report information on a timely basis, we record accruals based on the best available information at the time, which includes the reinsurance agreement terms and historical experience. We periodically compare actual and anticipated experience to the assumptions used to establish reinsurance assets and liabilities. See Note 6 – Reinsurance for more information.
Cash and Cash Equivalents		Cash and cash equivalents include deposits and short-term highly liquid investments with an original maturity of less than 90 days from the date of acquisition. Amounts included are readily convertible to known amounts of cash and are subject to an insignificant risk of change in value.
Restricted Cash		Restricted cash primarily consists of cash and cash equivalents held in funds in trust as part of certain coinsurance agreements to secure statutory reserves and liabilities of the coinsured parties. Restricted cash is reported separately on the consolidated balance sheets, but is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period amounts shown on the consolidated statements of cash flows.
Investments in Related Parties		Investments in related parties and associated earnings, other comprehensive income and cash flows are separately identified on the consolidated financial statements and accounted for consistently with the policies described above for each category of investment. Investments in related parties are primarily comprised of investments over which Apollo can exercise significant influence.
Deferred Acquisition Costs		Costs related directly to the successful acquisition of new, or renewal of, insurance or investment contracts are deferred to the extent they are recoverable from future premiums or gross profits. These costs consist of commissions and policy issuance costs, as well as sales inducements credited to policyholder account balances, and are included in deferred acquisition costs, deferred sales inducements and value of business acquired on the consolidated balance sheets. We perform periodic tests, including at issuance, to determine if the deferred costs are recoverable. If we determine that the deferred costs are not recoverable, we record a cumulative charge to the current period.Deferred costs related to universal life-type policies and investment contracts with significant revenue streams from sources other than investment of the policyholder funds are amortized over the lives of the policies, based upon the proportion of the present value of actual and expected deferred costs to the present value of actual and expected gross profits to be earned over the life of the policies. Gross profits include investment spread margins, surrender charge income, policy administration charges and expenses, changes in the guaranteed lifetime withdrawal benefit (GLWB) and guaranteed minimum death benefit (GMDB) reserves and realized gains and losses on investments. Current period gross profits for fixed indexed annuities also include the change in fair value of both freestanding and embedded derivatives. Estimates of the expected gross profits and margins are based on assumptions using accepted actuarial methods related to policyholder behavior, including lapses and the utilization of benefit riders, mortality, yields on investments supporting the liabilities, future interest credited amounts (including indexed related credited amounts on fixed indexed annuity products), and other policy changes as applicable, and the level of expenses necessary to maintain the policies over their expected lives. Each reporting period, we update estimated gross profits with actual gross profits as part of the amortization process and adjust the DAC and DSI balances due to the other comprehensive income (OCI) effects of unrealized investment gains and losses on AFS securities. We also periodically revise the key assumptions used in the amortization calculation, which results in revisions to the estimated future gross profits. The effects of changes in assumptions are recorded as unlocking in the period in which the changes are made.Deferred costs related to investment contracts without significant revenue streams from sources other than investment of the policyholder funds are amortized using the effective interest method. The effective interest method amortizes the deferred costs by discounting the future liability cash flows at a break-even rate. The break-even rate is solved for such that the present value of future liability cash flows is equal to the net liability at the inception of the contract.
Deferred Sales Inducements		Costs related directly to the successful acquisition of new, or renewal of, insurance or investment contracts are deferred to the extent they are recoverable from future premiums or gross profits. These costs consist of commissions and policy issuance costs, as well as sales inducements credited to policyholder account balances, and are included in deferred acquisition costs, deferred sales inducements and value of business acquired on the consolidated balance sheets. We perform periodic tests, including at issuance, to determine if the deferred costs are recoverable. If we determine that the deferred costs are not recoverable, we record a cumulative charge to the current period.Deferred costs related to universal life-type policies and investment contracts with significant revenue streams from sources other than investment of the policyholder funds are amortized over the lives of the policies, based upon the proportion of the present value of actual and expected deferred costs to the present value of actual and expected gross profits to be earned over the life of the policies. Gross profits include investment spread margins, surrender charge income, policy administration charges and expenses, changes in the guaranteed lifetime withdrawal benefit (GLWB) and guaranteed minimum death benefit (GMDB) reserves and realized gains and losses on investments. Current period gross profits for fixed indexed annuities also include the change in fair value of both freestanding and embedded derivatives. Estimates of the expected gross profits and margins are based on assumptions using accepted actuarial methods related to policyholder behavior, including lapses and the utilization of benefit riders, mortality, yields on investments supporting the liabilities, future interest credited amounts (including indexed related credited amounts on fixed indexed annuity products), and other policy changes as applicable, and the level of expenses necessary to maintain the policies over their expected lives. Each reporting period, we update estimated gross profits with actual gross profits as part of the amortization process and adjust the DAC and DSI balances due to the other comprehensive income (OCI) effects of unrealized investment gains and losses on AFS securities. We also periodically revise the key assumptions used in the amortization calculation, which results in revisions to the estimated future gross profits. The effects of changes in assumptions are recorded as unlocking in the period in which the changes are made.Deferred costs related to investment contracts without significant revenue streams from sources other than investment of the policyholder funds are amortized using the effective interest method. The effective interest method amortizes the deferred costs by discounting the future liability cash flows at a break-even rate. The break-even rate is solved for such that the present value of future liability cash flows is equal to the net liability at the inception of the contract.
Value of Business Acquired		We establish VOBA for blocks of insurance contracts acquired through the acquisition of insurance entities. We record the fair value of the liabilities assumed in two components: reserves and VOBA. Reserves are established using our best estimate assumptions consistent with the policies described below for future policy benefits and interest sensitive contract liabilities. VOBA is the difference between the fair value of the liabilities and the reserves. VOBA can be either positive or negative. Any negative VOBA is recorded to the same financial statement line on the consolidated balance sheets as the associated reserves. Positive VOBA is recorded in deferred acquisition costs, deferred sales inducements and value of business acquired on the consolidated balance sheets. We perform periodic tests to determine if the VOBA remains recoverable. If we determine that VOBA is not recoverable, we record a cumulative charge to the current period.VOBA associated with investment contracts without significant revenue streams from sources other than investment of the policyholder funds is amortized using the effective interest method. VOBA associated with immediate annuity contracts classified as long duration contracts is amortized at a constant rate in relation to net policyholder liabilities. For universal life-type policies and investment contracts with significant revenue streams from sources other than investment of policyholder funds, VOBA is amortized in relation to the present value of estimated gross profits using methods consistent with those used to amortize DAC and DSI. Negative VOBA is amortized at a constant rate in relation to applicable net policyholder liabilities.
Interest Sensitive Contract Liabilities		life-type policies and investment contracts include fixed indexed and traditional fixed annuities in the accumulation phase, funding agreements, universal life insurance, fixed indexed universal life insurance and immediate annuities without significant mortality risk (which includes pension group annuities without life contingencies). We carry liabilities for fixed annuities, universal life insurance and funding agreements at the account balances without reduction for potential surrender or withdrawal charges, except for a block of universal life business ceded to Global Atlantic Financial Group Limited (together with its subsidiaries, Global Atlantic) which we carry at fair value. Liabilities for immediate annuities without significant mortality risk are calculated as the present value of future liability cash flows and policy maintenance expenses discounted at contractual interest rates. For a discussion regarding our indexed products, refer above to the embedded derivative discussion.Changes in the interest sensitive contract liabilities, excluding deposits and withdrawals, are recorded in interest sensitive contract benefits or product charges on the consolidated statements of income. Interest sensitive contract liabilities are not reduced for amounts ceded under reinsurance agreements which are reported as reinsurance recoverable on the consolidated balance sheets.
Future Policy Benefits		We issue contracts classified as long-duration, which includes term and whole life, accident and health, disability, and deferred and immediate annuities with life contingencies (which includes pension group annuities with life contingencies). Liabilities for non-participating long-duration contracts are established using accepted actuarial valuation methods which require the use of assumptions related to expenses, investment yields, mortality, morbidity and persistency, with a provision for adverse deviation, at the date of issue or acquisition. As of December 31, 2021, the reserve investment yield assumptions for non-participating contracts range from 2.3% to 5.4% and are specific to our expected earned rate on the asset portfolio supporting the reserves. We base other key assumptions, such as mortality and morbidity, on industry standard data adjusted to align with actual company experience, if necessary. For long-duration contracts, the assumptions are locked in at contract inception and only modified if we deem the reserves to be inadequate. We periodically review actual and anticipated experience compared to the assumptions used to establish policy benefits. If the net GAAP liability (gross reserves less DAC, DSI and VOBA) is less than the gross premium liability, impairment is deemed to have occurred, and the DAC, DSI and VOBA asset balances are reduced until the net GAAP liability is equal to the gross premium liability. If the DAC, DSI and VOBA asset balances are completely written off and the net GAAP liability is still less than the gross premium liability, then an additional liability is recorded to arrive at the gross premium liability. We issue and reinsure deferred annuity contracts which contain GLWB and GMDB riders. We establish future policy benefits for GLWB and GMDB riders by estimating the expected value of withdrawal and death benefits in excess of the projected policyholder account balances. We recognize the excess proportionally over the accumulation period based on total actual and expected assessments. The methods we use to estimate the liabilities have assumptions about policyholder behavior, which includes lapses, withdrawals and utilization of benefit riders; mortality, expected yield on investments supporting the liability; and market conditions affecting the account balance growth. Future policy benefits includes liabilities for no-lapse guarantees on universal life insurance and fixed indexed universal life insurance. We establish future policy benefits for no-lapse guarantees by estimating the expected value of death benefits paid after policyholder account balances have been exhausted. We recognize these benefits proportionally over the life of the contracts based on total actual and expected assessments. The methods we use to estimate the liabilities have assumptions about policyholder behavior, mortality, expected yield on investments supporting the liability, and market conditions affecting policyholder account balance growth. For the liabilities associated with GLWB and GMDB riders and no-lapse guarantees, each reporting period, we update expected excess benefits and assessments with actual excess benefits and assessments and adjust the liability balances due to the OCI effects of unrealized investment gains and losses on AFS securities. We also periodically revise the key assumptions used in the calculation of the liabilities which results in revisions to the expected excess benefits and assessments. The effects of changes in assumptions are recorded as unlocking in the period in which the changes are made.
Closed Block Business		We established closed blocks of policies in connection with the reorganization of two predecessor subsidiaries from mutual companies to stock companies, collectively referred to as the Closed Blocks, and individually referred to as the AmerUs Life Insurance Company (AmerUs) closed block (AmerUs Closed Block) and the Indianapolis Life Insurance Company (ILICO) closed block (ILICO Closed Block). Insurance policies which had a dividend scale in effect as of each closed block establishment date were included in the respective closed block. The Closed Blocks were designed to give reasonable assurance to owners of insurance policies included therein that, after the reorganization, assets would be available to maintain the dividend scales and interest credits in effect prior to the reorganization, if the experience underlying such scales and crediting continued. The assets, including related revenue, allocated to the Closed Blocks will accrue solely to the benefit of the policyholders included in the Closed Blocks until they no longer exist. A policyholder dividend obligation is required to be established for earnings in the Closed Blocks that are not available to the shareholders. We have elected the fair value option for the AmerUs Closed Block and the ILICO Closed Block.
Other Policy Claims and Benefits		Other policy claims and benefits include amounts payable relating to in course of settlements (ICOS) and incurred but not reported (IBNR) liabilities associated with interest sensitive contract liabilities and future policy benefits. For traditional life and universal life policies, ICOS claim liabilities are established when we are notified of the death of the policyholder but the claim has not been paid as of the reporting date. For immediate annuities and supplemental contracts, ICOS claim liabilities are established to accrue suspended benefit payments between the date of notification of death and the date of verification of death.We determine IBNR claim liabilities using studies of past experience. The time that elapses from the death or claim date to when the claim is reported to us can vary significantly by product type, but generally ranges between one to six months for life business. We estimate IBNR claims on an undiscounted basis, using actuarial estimates of historical claims expense, adjusted for current trends and conditions. These estimates are continually reviewed and the ultimate liability may vary significantly from the amount recognized.
Dividends Payable to Policyholders		Participating policies entitle the policyholders to receive dividends based on actual interest, mortality, morbidity and expense experience for the year. Dividends are distributed to the policyholders through annual or terminal dividends which the board of directors of the applicable insurance subsidiary approves. As of December 31, 2021 and 2020, 10% of life policies, inclusive of ceded policies, were participating, and the related liability is recorded in dividends payable to policyholders on the consolidated balance sheets. Premiums related to participating policies represented 32%, 32% and 30% of total life insurance direct premiums and deposits for the years ended December 31, 2021, 2020 and 2019, respectively.Policyholder dividend liabilities are recorded in dividends payable to policyholders on the consolidated balance sheets and policyholder dividends are recorded in dividends to policyholders on the consolidated statements of income.
Share Repurchase		When shares are repurchased, we can choose to record treasury shares or account for the repurchase as a constructive retirement. We have accounted for share repurchases as constructive retirement, whereby we reduce common stock and additional paid-in capital by the amount of the original issuance, with any excess purchase price recorded as a reduction to retained earnings. Under this method, issued and outstanding shares are reduced by the shares repurchased, and no treasury stock is recognized on the consolidated balance sheets.
Earnings Per Share		We compute basic earnings per share (EPS) by dividing unrounded net income available to Athene Holding Ltd. shareholders by the weighted average number of common shares eligible for earnings and outstanding for the period. As a result, it may not be possible to recalculate EPS as presented in our consolidated financial statements. Diluted earnings per share includes the effect of all potentially dilutive instruments, such as common shares, options, warrants and restricted stock units (RSUs), outstanding during the period.
Foreign Currency		The accounts of foreign-based subsidiaries and equity method investments are measured using their functional currency. Revenue and expenses of these subsidiaries are translated into US dollars at the average exchange rate for the period. Assets and liabilities are translated at the exchange rate as of the end of the reporting period. For the equity method investments, our proportionate share of the investee’s income is translated into US dollars at the average exchange rate for the period and our investment is translated using the exchange rate as of the end of the reporting period. The resulting translation adjustments are included in equity as a component of AOCI. Gains or losses arising from transactions denominated in a currency other than the functional currency of the entity that is party to the transaction are included in net income. The impacts of any non-US dollar denominated AFS securities are included in AOCI along with the change in its fair value unless in a fair value hedging relationship as discussed in – Derivative Instruments above.
Recognition of Revenues and Related Expenses		Revenues for universal life-type policies and investment contracts, including surrender and market value adjustments, costs of insurance, policy administration, GMDB, GLWB and no-lapse guarantee charges, are earned when assessed against policyholder account balances during the period. Interest credited to policyholder account balances and the change in fair value of embedded derivatives within fixed indexed annuity contracts is included in interest sensitive contract benefits on the consolidated statements of income. Premiums for long-duration contracts, including products with fixed and guaranteed premiums and benefits, are recognized as revenue when due from policyholders. When premiums are due over a significantly shorter period than the period over which benefits are provided, such as immediate annuities with life contingencies (which includes pension group annuities), a deferred profit liability is established equal to the excess of the gross premium over the net premium. The deferred profit liability is recognized in future policy benefits on the consolidated balance sheets and amortized into income in a constant relationship to the benefit reserve through future policy and other policy benefits on the consolidated statements of income. All insurance related revenue is reported net of reinsurance ceded.
Income Taxes		We compute income taxes using the asset and liability method, under which deferred income taxes are provided for the temporary differences between the financial statement carrying amounts and the tax basis of our assets and liabilities using estimated tax rates expected to be in effect for the year in which the differences are expected to reverse. Such temporary differences are primarily due to the tax basis of reserves, DAC, VOBA, unrealized investment gains/losses, reinsurance related differences, embedded derivatives and net operating loss carryforwards. Changes in deferred income tax assets and liabilities associated with components of OCI are recorded directly to OCI. We evaluate the likelihood of realizing the benefit of our deferred tax assets and may record a valuation allowance if, based on all available evidence, we determine that it is more likely than not that some portion of the tax benefit will not be realized. We adjust the valuation allowance if, based on our evaluation, there is a change in the amount of deferred income tax assets that are deemed more-likely-than-not to be realized. Changes in deferred tax assets and liabilities attributable to changes in enacted income tax rates are recorded through net income in the period of enactment. We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the relevant taxing authorities, based on the technical merits of our position. For those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority. We recognize any income tax interest and penalties in income tax expense.
Reclassifications		Certain reclassifications have been made to conform with current year presentation.
Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements		Adopted Accounting Pronouncements Codification Improvements to Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs (ASU 2020-08) The amendments in this update clarify that callable debt securities should be reevaluated each reporting period to determine if the amortized cost exceeds the amount repayable by the issuer at the next earliest call date and, if so, the excess should be amortized to the next call date. We adopted this update January 1, 2021 on a prospective basis for existing or newly purchased callable debt securities. The adoption of this update did not have a material effect on our consolidated financial statements. Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (ASU 2020-01) The amendments in this update are related to certain equity securities without a readily determinable fair value that apply the measurement alternative to measure based on cost, minus impairment, if any, adjusted for any observable price changes in orderly transactions of identical or similar investments of the same issuer. The amendment clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative immediately before applying or upon discontinuing the equity method. The amendment further clarifies that for the purpose of applying accounting for certain forward contracts or purchased options, an entity should not consider whether the underlying securities would be accounted for under the equity method or the fair value option upon settlement or exercise. We adopted this update on a prospective basis effective January 1, 2021. This update did not have a material effect on our consolidated financial statements. Income Taxes – Simplifying the Accounting for Income Taxes (ASU 2019-12) The amendments in this update simplify the accounting for income taxes by eliminating certain exceptions to the tax accounting guidance related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities related to foreign investment ownership changes. It also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill and allocating consolidated income taxes to separate financial statements of entities not subject to income tax. We adopted this update January 1, 2021 and applied certain aspects of the update retrospectively while other aspects were applied on a modified retrospective basis. The adoption of this update did not have a material effect on our consolidated financial statements. Recently Issued Accounting Pronouncements Insurance – Targeted Improvements to the Accounting for Long-Duration Contracts (ASU 2020-11, ASU 2019-09, ASU 2018-12) These updates amend four key areas pertaining to the accounting and disclosures for long-duration insurance and investment contracts. • The update requires cash flow assumptions used to measure the liability for future policy benefits to be updated at least annually and no longer allows a provision for adverse deviation. The remeasurement of the liability associated with the update of assumptions is required to be recognized in net income. Loss recognition testing is eliminated for traditional and limited-payment contracts. The update also requires the discount rate used in measuring the liability to be an upper-medium grade fixed-income instrument yield, which is to be updated at each reporting date. The change in liability due to changes in the discount rate is to be recognized in other comprehensive income. • The update simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs are required to be written off for unexpected contract terminations but are not subject to impairment testing. • The update requires certain contract features meeting the definition of market risk benefits to be measured at fair value. Among the features included in this definition are the GLWB and GMDB riders attached to our annuity products. The change in fair value of the market risk benefits is to be recognized in net income, excluding the portion attributable to changes in instrument-specific credit risk which is recognized in other comprehensive income. • The update also introduces disclosure requirements around the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities, and deferred acquisition costs. This includes disaggregated rollforwards of these balances and information about significant inputs, judgments, assumptions and methods used in their measurement. We are required to adopt these updates on January 1, 2023. Certain provisions of the update are required to be adopted on a fully retrospective basis, while others may be adopted on a modified retrospective basis. Early adoption is permitted. We are currently evaluating the impact of this guidance on our consolidated financial statements.
Mergers and Acquisitions Policy Text Block	On March 8, 2021, we entered into an Agreement and Plan of Merger (Merger Agreement), by and among the Company, Apollo Global Management, Inc., a Delaware corporation (AGM, and together with its subsidiaries other than us or our subsidiaries, Apollo), Tango Holdings, Inc., a Delaware corporation and a direct wholly owned subsidiary of AGM (HoldCo), Blue Merger Sub, Ltd., a Bermuda exempted company and a direct wholly owned subsidiary of HoldCo (AHL Merger Sub), and Green Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of HoldCo (AGM Merger Sub). The Company and AGM agreed, subject to the terms and conditions of the Merger Agreement, to effect an all-stock merger transaction to combine our respective businesses by: (1) AGM merging with AGM Merger Sub, with AGM surviving such merger as a direct wholly owned subsidiary of HoldCo (AGM Merger), (2) the Company merging with AHL Merger Sub, with the Company surviving such merger as a direct wholly owned subsidiary of HoldCo (AHL Merger and, together with the AGM Merger, Mergers), and (3) as of the effective time of the Mergers, changing the name of HoldCo to be Apollo Global Management, Inc. On January 1, 2022, the Mergers were completed. The total preliminary purchase price for the transaction was approximately $12.2 billion, subject to completion of the purchase accounting analysis. The preliminary purchase price was calculated based on AGM’s December 31, 2021 closing share price multiplied by the AGM common shares issued in the exchange, as well as the fair value of stock-based compensation awards acquired, fair value of warrants converted to AGM common shares and other equity consideration. At the closing of the Mergers, we became a direct wholly owned subsidiary of AGM. Each issued and outstanding AHL Class A common share (other than AHL Class A common shares held by AHL Merger Sub, the Apollo Operating Group (AOG) or the respective direct or indirect wholly owned subsidiaries of Athene or the AOG) was converted automatically into 1.149 shares of AGM common shares and any cash paid in lieu of fractional AGM common shares. In connection with the Mergers, AGM issued to AHL Class A common shareholders 158.2 million AGM common shares in exchange for 137.6 million AHL Class A common shares that were issued and outstanding as of the acquisition date, exclusive of the 54.6 million shares previously held by AGM immediately before the acquisition date.

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Available-for-sale Securities by Contractual Maturity	The amortized cost and fair value of AFS securities, including related party, are shown by contractual maturity below: December 31, 2021 (In millions) Amortized Cost Fair Value AFS securities Due in one year or less $ 958 $ 968 Due after one year through five years 9,374 9,622 Due after five years through ten years 17,411 17,858 Due after ten years 37,496 40,342 CLO, ABS, CMBS and RMBS 31,219 31,369 Total AFS securities 96,458 100,159 AFS securities – related party Due after one year through five years 23 24 Due after five years through ten years 673 687 Due after ten years 146 148 CLO and ABS 9,559 9,543 Total AFS securities – related party 10,401 10,402 Total AFS securities including related party $ 106,859 $ 110,561
Schedule of Unrealized Loss on Investments	The following summarizes the number of AFS securities that were in an unrealized loss position, including related party, for which an allowance for credit losses has not been recorded: December 31, 2021 Unrealized loss position Unrealized loss position 12 months or more AFS securities 4,104 435 AFS securities – related party 78 9
Debt Securities, Available-for-sale, Allowance for Credit Loss	The following table summarizes the activity in the allowance for credit losses for AFS securities by asset type: Year ended December 31, 2021 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending Balance AFS securities Corporate $ 6 $ 3 $ — $ (7) $ (2) $ — CLO 1 7 — (1) (7) — ABS 6 5 — (2) 8 17 CMBS 10 4 — — (11) 3 RMBS 80 2 25 (20) 16 103 Total AFS securities 103 21 25 (30) 4 123 AFS securities – related party, CLO 1 5 — (1) (5) — Total AFS securities including related party $ 104 $ 26 $ 25 $ (31) $ (1) $ 123 Year ended December 31, 2020 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending Balance AFS securities Corporate $ — $ 44 $ — $ (14) $ (24) $ 6 CLO — 1 — — — 1 ABS — 7 — — (1) 6 CMBS — 24 — (1) (13) 10 RMBS 17 51 66 (17) (37) 80 Total AFS securities 17 127 66 (32) (75) 103 AFS securities – related party, CLO — 2 — (1) — 1 Total AFS securities including related party $ 17 $ 129 $ 66 $ (33) $ (75) $ 104
Net Investment Income	Net investment income by asset class consists of the following: Years ended December 31, (In millions) 2021 2020 2019 AFS securities $ 3,668 $ 3,225 $ 3,088 Trading securities 260 192 189 Equity securities 19 14 16 Mortgage loans 875 742 670 Investment funds 1,912 721 382 Funds withheld at interest 781 269 527 Other 271 226 159 Investment revenue 7,786 5,389 5,031 Investment expenses (609) (504) (435) Net investment income $ 7,177 $ 4,885 $ 4,596
Investment Related Gains (Losses)	Investment related gains (losses) by asset class consists of the following: Years ended December 31, (In millions) 2021 2020 2019 AFS securities Gross realized gains on investment activity $ 936 $ 602 $ 178 Gross realized losses on investment activity (633) (415) (56) Net realized investment gains on AFS securities 303 187 122 Net recognized investment gains (losses) on trading securities (70) 33 151 Net recognized investment gains (losses) on equity securities 237 (218) 25 Derivative gains 3,525 3,430 4,443 Provision for credit losses (5) (69) — Other gains (losses) 198 (54) (22) Investment related gains (losses) $ 4,188 $ 3,309 $ 4,719
Unrealized Gain (Loss) on Investments	The following table summarizes the change in unrealized gains (losses) on trading and equity securities, including related party and consolidated VIEs, we held as of the respective year end: Years ended December 31, (In millions) 2021 2020 2019 Trading securities $ (78) $ 130 $ 193 Trading securities – related party 56 (37) (18) Equity securities 213 (9) 19 Equity securities – related party 9 — (18)
Certain Loans and Debt Securities Acquired in Transfer Disclosure	The following table summarizes our PCD investment purchases with the following amounts at the time of purchase: Year ended December 31, 2021 (In millions) Fixed maturity securities Mortgage loans Purchase price $ 35 $ 335 Allowance for credit losses at acquisition 25 6 Discount (premiums) attributable to other factors (3) (26) Par value $ 57 $ 315
Investments Purchased with Credit Impairment, Accretable Yield Activity
Schedule of Repurchase Agreements	Repurchase Agreements —The following table summarizes the maturities of our repurchase agreements: December 31, 2021 Remaining Contractual Maturity (In millions) Overnight and continuous Less than 30 days 30–90 days 91 days to 1 year Greater than 1 year Total Payables for repurchase agreements 1 $ — $ 2,512 $ — $ — $ 598 $ 3,110 1 Included in payables for collateral on derivatives and securities to repurchase on the consolidated balance sheets. December 31, 2020 Remaining Contractual Maturity (In millions) Overnight and continuous Less than 30 days 30–90 days 91 days to 1 year Greater than 1 year Total Payables for repurchase agreements 1 $ — $ — $ — $ — $ 598 $ 598 1 Included in payables for collateral on derivatives and securities to repurchase on the consolidated balance sheets. The following table summarizes the securities pledged as collateral for repurchase agreements: December 31, 2021 2020 (In millions) Amortized cost Fair value Amortized cost Fair value AFS securities – Corporate $ 2,923 $ 3,208 $ 559 $ 644
Mortgage Loans, Net	Mortgage loans, net of allowances, consists of the following: December 31, (In millions) 2021 2020 Commercial mortgage loans $ 16,565 $ 11,383 Commercial mortgage loans under development 499 232 Total commercial mortgage loans 17,064 11,615 Allowance for credit losses on commercial mortgage loans (167) (167) Commercial mortgage loans, net of allowances 16,897 11,448 Residential mortgage loans 7,321 4,569 Allowance for credit losses on residential mortgage loans (70) (79) Residential mortgage loans, net of allowances 7,251 4,490 Mortgage loans, net of allowances $ 24,148 $ 15,938 The distribution of commercial mortgage loans, including those under development, net of allowances, by property type and geographic region, is as follows: December 31, 2021 2020 (In millions, except for percentages) Net carrying value Percentage of total Net carrying value Percentage of total Property type Office building $ 4,870 28.8 % $ 3,589 31.4 % Retail 2,022 12.0 % 2,083 18.2 % Apartment 4,626 27.4 % 2,441 21.3 % Hotels 1,727 10.2 % 1,294 11.3 % Industrial 2,336 13.8 % 1,362 11.9 % Other commercial 1,316 7.8 % 679 5.9 % Total commercial mortgage loans $ 16,897 100.0 % $ 11,448 100.0 % US region East North Central $ 1,697 10.0 % $ 1,209 10.5 % East South Central 470 2.8 % 402 3.5 % Middle Atlantic 3,637 21.5 % 3,069 26.8 % Mountain 460 2.7 % 487 4.2 % New England 453 2.7 % 350 3.1 % Pacific 3,994 23.6 % 2,746 24.0 % South Atlantic 2,817 16.7 % 1,773 15.5 % West North Central 271 1.6 % 145 1.3 % West South Central 997 5.9 % 640 5.6 % Total US region 14,796 87.5 % 10,821 94.5 % International region United Kingdom 1,279 7.6 % — — % Other International 1 822 4.9 % 627 5.5 % Total International region 2,101 12.5 % 627 5.5 % Total commercial mortgage loans $ 16,897 100.0 % $ 11,448 100.0 % 1 Represents all other countries, with each individual country comprising less than 5% of the portfolio. Our residential mortgage loan portfolio includes first lien residential mortgage loans collateralized by properties in various geographic locations and is summarized by proportion of the portfolio in the following table: December 31, 2021 2020 US states California 28.4 % 24.8 % Florida 11.4 % 13.3 % New York 4.8 % 6.2 % New Jersey 5.1 % 4.0 % Other 1 38.5 % 37.1 % Total US residential mortgage loan percentage 88.2 % 85.4 % International Ireland 6.4 % 12.9 % Other 2 5.4 % 1.7 % Total International residential mortgage loan percentage 11.8 % 14.6 % Total residential mortgage loan percentage 100.0 % 100.0 % 1 Represents all other states, with each individual state comprising less than 5% of the portfolio. 2 Represents all other countries, with each individual country comprising less than 5% of the portfolio.
Financing Receivable, Allowance for Credit Loss	The allowances for our mortgage loan portfolio and other loans are summarized as follows: Year ended December 31, 2021 (In millions) Commercial mortgage Residential mortgage Other investments Total Beginning balance $ 167 $ 79 $ 7 $ 253 Provision (reversal) for expected credit losses — (14) (7) (21) Initial credit losses on PCD loans — 6 — 6 Loans charged-off — (1) — (1) Ending balance $ 167 $ 70 $ — $ 237 Year ended December 31, 2020 (In millions) Commercial mortgage Residential mortgage Other investments Total Beginning balance $ 10 $ 1 $ — $ 11 Adoption of accounting standard 167 43 11 221 Provision (reversal) for expected credit losses (10) 29 (4) 15 Initial credit losses on PCD loans — 7 — 7 Loans charged-off — (1) — (1) Ending balance $ 167 $ 79 $ 7 $ 253
Financing Receivable, Past Due	The following represents our residential loan portfolio by origination year and performance status: December 31, 2021 (In millions) 2021 2020 2019 2018 2017 Prior Total Current (less than 30 days past due) $ 2,398 $ 319 $ 37 $ 383 $ 54 $ 2,568 $ 5,759 30 to 59 days past due 100 37 3 3 6 223 372 60 to 89 days past due 36 16 3 2 7 136 200 90 days or more past due 1 27 133 82 87 141 520 990 Total residential mortgages $ 2,561 $ 505 $ 125 $ 475 $ 208 $ 3,447 $ 7,321 1 Includes $856 million of residential mortgage loans that are guaranteed by US government-sponsored agencies. December 31, 2020 1 (In millions) 2020 2019 2018 2017 2016 Prior Total Current (less than 30 days past due) $ 274 $ 68 $ 845 $ 72 $ 7 $ 2,993 $ 4,259 30 to 59 days past due 28 1 3 — — 121 153 60 to 89 days past due 2 — 1 — — 47 50 90 days or more past due — 8 5 — — 94 107 Total residential mortgages $ 304 $ 77 $ 854 $ 72 $ 7 $ 3,255 $ 4,569 1 Previously reported amounts have been revised to correct a misstatement, which was not material, in the classification of residential mortgage loans by origination year. Commercial mortgage loans – The following represents our commercial mortgage loan portfolio by origination year and loan performance status: December 31, 2021 (In millions) 2021 2020 2019 2018 2017 Prior Total Current (less than 30 days past due) $ 6,003 $ 1,852 $ 4,129 $ 2,731 $ 952 $ 1,255 $ 16,922 30 to 59 days past due 52 — — — 90 — 142 Total commercial mortgages $ 6,055 $ 1,852 $ 4,129 $ 2,731 $ 1,042 $ 1,255 $ 17,064 December 31, 2020 (In millions) 2020 2019 2018 2017 2016 Prior Total Current (less than 30 days past due) $ 1,913 $ 4,400 $ 2,617 $ 987 $ 130 $ 1,452 $ 11,499 30 to 59 days past due — 20 45 25 — 5 95 90 days or more past due — — — — — 21 21 Total commercial mortgages $ 1,913 $ 4,420 $ 2,662 $ 1,012 $ 130 $ 1,478 $ 11,615
Financing Receivable, Nonaccrual	The following represents our residential loan portfolio in non-accrual status: December 31, (In millions) 2021 2020 Beginning amortized cost of residential mortgage loans in non-accrual status $ 107 $ 67 Ending amortized cost of residential mortgage loans in non-accrual status 134 107 Amortized cost of residential mortgage loans in non-accrual status without a related allowance for credit losses 76 13 The following represents our commercial mortgage loan portfolio in non-accrual status: December 31, (In millions) 2021 2020 Beginning amortized cost of commercial mortgage loans in non-accrual status $ 38 $ — Ending amortized cost of commercial mortgage loans in non-accrual status 62 38 Amortized cost of commercial mortgage loans in non-accrual status without a related allowance for credit losses — —
Credit Quality Indicators of the Commercial Mortgage Portfolio	The following represents the loan-to-value ratio of the commercial mortgage loan portfolio, excluding those under development, by origination year: December 31, 2021 (In millions) 2021 2020 2019 2018 2017 Prior Total Less than 50% $ 491 $ 211 $ 633 $ 293 $ 166 $ 957 $ 2,751 50% to 59% 2,127 566 1,275 629 381 191 5,169 60% to 69% 1,748 544 1,786 1,326 369 71 5,844 70% to 79% 1,442 417 360 420 101 — 2,740 80% to 99% — — — — 25 — 25 100% or greater — — — — — 36 36 Commercial mortgage loans $ 5,808 $ 1,738 $ 4,054 $ 2,668 $ 1,042 $ 1,255 $ 16,565 December 31, 2020 (In millions) 2020 2019 2018 2017 2016 Prior Total Less than 50% $ 431 $ 600 $ 201 $ 152 $ 44 $ 1,153 $ 2,581 50% to 59% 315 1,320 765 300 40 147 2,887 60% to 69% 583 1,988 1,222 440 46 106 4,385 70% to 79% 478 485 375 95 — 13 1,446 80% to 99% — — — 25 — 21 46 100% or greater — — — — — 38 38 Commercial mortgage loans $ 1,807 $ 4,393 $ 2,563 $ 1,012 $ 130 $ 1,478 $ 11,383 December 31, 2021 (In millions) 2021 2020 2019 2018 2017 Prior Total Greater than 1.20x $ 4,370 $ 1,123 $ 2,216 $ 2,163 $ 860 $ 1,095 $ 11,827 1.00x – 1.20x 1,018 496 1,429 66 — 82 3,091 Less than 1.00x 420 119 409 439 182 78 1,647 Commercial mortgage loans $ 5,808 $ 1,738 $ 4,054 $ 2,668 $ 1,042 $ 1,255 $ 16,565 December 31, 2020 (In millions) 2020 2019 2018 2017 2016 Prior Total Greater than 1.20x $ 1,274 $ 2,964 $ 2,440 $ 846 $ 129 $ 1,369 $ 9,022 1.00x – 1.20x 533 1,122 36 70 1 101 1,863 Less than 1.00x — 307 87 96 — 8 498 Commercial mortgage loans $ 1,807 $ 4,393 $ 2,563 $ 1,012 $ 130 $ 1,478 $ 11,383
Summary of Investment Funds	The following summarizes our investment funds, including related party: December 31, 2021 2020 (In millions, except for percentages) Carrying value Percent of total Carrying value Percent of total Investment funds Real estate $ 856 60.8 % $ 348 43.3 % Credit funds 86 6.1 % 107 13.3 % Private equity 343 24.4 % 267 33.3 % Real assets 122 8.7 % 81 10.1 % Total investment funds 1,407 100.0 % 803 100.0 % Investment funds – related parties Differentiated investments Athora Holding Ltd. (Athora) 1 743 8.8 % 709 13.4 % Athene Freedom Holdings LP 1 700 8.3 % — — % Catalina Holdings Ltd. (Catalina) 441 5.2 % 334 6.3 % Venerable Holdings, Inc. (Venerable) 1 219 2.6 % 123 2.3 % A-A Mortgage Opportunities, L.P. (A-A Mortgage) 1 26 0.3 % 444 8.4 % Other 433 5.1 % 279 5.3 % Total differentiated investments 2,562 30.3 % 1,889 35.7 % Real estate 1,507 17.8 % 828 15.7 % Credit funds 1,198 14.1 % 375 7.1 % Private equity 751 8.9 % 473 8.9 % Natural resources 172 2.0 % 113 2.1 % Real assets 157 1.9 % 172 3.3 % Public equities — — % 110 2.1 % Investment in Apollo 1 2,112 25.0 % 1,324 25.1 % Total investment funds – related parties 8,459 100.0 % 5,284 100.0 % Total investment funds including related party $ 9,866 $ 6,087 1 Our Venerable investment is in its parent company, VA Capital Company LLC (VA Capital). See further discussion on this investment and our investments in Apollo, Athora, A-A Mortgage and Athene Freedom Holdings LP in Note 14 – Related Parties. December 31, (In millions) 2021 2020 Assets $ 142,045 $ 130,807 Liabilities 108,525 109,654 Equity 33,520 21,153 Years ended December 31, (In millions) 2021 2020 2019 Net income $ 6,335 $ 2,196 $ 817 The following table presents the carrying value by ownership percentage of equity method investment funds, including related party investment funds: December 31, (In millions) 2021 2020 Ownership Percentage 100% $ 649 $ 717 50% – 99% 2,111 678 3% – 49% 2,668 2,412 Equity method investment funds $ 5,428 $ 3,807 The following table presents the carrying value by ownership percentage of investment funds held at fair value, either due to election of the fair value option or requirement, including related party investment funds: December 31, (In millions) 2021 2020 Ownership Percentage 100% $ 229 $ — 50% – 99% 201 28 3% – 49% 3,697 2,109 Less than 3% 311 143 Fair value investment funds $ 4,438 $ 2,280
Schedule of Variable Interest Entities	The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: December 31, 2021 2020 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 1,407 $ 2,225 $ 803 $ 1,265 Investment in related parties – investment funds 8,459 12,136 5,284 7,989 Investment in fixed maturity securities 31,769 31,622 23,325 23,027 Investment in related parties – fixed maturity securities 11,324 12,681 7,834 8,126 Investment in related parties – equity securities 284 284 72 72 Total non-consolidated investments $ 53,243 $ 58,948 $ 37,318 $ 40,479 The following summarizes the investments of these consolidated VIEs: December 31, (In millions) 2021 2020 Mortgage loans Hamlet $ 1,793 $ 1,880 A-A Euro 231 — Other 16 — Investment funds AOP 747 — NNN AGP Opportunities 264 — A-A SPN-9 194 — Java 35 — A-A Euro 57 —
Debt Securities, Available-for-sale	The following table represents the amortized cost, allowance for credit losses, gross unrealized gains and losses and fair value of our AFS investments by asset type: December 31, 2021 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 231 $ — $ 2 $ (10) $ 223 US state, municipal and political subdivisions 1,081 — 134 (2) 1,213 Foreign governments 1,110 — 35 (17) 1,128 Corporate 62,817 — 4,060 (651) 66,226 CLO 13,793 — 44 (185) 13,652 ABS 8,890 (17) 151 (35) 8,989 CMBS 2,764 (3) 56 (59) 2,758 RMBS 5,772 (103) 326 (25) 5,970 Total AFS securities 96,458 (123) 4,808 (984) 100,159 AFS securities – related party Corporate 842 — 19 (2) 859 CLO 2,573 — 5 (29) 2,549 ABS 6,986 — 61 (53) 6,994 Total AFS securities – related party 10,401 — 85 (84) 10,402 Total AFS securities including related party $ 106,859 $ (123) $ 4,893 $ (1,068) $ 110,561 December 31, 2020 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 349 $ — $ 3 $ (1) $ 351 US state, municipal and political subdivisions 864 — 169 — 1,033 Foreign governments 330 — 38 — 368 Corporate 51,934 (6) 6,368 (116) 58,180 CLO 9,631 (1) 145 (206) 9,569 ABS 4,259 (6) 140 (123) 4,270 CMBS 2,165 (10) 85 (71) 2,169 RMBS 6,568 (80) 447 (22) 6,913 Total AFS securities 76,100 (103) 7,395 (539) 82,853 AFS securities – related party Corporate 213 — 2 — 215 CLO 1,511 (1) 23 (13) 1,520 ABS 4,720 — 95 (30) 4,785 Total AFS securities – related party 6,444 (1) 120 (43) 6,520 Total AFS securities including related party $ 82,544 $ (104) $ 7,515 $ (582) $ 89,373
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value	The following summarizes the fair value and gross unrealized losses for AFS securities, including related party, for which an allowance for credit losses has not been recorded, aggregated by asset type and length of time the fair value has remained below amortized cost: December 31, 2021 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Fair Value Gross Fair Value Gross AFS securities US government and agencies $ 164 $ (8) $ 22 $ (2) $ 186 $ (10) US state, municipal and political subdivisions 122 (2) 1 — 123 (2) Foreign governments 387 (17) 1 — 388 (17) Corporate 18,995 (523) 863 (59) 19,858 (582) CLO 7,685 (124) 1,537 (35) 9,222 (159) ABS 4,038 (16) 165 (12) 4,203 (28) CMBS 880 (29) 177 (22) 1,057 (51) RMBS 437 (9) 274 (5) 711 (14) Total AFS securities 32,708 (728) 3,040 (135) 35,748 (863) AFS securities – related party Corporate 313 (2) — — 313 (2) CLO 1,245 (20) 163 (3) 1,408 (23) ABS 3,801 (52) 13 (1) 3,814 (53) Total AFS securities – related party 5,359 (74) 176 (4) 5,535 (78) Total AFS securities including related party $ 38,067 $ (802) $ 3,216 $ (139) $ 41,283 $ (941) December 31, 2020 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 31 $ (1) $ — $ — $ 31 $ (1) US state, municipal and political subdivisions 9 — 6 — 15 — Foreign governments 2 — — — 2 — Corporate 2,218 (66) 248 (24) 2,466 (90) CLO 1,649 (33) 3,179 (167) 4,828 (200) ABS 1,169 (73) 84 (18) 1,253 (91) CMBS 710 (37) 48 (13) 758 (50) RMBS 548 (11) 37 (2) 585 (13) Total AFS securities 6,336 (221) 3,602 (224) 9,938 (445) AFS securities – related party CLO 336 (3) 232 (10) 568 (13) ABS 1,012 (30) — — 1,012 (30) Total AFS securities – related party 1,348 (33) 232 (10) 1,580 (43) Total AFS securities including related party $ 7,684 $ (254) $ 3,834 $ (234) $ 11,518 $ (488)

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Notional Amount and Fair Value of Derivative Instruments	The following table presents the notional amount and fair value of derivative instruments: December 31, 2021 2020 Notional Amount Fair Value Notional Amount Fair Value (In millions) Assets Liabilities Assets Liabilities Derivatives designated as hedges Foreign currency hedges Swaps 6,371 $ 281 $ 56 4,417 $ 134 $ 181 Forwards 6,395 189 2 2,038 3 9 Interest rate swaps 2,783 — 173 — — — Forwards on net investments 231 — 4 173 — 2 Interest rate swaps 500 — 1 — — — Total derivatives designated as hedges 470 236 137 192 Derivatives not designated as hedges Equity options 57,890 3,629 115 53,666 3,209 22 Futures 33 67 — 24 58 2 Total return swaps 231 10 — 97 6 — Foreign currency swaps 2,592 57 19 1,510 96 — Interest rate swaps 483 78 1 803 — 34 Credit default swaps 10 — 3 10 — 4 Foreign currency forwards 7,382 76 98 3,595 17 44 Embedded derivatives Funds withheld including related party 1,360 45 2,806 59 Interest sensitive contract liabilities — 14,907 — 12,873 Total derivatives not designated as hedges 5,277 15,188 6,192 13,038 Total derivatives $ 5,747 $ 15,424 $ 6,329 $ 13,230
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location	December 31, 2021 December 31, 2020 (In millions) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) AFS securities – Foreign currency forwards $ 4,224 $ (136) $ 1,932 $ 117 Mortgage loans – Foreign currency forwards 1,686 (44) — — Interest sensitive contract liabilities Foreign currency forwards — — 65 (1) Foreign currency interest rate swaps 2,773 121 — — Interest rate swaps 500 — — — 1 The carrying amount disclosed for AFS securities is amortized cost. The following is a summary of the gains (losses) related to the derivatives and related hedged items in fair value hedge relationships: Amounts Excluded (In millions) Derivatives Hedged Items Net Recognized in income through amortization approach Recognized in income through changes in fair value Year ended December 31, 2021 Investment related gains (losses) Foreign currency forwards $ 420 $ (440) $ (20) $ 21 $ 16 Foreign currency interest rate swaps (102) 99 (3) — — Interest rate swaps (1) 1 — — — Interest sensitive contract benefits Foreign currency interest rate swaps 23 (21) 2 — — Year ended December 31, 2020 Investment related gains (losses) – Foreign currency forwards (118) 116 (2) — — Interest sensitive contract benefits – Foreign currency forwards 1 (1) — — — Year ended December 31, 2019 Investment related gains (losses) – Foreign currency forwards 2 — 2 — —
Gains (Losses) Related to Derivatives Not Designated as Hedges	The following is a summary of the gains (losses) related to derivatives not designated as hedges: Years ended December 31, (In millions) 2021 2020 2019 Equity options $ 2,452 $ 819 $ 2,169 Futures 81 123 (13) Swaps 15 82 43 Foreign currency forwards 37 (127) (2) Embedded derivatives on funds withheld 572 2,651 2,246 Amounts recognized in investment related gains (losses) 3,157 3,548 4,443 Embedded derivatives in indexed annuity products 1 (1,451) (1,384) (2,526) Total net gains on derivatives not designated as hedges $ 1,706 $ 2,164 $ 1,917 1 Included in interest sensitive contract benefits on the consolidated statements of income.
Estimated Fair Value of Net Derivative and Other Financial Assets	The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral December 31, 2021 Derivative assets $ 4,387 $ (430) $ (3,934) $ 23 $ — $ 23 Derivative liabilities (472) 430 32 (10) — (10) December 31, 2020 Derivative assets $ 3,523 $ (165) $ (3,196) $ 162 $ (46) $ 116 Derivative liabilities (298) 165 144 11 — 11 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the consolidated balance sheets. As of December 31, 2021 and 2020, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received.
Estimated Fair Value of Net Derivative and Other Financial Liabilities	The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral December 31, 2021 Derivative assets $ 4,387 $ (430) $ (3,934) $ 23 $ — $ 23 Derivative liabilities (472) 430 32 (10) — (10) December 31, 2020 Derivative assets $ 3,523 $ (165) $ (3,196) $ 162 $ (46) $ 116 Derivative liabilities (298) 165 144 11 — 11 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the consolidated balance sheets. As of December 31, 2021 and 2020, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received. December 31, (In millions) 2021 2020 Fair value of derivative liabilities with credit related provisions $ 3 $ 4 Maximum exposure for credit default swaps 10 10
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	The following is a summary of the gains (losses) related to cash flow hedges: Years ended December 31, (In millions) 2021 2020 2019 Foreign currency swaps – Other comprehensive income (loss) $ 254 $ (106) $ 29 Foreign currency swaps – Investment related gains (losses) 14 — — There were no amounts deemed ineffective during the years ended December 31, 2021 , 2020 or 2019. As of December 31, 2021, no amounts are expected to be reclassified to income within the next 12 months.

Organization, Consolidation and

Organization, Consolidation and Presentation of Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Variable Interest Entities	The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: December 31, 2021 2020 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 1,407 $ 2,225 $ 803 $ 1,265 Investment in related parties – investment funds 8,459 12,136 5,284 7,989 Investment in fixed maturity securities 31,769 31,622 23,325 23,027 Investment in related parties – fixed maturity securities 11,324 12,681 7,834 8,126 Investment in related parties – equity securities 284 284 72 72 Total non-consolidated investments $ 53,243 $ 58,948 $ 37,318 $ 40,479 The following summarizes the investments of these consolidated VIEs: December 31, (In millions) 2021 2020 Mortgage loans Hamlet $ 1,793 $ 1,880 A-A Euro 231 — Other 16 — Investment funds AOP 747 — NNN AGP Opportunities 264 — A-A SPN-9 194 — Java 35 — A-A Euro 57 —

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The following represents the hierarchy for our assets and liabilities measured at fair value on a recurring basis: December 31, 2021 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 223 $ — $ 214 $ 9 $ — US state, municipal and political subdivisions 1,213 — — 1,213 — Foreign governments 1,128 — — 1,126 2 Corporate 66,226 — — 64,887 1,339 CLO 13,652 — — 13,638 14 ABS 8,989 — — 5,370 3,619 CMBS 2,758 — — 2,715 43 RMBS 5,970 — — 5,970 — Total AFS securities 100,159 — 214 94,928 5,017 Trading securities US government and agencies 6 — 3 3 — US state, municipal and political subdivisions 101 — — 101 — Foreign governments 19 — — 19 — Corporate 1,530 — — 1,530 — CLO 11 — — 6 5 ABS 141 — — 96 45 CMBS 94 — — 94 — RMBS 154 — — 135 19 Total trading securities 2,056 — 3 1,984 69 Equity securities 1,170 — 86 655 429 Mortgage loans 17 — — — 17 Investment funds 412 165 — — 247 Funds withheld at interest – embedded derivative 782 — — — 782 Derivative assets 4,387 — 67 4,320 — Short-term investments 139 — 49 61 29 Other investments 130 — — 130 — Cash and cash equivalents 9,633 — 9,633 — — Restricted cash 796 — 796 — — Investments in related parties AFS securities Corporate 859 — — 189 670 CLO 2,549 — — 2,347 202 ABS 6,994 — — 549 6,445 Total AFS securities – related party 10,402 — — 3,085 7,317 Trading securities CLO 52 — — 10 42 ABS 1,729 — — — 1,729 Total trading securities – related party 1,781 — — 10 1,771 Equity securities 284 — — — 284 Investment funds 4,026 103 — — 3,923 Funds withheld at interest – embedded derivative 578 — — — 578 Reinsurance recoverable 1,991 — — — 1,991 Total assets measured at fair value $ 138,743 $ 268 $ 10,848 $ 105,173 $ 22,454 (Continued) December 31, 2021 (In millions) Total NAV Level 1 Level 2 Level 3 Liabilities Interest sensitive contract liabilities Embedded derivative $ 14,907 $ — $ — $ — $ 14,907 Universal life benefits 1,235 — — — 1,235 Future policy benefits AmerUs Closed Block 1,520 — — — 1,520 ILICO Closed Block and life benefits 742 — — — 742 Derivative liabilities 472 — — 469 3 Funds withheld liability – embedded derivative 45 — — 45 — Total liabilities measured at fair value $ 18,921 $ — $ — $ 514 $ 18,407 (Concluded) December 31, 2020 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 351 $ — $ 332 $ 19 $ — US state, municipal and political subdivisions 1,033 — — 999 34 Foreign governments 368 — — 366 2 Corporate 58,180 — — 57,402 778 CLO 9,569 — — 9,361 208 ABS 4,270 — — 3,470 800 CMBS 2,169 — — 2,126 43 RMBS 6,913 — — 6,913 — Total AFS securities 82,853 — 332 80,656 1,865 Trading securities US government and agencies 6 — 3 3 — US state, municipal and political subdivisions 106 — — 106 — Corporate 1,577 — — 1,577 — CLO 4 — — — 4 ABS 128 — — 93 35 CMBS 52 — — 52 — RMBS 220 — — 173 47 Total trading securities 2,093 — 3 2,004 86 Equity securities 330 — 57 262 11 Mortgage loans 19 — — — 19 Investment funds 161 144 — — 17 Funds withheld at interest – embedded derivative 1,944 — — — 1,944 Derivative assets 3,523 — 58 3,465 — Short-term investments 222 — 146 74 2 Other investments 105 — — 105 — Cash and cash equivalents 7,704 — 7,704 — — Restricted cash 738 — 738 — — (Continued) December 31, 2020 (In millions) Total NAV Level 1 Level 2 Level 3 Investments in related parties AFS securities Corporate 215 — — 20 195 CLO 1,520 — — 1,520 — ABS 4,785 — — 676 4,109 Total AFS securities – related party 6,520 — — 2,216 4,304 Trading securities CLO 54 — — 4 50 ABS 1,475 — — — 1,475 Total trading securities – related party 1,529 — — 4 1,525 Equity securities 72 — — — 72 Investment funds 2,119 86 — — 2,033 Funds withheld at interest – embedded derivative 862 — — — 862 Reinsurance recoverable 2,100 — — — 2,100 Total assets measured at fair value $ 112,894 $ 230 $ 9,038 $ 88,786 $ 14,840 Liabilities Interest sensitive contract liabilities Embedded derivative $ 12,873 $ — $ — $ — $ 12,873 Universal life benefits 1,308 — — — 1,308 Future policy benefits AmerUs Closed Block 1,600 — — — 1,600 ILICO Closed Block and life benefits 776 — — — 776 Derivative liabilities 298 — 2 292 4 Funds withheld liability – embedded derivative 59 — — 59 — Total liabilities measured at fair value $ 16,914 $ — $ 2 $ 351 $ 16,561 (Concluded)
Summary of Fair Value Option	The following represents the gains (losses) recorded for instruments for which we have elected the fair value option, including related parties: Years ended December 31, (In millions) 2021 2020 2019 Trading securities $ (70) $ 33 $ 151 Investment funds 826 295 (3) Future policy benefits 80 (54) (103) Total gains (losses) $ 836 $ 274 $ 45 The following summarizes information for fair value option mortgage loans: December 31, (In millions) 2021 2020 Unpaid principal balance $ 15 $ 17 Mark to fair value 2 2 Fair value $ 17 $ 19
Reconciliation of Level 3 Assets Measured on a Recurring Basis	The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. All transfers in and out of Level 3 are based on changes in the availability of pricing sources, as described in the valuation methods above. Year ended December 31, 2021 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities US state, municipal and political subdivisions $ 34 $ — $ — $ — $ (34) $ — $ — $ — Foreign governments 2 — — — — 2 — — Corporate 778 6 27 428 100 1,339 — 27 CLO 208 — 1 (37) (158) 14 — 1 ABS 800 (17) 45 2,958 (167) 3,619 — 45 CMBS 43 2 6 (11) 3 43 — 6 Trading securities CLO 4 — — 1 — 5 — — ABS 35 (1) — — 11 45 (1) — RMBS 47 (10) — — (18) 19 (4) — Equity securities 11 16 — 402 — 429 16 — Mortgage loans 19 — — (2) — 17 — — Investment funds 17 (27) — 148 109 247 (27) — Funds withheld at interest – embedded derivative 1,944 (1,162) — — — 782 — — Short-term investments 2 — — 27 — 29 — — Investments in related parties AFS securities Corporate 195 2 7 661 (195) 670 — 7 CLO — — — 202 — 202 — — ABS 4,109 (6) (44) 2,386 — 6,445 — (44) Trading securities CLO 50 (7) — 9 (10) 42 — — ABS 1,475 27 — 227 — 1,729 40 — Equity securities 72 8 — 204 — 284 8 — Investment funds 2,033 853 — 1,037 — 3,923 853 — Funds withheld at interest – embedded derivative 862 (284) — — — 578 — — Reinsurance recoverable 2,100 (109) — — — 1,991 — — Total Level 3 assets $ 14,840 $ (709) $ 42 $ 8,640 $ (359) $ 22,454 $ 885 $ 42 Liabilities Interest sensitive contract liabilities Embedded derivative $ (12,873) $ (1,451) $ — $ (583) $ — $ (14,907) $ — $ — Universal life benefits (1,308) 73 — — — (1,235) — — Future policy benefits AmerUs Closed Block (1,600) 80 — — — (1,520) — — ILICO Closed Block and life benefits (776) 34 — — — (742) — — Derivative liabilities (4) 1 — — — (3) — — Total Level 3 liabilities $ (16,561) $ (1,263) $ — $ (583) $ — $ (18,407) $ — $ — 1 Related to instruments held at end of period. Year ended December 31, 2020 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities US state, municipal and political subdivisions $ 40 $ — $ — $ (6) $ — $ 34 $ — $ — Foreign governments — — — 2 — 2 — — Corporate 725 10 5 10 28 778 — 5 CLO 121 — — 109 (22) 208 — — ABS 1,374 20 (48) (282) (264) 800 — (47) CMBS 46 (4) (5) (5) 11 43 — (4) Trading securities CLO 6 (2) — — — 4 — — ABS 16 — — 19 — 35 — — RMBS 52 (9) — — 4 47 2 — Equity securities 3 3 — 5 — 11 3 — Mortgage loans 27 — — (8) — 19 — — Investment funds 22 (5) — — — 17 (5) — Funds withheld at interest – embedded derivative 801 1,143 — — — 1,944 — — Short-term investments 41 — — (39) — 2 — — Investments in related parties AFS securities Corporate — — — 195 — 195 — — ABS 2,324 24 37 1,889 (165) 4,109 — 37 Trading securities CLO 38 (13) — 14 11 50 (9) — ABS 711 (13) — 777 — 1,475 (14) — Equity securities 64 1 — 12 (5) 72 1 — Investment funds 132 298 — 1,603 — 2,033 122 — Funds withheld at interest – embedded derivative 594 268 — — — 862 — — Reinsurance recoverable 1,821 279 — — — 2,100 — — Total Level 3 assets $ 8,958 $ 2,000 $ (11) $ 4,295 $ (402) $ 14,840 $ 100 $ (9) Liabilities Interest sensitive contract liabilities Embedded derivative $ (10,942) $ (1,384) $ — $ (547) $ — $ (12,873) $ — $ — Universal life benefits (1,050) (258) — — — (1,308) — — Future policy benefits AmerUs Closed Block (1,546) (54) — — — (1,600) — — ILICO Closed Block and life benefits (755) (21) — — — (776) — — Derivative liabilities (3) (1) — — — (4) (1) — Total Level 3 liabilities $ (14,296) $ (1,718) $ — $ (547) $ — $ (16,561) $ (1) $ — 1 Related to instruments held at end of period.
Reconciliation of Level 3 Liabilities Measured on a Recurring Basis	The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. All transfers in and out of Level 3 are based on changes in the availability of pricing sources, as described in the valuation methods above. Year ended December 31, 2021 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities US state, municipal and political subdivisions $ 34 $ — $ — $ — $ (34) $ — $ — $ — Foreign governments 2 — — — — 2 — — Corporate 778 6 27 428 100 1,339 — 27 CLO 208 — 1 (37) (158) 14 — 1 ABS 800 (17) 45 2,958 (167) 3,619 — 45 CMBS 43 2 6 (11) 3 43 — 6 Trading securities CLO 4 — — 1 — 5 — — ABS 35 (1) — — 11 45 (1) — RMBS 47 (10) — — (18) 19 (4) — Equity securities 11 16 — 402 — 429 16 — Mortgage loans 19 — — (2) — 17 — — Investment funds 17 (27) — 148 109 247 (27) — Funds withheld at interest – embedded derivative 1,944 (1,162) — — — 782 — — Short-term investments 2 — — 27 — 29 — — Investments in related parties AFS securities Corporate 195 2 7 661 (195) 670 — 7 CLO — — — 202 — 202 — — ABS 4,109 (6) (44) 2,386 — 6,445 — (44) Trading securities CLO 50 (7) — 9 (10) 42 — — ABS 1,475 27 — 227 — 1,729 40 — Equity securities 72 8 — 204 — 284 8 — Investment funds 2,033 853 — 1,037 — 3,923 853 — Funds withheld at interest – embedded derivative 862 (284) — — — 578 — — Reinsurance recoverable 2,100 (109) — — — 1,991 — — Total Level 3 assets $ 14,840 $ (709) $ 42 $ 8,640 $ (359) $ 22,454 $ 885 $ 42 Liabilities Interest sensitive contract liabilities Embedded derivative $ (12,873) $ (1,451) $ — $ (583) $ — $ (14,907) $ — $ — Universal life benefits (1,308) 73 — — — (1,235) — — Future policy benefits AmerUs Closed Block (1,600) 80 — — — (1,520) — — ILICO Closed Block and life benefits (776) 34 — — — (742) — — Derivative liabilities (4) 1 — — — (3) — — Total Level 3 liabilities $ (16,561) $ (1,263) $ — $ (583) $ — $ (18,407) $ — $ — 1 Related to instruments held at end of period. Year ended December 31, 2020 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities US state, municipal and political subdivisions $ 40 $ — $ — $ (6) $ — $ 34 $ — $ — Foreign governments — — — 2 — 2 — — Corporate 725 10 5 10 28 778 — 5 CLO 121 — — 109 (22) 208 — — ABS 1,374 20 (48) (282) (264) 800 — (47) CMBS 46 (4) (5) (5) 11 43 — (4) Trading securities CLO 6 (2) — — — 4 — — ABS 16 — — 19 — 35 — — RMBS 52 (9) — — 4 47 2 — Equity securities 3 3 — 5 — 11 3 — Mortgage loans 27 — — (8) — 19 — — Investment funds 22 (5) — — — 17 (5) — Funds withheld at interest – embedded derivative 801 1,143 — — — 1,944 — — Short-term investments 41 — — (39) — 2 — — Investments in related parties AFS securities Corporate — — — 195 — 195 — — ABS 2,324 24 37 1,889 (165) 4,109 — 37 Trading securities CLO 38 (13) — 14 11 50 (9) — ABS 711 (13) — 777 — 1,475 (14) — Equity securities 64 1 — 12 (5) 72 1 — Investment funds 132 298 — 1,603 — 2,033 122 — Funds withheld at interest – embedded derivative 594 268 — — — 862 — — Reinsurance recoverable 1,821 279 — — — 2,100 — — Total Level 3 assets $ 8,958 $ 2,000 $ (11) $ 4,295 $ (402) $ 14,840 $ 100 $ (9) Liabilities Interest sensitive contract liabilities Embedded derivative $ (10,942) $ (1,384) $ — $ (547) $ — $ (12,873) $ — $ — Universal life benefits (1,050) (258) — — — (1,308) — — Future policy benefits AmerUs Closed Block (1,546) (54) — — — (1,600) — — ILICO Closed Block and life benefits (755) (21) — — — (776) — — Derivative liabilities (3) (1) — — — (4) (1) — Total Level 3 liabilities $ (14,296) $ (1,718) $ — $ (547) $ — $ (16,561) $ (1) $ — 1 Related to instruments held at end of period.
Gross Components of Purchases, Sales, Issuances and Settlements, net	Year ended December 31, 2021 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities US state, municipal and political subdivisions $ — $ — $ — $ — $ — $ — $ (34) $ (34) Foreign governments 1 — — (1) — — — — Corporate 636 — (96) (112) 428 228 (128) 100 CLO — — — (37) (37) — (158) (158) ABS 4,455 — (1,001) (496) 2,958 160 (327) (167) CMBS — — (10) (1) (11) 43 (40) 3 Trading securities CLO 5 — (4) — 1 — — — ABS — — — — — 11 — 11 RMBS — — — — — 4 (22) (18) Equity securities 402 — — — 402 — — — Mortgage loans — — — (2) (2) — — — Investment funds 285 — (137) — 148 109 — 109 Short-term investments 30 — (3) — 27 — — — Investments in related parties AFS securities Corporate 661 — — — 661 — (195) (195) CLO 202 — — — 202 — — — ABS 3,679 — (212) (1,081) 2,386 — — — Trading securities CLO 18 — (2) (7) 9 — (10) (10) ABS 404 — (115) (62) 227 — — — Equity securities 213 — — (9) 204 — — — Investment funds 1,037 — — — 1,037 — — — Total Level 3 assets $ 12,028 $ — $ (1,580) $ (1,808) $ 8,640 $ 555 $ (914) $ (359) Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (1,474) $ — $ 891 $ (583) $ — $ — $ — Total Level 3 liabilities $ — $ (1,474) $ — $ 891 $ (583) $ — $ — $ —
Summary of the Unobservable Inputs for the Embedded Derivative of Fixed Indexed Annuities	The following summarizes the unobservable inputs for AFS and trading securities and the embedded derivatives of fixed indexed annuities: December 31, 2021 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS and trading securities $ 10,167 Discounted cash flow Discount rate 1.4 % 19.4 % 5.2 % 1 Decrease Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives $ 14,907 Option budget method Nonperformance risk 0.1 % 1.0 % 0.6 % 2 Decrease Option budget 0.4 % 3.4 % 1.9 % 3 Increase Surrender rate 5.9 % 10.7 % 8.0 % 4 Decrease December 31, 2020 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS and trading securities $ 5,858 Discounted cash flow Discount rate 1.7 % 35.0 % 4.6 % 1 Decrease Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives $ 12,873 Option budget method Nonperformance risk 0.0 % 1.1 % 0.5 % 2 Decrease Option budget 0.6 % 3.5 % 1.9 % 3 Increase Surrender rate 5.3 % 9.5 % 7.1 % 4 Decrease 1 The discount rate weighted average is calculated based on the relative fair values of the securities. 2 The nonperformance risk weighted average is based on the projected excess benefits of reserves used in the calculation of the embedded derivative. 3 The option budget weighted average is calculated based on the indexed account values. 4 The surrender rate weighted average is calculated based on projected account values.
Summary of Financial Instruments Not Carried at Fair Value on the Balance Sheet	The following represents our financial instruments not carried at fair value on the consolidated balance sheets: December 31, 2021 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Mortgage loans $ 22,540 $ 23,059 $ — $ — $ — $ 23,059 Investment funds 995 995 995 — — — Policy loans 312 312 — — 312 — Funds withheld at interest 43,125 43,125 — — — 43,125 Other investments 1,343 1,343 — — — 1,343 Investments in related parties Mortgage loans 1,591 1,600 — — — 1,600 Investment funds 4,433 4,433 4,433 — — — Funds withheld at interest 11,629 11,629 — — — 11,629 Other investments 222 223 — — — 223 Total financial assets not carried at fair value $ 86,190 $ 86,719 $ 5,428 $ — $ 312 $ 80,979 Financial liabilities Interest sensitive contract liabilities $ 105,293 $ 108,621 $ — $ — $ — $ 108,621 Long-term debt 2,964 3,295 — — 3,295 — Securities to repurchase 3,110 3,110 — — 3,110 — Funds withheld liability 394 394 — — 394 — Total financial liabilities not carried at fair value $ 111,761 $ 115,420 $ — $ — $ 6,799 $ 108,621 December 31, 2020 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Mortgage loans $ 15,245 $ 15,811 $ — $ — $ — $ 15,811 Investment funds 642 642 642 — — — Policy loans 369 369 — — 369 — Funds withheld at interest 46,668 46,668 — — — 46,668 Other investments 467 471 — — — 471 Investments in related parties Mortgage loans 674 694 — — — 694 Investment funds 3,165 3,165 3,165 — — — Funds withheld at interest 12,168 12,168 — — — 12,168 Other investments 469 499 — — — 499 Total financial assets not carried at fair value $ 79,867 $ 80,487 $ 3,807 $ — $ 369 $ 76,311 Financial liabilities Interest sensitive contract liabilities $ 94,685 $ 98,945 $ — $ — $ — $ 98,945 Long-term debt 1,976 2,259 — — 2,259 — Securities to repurchase 598 598 — — 598 — Funds withheld liability 393 393 — — 393 — Total financial liabilities not carried at fair value $ 97,652 $ 102,195 $ — $ — $ 3,250 $ 98,945
Equity Securities without Readily Determinable Fair Value	Financial Instruments Without Readily Determinable Fair Values —We had elected the measurement alternative for certain equity securities that did not have a readily determinable fair value. The equity securities were held at cost less impairment. As of December 31, 2021, these equity securities no longer qualified for the measurement alternative and are measured at fair value. As of December 31, 2020, the carrying amount of the equity securities was $202 million, with a cumulative impairment of $231 million.

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2021
Insurance [Abstract]
Effects of Reinsurance	The following summarizes the effect of reinsurance on premiums and future policy and other policy benefits on the consolidated statements of income: Years ended December 31, (In millions) 2021 2020 2019 Premiums Direct $ 13,989 $ 5,691 $ 5,449 Reinsurance assumed 388 413 1,092 Reinsurance ceded (115) (141) (159) Total premiums $ 14,262 $ 5,963 $ 6,382 Future policy and other policy benefits Direct $ 15,482 $ 7,016 $ 6,697 Reinsurance assumed 503 522 1,223 Reinsurance ceded (251) (351) (333) Total future policy and other policy benefits $ 15,734 $ 7,187 $ 7,587 Years ended December 31, (In millions) 2020 2019 Liabilities assumed $ 27,439 $ 791 Less: Assets received 28,805 818 Net cost of reinsurance $ (1,366) $ (27) Unearned revenue reserve 1 $ (1,366) $ — Deferred profit liability 2 — (27) Net cost of reinsurance $ (1,366) $ (27) 1 Included within interest sensitive contract liabilities on the consolidated balance sheets. 2 Included within future policy benefits on the consolidated balance sheets.
Ceded Credit Risk	The following summarizes our reinsurance recoverable from the following: December 31, (In millions) 2021 2020 Global Atlantic $ 2,916 $ 3,108 Protective 1,515 1,558 Other 1 163 182 Reinsurance recoverable $ 4,594 $ 4,848 1 Represents all other reinsurers, with no single reinsurer having a carrying value in excess of 5% of total recoverable.

Deferred Acquisition Costs, D_2

Deferred Acquisition Costs, Deferred Sales Inducements, and Value of Business Acquired (Tables)	12 Months Ended
	Dec. 31, 2021
Insurance [Abstract]
Deferred Acquisition Costs	The following represents a rollforward of DAC, DSI and VOBA: (In millions) DAC DSI VOBA Total Balance at December 31, 2018 $ 3,921 $ 799 $ 1,187 $ 5,907 Additions 645 226 — 871 Unlocking (117) (9) (24) (150) Amortization (749) (65) (68) (882) Impact of unrealized investment (gains) losses (426) (131) (181) (738) Balance at December 31, 2019 3,274 820 914 5,008 Adoption of accounting standard 12 5 5 22 Additions 633 178 — 811 Unlocking (36) (13) (11) (60) Amortization (414) (53) (60) (527) Impact of unrealized investment (gains) losses (233) (80) (35) (348) Balance at December 31, 2020 3,236 857 813 4,906 Additions 698 265 — 963 Unlocking (18) (16) 24 (10) Amortization (483) (182) (155) (820) Impact of unrealized investment (gains) losses 182 54 87 323 Balance at December 31, 2021 $ 3,615 $ 978 $ 769 $ 5,362 The expected amortization of VOBA for the next five years is as follows: (In millions) Expected Amortization 2022 $ 59 2023 62 2024 64 2025 62 2026 59
Deferred Sales Inducements	The following represents a rollforward of DAC, DSI and VOBA: (In millions) DAC DSI VOBA Total Balance at December 31, 2018 $ 3,921 $ 799 $ 1,187 $ 5,907 Additions 645 226 — 871 Unlocking (117) (9) (24) (150) Amortization (749) (65) (68) (882) Impact of unrealized investment (gains) losses (426) (131) (181) (738) Balance at December 31, 2019 3,274 820 914 5,008 Adoption of accounting standard 12 5 5 22 Additions 633 178 — 811 Unlocking (36) (13) (11) (60) Amortization (414) (53) (60) (527) Impact of unrealized investment (gains) losses (233) (80) (35) (348) Balance at December 31, 2020 3,236 857 813 4,906 Additions 698 265 — 963 Unlocking (18) (16) 24 (10) Amortization (483) (182) (155) (820) Impact of unrealized investment (gains) losses 182 54 87 323 Balance at December 31, 2021 $ 3,615 $ 978 $ 769 $ 5,362 The expected amortization of VOBA for the next five years is as follows: (In millions) Expected Amortization 2022 $ 59 2023 62 2024 64 2025 62 2026 59

Closed Block (Tables)

Closed Block (Tables)	12 Months Ended
	Dec. 31, 2021
Insurance [Abstract]
Schedule of Closed Block Assets and Liabilities	Summarized financial information of the AmerUs Closed Block is presented below. December 31, (In millions) 2021 2020 Liabilities Future policy benefits $ 1,520 $ 1,600 Other policy claims and benefits 16 15 Dividends payable to policyholders 75 84 Total liabilities 1,611 1,699 Assets Trading securities 1,321 1,431 Mortgage loans, net of allowances 17 19 Policy loans 108 124 Total investments 1,446 1,574 Cash and cash equivalents 63 35 Accrued investment income 46 44 Reinsurance recoverable 14 16 Other assets 10 2 Total assets 1,579 1,671 Maximum future earnings to be recognized from AmerUs Closed Block $ 32 $ 28
Closed Block Operations, Net Results	The following represents the contribution from AmerUs Closed Block. Years ended December 31, (In millions) 2021 2020 2019 Revenues Premiums $ 42 $ 48 $ 54 Net investment income 68 71 74 Investment related gains (losses) (61) 99 147 Total revenues 49 218 275 Benefits and Expenses Future policy and other policy benefits 24 177 234 Dividends to policyholders 27 38 36 Total benefits and expenses 51 215 270 Contribution (to) from AmerUs Closed Block before income taxes (2) 3 5 Income tax expense (benefit) 2 1 (1) Contribution (to) from AmerUs Closed Block, net of income taxes $ (4) $ 2 $ 6

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following is a summary of our senior notes as of December 31, 2021: 2028 Notes 2030 Notes 2031 Notes 2051 Notes 2052 Notes Issue date January 12, 2018 April 3, 2020 October 8, 2020 May 25, 2021 December 13, 2021 Principal balance (in millions) $ 1,000 $ 500 $ 500 $ 500 $ 500 Outstanding balance (in millions) $ 994 $ 495 $ 490 $ 491 $ 494 Interest rate 4.125 % 6.150 % 3.500 % 3.950 % 3.450 % Maturity date January 12, 2028 April 3, 2030 January 15, 2031 May 25, 2051 May 15, 2052

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Schedule of Stock by Class [Table Text Block]	The following summarizes the activity on our share repurchase authorizations: Years ended December 31, (In millions) 2021 2020 2019 Beginning balance $ 221 $ 640 $ 150 Authorizations — — 1,317 Repurchases — (419) (827) Ending balance $ 221 $ 221 $ 640 The table below shows the changes in each class of shares issued and outstanding: Years ended December 31, (In millions) 2021 2020 2019 Class A Beginning balance 191.5 143.2 162.4 Issued shares 0.9 36.0 0.7 Forfeited shares (0.2) (0.1) (0.1) Repurchased shares — (13.3) (19.8) Converted from Class B shares — 25.4 — Converted from Class M — 0.3 — Ending balance 192.2 191.5 143.2 Class B Beginning balance — 25.4 25.4 Converted to Class A shares — (25.4) — Ending balance — — 25.4 Class M-1 Beginning balance — 3.3 3.4 Converted to Class A shares — (0.2) (0.1) Converted to warrants — (3.1) — Ending balance — — 3.3 Class M-2 Beginning balance — 0.8 0.8 Converted to Class A shares — 0.0 — Converted to warrants — (0.8) — Ending balance — — 0.8 Class M-3 Beginning balance — 1.0 1.0 Converted to Class A shares — 0.0 — Converted to warrants — (1.0) — Ending balance — — 1.0 Class M-4 Beginning balance — 4.0 4.1 Converted to Class A shares — (0.1) (0.1) Converted to warrants — (3.6) — Repurchased shares — (0.3) — Ending balance — — 4.0
Accumulated Other Comprehensive Income	(In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance 2 Unrealized investment gains (losses) on AFS securities with a credit allowance 2 DAC, DSI, VOBA and future policy benefits adjustments on AFS securities Unrealized gains (losses) on hedging instruments Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at December 31, 2018 $ (628) $ — $ 121 $ 39 $ (4) $ (472) Other comprehensive income (loss) before reclassifications 4,929 — (1,322) 29 1 3,637 Less: Reclassification adjustments for gains (losses) realized in net income 1 225 — (56) — — 169 Less: Income tax expense (benefit) 958 — (266) 6 — 698 Less: Other comprehensive income attributable to NCI, net of subsidiary issuance of equity interests and tax 16 — — 1 — 17 Balance at December 31, 2019 3,102 — (879) 61 (3) 2,281 Adoption of accounting standards 4 (4) (6) — — (6) Other comprehensive income (loss) before reclassifications 3,312 (61) (634) (106) 18 2,529 Less: Reclassification adjustments for gains (losses) realized in net income 1 353 — (94) — — 259 Less: Income tax expense (benefit) 566 (12) (115) (26) — 413 Less: Other comprehensive income attributable to NCI 147 — — 7 7 161 Balance at December 31, 2020 5,352 (53) (1,310) (26) 8 3,971 Other comprehensive income (loss) before reclassifications (2,988) 52 605 246 (10) (2,095) Less: Reclassification adjustments for gains (losses) realized in net income 1 (65) — 17 14 — (34) Less: Income tax expense (benefit) (558) 10 123 54 — (371) Less: Other comprehensive income (loss) attributable to NCI (154) — — 6 (1) (149) Balance at December 31, 2021 $ 3,141 $ (11) $ (845) $ 146 $ (1) $ 2,430 1 Recognized in investment related gains (losses) on the consolidated statements of income. 2 Previously reported amounts for the year ending December 31, 2020 have been revised to correct a misstatement, which was not material, in the classification of balances and changes attributable to AFS securities with and without credit allowances.
Dividends Declared	The following summarizes dividends declared and paid per preferred stock share by series: Years ended December 31, (Per share) 2021 2020 2019 Series A $ 1,587.50 $ 1,587.51 $ 881.95 Series B 1,406.25 1,406.25 394.53 Series C 1,593.75 880.99 — Series D 1,259.38 — — The following summarizes dividends declared and paid in the aggregate on the preferred stock by series: Years ended December 31, (In millions) 2021 2020 2019 Series A $ 55 $ 55 $ 31 Series B 19 19 5 Series C 38 21 — Series D 29 — — Total dividends declared and paid $ 141 $ 95 $ 36
Schedule of Preferred Stock	We have four series of preferred stock: 6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, Series A (Series A); 5.625% Fixed-Rate Perpetual Non-Cumulative Preference Shares, Series B (Series B); 6.375% Fixed-Rate Reset Perpetual Non-Cumulative Preference Shares, Series C (Series C); and 4.875% Fixed-Rate Perpetual Non-Cumulative Preference Shares, Series D (Series D) as summarized below: Series A Series B Series C Series D Issue date June 10, 2019 September 19, 2019 June 11, 2020 December 18, 2020 Authorized, issued and outstanding 34,500 13,800 24,000 23,000 Liquidation preference per share $ 25,000 $ 25,000 $ 25,000 $ 25,000

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Basic and Diluted Earnings Per Share	The following represents our basic and diluted EPS calculations: Year ended December 31, 2021 (In millions, except per share data) Class A Net income available to Athene Holding Ltd. common shareholders – basic and diluted $ 3,718 Basic weighted average shares outstanding 191.6 Dilutive effect of stock compensation plans and warrants 7.1 Diluted weighted average shares outstanding 198.7 Earnings per share Basic $ 19.40 Diluted $ 18.71 Year ended December 31, 2020 (In millions, except per share data) Class A Class B Class M-1 Class M-2 Class M-3 Class M-4 Net income (loss) available to Athene Holding Ltd. common shareholders – basic and diluted $ 1,573 $ (98) $ (13) $ (3) $ (4) $ (9) Basic weighted average shares outstanding 184.9 25.4 3.3 0.8 1.0 2.4 Dilutive effect of stock compensation plans and warrants 3.7 — — — — — Diluted weighted average shares outstanding 188.6 25.4 3.3 0.8 1.0 2.4 Earnings (loss) per share Basic $ 8.51 $ (3.87) $ (3.87) $ (3.87) $ (3.87) $ (3.87) Diluted $ 8.34 $ (3.87) $ (3.87) $ (3.87) $ (3.87) $ (3.87) Year ended December 31, 2019 (In millions, except per share data) Class A Class B Class M-1 Class M-2 Class M-3 Class M-4 Net income available to Athene Holding Ltd. common shareholders – basic and diluted $ 1,760 $ 291 $ 38 $ 10 $ 11 $ 26 Basic weighted average shares outstanding 153.9 25.4 3.3 0.8 1.0 2.2 Dilutive effect of stock compensation plans 0.4 — — — — 0.3 Diluted weighted average shares outstanding 154.3 25.4 3.3 0.8 1.0 2.5 Earnings per share Basic $ 11.44 $ 11.44 $ 11.44 $ 11.44 $ 11.44 $ 11.44 Diluted $ 11.41 $ 11.44 $ 11.44 $ 11.44 $ 11.44 $ 9.94

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Components of Income Tax Expense (Benefit)	Income tax expense consists of the following: Years ended December 31, (In millions) 2021 2020 2019 Current $ 410 $ 107 $ 53 Deferred (24) 178 64 Income tax expense $ 386 $ 285 $ 117 Total income taxes were as follows: Years ended December 31, (In millions) 2021 2020 2019 Income tax expense $ 386 $ 285 $ 117 Income tax expense (benefit) from OCI (371) 413 698 Total income tax expense $ 15 $ 698 $ 815
Schedule of Income before Income Tax	Income tax expense was calculated based on the following income (loss) before income taxes by jurisdiction: Years ended December 31, (In millions) 2021 2020 2019 Bermuda $ 2,780 $ 903 $ 1,895 US 1,559 1,083 528 United Kingdom (153) 220 (121) Income before income taxes $ 4,186 $ 2,206 $ 2,302
Schedule of Effective Income Tax Rate Reconciliation	The expected tax provision computed on pre-tax income at the weighted average tax rate has been calculated as the sum of the pre-tax income in each jurisdiction multiplied by that jurisdiction’s applicable statutory tax rate. Statutory tax rates of 0%, 21% and 19% have been used for Bermuda, the US and the United Kingdom (UK), respectively, for the years ended December 31, 2021, 2020 and 2019. A reconciliation of the difference between the expected tax provision at the weighted average tax rate and income tax expense is as follows: Years ended December 31, (In millions, except for percentages) 2021 2020 2019 Expected tax provision computed on pre-tax income at weighted average income tax rate $ 299 $ 268 $ 88 Increase in income taxes resulting from: Deferred tax valuation allowance (2) 8 16 Non-deductible expenses 19 5 17 Prior year true-up 4 (4) 2 Corporate owned life insurance 52 (6) (6) Stock compensation expense 2 — 2 State taxes and other 12 14 (2) Income tax expense $ 386 $ 285 $ 117 Effective tax rate 9 % 13 % 5 %
Schedule of Gross Current and Deferred Tax Assets and Liabilities	Current and deferred income tax assets and liabilities were as follows: December 31, (In millions) 2021 2020 Current income tax recoverable $ 2 $ 55 Current income tax payable 169 — Net current income tax recoverable (payable) $ (167) $ 55 Deferred tax assets $ — $ — Deferred tax liabilities 576 972 Net deferred tax liabilities $ (576) $ (972)
Schedule of Deferred Tax Assets and Liabilities	Deferred income tax assets and liabilities consisted of the following: December 31, (In millions) 2021 2020 Deferred tax assets Insurance liabilities $ 2,169 $ 1,723 Net operating and capital loss carryforwards 60 86 Employee benefits 22 20 Other 39 36 Total deferred tax assets 2,290 1,865 Valuation allowance (66) (74) Deferred tax assets, net of valuation allowance 2,224 1,791 Deferred tax liabilities Investments, including derivatives 974 998 Net unrealized gains on AFS 626 997 DAC, DSI and VOBA 1,026 767 Other 174 1 Total deferred tax liabilities 2,800 2,763 Net deferred tax liabilities $ (576) $ (972)
Summary of Valuation Allowance	The valuation allowance consists of the following: December 31, (In millions) 2021 2020 US federal and state net operating losses and other deferred tax assets $ 30 $ 50 UK net operating losses and other deferred tax assets 36 24 Total valuation allowance $ 66 $ 74

Statutory Requirements (Tables)

Statutory Requirements (Tables)	12 Months Ended
	Dec. 31, 2021
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices Disclosure [Table Text Block]	The following represents the EBS capital and surplus and BSCR ratios: EBS capital & surplus BSCR ratio December 31, December 31, (In millions) 2021 2020 2021 2020 ALRe $ 14,630 $ 17,168 209 % 254 % AARe 6,632 2,441 2,460 % 967 % ACRA 1A 3,872 2,945 183 % 236 % December 31, 2021 (In millions) ALRe AARe 1 ACRA 1A Decrease to capital and surplus due to permitted practices $ 3,963 $ (4,979) $ 980 Decrease to statutory net income due to permitted practices (635) 2,678 599 1 AARe has permission to use amortized cost instead of fair value as the basis for certain investments but does not produce GAAP financial statements. The effect of the permitted practices to the AARe statutory financial statements reflects the impact of the difference between amortized cost and fair value for certain investments. December 31, (In millions) 2021 2020 ALRe $ 7,122 $ 9,971 AARe 165 1,096 ACRA 1A 1,759 1,592 Statutory capital and surplus and net income (loss) —The following table presents, for each of our primary insurance subsidiaries, the statutory capital and surplus and the statutory net income (loss), based on the most recent statutory financial statements to be filed with insurance regulators: Statutory capital & surplus Statutory net income (loss) December 31, Years ended December 31, (In millions) 2021 2020 2021 2020 2019 ALRe $ 11,823 $ 13,518 $ 3,278 $ 1,544 $ 1,247 AARe 2,649 2,457 (3,703) 92 248 ACRA 1A 4,187 2,718 293 1,522 265 AADE 1,605 1,700 (70) 54 (86) AAIA 1,279 1,312 (182) (8) 241 AANY 304 320 (8) (25) 33

Related Parties (Tables)

Related Parties (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party Transaction [Line Items]
Schedule of Related Party Transactions	The following summarizes these investments in Wheels/Donlen: (In millions) December 31, 2021 AFS securities $ 2,419 Investment fund 700 Total investment in Wheels/Donlen $ 3,119 The following summarizes these investments in MidCap: December 31, (In millions) 2021 2020 Profit participating notes $ 635 $ 534 Senior unsecured notes 158 — Redeemable preferred stock 7 77 Subordinated debt facility — 328 Total investment in MidCap $ 800 $ 939 The following table summarizes our investments in Athora: December 31, (In millions) 2021 2020 Investment fund $ 743 $ 709 Non-redeemable preferred equity securities 171 — Total investment in Athora $ 914 $ 709

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Restricted Pledged Assets and Funds in Trust	The total restricted assets included on the consolidated balance sheets are as follows: December 31, (In millions) 2021 2020 AFS securities $ 9,111 $ 9,884 Trading securities 75 60 Equity securities 30 26 Mortgage loans 5,033 5,028 Investment funds 174 68 Derivative assets 96 107 Short-term investments — 52 Other investments 130 105 Restricted cash 796 738 Total restricted assets $ 15,445 $ 16,068

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Reconciliation of Segment Operating Revenues to Consolidation	The table below reconciles segment adjusted operating revenues to total revenues presented on the consolidated statements of income: Years ended December 31, (In millions) 2021 2020 2019 Retirement Services $ 14,903 $ 10,681 $ 11,460 Corporate and Other 1,152 266 117 Non-operating adjustments Change in fair values of derivatives and embedded derivatives – index annuities, net of offsets 2,507 868 2,346 Investment gains (losses), net of offsets (6) 720 1,685 Noncontrolling interests, VIE expenses and other adjustments to revenues 7,764 2,229 650 Total revenues $ 26,320 $ 14,764 $ 16,258
Reconciliation of Segment Operating Income to Consolidation	The table below reconciles segment adjusted operating income available to common shareholders to net income available to Athene Holding Ltd. common shareholders presented on the consolidated statements of income: Years ended December 31, (In millions) 2021 2020 2019 Retirement Services $ 2,423 $ 1,266 $ 1,322 Corporate and Other 643 (24) (33) Non-operating adjustments Investment gains (losses), net of offsets 160 508 994 Change in fair values of derivatives and embedded derivatives – index annuities, net of offsets 692 (235) (65) Integration, restructuring and other non-operating expenses (124) (10) (70) Stock-based compensation, excluding LTIP (2) (11) (12) Income tax expense – non-operating (74) (48) — Net income available to Athene Holding Ltd. common shareholders $ 3,718 $ 1,446 $ 2,136
Reconciliation of Segment Net Investment Income	Years ended December 31, (In millions) 2021 2020 2019 Retirement Services $ 6,791 $ 5,287 $ 5,062 Corporate and Other 288 41 117 Adjustments to net investment income Change in fair value of reinsurance assets (1,451) (1,408) (680) Alternative (gains) losses (144) 102 (1) Noncontrolling interests 943 559 61 Apollo investment gain 864 225 — Held for trading amortization and other (114) 79 37 Net investment income $ 7,177 $ 4,885 $ 4,596 Years ended December 31, (In millions) 2021 2020 2019 Retirement Services $ 89 $ 164 $ 117 Corporate and Other 182 60 — Adjustments to income tax expense Noncontrolling interest tax expense 41 13 — Income tax expense – non-operating 74 48 — Income tax expense $ 386 $ 285 $ 117
Total Assets by Segment	The following represents total assets by segment: December 31, (In millions) 2021 2020 Retirement Services $ 228,835 $ 197,295 Corporate and Other 6,314 5,476 Total assets $ 235,149 $ 202,771
Revenue from External Customers by Geographic Areas	Deposits and premiums by geographical location are as follows: Years ended December 31, (In millions) 2021 2020 1 2019 1 United States $ 25,380 $ 19,187 $ 16,614 Bermuda 12,348 35,692 1,893 Total premiums and deposits, net of ceded $ 37,728 $ 54,879 $ 18,507 1 Previously reported amounts have been revised to correct a misstatement, which was not material, in the classification between the United States and Bermuda geographical locations.
Revenue from External Customers by Products and Services	We market annuity products, primarily fixed rate and fixed indexed annuities. Deposits, which are generally not included in revenues on the consolidated statements of income, and premiums collected are as follows: Years ended December 31, (In millions) 2021 2020 2019 Fixed indexed annuities $ 8,408 $ 20,257 $ 7,304 Fixed rate annuities 2,662 20,433 3,192 Payouts without life contingencies 542 545 341 Funding agreements 11,852 7,679 1,301 Life and other deposits 2 2 (13) Total deposits 23,466 48,916 12,125 Payouts with life contingencies 14,217 5,911 6,332 Life and other premiums 45 52 50 Total premiums 14,262 5,963 6,382 Total premiums and deposits, net of ceded $ 37,728 $ 54,879 $ 18,507

Business, Basis of Presentati_3

Business, Basis of Presentation, and Significant Accounting Policies (Details) - USD ($) shares in Millions, $ in Billions	Jan. 01, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Significant Accounting Policies [Line Items]
Number of days interest is past due for nonaccrual status		90 days
Ownership percentage at which fair value option is elected		3.00%
Number of predecessors		2
Class A
Significant Accounting Policies [Line Items]
Common stock outstanding (in shares)		192.2	191.5	143.2	162.4
Subsequent Event [Member] | Related Party | Apollo
Significant Accounting Policies [Line Items]
Business Combination, Consideration Transferred	$ 12.2
Common Stock, Conversion Basis, Percentage Of Share Value Converted	114.90%
Subsequent Event [Member] | Related Party | Apollo | Apollo Global Management, Inc.
Significant Accounting Policies [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	158.2
Subsequent Event [Member] | Related Party | Apollo | Class A
Significant Accounting Policies [Line Items]
Common stock outstanding (in shares)	137.6
Common Stock, Shares, Outstanding and previously held	54.6
Nonparticipating Life Insurance Policy | Minimum
Significant Accounting Policies [Line Items]
Investment yield assumption for non-participation contracts		2.30%
Nonparticipating Life Insurance Policy | Maximum
Significant Accounting Policies [Line Items]
Investment yield assumption for non-participation contracts		5.40%
Life Insurance Product Line
Significant Accounting Policies [Line Items]
Percent of participating policies		10.00%	10.00%
Premiums related to participation policies, percent		32.00%	32.00%	30.00%

Investments - Schedule of AFS S

Investments - Schedule of AFS Securities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2020
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 106,859	$ 82,544
Allowance for Credit Losses	(123)	(104)	$ (17)
Gross Unrealized Gains	4,893	7,515
Gross Unrealized Losses	(1,068)	(582)
Fair Value	110,561	89,373
Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	96,458	76,100
Allowance for Credit Losses	(123)	(103)	(17)
Gross Unrealized Gains	4,808	7,395
Gross Unrealized Losses	(984)	(539)
Fair Value	100,159	82,853
Related Party
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	10,401	6,444
Allowance for Credit Losses	0	(1)
Gross Unrealized Gains	85	120
Gross Unrealized Losses	(84)	(43)
Fair Value	10,402	6,520
US government and agencies | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	231	349
Allowance for Credit Losses	0	0
Gross Unrealized Gains	2	3
Gross Unrealized Losses	(10)	(1)
Fair Value	223	351
US state, municipal and political subdivisions | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,081	864
Allowance for Credit Losses	0	0
Gross Unrealized Gains	134	169
Gross Unrealized Losses	2	0
Fair Value	1,213	1,033
Foreign governments | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,110	330
Allowance for Credit Losses	0	0
Gross Unrealized Gains	35	38
Gross Unrealized Losses	17	0
Fair Value	1,128	368
Corporate | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	62,817	51,934
Allowance for Credit Losses	0	(6)	0
Gross Unrealized Gains	4,060	6,368
Gross Unrealized Losses	(651)	(116)
Fair Value	66,226	58,180
Corporate | Related Party
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	842	213
Allowance for Credit Losses	0	0
Gross Unrealized Gains	19	2
Gross Unrealized Losses	(2)	0
Fair Value	859	215
CLO | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	13,793	9,631
Allowance for Credit Losses	0	(1)	0
Gross Unrealized Gains	44	145
Gross Unrealized Losses	(185)	(206)
Fair Value	13,652	9,569
CLO | Related Party
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,573	1,511
Allowance for Credit Losses	0	(1)	0
Gross Unrealized Gains	5	23
Gross Unrealized Losses	(29)	(13)
Fair Value	2,549	1,520
ABS | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	8,890	4,259
Allowance for Credit Losses	(17)	(6)	0
Gross Unrealized Gains	151	140
Gross Unrealized Losses	(35)	(123)
Fair Value	8,989	4,270
ABS | Related Party
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	6,986	4,720
Allowance for Credit Losses	0	0
Gross Unrealized Gains	61	95
Gross Unrealized Losses	(53)	(30)
Fair Value	6,994	4,785
CMBS | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,764	2,165
Allowance for Credit Losses	(3)	(10)	0
Gross Unrealized Gains	56	85
Gross Unrealized Losses	(59)	(71)
Fair Value	2,758	2,169
RMBS | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	5,772	6,568
Allowance for Credit Losses	(103)	(80)	$ (17)
Gross Unrealized Gains	326	447
Gross Unrealized Losses	(25)	(22)
Fair Value	$ 5,970	$ 6,913

Investments - Maturities of AFS

Investments - Maturities of AFS Securities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Amortized Cost
Amortized Cost	$ 106,859	$ 82,544
Fair Value
Total AFS securities	110,561	89,373
Consolidated Entity Excluding Affiliated Entity
Amortized Cost
Due in one year or less	958
Due after one year through five years	9,374
Due after five years through ten years	17,411
Due after ten years	37,496
CLO, ABS, CMBS and RMBS	31,219
Amortized Cost	96,458	76,100
Fair Value
Due in one year or less	968
Due after one year through five years	9,622
Due after five years through ten years	17,858
Due after ten years	40,342
CLO, ABS, CMBS and RMBS	31,369
Total AFS securities	100,159	82,853
Related Party
Amortized Cost
Due after one year through five years	23
Due after five years through ten years	673
Due after ten years	146
CLO, ABS, CMBS and RMBS	9,559
Amortized Cost	10,401	6,444
Fair Value
Due after one year through five years	24
Due after five years through ten years	687
Due after ten years	148
CLO, ABS, CMBS and RMBS	9,543
Total AFS securities	$ 10,402	$ 6,520

Investments - Unrealized Losses

Investments - Unrealized Losses on AFS Securities (Details) $ in Millions	Dec. 31, 2021USD ($)security	Dec. 31, 2020USD ($)
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	$ 38,067	$ 7,684
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(802)	(254)
12 months or more, Fair Value	3,216	3,834
12 months or more, Gross Unrealized Losses	(139)	(234)
Fair Value	41,283	11,518
Gross Unrealized Losses	(941)	(488)
Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	32,708	6,336
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(728)	(221)
12 months or more, Fair Value	3,040	3,602
12 months or more, Gross Unrealized Losses	(135)	(224)
Fair Value	35,748	9,938
Gross Unrealized Losses	$ (863)	(445)
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security	4,104
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | security	435
Related Party
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	$ 5,359	1,348
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(74)	(33)
12 months or more, Fair Value	176	232
12 months or more, Gross Unrealized Losses	(4)	(10)
Fair Value	5,535	1,580
Gross Unrealized Losses	$ (78)	(43)
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security	78
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | security	9
US government and agencies | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	$ 164	31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(8)	(1)
12 months or more, Fair Value	22	0
12 months or more, Gross Unrealized Losses	(2)	0
Fair Value	186	31
Gross Unrealized Losses	(10)	(1)
US state, municipal and political subdivisions | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	122	9
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(2)	0
12 months or more, Fair Value	1	6
12 months or more, Gross Unrealized Losses	0	0
Fair Value	123	15
Gross Unrealized Losses	(2)	0
Foreign governments | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	387	2
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(17)	0
12 months or more, Fair Value	1	0
12 months or more, Gross Unrealized Losses	0	0
Fair Value	388	2
Gross Unrealized Losses	(17)	0
Corporate | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	18,995	2,218
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(523)	(66)
12 months or more, Fair Value	863	248
12 months or more, Gross Unrealized Losses	(59)	(24)
Fair Value	19,858	2,466
Gross Unrealized Losses	(582)	(90)
Corporate | Related Party
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	313
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(2)
12 months or more, Fair Value	0
12 months or more, Gross Unrealized Losses	0
Fair Value	313
Gross Unrealized Losses	(2)
CLO | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	7,685	1,649
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(124)	(33)
12 months or more, Fair Value	1,537	3,179
12 months or more, Gross Unrealized Losses	(35)	(167)
Fair Value	9,222	4,828
Gross Unrealized Losses	(159)	(200)
CLO | Related Party
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	1,245	336
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(20)	(3)
12 months or more, Fair Value	163	232
12 months or more, Gross Unrealized Losses	(3)	(10)
Fair Value	1,408	568
Gross Unrealized Losses	(23)	(13)
ABS | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	4,038	1,169
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(16)	(73)
12 months or more, Fair Value	165	84
12 months or more, Gross Unrealized Losses	(12)	(18)
Fair Value	4,203	1,253
Gross Unrealized Losses	(28)	(91)
ABS | Related Party
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	3,801	1,012
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(52)	(30)
12 months or more, Fair Value	13	0
12 months or more, Gross Unrealized Losses	(1)	0
Fair Value	3,814	1,012
Gross Unrealized Losses	(53)	(30)
CMBS | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	880	710
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(29)	(37)
12 months or more, Fair Value	177	48
12 months or more, Gross Unrealized Losses	(22)	(13)
Fair Value	1,057	758
Gross Unrealized Losses	(51)	(50)
RMBS | Consolidated Entity Excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Fair Value	437	548
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(9)	(11)
12 months or more, Fair Value	274	37
12 months or more, Gross Unrealized Losses	(5)	(2)
Fair Value	711	585
Gross Unrealized Losses	$ (14)	$ (13)

Investments - Net Investment In

Investments - Net Investment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net Investment Income [Line Items]
Investment revenue	$ 7,786	$ 5,389	$ 5,031
Investment expenses	(609)	(504)	(435)
Net investment income	7,177	4,885	4,596
Trading securities
Net Investment Income [Line Items]
Investment revenue	260	192	189
Equity securities
Net Investment Income [Line Items]
Investment revenue	19	14	16
Mortgage loans, net of allowances
Net Investment Income [Line Items]
Investment revenue	875	742	670
Investment funds
Net Investment Income [Line Items]
Investment revenue	1,912	721	382
Funds withheld at interest
Net Investment Income [Line Items]
Investment revenue	781	269	527
Other
Net Investment Income [Line Items]
Investment revenue	271	226	159
AFS securities – Foreign currency forwards
Net Investment Income [Line Items]
Investment revenue	$ 3,668	$ 3,225	$ 3,088

Investments - Investment Relate

Investments - Investment Related Gains (Losses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Gain (Loss) on Securities [Line Items]
Proceeds from Sale of Debt Securities, Available-for-sale	$ 11,092	$ 7,911
AFS securities
Gross realized gains on investment activity	936	602	$ 178
Gross realized losses on investment activity	(633)	(415)	(56)
Net realized investment gains on AFS securities	303	187	122
Net recognized investment gains (losses) on trading securities	(70)	33	151
Net recognized investment gains (losses) on equity securities	237	(218)	25
Derivative gains	3,525	3,430	4,443
Other gains (losses)	198	(54)	(22)
Proceeds from sale of available-for-sale securities			6,886
Provision for Loan, Lease, and Other Losses	(5)	(69)	0
Gain (Loss) on Investments	4,188	3,309	4,719
Consolidated Entity Excluding Affiliated Entity
AFS securities
Debt Securities, Trading, Unrealized Gain (Loss)	(78)	130	193
Equity Securities, FV-NI, Unrealized Gain (Loss)	213	(9)	19
Related Party
AFS securities
Debt Securities, Trading, Unrealized Gain (Loss)	56	(37)	(18)
Equity Securities, FV-NI, Unrealized Gain (Loss)	9	0	(18)
Gain (Loss) on Investments	$ 252	$ 702	$ 1,009

Investments - PCD Securities (D

Investments - PCD Securities (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)
Purchased Financial Assets with Credit Deterioration [Line Items]
Debt Securities, Available-for-sale, Purchased with Credit Deterioration, Amount at Purchase Price	$ 35
Debt Securities, Available-for-sale, Purchased with Credit Deterioration, Allowance for Credit Loss at Acquisition Date	25
Debt Securities, Available-for-sale, Purchased with Credit Deterioration, Discount (Premium)	(3)
Debt Securities, Available-for-sale, Purchased with Credit Deterioration, Amount at Par Value	57
Mortgage loans, net of allowances
Purchased Financial Assets with Credit Deterioration [Line Items]
Financing Receivable, Purchased with Credit Deterioration, Amount at Purchase Price	335
Financing Receivable, Purchased with Credit Deterioration, Allowance for Credit Loss at Acquisition Date	6
Financing Receivable, Purchased with Credit Deterioration, Discount (Premium)	(26)
Financing Receivable, Purchased with Credit Deterioration, Amount at Par Value	$ 315

Investments - Repurchase Agreem

Investments - Repurchase Agreements (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Secured Debt, Repurchase Agreements	$ 3,110	$ 598
Maturity Overnight and on Demand [Member]
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Secured Debt, Repurchase Agreements	0	0
Maturity Less than 30 Days [Member]
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Secured Debt, Repurchase Agreements	2,512	0
Maturity 30 to 90 Days [Member]
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Secured Debt, Repurchase Agreements	0	0
Maturity Greater than 1 Year [Member]
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Secured Debt, Repurchase Agreements	598	598
90 Days to 1 Year [Member]
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Secured Debt, Repurchase Agreements	0	0
Corporate | AFS securities – Foreign currency forwards
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Pledged Financial Instruments, Not Separately Reported, Securities for Repurchase Agreements, Amortized Cost	2,923	559
Pledged Financial Instruments, Not Separately Reported, Securities for Repurchase Agreements	$ 3,208	$ 644

Investments - Mortgage Loans, N

Investments - Mortgage Loans, Net (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 24,148	$ 15,938
Commercial mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	16,897	11,448
Financing Receivable, before Allowance for Credit Loss	17,064	11,615
Allowance for Loan and Lease Losses, Real Estate	(167)	(167)
Commercial mortgage loans | Commercial mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Financing Receivable, before Allowance for Credit Loss	16,565	11,383
Commercial mortgage loans | Commercial mortgage loans under development
Loans and Leases Receivable Disclosure [Line Items]
Financing Receivable, before Allowance for Credit Loss	499	232
Residential Mortgage [Member]
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	7,251	4,490
Financing Receivable, before Allowance for Credit Loss	7,321	4,569
Allowance for Loan and Lease Losses, Real Estate	$ (70)	$ (79)

Investments - Mortgage Loans,_2

Investments - Mortgage Loans, Net by Property Type and Geographic Region (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 24,148	$ 15,938
Commercial mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 16,897	$ 11,448
Commercial mortgage loans | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	100.00%	100.00%
Commercial mortgage loans | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	100.00%	100.00%
Commercial mortgage loans | Total US region
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 14,796	$ 10,821
Commercial mortgage loans | Total US region | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	87.50%	94.50%
Commercial mortgage loans | East North Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 1,697	$ 1,209
Commercial mortgage loans | East North Central | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	10.00%	10.50%
Commercial mortgage loans | East South Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 470	$ 402
Commercial mortgage loans | East South Central | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	2.80%	3.50%
Commercial mortgage loans | Middle Atlantic
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 3,637	$ 3,069
Commercial mortgage loans | Middle Atlantic | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	21.50%	26.80%
Commercial mortgage loans | Mountain
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 460	$ 487
Commercial mortgage loans | Mountain | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	2.70%	4.20%
Commercial mortgage loans | New England
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 453	$ 350
Commercial mortgage loans | New England | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	2.70%	3.10%
Commercial mortgage loans | Pacific
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 3,994	$ 2,746
Commercial mortgage loans | Pacific | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	23.60%	24.00%
Commercial mortgage loans | South Atlantic
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 2,817	$ 1,773
Commercial mortgage loans | South Atlantic | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	16.70%	15.50%
Commercial mortgage loans | West North Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 271	$ 145
Commercial mortgage loans | West North Central | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	1.60%	1.30%
Commercial mortgage loans | West South Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 997	$ 640
Commercial mortgage loans | West South Central | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	5.90%	5.60%
Commercial mortgage loans | UNITED KINGDOM
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 1,279	$ 0
Commercial mortgage loans | UNITED KINGDOM | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	7.60%	0.00%
Commercial mortgage loans | International Other
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 822	$ 627
Commercial mortgage loans | International Other | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	4.90%	5.50%
Commercial mortgage loans | International
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 2,101	$ 627
Commercial mortgage loans | International | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	12.50%	5.50%
Commercial mortgage loans | Office building
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 4,870	$ 3,589
Commercial mortgage loans | Office building | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	28.80%	31.40%
Commercial mortgage loans | Retail
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 2,022	$ 2,083
Commercial mortgage loans | Retail | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	12.00%	18.20%
Commercial mortgage loans | Apartment
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 4,626	$ 2,441
Commercial mortgage loans | Apartment | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	27.40%	21.30%
Commercial mortgage loans | Hotels
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 1,727	$ 1,294
Commercial mortgage loans | Hotels | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	10.20%	11.30%
Commercial mortgage loans | Industrial
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 2,336	$ 1,362
Commercial mortgage loans | Industrial | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	13.80%	11.90%
Commercial mortgage loans | Other commercial
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 1,316	$ 679
Commercial mortgage loans | Other commercial | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total	7.80%	5.90%

Investments - Residential Mortg

Investments - Residential Mortgage Loans, Percentage by Geographical Location (Details) - Residential Mortgage [Member] - Geographic Concentration Risk - Mortgage Loans, Net	Dec. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	100.00%	100.00%
Total US region
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	88.20%	85.40%
California
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	28.40%	24.80%
Florida
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	11.40%	13.30%
TEXAS
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	4.80%	6.20%
Other U.S. States
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	38.50%	37.10%
IRELAND
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	6.40%	12.90%
International Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	5.40%	1.70%
International
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	11.80%	14.60%
NEW JERSEY
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of total	5.10%	4.00%

Investments - Loan Valuation Al

Investments - Loan Valuation Allowance (Details) - USD ($)	Jan. 01, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss		$ 237,000,000	$ 253,000,000	$ 11,000,000
Financing Receivable, Credit Loss, Expense (Reversal)		(21,000,000)	15,000,000
Financing Receivable, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		6,000,000	7,000,000
Financing Receivable, Allowance for Credit Loss, Writeoff		(1,000,000)	(1,000,000)
Debt Securities, Available-for-sale, Allowance for Credit Loss	$ 17,000,000	123,000,000	104,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		26,000,000	129,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		25,000,000	66,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		(31,000,000)	(33,000,000)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		(1,000,000)	(75,000,000)
Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss		232,000,000	232,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss	17,000,000	123,000,000	103,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		21,000,000	127,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		25,000,000	66,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		(30,000,000)	(32,000,000)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		4,000,000	(75,000,000)
Related Party
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss		5,000,000	14,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss		0	1,000,000
Corporate | Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	0	6,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		3,000,000	44,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		(7,000,000)	(14,000,000)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		(2,000,000)	(24,000,000)
Corporate | Related Party
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss		0	0
CLO | Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	0	1,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		7,000,000	1,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		(1,000,000)	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		(7,000,000)	0
CLO | Related Party
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	0	1,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		5,000,000	2,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		(1,000,000)	(1,000,000)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		(5,000,000)	0
ABS | Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	17,000,000	6,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		5,000,000	7,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		(2,000,000)	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		8,000,000	(1,000,000)
ABS | Related Party
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss		0	0
CMBS | Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss	0	3,000,000	10,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		4,000,000	24,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		0	(1,000,000)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		(11,000,000)	(13,000,000)
RMBS | Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss	17,000,000	103,000,000	80,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		2,000,000	51,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		25,000,000	66,000,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		(20,000,000)	(17,000,000)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		16,000,000	(37,000,000)
US government and agencies | Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss		0	0
US state, municipal and political subdivisions | Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss		0	0
Foreign governments | Consolidated Entity Excluding Affiliated Entity
Financing Receivable, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-sale, Allowance for Credit Loss		0	0
Accounting Standards Update 2016-13 [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)	221,000,000
Commercial mortgage loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss		167,000,000	167,000,000	10,000,000
Financing Receivable, Credit Loss, Expense (Reversal)		0	(10,000,000)
Financing Receivable, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0	0
Financing Receivable, Allowance for Credit Loss, Writeoff		0	0
Commercial mortgage loans | Accounting Standards Update 2016-13 [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)	167,000,000
Residential Mortgage [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss		70,000,000	79,000,000	1,000,000
Financing Receivable, Credit Loss, Expense (Reversal)		(14,000,000)	29,000,000
Financing Receivable, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		6,000,000	7,000,000
Financing Receivable, Allowance for Credit Loss, Writeoff		(1,000,000)	(1,000,000)
Residential Mortgage [Member] | Accounting Standards Update 2016-13 [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)	43,000,000
Other investments
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss		0	7,000,000	$ 0
Financing Receivable, Credit Loss, Expense (Reversal)		(7,000,000)	(4,000,000)
Financing Receivable, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0	0
Financing Receivable, Allowance for Credit Loss, Writeoff		$ 0	$ 0
Other investments | Accounting Standards Update 2016-13 [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)	$ 11,000,000

Investments - Mortgage Loans,_3

Investments - Mortgage Loans, Net Past Due (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Past Due [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 24,148	$ 15,938
Commercial mortgage loans
Financing Receivable, Past Due [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	16,897	11,448
Financing Receivable, Year One, Originated, Current Fiscal Year	6,055	1,913
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	1,852	4,420
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	4,129	2,662
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	2,731	1,012
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	1,042	130
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	1,255	1,478
Financing Receivable, before Allowance for Credit Loss	17,064	11,615
Commercial mortgage loans | Financial Asset, 1 to 29 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	6,003	1,913
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	1,852	4,400
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	4,129	2,617
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	2,731	987
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	952	130
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	1,255	1,452
Financing Receivable, before Allowance for Credit Loss	16,922	11,499
Commercial mortgage loans | Financial Asset, 30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	52	0
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	0	20
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	0	45
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	0	25
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	90	0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	0	5
Financing Receivable, before Allowance for Credit Loss	142	95
Commercial mortgage loans | Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year		0
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year		0
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year		0
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year		0
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year		0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year		21
Financing Receivable, before Allowance for Credit Loss		21
Residential Mortgage [Member]
Financing Receivable, Past Due [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	7,251	4,490
Financing Receivable, Year One, Originated, Current Fiscal Year	2,561	304
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	505	77
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	125	854
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	475	72
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	208	7
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	3,447	3,255
Financing Receivable, before Allowance for Credit Loss	$ 7,321	4,569
Forecast Period	1 year
Financing Receivable, 90 Days or More Past Due, Still Accruing	$ 856	0
Residential Mortgage [Member] | Financial Asset, 1 to 29 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	2,398	274
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	319	68
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	37	845
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	383	72
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	54	7
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	2,568	2,993
Financing Receivable, before Allowance for Credit Loss	5,759	4,259
Residential Mortgage [Member] | Financial Asset, 30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	100	28
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	37	1
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	3	3
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	3	0
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	6	0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	223	121
Financing Receivable, before Allowance for Credit Loss	372	153
Residential Mortgage [Member] | Financial Asset, 60 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	36	2
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	16	0
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	3	1
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	2	0
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	7	0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	136	47
Financing Receivable, before Allowance for Credit Loss	200	50
Residential Mortgage [Member] | Financial Asset, Equal to or Greater than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	27	0
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	133	8
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	82	5
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	87	0
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	141	0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	520	94
Financing Receivable, before Allowance for Credit Loss	990	$ 107
Residential Mortgage [Member] | Financial Asset, Equal to or Greater than 90 Days Past Due | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Past Due [Line Items]
Financing Receivable, before Allowance for Credit Loss	$ 856
Commercial Loan [Member]
Financing Receivable, Past Due [Line Items]
Forecast Period	1 year
Commercial Loan [Member] | Maximum
Financing Receivable, Past Due [Line Items]
Forecast Period	1 year

Investments - Nonaccrual Status

Investments - Nonaccrual Status (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Residential Mortgage [Member]
Financing Receivable, Nonaccrual [Line Items]
Financing Receivable, Nonaccrual	$ 134	$ 107	$ 67
Financing Receivable, Nonaccrual, No Allowance	76	13
Financing Receivable, Nonaccrual, Interest Income	8	5
Commercial mortgage loans
Financing Receivable, Nonaccrual [Line Items]
Financing Receivable, Nonaccrual	62	38	$ 0
Financing Receivable, Nonaccrual, No Allowance	0	0
Financing Receivable, Nonaccrual, Interest Income	$ 0	$ 0

Investments - Mortgage Loans, L

Investments - Mortgage Loans, Loan to Value Ratio (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Credit Quality Indicator [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 24,148	$ 15,938
Commercial mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	16,897	11,448
Financing Receivable, Year One, Originated, Current Fiscal Year	6,055	1,913
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	1,852	4,420
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	4,129	2,662
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	2,731	1,012
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	1,042	130
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	1,255	1,478
Financing Receivable, before Allowance for Credit Loss	17,064	11,615
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development
Financing Receivable, Credit Quality Indicator [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	5,808	1,807
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	1,738	4,393
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	4,054	2,563
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	2,668	1,012
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	1,042	130
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	1,255	1,478
Financing Receivable, before Allowance for Credit Loss	16,565	11,383
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | LTV 81 to 100 Percent [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	0	0
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	0	0
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	0	0
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	0	25
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	25	0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	0	21
Financing Receivable, before Allowance for Credit Loss	25	46
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | LTV 61 to 70 Percent [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	1,748	583
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	544	1,988
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	1,786	1,222
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	1,326	440
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	369	46
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	71	106
Financing Receivable, before Allowance for Credit Loss	5,844	4,385
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | LTV Less Than 50 Percent [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	491	431
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	211	600
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	633	201
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	293	152
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	166	44
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	957	1,153
Financing Receivable, before Allowance for Credit Loss	2,751	2,581
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | LTV 50 to 60 Percent [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	2,127	315
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	566	1,320
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	1,275	765
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	629	300
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	381	40
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	191	147
Financing Receivable, before Allowance for Credit Loss	5,169	2,887
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | LTV 71 to 80 Percent [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	1,442	478
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	417	485
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	360	375
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	420	95
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	101	0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	0	13
Financing Receivable, before Allowance for Credit Loss	2,740	1,446
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | LTV Greater than 100 Percent [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	0	0
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	0	0
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	0	0
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	0	0
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	0	0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	36	38
Financing Receivable, before Allowance for Credit Loss	$ 36	$ 38

Investments - Mortgage Loans, D

Investments - Mortgage Loans, Debt Service Coverage Ratio (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 24,148	$ 15,938
Commercial mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	16,897	11,448
Financing Receivable, Year One, Originated, Current Fiscal Year	6,055	1,913
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	1,852	4,420
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	4,129	2,662
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	2,731	1,012
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	1,042	130
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	1,255	1,478
Financing Receivable, before Allowance for Credit Loss	17,064	11,615
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development
Loans and Leases Receivable Disclosure [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	5,808	1,807
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	1,738	4,393
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	4,054	2,563
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	2,668	1,012
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	1,042	130
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	1,255	1,478
Financing Receivable, before Allowance for Credit Loss	16,565	11,383
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | Debt Service Coverage Ratio, Greater than 1.20 [Member]
Loans and Leases Receivable Disclosure [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	4,370	1,274
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	1,123	2,964
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	2,216	2,440
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	2,163	846
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	860	129
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	1,095	1,369
Financing Receivable, before Allowance for Credit Loss	11,827	9,022
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | Debt Service Coverage Ratio, 1.00 to 1.20 [Member]
Loans and Leases Receivable Disclosure [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	1,018	533
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	496	1,122
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	1,429	36
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	66	70
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	0	1
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	82	101
Financing Receivable, before Allowance for Credit Loss	3,091	1,863
Commercial mortgage loans | Commercial mortgage loans, excluding loans under development | Debt Service Coverage Ratio, Less than 1.00 [Member]
Loans and Leases Receivable Disclosure [Line Items]
Financing Receivable, Year One, Originated, Current Fiscal Year	420	0
Financing Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year	119	307
Financing Receivable, Year Three, Originated, Two Years before Current Fiscal Year	409	87
Financing Receivable, Year Four, Originated, Three Years before Current Fiscal Year	439	96
Financing Receivable, Year Five, Originated, Four Years before Current Fiscal Year	182	0
Financing Receivable, Originated, More than Five Years before Current Fiscal Year	78	8
Financing Receivable, before Allowance for Credit Loss	$ 1,647	$ 498

Investments - Investment Funds

Investments - Investment Funds Summary (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 9,866	$ 6,087
Consolidated Entity Excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 1,407	$ 803
Carrying Amount, Assets, Percent of Total	100.00%	100.00%
Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 8,459	$ 5,284
Carrying Amount, Assets, Percent of Total	100.00%	100.00%
Differentiated Investments [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 2,562	$ 1,889
Carrying Amount, Assets, Percent of Total	30.30%	35.70%
Private Equity Funds [Member] | Consolidated Entity Excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 343	$ 267
Carrying Amount, Assets, Percent of Total	24.40%	33.30%
Private Equity Funds [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 751	$ 473
Carrying Amount, Assets, Percent of Total	8.90%	8.90%
Real Assets [Member] | Consolidated Entity Excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 122	$ 81
Carrying Amount, Assets, Percent of Total	8.70%	10.10%
Real Assets [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 157	$ 172
Carrying Amount, Assets, Percent of Total	1.90%	3.30%
Real Estate Funds [Member] | Consolidated Entity Excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 856	$ 348
Carrying Amount, Assets, Percent of Total	60.80%	43.30%
Real Estate Funds [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 1,507	$ 828
Carrying Amount, Assets, Percent of Total	17.80%	15.70%
Commodities Investment [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 172	$ 113
Carrying Amount, Assets, Percent of Total	2.00%	2.10%
Credit Funds [Member] | Consolidated Entity Excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 86	$ 107
Carrying Amount, Assets, Percent of Total	6.10%	13.30%
Credit Funds [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 1,198	$ 375
Carrying Amount, Assets, Percent of Total	14.10%	7.10%
Equity securities | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 0	$ 110
Carrying Amount, Assets, Percent of Total	0.00%	2.10%
AmeriHome [Member] | Differentiated Investments [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 26	$ 444
Carrying Amount, Assets, Percent of Total	0.30%	8.40%
Catalina Holdings (Bermuda) Ltd [Member] | Differentiated Investments [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 441	$ 334
Carrying Amount, Assets, Percent of Total	5.20%	6.30%
Athora Holding Ltd. [Member] | Differentiated Investments [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 743	$ 709
Carrying Amount, Assets, Percent of Total	8.80%	13.40%
Venerable Holdings, Inc. | Differentiated Investments [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 219	$ 123
Carrying Amount, Assets, Percent of Total	2.60%	2.30%
Apollo | Other Fund [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 2,112	$ 1,324
Carrying Amount, Assets, Percent of Total	25.00%	25.10%
Individually Immaterial Counterparties | Differentiated Investments [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 433	$ 279
Carrying Amount, Assets, Percent of Total	5.10%	5.30%
Athene Freedom Holdings, LP | Differentiated Investments [Member] | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 700	$ 0
Carrying Amount, Assets, Percent of Total	8.30%	0.00%

Investments - Equity Method Inv

Investments - Equity Method Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]
Less: Assets received	$ 235,149	$ 202,771
Liabilities assumed	212,968	182,631
Equity	22,181	20,140	$ 14,141	$ 8,276
Net income	3,800	1,921	2,185
Equity Method Investment, Nonconsolidated Investee, Other [Member]
Schedule of Equity Method Investments [Line Items]
Less: Assets received	142,045	130,807
Liabilities assumed	108,525	109,654
Equity	33,520	21,153
Net income	$ 6,335	$ 2,196	$ 817

Investments - Equity Method I_2

Investments - Equity Method Investment Ownership (Details) - Investment funds - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Fair Value, Option, Fair Value Carrying Amount, Assets	$ 4,438	$ 2,280
Equity Method Investments	5,428	3,807
Ownership Percentage, One Hundred Percent [Member]
Schedule of Equity Method Investments [Line Items]
Fair Value, Option, Fair Value Carrying Amount, Assets	229	0
Equity Method Investments	649	717
Ownership Percentage, Greater than Three Percent and Less than or Equal to Forty Nine Percent [Member]
Schedule of Equity Method Investments [Line Items]
Fair Value, Option, Fair Value Carrying Amount, Assets	3,697	2,109
Equity Method Investments	2,668	2,412
Ownership Percentage, Greater than or Equal to Fifty Percentage and Less than or Equal to Ninety Nine Percent [Member]
Schedule of Equity Method Investments [Line Items]
Fair Value, Option, Fair Value Carrying Amount, Assets	201	28
Equity Method Investments	2,111	678
Ownership Percentage, Less than Three Percent [Member]
Schedule of Equity Method Investments [Line Items]
Fair Value, Option, Fair Value Carrying Amount, Assets	$ 311	$ 143

Investments - Summary of Maximu

Investments - Summary of Maximum Loss Exposure (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 58,948	$ 40,479
Less: Assets received	235,149	202,771
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Less: Assets received	53,243	37,318
Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity | Investment funds
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	12,136	7,989
Less: Assets received	8,459	5,284
Variable Interest Entity, Not Primary Beneficiary, Consolidated Entity Excluding Affiliated Entity | Investment funds
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	2,225	1,265
Less: Assets received	1,407	803
Fixed Maturity Securities | Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	12,681	8,126
Less: Assets received	11,324	7,834
Fixed Maturity Securities | Variable Interest Entity, Not Primary Beneficiary, Consolidated Entity Excluding Affiliated Entity
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	31,622	23,027
Less: Assets received	31,769	23,325
Equity securities | Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	284	72
Less: Assets received	$ 284	$ 72

Derivative Instruments - Summar

Derivative Instruments - Summary of Notional and Fair Value of Derivative Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Derivative assets, fair value	$ 4,387	$ 3,523
Gross amount recognized	472	298
Funds withheld liability	439	452
Total derivative assets, including embedded derivatives, fair value	5,747	6,329
Total derivative liabilities, including embedded derivatives, fair value	15,424	13,230
Derivatives designated as hedges
Derivative [Line Items]
Derivative assets, fair value	470	137
Gross amount recognized	$ 236	$ 192
Derivatives designated as hedges | Swaps
Derivative [Line Items]
Notional Amount	6,371	4,417
Derivative assets, fair value	$ 281	$ 134
Gross amount recognized	$ 56	$ 181
Derivatives designated as hedges | Foreign currency forwards
Derivative [Line Items]
Notional Amount	6,395	2,038
Derivative assets, fair value	$ 189	$ 3
Gross amount recognized	$ 2	$ 9
Derivatives designated as hedges | Interest rate swaps
Derivative [Line Items]
Notional Amount	500	0
Derivative assets, fair value	$ 0	$ 0
Gross amount recognized	$ 1	$ 0
Derivatives designated as hedges | Foreign currency interest rate swaps
Derivative [Line Items]
Notional Amount	2,783	0
Derivative assets, fair value	$ 0	$ 0
Gross amount recognized	$ 173	$ 0
Derivatives designated as hedges | Forwards on net investments | Foreign currency forwards
Derivative [Line Items]
Notional Amount	231	173
Derivative assets, fair value	$ 0	$ 0
Gross amount recognized	4	2
Derivatives not designated as hedges
Derivative [Line Items]
Total derivative assets, including embedded derivatives, fair value	5,277	6,192
Total derivative liabilities, including embedded derivatives, fair value	$ 15,188	$ 13,038
Derivatives not designated as hedges | Swaps
Derivative [Line Items]
Notional Amount	2,592	1,510
Derivative assets, fair value	$ 57	$ 96
Gross amount recognized	$ 19	$ 0
Derivatives not designated as hedges | Foreign currency forwards
Derivative [Line Items]
Notional Amount	7,382	3,595
Derivative assets, fair value	$ 76	$ 17
Gross amount recognized	$ 98	$ 44
Derivatives not designated as hedges | Equity options
Derivative [Line Items]
Notional Amount	57,890	53,666
Derivative assets, fair value	$ 3,629	$ 3,209
Gross amount recognized	$ 115	$ 22
Derivatives not designated as hedges | Futures
Derivative [Line Items]
Notional Amount	33	24
Derivative assets, fair value	$ 67	$ 58
Gross amount recognized	$ 0	$ 2
Derivatives not designated as hedges | Total return swaps
Derivative [Line Items]
Notional Amount	231	97
Derivative assets, fair value	$ 10	$ 6
Gross amount recognized	$ 0	$ 0
Derivatives not designated as hedges | Interest rate swaps
Derivative [Line Items]
Notional Amount	483	803
Derivative assets, fair value	$ 78	$ 0
Gross amount recognized	$ 1	$ 34
Derivatives not designated as hedges | Credit default swaps
Derivative [Line Items]
Notional Amount	10	10
Derivative assets, fair value	$ 0	$ 0
Gross amount recognized	3	4
Derivatives not designated as hedges | Embedded derivatives | Funds withheld including related party
Derivative [Line Items]
Funds withheld at interest	1,360	2,806
Funds withheld liability	45	59
Derivatives not designated as hedges | Embedded derivatives | Interest sensitive contract liabilities
Derivative [Line Items]
Embedded derivative assets, fair value	0	0
Embedded derivative liabilities, fair value	$ 14,907	$ 12,873

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Gains (losses) on foreign currency forwards on net investments	$ (2,061,000,000)	$ 2,270,000,000	$ 3,468,000,000
Net investment hedge loss	1,000,000	0
Additional collateral	0	0
Cash flow hedges | Derivatives designated as hedges | Swaps
Derivative [Line Items]
Foreign currency swap gains (losses)	254,000,000	(106,000,000)	29,000,000
Foreign currency swap gain (loss) reclassified to income	14,000,000	0	0
Expected to be reclassified to income	0
Fair Value Hedging | Derivatives designated as hedges | Forwards on net investments
Derivative [Line Items]
Gains (losses) on foreign currency forwards on net investments	$ 1,000,000	$ 2,000,000	$ (2,000,000)

Derivative Instruments - Cumula

Derivative Instruments - Cumulative Fair Value of Hedge Adjustments (Details) - Fair Value Hedging - Derivatives designated as hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Foreign currency forwards
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net, Recorded in Other Comprehensive Income	$ (22)	$ 0	$ 0
AFS securities – Foreign currency forwards | Foreign currency forwards
Derivative [Line Items]
Carrying amount of the hedged assets or liabilities	4,224	1,932
Cumulative amount of fair value hedging gains (losses), AFS securities	(136)	117
Interest sensitive contract liabilities | Foreign currency forwards
Derivative [Line Items]
Carrying amount of the hedged assets or liabilities	0	65
Cumulative amount of fair value hedging gains (losses), AFS securities	0	(1)
Interest sensitive contract liabilities | Foreign currency interest rate swaps
Derivative [Line Items]
Carrying amount of the hedged assets or liabilities	2,773	0
Cumulative amount of fair value hedging gains (losses), AFS securities	121	0
Interest sensitive contract liabilities | Interest rate swaps
Derivative [Line Items]
Carrying amount of the hedged assets or liabilities	500	0
Cumulative amount of fair value hedging gains (losses), AFS securities	0	0
Mortgage Loans, Net | Foreign currency forwards
Derivative [Line Items]
Carrying amount of the hedged assets or liabilities	1,686	0
Cumulative amount of fair value hedging gains (losses), AFS securities	$ (44)	$ 0

Derivative Instruments - Gains

Derivative Instruments - Gains (Losses) Related to Derivative and Hedge Items (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Gains (losses) on foreign currency forwards on net investments	$ (2,061,000,000)	$ 2,270,000,000	$ 3,468,000,000
Net investment hedge loss	1,000,000	0
Amount deemed ineffective	0	0	0
Foreign currency forwards | Fair Value Hedging | Derivatives designated as hedges
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net, Recorded in Other Comprehensive Income	(22,000,000)	0	0
Foreign currency forwards | Fair Value Hedging | Derivatives designated as hedges | Investment related gains (losses)
Derivative [Line Items]
Derivatives	420,000,000	(118,000,000)	2,000,000
Hedged Items	(440,000,000)	116,000,000	0
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(20,000,000)	(2,000,000)	2,000,000
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	16,000,000	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	21,000,000	0	0
Foreign currency forwards | Fair Value Hedging | Derivatives designated as hedges | Foreign currency forwards
Derivative [Line Items]
Derivatives		1,000,000
Hedged Items		(1,000,000)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)		0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net		0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach		0
Foreign currency interest rate swaps | Fair Value Hedging | Derivatives designated as hedges | Investment related gains (losses)
Derivative [Line Items]
Derivatives	(102,000,000)
Hedged Items	99,000,000
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(3,000,000)
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0
Foreign currency interest rate swaps | Fair Value Hedging | Derivatives designated as hedges | Foreign currency forwards
Derivative [Line Items]
Derivatives	23,000,000
Hedged Items	(21,000,000)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	2,000,000
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0
Forwards on net investments | Fair Value Hedging | Derivatives designated as hedges
Derivative [Line Items]
Gains (losses) on foreign currency forwards on net investments	1,000,000	$ 2,000,000	$ (2,000,000)
Interest rate swaps | Fair Value Hedging | Derivatives designated as hedges | Investment related gains (losses)
Derivative [Line Items]
Derivatives	(1,000,000)
Hedged Items	1,000,000
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	$ 0

Derivative Instruments - Gain_2

Derivative Instruments - Gains (Losses) Related to Derivatives Not Designated as Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Total net gains on derivatives not designated as hedges	$ 1,706	$ 2,164	$ 1,917
Investment related gains (losses)
Derivative [Line Items]
Total net gains on derivatives not designated as hedges	3,157	3,548	4,443
Equity options | Investment related gains (losses)
Derivative [Line Items]
Total net gains on derivatives not designated as hedges	2,452	819	2,169
Futures | Investment related gains (losses)
Derivative [Line Items]
Total net gains on derivatives not designated as hedges	81	123	(13)
Swaps | Investment related gains (losses)
Derivative [Line Items]
Total net gains on derivatives not designated as hedges	15	82	43
Foreign currency forwards | Investment related gains (losses)
Derivative [Line Items]
Total net gains on derivatives not designated as hedges	37	(127)	(2)
Embedded derivatives | Investment related gains (losses)
Derivative [Line Items]
Total net gains on derivatives not designated as hedges	572	2,651	2,246
Embedded derivatives | Foreign currency forwards
Derivative [Line Items]
Total net gains on derivatives not designated as hedges	$ (1,451)	$ (1,384)	$ (2,526)

Derivative Instruments - Fair V

Derivative Instruments - Fair Value of Net Derivative and Other Financial Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivative assets
Derivative assets	$ 4,387	$ 3,523
Financial instruments	(430)	(165)
Collateral (received)/pledged	(3,934)	(3,196)
Net amount	23	162
Off-balance sheet securities collateral	0	(46)
Net amount after securities collateral	(23)	(116)
Derivative liabilities
Derivative Liability	(472)	(298)
Financial instruments	430	165
Collateral (received)/pledged	32	144
Net amount	(10)	11
Off-balance sheet securities collateral	0	0
Net amount after securities collateral	$ (10)	$ 11

Derivative Instruments - Summ_2

Derivative Instruments - Summary of Exposure to Credit-Related Events (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair value of derivative liabilities with credit related provisions	$ 3	$ 4
Maximum exposure for credit default swaps	$ 10	$ 10

Derivative Instruments - Cash F

Derivative Instruments - Cash Flow Hedges (Details) - Swaps - Cash flow hedges - Derivatives designated as hedges - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Foreign currency swap gains (losses)	$ 254,000,000	$ (106,000,000)	$ 29,000,000
Foreign currency swap gain (loss) reclassified to income	14,000,000	0	0
Gain (Loss) on Foreign Currency Cash Flow Hedge Ineffectiveness	$ 0	$ 0	$ 0

Variable Interest Entities (Det

Variable Interest Entities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	$ 24,148	$ 15,938
Investment funds	9,866	6,087
Variable Interest Entity, Primary Beneficiary, Excluding Affiliated Entity
Variable Interest Entity [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	1,809	1,880
Investment funds	229	0
Variable Interest Entity, Primary Beneficiary, Excluding Affiliated Entity | Hamlet
Variable Interest Entity [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	1,793	1,880
Variable Interest Entity, Primary Beneficiary, Excluding Affiliated Entity | A-A Euro
Variable Interest Entity [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	231	0
Investment funds	57	0
Variable Interest Entity, Primary Beneficiary, Excluding Affiliated Entity | Other Fund [Member]
Variable Interest Entity [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	16	0
Variable Interest Entity, Primary Beneficiary, Excluding Affiliated Entity | AOP
Variable Interest Entity [Line Items]
Investment funds	747	0
Variable Interest Entity, Primary Beneficiary, Excluding Affiliated Entity | A-A SPN-9
Variable Interest Entity [Line Items]
Investment funds	194	0
Variable Interest Entity, Primary Beneficiary, Excluding Affiliated Entity | Java
Variable Interest Entity [Line Items]
Investment funds	35	0
Variable Interest Entity, Primary Beneficiary, Affiliated Entity
Variable Interest Entity [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net	231	0
Investment funds	1,068	0
Variable Interest Entity, Primary Beneficiary, Affiliated Entity | NNN AGP Opportunities
Variable Interest Entity [Line Items]
Investment funds	$ 264	$ 0

Fair Value - Assets and Liabili

Fair Value - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets
Fair Value	$ 110,561	$ 89,373
Mortgage loans	24,148	15,938
Investment funds	9,866	6,087
Derivative assets, fair value	4,387	3,523
Restricted Cash and Cash Equivalents	796	738
Reinsurance recoverable	4,594	4,848
Liabilities
Interest Sensitive Contract Liabilities	156,325	144,566
Future Policy Benefits	42,488	29,258
Derivative liabilities	472	298
Funds withheld liability	439	452
Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	100,159	82,853
Trading securities	2,056	2,093
Mortgage loans	22,557	15,264
Investment funds	1,407	803
Investment funds	412	161
Funds withheld at interest	43,907	48,612
Derivative assets, fair value	4,387	3,523
Short-term investments	139	222
Other investments	1,473	572
Related Party
Assets
Fair Value	10,402	6,520
Trading securities	1,781	1,529
Mortgage loans	1,591	674
Investment funds	8,459	5,284
Investment funds	4,026	2,119
Funds withheld at interest	12,207	13,030
Other investments	222	469
Liabilities
Interest Sensitive Contract Liabilities	12,948	14,150
Future Policy Benefits	1,853	1,610
U.S. government and agencies | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	223	351
US state, municipal and political subdivisions | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	1,213	1,033
Foreign governments | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	1,128	368
Corporate | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	66,226	58,180
Corporate | Related Party
Assets
Fair Value	859	215
CLO | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	13,652	9,569
CLO | Related Party
Assets
Fair Value	2,549	1,520
ABS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	8,989	4,270
ABS | Related Party
Assets
Fair Value	6,994	4,785
CMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	2,758	2,169
RMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	5,970	6,913
Level 3
Assets
Fair Value	10,167	5,858
Recurring | Level 1
Assets
Cash and cash equivalents	9,633	7,704
Restricted Cash and Cash Equivalents	796	738
Reinsurance recoverable	0	0
Total assets not carried at fair value	10,848	9,038
Liabilities
Derivative liabilities	0	2
Total liabilities measured at fair value	0	2
Recurring | Level 1 | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	214	332
Trading securities	3	3
Equity securities	86	57
Mortgage loans	0	0
Investment funds	0	0
Derivative assets, fair value	67	58
Short-term investments	49	146
Other investments	0	0
Recurring | Level 1 | Related Party
Assets
Fair Value	0	0
Trading securities	0	0
Equity securities	0	0
Investment funds	0	0
Recurring | Level 1 | Universal life
Liabilities
Interest Sensitive Contract Liabilities	0	0
Recurring | Level 1 | AmerUs Closed Block
Liabilities
Future Policy Benefits	0	0
Recurring | Level 1 | ILICO Closed Block and life benefits
Liabilities
Future Policy Benefits	0	0
Recurring | Level 1 | Embedded derivatives
Liabilities
Interest Sensitive Contract Liabilities	0	0
Funds withheld liability	0	0
Recurring | Level 1 | Embedded derivatives | Consolidated Entity Excluding Affiliated Entity
Assets
Funds withheld at interest	0	0
Recurring | Level 1 | Embedded derivatives | Related Party
Assets
Funds withheld at interest	0	0
Recurring | Level 1 | U.S. government and agencies | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	214	332
Trading securities	3	3
Recurring | Level 1 | US state, municipal and political subdivisions | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 1 | Foreign governments | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	0
Recurring | Level 1 | Corporate | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 1 | Corporate | Related Party
Assets
Fair Value	0	0
Recurring | Level 1 | CLO | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 1 | CLO | Related Party
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 1 | ABS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 1 | ABS | Related Party
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 1 | CMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 1 | RMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 2
Assets
Cash and cash equivalents	0	0
Restricted Cash and Cash Equivalents	0	0
Reinsurance recoverable	0	0
Total assets not carried at fair value	105,173	88,786
Liabilities
Derivative liabilities	469	292
Total liabilities measured at fair value	514	351
Recurring | Level 2 | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	94,928	80,656
Trading securities	1,984	2,004
Equity securities	655	262
Mortgage loans	0	0
Investment funds	0	0
Derivative assets, fair value	4,320	3,465
Short-term investments	61	74
Other investments	130	105
Recurring | Level 2 | Related Party
Assets
Fair Value	3,085	2,216
Trading securities	10	4
Equity securities	0	0
Investment funds	0	0
Recurring | Level 2 | Universal life
Liabilities
Interest Sensitive Contract Liabilities	0	0
Recurring | Level 2 | AmerUs Closed Block
Liabilities
Future Policy Benefits	0	0
Recurring | Level 2 | ILICO Closed Block and life benefits
Liabilities
Future Policy Benefits	0	0
Recurring | Level 2 | Embedded derivatives
Liabilities
Interest Sensitive Contract Liabilities	0	0
Funds withheld liability	45	59
Recurring | Level 2 | Embedded derivatives | Consolidated Entity Excluding Affiliated Entity
Assets
Funds withheld at interest	0	0
Recurring | Level 2 | Embedded derivatives | Related Party
Assets
Funds withheld at interest	0	0
Recurring | Level 2 | U.S. government and agencies | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	9	19
Trading securities	3	3
Recurring | Level 2 | US state, municipal and political subdivisions | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	1,213	999
Trading securities	101	106
Recurring | Level 2 | Foreign governments | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	1,126	366
Trading securities	19
Recurring | Level 2 | Corporate | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	64,887	57,402
Trading securities	1,530	1,577
Recurring | Level 2 | Corporate | Related Party
Assets
Fair Value	189	20
Recurring | Level 2 | CLO | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	13,638	9,361
Trading securities	6	0
Recurring | Level 2 | CLO | Related Party
Assets
Fair Value	2,347	1,520
Trading securities	10	4
Recurring | Level 2 | ABS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	5,370	3,470
Trading securities	96	93
Recurring | Level 2 | ABS | Related Party
Assets
Fair Value	549	676
Trading securities	0	0
Recurring | Level 2 | CMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	2,715	2,126
Trading securities	94	52
Recurring | Level 2 | RMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	5,970	6,913
Trading securities	135	173
Recurring | Level 3
Assets
Cash and cash equivalents	0	0
Restricted Cash and Cash Equivalents	0	0
Reinsurance recoverable	1,991	2,100
Total assets not carried at fair value	22,454	14,840
Liabilities
Derivative liabilities	3	4
Total liabilities measured at fair value	18,407	16,561
Recurring | Level 3 | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	5,017	1,865
Trading securities	69	86
Equity securities	429	11
Mortgage loans	17	19
Investment funds	247	17
Derivative assets, fair value	0	0
Short-term investments	29	2
Other investments	0	0
Recurring | Level 3 | Related Party
Assets
Fair Value	7,317	4,304
Trading securities	1,771	1,525
Equity securities	284	72
Investment funds	3,923	2,033
Recurring | Level 3 | Universal life
Liabilities
Interest Sensitive Contract Liabilities	1,235	1,308
Recurring | Level 3 | AmerUs Closed Block
Liabilities
Future Policy Benefits	1,520	1,600
Recurring | Level 3 | ILICO Closed Block and life benefits
Liabilities
Future Policy Benefits	742	776
Recurring | Level 3 | Embedded derivatives
Liabilities
Interest Sensitive Contract Liabilities	14,907	12,873
Funds withheld liability	0	0
Recurring | Level 3 | Embedded derivatives | Consolidated Entity Excluding Affiliated Entity
Assets
Funds withheld at interest	782	1,944
Recurring | Level 3 | Embedded derivatives | Related Party
Assets
Funds withheld at interest	578	862
Recurring | Level 3 | U.S. government and agencies | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	0	0
Recurring | Level 3 | US state, municipal and political subdivisions | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	34
Trading securities	0	0
Recurring | Level 3 | Foreign governments | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	2	2
Trading securities	0
Recurring | Level 3 | Corporate | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	1,339	778
Trading securities	0	0
Recurring | Level 3 | Corporate | Related Party
Assets
Fair Value	670	195
Recurring | Level 3 | CLO | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	14	208
Trading securities	5	4
Recurring | Level 3 | CLO | Related Party
Assets
Fair Value	202	0
Trading securities	42	50
Recurring | Level 3 | ABS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	3,619	800
Trading securities	45	35
Recurring | Level 3 | ABS | Related Party
Assets
Fair Value	6,445	4,109
Trading securities	1,729	1,475
Recurring | Level 3 | CMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	43	43
Trading securities	0	0
Recurring | Level 3 | RMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	0	0
Trading securities	19	47
Recurring | NAV
Assets
Investment funds	268	230
Recurring | NAV | Consolidated Entity Excluding Affiliated Entity
Assets
Investment funds	165	144
Recurring | NAV | Related Party
Assets
Investment funds	103	86
Fair Value
Assets
Total assets not carried at fair value	86,719	80,487
Liabilities
Interest Sensitive Contract Liabilities	108,621	98,945
Funds withheld liability	394	393
Fair Value | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	23,059	15,811
Investment funds	995	642
Funds withheld at interest	43,125	46,668
Other investments	1,343	471
Fair Value | Related Party
Assets
Mortgage loans	1,600	694
Investment funds	4,433	3,165
Funds withheld at interest	11,629	12,168
Other investments	223	499
Fair Value | Level 1
Assets
Total assets not carried at fair value	0	0
Liabilities
Interest Sensitive Contract Liabilities	0	0
Funds withheld liability	0	0
Fair Value | Level 1 | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	0	0
Investment funds	0	0
Funds withheld at interest	0	0
Other investments	0	0
Fair Value | Level 1 | Related Party
Assets
Mortgage loans	0	0
Investment funds	0	0
Funds withheld at interest	0	0
Other investments	0	0
Fair Value | Level 2
Assets
Total assets not carried at fair value	312	369
Liabilities
Interest Sensitive Contract Liabilities	0	0
Funds withheld liability	394	393
Fair Value | Level 2 | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	0	0
Investment funds	0	0
Funds withheld at interest	0	0
Other investments	0	0
Fair Value | Level 2 | Related Party
Assets
Mortgage loans	0	0
Investment funds	0	0
Funds withheld at interest	0	0
Other investments	0	0
Fair Value | Level 3
Assets
Total assets not carried at fair value	80,979	76,311
Liabilities
Interest Sensitive Contract Liabilities	108,621	98,945
Funds withheld liability	0	0
Fair Value | Level 3 | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	23,059	15,811
Investment funds	0	0
Funds withheld at interest	43,125	46,668
Other investments	1,343	471
Fair Value | Level 3 | Related Party
Assets
Mortgage loans	1,600	694
Investment funds	0	0
Funds withheld at interest	11,629	12,168
Other investments	223	499
Fair Value | NAV
Assets
Total assets not carried at fair value	5,428	3,807
Fair Value | NAV | Consolidated Entity Excluding Affiliated Entity
Assets
Investment funds	995	642
Fair Value | NAV | Related Party
Assets
Investment funds	4,433	3,165
Fair Value | Recurring
Assets
Cash and cash equivalents	9,633	7,704
Restricted Cash and Cash Equivalents	796	738
Reinsurance recoverable	1,991	2,100
Total assets not carried at fair value	138,743	112,894
Liabilities
Interest Sensitive Contract Liabilities	16,142	14,181
Future Policy Benefits	2,262	2,376
Derivative liabilities	472	298
Funds withheld liability	45	59
Total liabilities measured at fair value	18,921	16,914
Fair Value | Recurring | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	100,159	82,853
Trading securities	2,056	2,093
Equity securities	1,170	330
Mortgage loans	17	19
Investment funds	412	161
Funds withheld at interest	782	1,944
Derivative assets, fair value	4,387	3,523
Short-term investments	139	222
Other investments	130	105
Fair Value | Recurring | Related Party
Assets
Fair Value	10,402	6,520
Trading securities	1,781	1,529
Equity securities	284	72
Investment funds	4,026	2,119
Funds withheld at interest	578	862
Fair Value | Recurring | Universal life
Liabilities
Interest Sensitive Contract Liabilities	1,235	1,308
Fair Value | Recurring | AmerUs Closed Block
Liabilities
Future Policy Benefits	1,520	1,600
Fair Value | Recurring | ILICO Closed Block and life benefits
Liabilities
Future Policy Benefits	742	776
Fair Value | Recurring | Embedded derivatives
Liabilities
Interest Sensitive Contract Liabilities	14,907	12,873
Funds withheld liability	45	59
Fair Value | Recurring | Embedded derivatives | Consolidated Entity Excluding Affiliated Entity
Assets
Funds withheld at interest	782	1,944
Fair Value | Recurring | Embedded derivatives | Related Party
Assets
Funds withheld at interest	578	862
Fair Value | Recurring | U.S. government and agencies | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	223	351
Trading securities	6	6
Fair Value | Recurring | US state, municipal and political subdivisions | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	1,213	1,033
Trading securities	101	106
Fair Value | Recurring | Foreign governments | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	1,128	368
Trading securities	19
Fair Value | Recurring | Corporate | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	66,226	58,180
Trading securities	1,530	1,577
Fair Value | Recurring | Corporate | Related Party
Assets
Fair Value	859	215
Fair Value | Recurring | CLO | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	13,652	9,569
Trading securities	11	4
Fair Value | Recurring | CLO | Related Party
Assets
Fair Value	2,549	1,520
Trading securities	52	54
Fair Value | Recurring | ABS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	8,989	4,270
Trading securities	141	128
Fair Value | Recurring | ABS | Related Party
Assets
Fair Value	6,994	4,785
Trading securities	1,729	1,475
Fair Value | Recurring | CMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	2,758	2,169
Trading securities	94	52
Fair Value | Recurring | RMBS | Consolidated Entity Excluding Affiliated Entity
Assets
Fair Value	5,970	6,913
Trading securities	$ 154	$ 220

Fair Value - Fair Value Option

Fair Value - Fair Value Option (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	$ 836	$ 274	$ 45
Mortgage loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Unpaid principal balance	15	17
Mark to fair value	2	2
Fair value	17	19
Investment Income [Member] | Investment funds
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	826	295	(3)
Investment related gains (losses) | Trading securities
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	(70)	33	151
Future policy benefits | Insurance Contract, Rights and Obligations [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	$ 80	$ (54)	$ (103)

Fair Value - Reconciliation of

Fair Value - Reconciliation of Level 3 Financial Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	$ 14,840	$ 8,958
Total realized and unrealized gains (losses) included in income	(709)	2,000
Total realized and unrealized gains (losses), Included in OCI	42	(11)
Purchases, (Sales), Issuances, (Settlements)	8,640	4,295
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(359)	(402)
Transfers (Out)	(914)	(509)
Ending Balance	22,454	14,840
Total gains (losses) included in earnings	885	100
Beginning Balance	(16,561)	(14,296)
Total realized and unrealized gains (losses), Included in income	(1,263)	(1,718)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements), Liabilities	(583)	(547)
Transfers (Out)	0	0
Ending Balance	(18,407)	(16,561)
Total gains (losses) included in earnings	0	(1)
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	42	(9)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfers (Out)		0
Equity securities | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	11	3
Total realized and unrealized gains (losses) included in income	16	3
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	402	5
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Transfers (Out)	0
Ending Balance	429	11
Total gains (losses) included in earnings	16	3
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Equity securities | Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	72	64
Total realized and unrealized gains (losses) included in income	8	1
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	204	12
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	(5)
Transfers (Out)	0	(5)
Ending Balance	284	72
Total gains (losses) included in earnings	8	1
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
US state, municipal and political subdivisions | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	34	40
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	0	(6)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(34)	0
Transfers (Out)	(34)	0
Ending Balance	0	34
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Foreign governments | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	2	0
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	0	2
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Transfers (Out)	0	0
Ending Balance	2	2
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Corporate | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	778	725
Total realized and unrealized gains (losses) included in income	6	10
Total realized and unrealized gains (losses), Included in OCI	27	5
Purchases, (Sales), Issuances, (Settlements)	428	10
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	100	28
Transfers (Out)	(128)	(41)
Ending Balance	1,339	778
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	27	5
Corporate | AFS securities – Foreign currency forwards | Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	195	0
Total realized and unrealized gains (losses) included in income	2	0
Total realized and unrealized gains (losses), Included in OCI	7	0
Purchases, (Sales), Issuances, (Settlements)	661	195
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(195)	0
Transfers (Out)	(195)	0
Ending Balance	670	195
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	7	0
CLO | Trading securities | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	4	6
Total realized and unrealized gains (losses) included in income	0	(2)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	1	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Transfers (Out)	0
Ending Balance	5	4
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
CLO | Trading securities | Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	50	38
Total realized and unrealized gains (losses) included in income	(7)	(13)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	9	14
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(10)	11
Transfers (Out)	(10)	(4)
Ending Balance	42	50
Total gains (losses) included in earnings	0	(9)
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
CLO | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	208	121
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses), Included in OCI	1	0
Purchases, (Sales), Issuances, (Settlements)	(37)	109
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(158)	(22)
Transfers (Out)	(158)	(22)
Ending Balance	14	208
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	1	0
CLO | AFS securities – Foreign currency forwards | Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	0
Total realized and unrealized gains (losses) included in income	0
Total realized and unrealized gains (losses), Included in OCI	0
Purchases, (Sales), Issuances, (Settlements)	202
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Transfers (Out)	0
Ending Balance	202	0
Total gains (losses) included in earnings	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0
ABS | Trading securities | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	35	16
Total realized and unrealized gains (losses) included in income	(1)	0
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	0	19
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	11	0
Transfers (Out)	0	0
Ending Balance	45	35
Total gains (losses) included in earnings	(1)	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
ABS | Trading securities | Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	1,475	711
Total realized and unrealized gains (losses) included in income	27	(13)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	227	777
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Transfers (Out)	0	0
Ending Balance	1,729	1,475
Total gains (losses) included in earnings	40	(14)
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
ABS | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	800	1,374
Total realized and unrealized gains (losses) included in income	(17)	20
Total realized and unrealized gains (losses), Included in OCI	45	(48)
Purchases, (Sales), Issuances, (Settlements)	2,958	(282)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(167)	(264)
Transfers (Out)	(327)	(271)
Ending Balance	3,619	800
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	45	(47)
ABS | AFS securities – Foreign currency forwards | Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	4,109	2,324
Total realized and unrealized gains (losses) included in income	(6)	24
Total realized and unrealized gains (losses), Included in OCI	(44)	37
Purchases, (Sales), Issuances, (Settlements)	2,386	1,889
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	(165)
Transfers (Out)	0	(165)
Ending Balance	6,445	4,109
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	(44)	37
CMBS | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	43	46
Total realized and unrealized gains (losses) included in income	2	(4)
Total realized and unrealized gains (losses), Included in OCI	6	(5)
Purchases, (Sales), Issuances, (Settlements)	(11)	(5)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	3	11
Transfers (Out)	(40)	0
Ending Balance	43	43
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	6	(4)
RMBS | Trading securities | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	47	52
Total realized and unrealized gains (losses) included in income	(10)	(9)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(18)	4
Transfers (Out)	(22)	(1)
Ending Balance	19	47
Total gains (losses) included in earnings	(4)	2
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Investment funds | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	17	22
Total realized and unrealized gains (losses) included in income	(27)	(5)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	148	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	109	0
Transfers (Out)	0
Ending Balance	247	17
Total gains (losses) included in earnings	(27)	(5)
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Investment funds | Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	2,033	132
Total realized and unrealized gains (losses) included in income	853	298
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	1,037	1,603
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Transfers (Out)	0	0
Ending Balance	3,923	2,033
Total gains (losses) included in earnings	853	122
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Mortgage loans | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	19	27
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	(2)	(8)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Transfers (Out)	0	0
Ending Balance	17	19
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Reinsurance recoverable
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	2,100	1,821
Total realized and unrealized gains (losses) included in income	(109)	279
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Ending Balance	1,991	2,100
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Short-term Investments | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	2	41
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	27	(39)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Ending Balance	29	2
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Embedded derivatives | Funds withheld at interest | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	1,944	801
Total realized and unrealized gains (losses) included in income	(1,162)	1,143
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Ending Balance	782	1,944
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Embedded derivatives | Funds withheld at interest | Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	862	594
Total realized and unrealized gains (losses) included in income	(284)	268
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Ending Balance	578	862
Total gains (losses) included in earnings	0	0
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Interest sensitive contract liabilities | Universal life
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	(1,308)	(1,050)
Total realized and unrealized gains (losses), Included in income	73	(258)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Ending Balance	(1,235)	(1,308)
Total gains (losses) included in earnings	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Interest sensitive contract liabilities | Embedded derivatives
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	(12,873)	(10,942)
Total realized and unrealized gains (losses), Included in income	(1,451)	(1,384)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements), Liabilities	(583)	(547)
Transfers (Out)	0	0
Ending Balance	(14,907)	(12,873)
Total gains (losses) included in earnings	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Future policy benefits | AmerUs Closed Block
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	(1,600)	(1,546)
Total realized and unrealized gains (losses), Included in income	80	(54)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Ending Balance	(1,520)	(1,600)
Total gains (losses) included in earnings	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Future policy benefits | ILICO Closed Block and life benefits
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	(776)	(755)
Total realized and unrealized gains (losses), Included in income	34	(21)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Ending Balance	(742)	(776)
Total gains (losses) included in earnings	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Derivative liabilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	(4)	(3)
Total realized and unrealized gains (losses), Included in income	1	(1)
Total realized and unrealized gains (losses), Included in OCI	0	0
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Ending Balance	(3)	(4)
Total gains (losses) included in earnings	0	(1)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	$ 0	$ 0

Fair Value - Gross Components o

Fair Value - Gross Components of Purchases, Sales, Issuances and Settlements, net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	$ 12,028	$ 5,377
Sales	(1,580)	(145)
Settlements	(1,808)	(937)
Purchases, (Sales), Issuances, (Settlements)	8,640	4,295
Purchases	0	0
Issuances	(1,474)	(1,188)
Sales	0	0
Settlements	891	641
Purchases, (Sales), Issuances, (Settlements), Liabilities	(583)	(547)
Transfer In	555	107
Transfers (Out)	(914)	(509)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(359)	(402)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Transfers In	0	0
Transfers (Out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Transfer In		0
Transfers (Out)		0
Equity securities | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	402	11
Sales	0	0
Settlements	0	(6)
Purchases, (Sales), Issuances, (Settlements)	402	5
Transfer In	0
Transfers (Out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Equity securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	213	18
Sales	0	(1)
Settlements	(9)	(5)
Purchases, (Sales), Issuances, (Settlements)	204	12
Transfer In	0	0
Transfers (Out)	0	(5)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	(5)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Short-term Investments | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	30	3
Sales	(3)	(7)
Settlements	0	(35)
Purchases, (Sales), Issuances, (Settlements)	27	(39)
Transfer In	0	0
Transfers (Out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
US state, municipal and political subdivisions | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0
Sales	0	(5)
Settlements	0	(1)
Purchases, (Sales), Issuances, (Settlements)	0	(6)
Transfer In	0	0
Transfers (Out)	(34)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(34)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Foreign governments | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	1	2
Sales	0	0
Settlements	(1)	0
Purchases, (Sales), Issuances, (Settlements)	0	2
Transfer In	0	0
Transfers (Out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Corporate | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	636	177
Sales	(96)	0
Settlements	(112)	(167)
Purchases, (Sales), Issuances, (Settlements)	428	10
Transfer In	228	69
Transfers (Out)	(128)	(41)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	100	28
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Corporate | AFS securities – Foreign currency forwards | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	661	195
Sales	0	0
Settlements	0	0
Purchases, (Sales), Issuances, (Settlements)	661	195
Transfer In	0	0
Transfers (Out)	(195)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(195)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
CLO | Trading securities | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	5
Sales	(4)
Settlements	0
Purchases, (Sales), Issuances, (Settlements)	1	0
Transfer In	0
Transfers (Out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0
CLO | Trading securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	18	27
Sales	(2)	(13)
Settlements	(7)	0
Purchases, (Sales), Issuances, (Settlements)	9	14
Transfer In	0	15
Transfers (Out)	(10)	(4)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(10)	11
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
CLO | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	145
Sales	0	(8)
Settlements	(37)	(28)
Purchases, (Sales), Issuances, (Settlements)	(37)	109
Transfer In	0	0
Transfers (Out)	(158)	(22)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(158)	(22)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
CLO | AFS securities – Foreign currency forwards | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	202
Sales	0
Settlements	0
Purchases, (Sales), Issuances, (Settlements)	202
Transfer In	0
Transfers (Out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0
ABS | Trading securities | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	35
Sales	0	(16)
Settlements	0	0
Purchases, (Sales), Issuances, (Settlements)	0	19
Transfer In	11	0
Transfers (Out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	11	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
ABS | Trading securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	404	802
Sales	(115)	(11)
Settlements	(62)	(14)
Purchases, (Sales), Issuances, (Settlements)	227	777
Transfer In	0	0
Transfers (Out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
ABS | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	4,455	128
Sales	(1,001)	0
Settlements	(496)	(410)
Purchases, (Sales), Issuances, (Settlements)	2,958	(282)
Transfer In	160	7
Transfers (Out)	(327)	(271)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(167)	(264)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
ABS | AFS securities – Foreign currency forwards | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	3,679	2,156
Sales	(212)	(5)
Settlements	(1,081)	(262)
Purchases, (Sales), Issuances, (Settlements)	2,386	1,889
Transfer In	0	0
Transfers (Out)	0	(165)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	(165)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
RMBS | Trading securities | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0
Sales	0	0
Settlements	0	0
Purchases, (Sales), Issuances, (Settlements)	0	0
Transfer In	4	5
Transfers (Out)	(22)	(1)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(18)	4
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
CMBS | AFS securities – Foreign currency forwards | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0
Sales	(10)	(4)
Settlements	(1)	(1)
Purchases, (Sales), Issuances, (Settlements)	(11)	(5)
Transfer In	43	11
Transfers (Out)	(40)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	3	11
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Mortgage loans | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0
Sales	0	0
Settlements	(2)	(8)
Purchases, (Sales), Issuances, (Settlements)	(2)	(8)
Transfer In	0	0
Transfers (Out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Investment funds | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	285
Sales	(137)
Settlements	0
Purchases, (Sales), Issuances, (Settlements)	148	0
Transfer In	109
Transfers (Out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	109	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0
Investment funds | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	1,037	1,678
Sales	0	(75)
Settlements	0	0
Purchases, (Sales), Issuances, (Settlements)	1,037	1,603
Transfer In	0	0
Transfers (Out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances	0	0
Embedded derivatives | Funds withheld at interest | Consolidated Entity Excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Embedded derivatives | Funds withheld at interest | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Interest sensitive contract liabilities | Embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0
Issuances	(1,474)	(1,188)
Sales	0	0
Settlements	891	641
Purchases, (Sales), Issuances, (Settlements), Liabilities	(583)	(547)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Transfers In	0	0
Transfers (Out)	0	0
Derivative liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	$ 0	$ 0

Fair Value - Summary of Unobser

Fair Value - Summary of Unobservable Inputs for the Embedded Derivatives of Interest Sensitive Contract Liabilities (Details) $ in Millions	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Fair Value Unobservable Inputs
Fair Value	$ 110,561	$ 89,373
Level 3
Fair Value Unobservable Inputs
Fair Value	10,167	5,858
Interest sensitive contract liabilities | Embedded derivatives | Level 3
Fair Value Unobservable Inputs
Total liabilities measured at fair value	$ 14,907	$ 12,873
Measurement Input, Entity Credit Risk [Member] | Minimum
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.001	0
Measurement Input, Entity Credit Risk [Member] | Maximum
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.010	0.011
Measurement Input, Entity Credit Risk [Member] | Weighted Average
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.006	0.005
Measurement Input, Option Volatility [Member] | Minimum
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.004	0.006
Measurement Input, Option Volatility [Member] | Maximum
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.034	0.035
Measurement Input, Option Volatility [Member] | Weighted Average
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.019	0.019
Measurement Input, Withdrawal Rate [Member] | Minimum
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.059	0.053
Measurement Input, Withdrawal Rate [Member] | Maximum
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.107	0.095
Measurement Input, Withdrawal Rate [Member] | Weighted Average
Fair Value Unobservable Inputs
Embedded Derivative Liability, Measurement Input	0.080	0.071
Discount rate | Minimum
Fair Value Unobservable Inputs
Debt Securities, Available-for-sale, Measurement Input	0.014	0.017
Discount rate | Maximum
Fair Value Unobservable Inputs
Debt Securities, Available-for-sale, Measurement Input	0.194	0.350
Discount rate | Weighted Average
Fair Value Unobservable Inputs
Debt Securities, Available-for-sale, Measurement Input	0.052	0.046

Fair Value - Equity Securities

Fair Value - Equity Securities Without a Readily Determinable Fair Value (Details) $ in Millions	Dec. 31, 2020USD ($)
Fair Value Disclosures [Abstract]
Equity Securities without Readily Determinable Fair Value, Amount	$ 202
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount	$ 231

Fair Value - Financial Instrume

Fair Value - Financial Instruments Not Carried at Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets
Mortgage loans	$ 24,148	$ 15,938
Investment funds	9,866	6,087
Liabilities
Interest Sensitive Contract Liabilities	156,325	144,566
Long-term Debt	2,964	1,976
Funds withheld liability	439	452
Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	22,557	15,264
Investment funds	1,407	803
Loans, Gross, Insurance Policy	312	369
Funds withheld at interest	43,907	48,612
Other investments	1,473	572
Short-term investments	139	222
Related Party
Assets
Mortgage loans	1,591	674
Investment funds	8,459	5,284
Funds withheld at interest	12,207	13,030
Other investments	222	469
Liabilities
Interest Sensitive Contract Liabilities	12,948	14,150
Carrying Value
Assets
Total assets not carried at fair value	86,190	79,867
Liabilities
Interest Sensitive Contract Liabilities	105,293	94,685
Long-term Debt	2,964	1,976
Payables for collateral on derivatives and securities to repurchase	3,110	598
Funds withheld liability	394	393
Total liabilities not carried at fair value	111,761	97,652
Carrying Value | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	22,540	15,245
Investment funds	995	642
Loans, Gross, Insurance Policy	312	369
Funds withheld at interest	43,125	46,668
Other investments	1,343	467
Carrying Value | Related Party
Assets
Mortgage loans	1,591	674
Investment funds	4,433	3,165
Funds withheld at interest	11,629	12,168
Other investments	222	469
Fair Value
Assets
Total assets not carried at fair value	86,719	80,487
Liabilities
Interest Sensitive Contract Liabilities	108,621	98,945
Long-term Debt	3,295	2,259
Payables for collateral on derivatives and securities to repurchase	3,110	598
Funds withheld liability	394	393
Total liabilities not carried at fair value	115,420	102,195
Fair Value | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	23,059	15,811
Investment funds	995	642
Loans, Gross, Insurance Policy	312	369
Funds withheld at interest	43,125	46,668
Other investments	1,343	471
Fair Value | Related Party
Assets
Mortgage loans	1,600	694
Investment funds	4,433	3,165
Funds withheld at interest	11,629	12,168
Other investments	223	499
NAV | Fair Value
Assets
Total assets not carried at fair value	5,428	3,807
NAV | Fair Value | Consolidated Entity Excluding Affiliated Entity
Assets
Investment funds	995	642
NAV | Fair Value | Related Party
Assets
Investment funds	4,433	3,165
Level 1 | Fair Value
Assets
Total assets not carried at fair value	0	0
Liabilities
Interest Sensitive Contract Liabilities	0	0
Long-term Debt	0	0
Payables for collateral on derivatives and securities to repurchase	0	0
Funds withheld liability	0	0
Total liabilities not carried at fair value	0	0
Level 1 | Fair Value | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	0	0
Investment funds	0	0
Loans, Gross, Insurance Policy	0	0
Funds withheld at interest	0	0
Other investments	0	0
Level 1 | Fair Value | Related Party
Assets
Mortgage loans	0	0
Investment funds	0	0
Funds withheld at interest	0	0
Other investments	0	0
Level 2 | Fair Value
Assets
Total assets not carried at fair value	312	369
Liabilities
Interest Sensitive Contract Liabilities	0	0
Long-term Debt	3,295	2,259
Payables for collateral on derivatives and securities to repurchase	3,110	598
Funds withheld liability	394	393
Total liabilities not carried at fair value	6,799	3,250
Level 2 | Fair Value | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	0	0
Investment funds	0	0
Loans, Gross, Insurance Policy	312	369
Funds withheld at interest	0	0
Other investments	0	0
Level 2 | Fair Value | Related Party
Assets
Mortgage loans	0	0
Investment funds	0	0
Funds withheld at interest	0	0
Other investments	0	0
Level 3 | Fair Value
Assets
Total assets not carried at fair value	80,979	76,311
Liabilities
Interest Sensitive Contract Liabilities	108,621	98,945
Long-term Debt	0	0
Payables for collateral on derivatives and securities to repurchase	0	0
Funds withheld liability	0	0
Total liabilities not carried at fair value	108,621	98,945
Level 3 | Fair Value | Consolidated Entity Excluding Affiliated Entity
Assets
Mortgage loans	23,059	15,811
Investment funds	0	0
Loans, Gross, Insurance Policy	0	0
Funds withheld at interest	43,125	46,668
Other investments	1,343	471
Level 3 | Fair Value | Related Party
Assets
Mortgage loans	1,600	694
Investment funds	0	0
Funds withheld at interest	11,629	12,168
Other investments	$ 223	$ 499

Fair Value - Narrative (Details

Fair Value - Narrative (Details)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Mortgage loans
Fair Value Measurement Inputs
Fair value option, loans, 90 days or more past due	$ 0	$ 0
Discount rate | Minimum
Fair Value Measurement Inputs
Debt Securities, Available-for-sale, Measurement Input	0.014	0.017
Discount rate | Maximum
Fair Value Measurement Inputs
Debt Securities, Available-for-sale, Measurement Input	0.194	0.350

Reinsurance Reinsurance - Premi

Reinsurance Reinsurance - Premiums and future policy benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Premiums
Direct	$ 13,989	$ 5,691	$ 5,449
Reinsurance assumed	388	413	1,092
Reinsurance ceded	(115)	(141)	(159)
Total premiums	14,262	5,963	6,382
Future policy and other policy benefits
Direct	15,482	7,016	6,697
Reinsurance assumed	503	522	1,223
Reinsurance ceded	(251)	(351)	(333)
Total future policy and other policy benefits	$ 15,734	$ 7,187	$ 7,587

Reinsurance - Narrative (Detail

Reinsurance - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Jul. 01, 2020
MassMutual
Effects of Reinsurance [Line Items]
Funds withheld at interest			$ 5,021
Protective
Effects of Reinsurance [Line Items]
Assets held-in-trust	$ 1,624	$ 1,722
Minimum
Effects of Reinsurance [Line Items]
Assets held-in-trust	6,380	6,538
Minimum | Global Atlantic
Effects of Reinsurance [Line Items]
Assets held-in-trust	$ 2,854	$ 3,022

Reinsurance Reinsurance - Trans

Reinsurance Reinsurance - Transactions (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Effects of Reinsurance [Line Items]
Liabilities assumed	$ 212,968	$ 182,631
Less: Assets received	235,149	202,771
DAC	3,615	3,236	$ 3,274	$ 3,921
Interest Sensitive Contract Liabilities	156,325	144,566
Future policy benefits	$ (42,488)	(29,258)
Reinsurance agreement
Effects of Reinsurance [Line Items]
Liabilities assumed		27,439	791
Less: Assets received		28,805	818
Net cost of reinsurance		(1,366)	(27)
Interest Sensitive Contract Liabilities		1,366	0
Future policy benefits		$ 0	$ (27)

Reinsurance - Ceded Credit Risk

Reinsurance - Ceded Credit Risk (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Ceded Credit Risk [Line Items]
Reinsurance recoverable	$ 4,594	$ 4,848
Global Atlantic
Ceded Credit Risk [Line Items]
Reinsurance recoverable	2,916	3,108
Protective
Ceded Credit Risk [Line Items]
Reinsurance recoverable	1,515	1,558
Other
Ceded Credit Risk [Line Items]
Reinsurance recoverable	$ 163	$ 182

Deferred Acquisition Costs, D_3

Deferred Acquisition Costs, Deferred Sales Inducements, and Value of Business Acquired - Roll Forward of DAC, DSI, and VOBA (Details) - USD ($) $ in Millions	Jan. 01, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
DAC
Beginning balance	$ 3,274	$ 3,236	$ 3,274	$ 3,921
Additions		698	633	645
Unlocking		18	36	117
Amortization		(483)	(414)	(749)
Impact of unrealized investment (gains) losses		182	(233)	(426)
Ending balance		3,615	3,236	3,274
DSI
Beginning balance	820	857	820	799
Additions		265	178	226
Unlocking		16	13	9
Amortization		182	53	65
Impact of unrealized investment (gains) losses		54	(80)	(131)
Ending balance		978	857	820
VOBA
Beginning balance	914	813	914	1,187
Additions		0	0	0
Unlocking		(24)	11	24
Amortization		(155)	(60)	(68)
Impact of unrealized investment (gains) losses		87	(35)	(181)
Ending balance		769	813	914
Total
Beginning balance	5,008	4,906	5,008	5,907
Additions		963	811	871
Unlocking		10	60	150
Amortization		(820)	(527)	(882)
Impact of unrealized investment (gains) losses		323	(348)	(738)
Ending balance		5,362	4,906	5,008
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
DAC		3,615	3,236	3,274
Deferred Sale Inducement Cost		978	857	820
Present Value of Future Insurance Profits, Net		769	813	914
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits		5,362	4,906	5,008
Deferred Policy Acquisition Cost, Capitalization		698	633	645
Additions		265	178	226
Additions		0	0	0
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits, Additions		963	811	871
Unlocking		18	36	117
Unlocking		16	13	9
Unlocking		(24)	11	24
Unlocking		10	60	150
Deferred Policy Acquisition Cost, Amortization Expense, Other		483	414	749
Amortization		182	53	65
Present Value of Future Insurance Profits, Amortization Expense		155	60	68
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits, Amortization Expense Excluding Unlocking		820	527	882
Deferred Policy Acquisition Cost, Unrealized Investment Gain (Loss)		(182)	233	426
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment		(54)	80	131
Present Value of Future Insurance Profits, Unrealized Gain (Loss) on Investment		(87)	35	181
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits, Unrealized Investment Gains (Losses)		$ (323)	$ 348	$ 738
Accounting Standards Update 2016-13 [Member]
DAC
Adoption of accounting standard	12
DSI
Adoption of accounting standard	5
VOBA
Adoption of accounting standard	5
Total
Additions	22
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits, Additions	22
Adoption of accounting standard	12
Adoption of accounting standard	5
Adoption of accounting standard	$ 5

Deferred Acquisition Costs, D_4

Deferred Acquisition Costs, Deferred Sales Inducements, and Value of Business Acquired - Expected Amortization of VOBA (Details) $ in Millions	Dec. 31, 2021USD ($)
Insurance [Abstract]
2022	$ 59
2023	62
2024	64
2025	62
2026	$ 59

Closed Block - Schedule of Clos

Closed Block - Schedule of Closed Block Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Liabilities
Future policy benefits	$ 1,520	$ 1,600
Other policy claims and benefits	16	15
Dividends payable to policyholders	75	84
Total liabilities	1,611	1,699
Assets
Trading securities	1,321	1,431
Mortgage loans, net of allowances	17	19
Policy loans	108	124
Total investments	1,446	1,574
Cash and cash equivalents	63	35
Accrued investment income	46	44
Reinsurance recoverable	14	16
Other assets	10	2
Total assets	1,579	1,671
Maximum future earnings to be recognized from AmerUs Closed Block	$ 32	$ 28

Closed Block - Results of Opera

Closed Block - Results of Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues
Premiums	$ 42	$ 48	$ 54
Net investment income	68	71	74
Investment related gains (losses)	(61)	99	147
Total revenues	49	218	275
Benefits and Expenses
Future policy and other policy benefits	24	177	234
Dividends to policyholders	27	38	36
Total benefits and expenses	51	215	270
Contribution (to) from AmerUs Closed Block before income taxes	(2)	3	5
Income tax expense (benefit)	2	1	(1)
Contribution (to) from AmerUs Closed Block, net of income taxes	$ (4)	$ 2	$ 6

Debt - Credit Facility (Details

Debt - Credit Facility (Details) - Revolving Credit Facility - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Line of Credit Facility [Line Items]
Borrowing capacity	$ 1,250
Maximum borrowing capacity	$ 1,750
Capitalization ratio	35.00%
Minimum consolidated net worth	$ 7,300
Outstanding line of credit	$ 0	$ 0
Commitment fee, percent	0.15%	0.15%
Minimum
Line of Credit Facility [Line Items]
Commitment fee, percent	0.10%
Maximum
Line of Credit Facility [Line Items]
Commitment fee, percent	0.30%

Debt - Senior Note Issuance (De

Debt - Senior Note Issuance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Line of Credit Facility [Line Items]
Long-term Debt	$ 2,964	$ 1,976
Interest Expense, Long-term Debt	$ 105	69	$ 42
Senior Notes due 2028
Line of Credit Facility [Line Items]
Debt Instrument, Issuance Date	Jan. 12, 2018
Debt Instrument, Face Amount	$ 1,000	1,000
Long-term Debt	$ 994	$ 994
Interest rate	4.125%	4.125%
Long-term Debt, Maturity Date	Jan. 12, 2028
Senior Notes due 2030
Line of Credit Facility [Line Items]
Debt Instrument, Issuance Date	Apr. 3, 2020
Debt Instrument, Face Amount	$ 500	$ 500
Long-term Debt	$ 495	495
Interest rate	6.15%
Long-term Debt, Maturity Date	Apr. 3, 2030
Senior Notes due 2031
Line of Credit Facility [Line Items]
Debt Instrument, Issuance Date	Oct. 8, 2020
Debt Instrument, Face Amount	$ 500	500
Long-term Debt	$ 490	$ 490
Interest rate	3.50%
Long-term Debt, Maturity Date	Jan. 15, 2031
Senior Notes due 2051
Line of Credit Facility [Line Items]
Debt Instrument, Issuance Date	May 25, 2021
Debt Instrument, Face Amount	$ 500
Long-term Debt	$ 491
Interest rate	3.95%
Long-term Debt, Maturity Date	May 25, 2051
Senior Notes due 2052
Line of Credit Facility [Line Items]
Debt Instrument, Issuance Date	Dec. 13, 2021
Debt Instrument, Face Amount	$ 500
Long-term Debt	$ 494
Interest rate	3.45%
Long-term Debt, Maturity Date	May 15, 2052

Equity - Schedule of Stock by C

Equity - Schedule of Stock by Class (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Class of Stock [Line Items]
Dividends, Preferred Stock, Cash	$ 141	$ 95	$ 36
Class A
Class of Stock [Line Items]
Common stock outstanding (in shares)	192.2	191.5	143.2	162.4
Stock Issued During Period, Shares, New Issues	0.9	36	0.7
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited	(0.2)	(0.1)	(0.1)
Stock Repurchased During Period, Shares	0	(13.3)	(19.8)
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	(25.4)	0
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	0	0.3	0
Class B
Class of Stock [Line Items]
Common stock outstanding (in shares)	0	0	25.4	25.4
Class B | Common stock
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	(25.4)	0
Class M-1
Class of Stock [Line Items]
Common stock outstanding (in shares)	0	0	3.3	3.4
Class M-1 | Warrant
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	(3.1)	0
Class M-1 | Common stock
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	(0.2)	(0.1)
Class M-2
Class of Stock [Line Items]
Common stock outstanding (in shares)	0	0	0.8	0.8
Class M-2 | Warrant
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	(0.8)	0
Class M-2 | Common stock
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	0	0
Class M-3
Class of Stock [Line Items]
Common stock outstanding (in shares)	0	0	1	1
Class M-3 | Warrant
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	(1)	0
Class M-3 | Common stock
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	0	0
Class M-4
Class of Stock [Line Items]
Common stock outstanding (in shares)	0	0	4	4.1
Stock Repurchased During Period, Shares	0	(0.3)	0
Class M-4 | Warrant
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	(3.6)	0
Class M-4 | Common stock
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	0	0.1	0.1
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Liquidation Preference Per Share	$ 25,000
Preferred Stock, Issuance Date	Jun. 10, 2019
Dividends, Preferred Stock, Cash	$ 55	$ 55	$ 31
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Liquidation Preference Per Share	$ 25,000
Preferred Stock, Issuance Date	Sep. 19, 2019
Dividends, Preferred Stock, Cash	$ 19	19	5
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Liquidation Preference Per Share	$ 25,000
Preferred Stock, Issuance Date	Jun. 11, 2020
Dividends, Preferred Stock, Cash	$ 38	21	0
Series D Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Liquidation Preference Per Share	$ 25,000
Preferred Stock, Issuance Date	Dec. 18, 2020
Dividends, Preferred Stock, Cash	$ 29	$ 0	$ 0

Equity - Narrative (Details)

Equity - Narrative (Details) - USD ($)	Feb. 28, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Class of Stock [Line Items]
Dividends, Preferred Stock, Cash		$ 141,000,000	$ 95,000,000	$ 36,000,000
Common Stock, Voting Rights, Maximum Voting Power for Single Shareholder		9.90%
Common Stock, Amount Authorized and Reserved for Future Issuance		$ 406,810
Class of Warrant or Right, Outstanding		8,100,000
Dividends, Common Stock, Cash		$ 750,000,000
Weighted Average
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 18.40
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage		6.35%
Preferred Stock, Liquidation Preference Per Share		$ 25,000
Preferred Stock, Par or Stated Value Per Share		1	$ 1
Preferred Stock, Dividends, Per Share, Cash Paid		$ 1,587.5	$ 1,587.51	$ 881.95
Dividends, Preferred Stock, Cash		$ 55,000,000	$ 55,000,000	$ 31,000,000
Preferred Stock, Shares Issued		34,500	0
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage		5.625%
Preferred Stock, Liquidation Preference Per Share		$ 25,000
Preferred Stock, Par or Stated Value Per Share		1	$ 1
Preferred Stock, Dividends, Per Share, Cash Paid		$ 1,406.25	$ 1,406.25	$ 394.53
Dividends, Preferred Stock, Cash		$ 19,000,000	$ 19,000,000	$ 5,000,000
Preferred Stock, Shares Issued		13,800	0
Class B | Common stock
Class of Stock [Line Items]
Shares issued from conversion of securities (in shares)		0	25,400,000	0
Common Class M | Common stock
Class of Stock [Line Items]
Common Stock, Conversion Basis, Percentage Of Share Value Converted	5.00%
Common Class M | Warrant
Class of Stock [Line Items]
Common Stock, Conversion Basis, Percentage Of Share Value Converted	95.00%
Class A
Class of Stock [Line Items]
Shares issued from conversion of securities (in shares)		0	25,400,000	0
Stock Repurchase Program, Authorized Amount		$ 1,567,000,000
Stock Repurchased During Period, Shares		0	13,300,000	19,800,000
Stock Issued During Period, Shares, New Issues		900,000	36,000,000	700,000
Excess Stock, Shares Authorized		406,800,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage		6.375%
Preferred Stock, Liquidation Preference Per Share		$ 25,000
Preferred Stock, Par or Stated Value Per Share		1	$ 1
Preferred Stock, Dividends, Per Share, Cash Paid		$ 1,593.75	$ 880.99	$ 0
Dividends, Preferred Stock, Cash		$ 38,000,000	$ 21,000,000	$ 0
Preferred Stock, Shares Issued		24,000	0
Series D Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage		4.875%
Preferred Stock, Liquidation Preference Per Share		$ 25,000
Preferred Stock, Par or Stated Value Per Share		1	$ 1
Preferred Stock, Dividends, Per Share, Cash Paid		$ 1,259.38	$ 0	$ 0
Dividends, Preferred Stock, Cash		$ 29,000,000	$ 0	$ 0
Preferred Stock, Shares Issued		23,000	0
Repurchase Authorizations 2019 [Member] | Class A
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount			$ 221,000,000	640,000,000
Stock Repurchased During Period, Value		$ 0	419,000,000	827,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount		221,000,000	221,000,000	640,000,000
Stock Repurchase Program, Additional Authorized Amount		$ 0	$ 0	$ 1,317,000,000
Repurchase Authorization 2018 [Member] | Class A
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount					$ 150,000,000

Equity - AOCI (Details)

Equity - AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 01, 2020	Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	$ (2,095)	$ 2,529	$ 3,637
Reclassification adjustments for gains (losses) realized in net income	(34)	259	169
Income tax expense (benefit) related to other comprehensive income (loss)	(371)	413	698
Other comprehensive income attributable to NCI, net of tax	(149)	161	17
Accumulated other comprehensive income (loss)	2,430	3,971	2,281		$ (472)
Deferred Acquisition Costs, Deferred Value of Business Acquired and Future Policy Benefit Adjustment on Available-for-sale Securities Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income attributable to NCI, net of tax	0	0	0
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income attributable to NCI, net of tax	6	7	1
Unrealized gains (losses) on AFS securities, including DAC, DSI, VOBA, and future policy benefits
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	605	(634)	(1,322)
Reclassification adjustments for gains (losses) realized in net income	17	(94)	(56)
Income tax expense (benefit) related to other comprehensive income (loss)	123	(115)	(266)
Accumulated other comprehensive income (loss)	(845)	(1,310)	(879)		121
Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	246	(106)	29
Reclassification adjustments for gains (losses) realized in net income	14	0	0
Income tax expense (benefit) related to other comprehensive income (loss)	54	(26)	6
Accumulated other comprehensive income (loss)	146	(26)	61		39
Accumulated Foreign Currency Adjustment and Other Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income attributable to NCI, net of tax	(1)	7	0
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	(10)	18	1
Reclassification adjustments for gains (losses) realized in net income	0	0	0
Income tax expense (benefit) related to other comprehensive income (loss)	0	0	0
Accumulated other comprehensive income (loss)	(1)	8	(3)		(4)
AOCI, Gain (Loss), Debt Securities, Available-for-sale, without Allowance for Credit Loss, Including Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	(2,988)	3,312	4,929
Reclassification adjustments for gains (losses) realized in net income	(65)	353	225
Income tax expense (benefit) related to other comprehensive income (loss)	(558)	566	958
Accumulated other comprehensive income (loss)	3,141	5,352	3,102		(628)
AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Including Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	52	(61)	0
Reclassification adjustments for gains (losses) realized in net income	0	0	0
Income tax expense (benefit) related to other comprehensive income (loss)	10	(12)	0
Accumulated other comprehensive income (loss)	(11)	(53)	0		$ 0
AOCI, Gain (Loss), Debt Securities, Available-for-sale, without Allowance for Credit Loss, Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income attributable to NCI, net of tax	(154)	147	16
AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income attributable to NCI, net of tax	$ 0	$ 0	$ 0
Accounting Standards Update 2016-13 [Member] | Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)				$ (6)
Accounting Standards Update 2016-13 [Member] | Unrealized gains (losses) on AFS securities, including DAC, DSI, VOBA, and future policy benefits | Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)				(6)
Accounting Standards Update 2016-13 [Member] | Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member] | Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)				0
Accounting Standards Update 2016-13 [Member] | Accumulated Foreign Currency Adjustment Attributable to Parent [Member] | Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)				0
Accounting Standards Update 2016-13 [Member] | AOCI, Gain (Loss), Debt Securities, Available-for-sale, without Allowance for Credit Loss, Including Noncontrolling Interest [Member] | Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)				4
Accounting Standards Update 2016-13 [Member] | AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Including Noncontrolling Interest | Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)				$ (4)

Equity - Schedule of Preferred

Equity - Schedule of Preferred Stock (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage	6.35%
Preferred Stock, Liquidation Preference Per Share	$ 25,000
Preferred Stock, Issuance Date	Jun. 10, 2019
Preferred Stock, Shares Authorized	34,500	0
Preferred Stock, Shares Issued	34,500	0
Preferred Stock, Shares Outstanding	34,500	0
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage	5.625%
Preferred Stock, Liquidation Preference Per Share	$ 25,000
Preferred Stock, Issuance Date	Sep. 19, 2019
Preferred Stock, Shares Authorized	13,800	0
Preferred Stock, Shares Issued	13,800	0
Preferred Stock, Shares Outstanding	13,800	0
Series D Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage	4.875%
Preferred Stock, Liquidation Preference Per Share	$ 25,000
Preferred Stock, Issuance Date	Dec. 18, 2020
Preferred Stock, Shares Authorized	23,000	0
Preferred Stock, Shares Issued	23,000	0
Preferred Stock, Shares Outstanding	23,000	0
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage	6.375%
Preferred Stock, Liquidation Preference Per Share	$ 25,000
Preferred Stock, Issuance Date	Jun. 11, 2020
Preferred Stock, Shares Authorized	24,000	0
Preferred Stock, Shares Issued	24,000	0
Preferred Stock, Shares Outstanding	24,000	0

Equity - Preferred Stock Divide

Equity - Preferred Stock Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Preferred Stock [Line Items]
Dividends, Preferred Stock, Cash	$ 141	$ 95	$ 36
Series A Preferred Stock [Member]
Schedule of Preferred Stock [Line Items]
Preferred Stock, Dividends, Per Share, Cash Paid	$ 1,587.5	$ 1,587.51	$ 881.95
Dividends, Preferred Stock, Cash	$ 55	$ 55	$ 31
Series B Preferred Stock [Member]
Schedule of Preferred Stock [Line Items]
Preferred Stock, Dividends, Per Share, Cash Paid	$ 1,406.25	$ 1,406.25	$ 394.53
Dividends, Preferred Stock, Cash	$ 19	$ 19	$ 5
Series C Preferred Stock [Member]
Schedule of Preferred Stock [Line Items]
Preferred Stock, Dividends, Per Share, Cash Paid	$ 1,593.75	$ 880.99	$ 0
Dividends, Preferred Stock, Cash	$ 38	$ 21	$ 0
Series D Preferred Stock
Schedule of Preferred Stock [Line Items]
Preferred Stock, Dividends, Per Share, Cash Paid	$ 1,259.38	$ 0	$ 0
Dividends, Preferred Stock, Cash	$ 29	$ 0	$ 0

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of EPS (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income available to Athene Holding Ltd. common shareholders – basic and diluted	$ 3,718	$ 1,446	$ 2,136
Class A
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income available to Athene Holding Ltd. common shareholders – basic and diluted	3,718	1,573	1,760
Net income available to AHL shareholders – diluted	$ 3,718	$ 1,573	$ 1,760
Basic weighted average shares outstanding (in shares)	191.6	184.9	153.9
Dilutive effect of stock compensation plans (in shares)	7.1	3.7	0.4
Diluted weighted average shares outstanding (in shares)	198.7	188.6	154.3
Earnings per share
Basic (in USD per share)	$ 19.40	$ 8.51	$ 11.44
Diluted (in USD per share)	$ 18.71	$ 8.34	$ 11.41
Class B
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income available to Athene Holding Ltd. common shareholders – basic and diluted		$ (98)	$ 291
Net income available to AHL shareholders – diluted		$ (98)	$ 291
Basic weighted average shares outstanding (in shares)		25.4	25.4
Dilutive effect of stock compensation plans (in shares)		0	0
Diluted weighted average shares outstanding (in shares)		25.4	25.4
Earnings per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 11.44
Class M-1
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income available to Athene Holding Ltd. common shareholders – basic and diluted		$ (13)	$ 38
Net income available to AHL shareholders – diluted		$ (13)	$ 38
Basic weighted average shares outstanding (in shares)		3.3	3.3
Dilutive effect of stock compensation plans (in shares)		0	0
Diluted weighted average shares outstanding (in shares)		3.3	3.3
Earnings per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 11.44
Class M-2
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income available to Athene Holding Ltd. common shareholders – basic and diluted		$ (3)	$ 10
Net income available to AHL shareholders – diluted		$ (3)	$ 10
Basic weighted average shares outstanding (in shares)		0.8	0.8
Dilutive effect of stock compensation plans (in shares)		0	0
Diluted weighted average shares outstanding (in shares)		0.8	0.8
Earnings per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 11.44
Class M-3
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income available to Athene Holding Ltd. common shareholders – basic and diluted		$ (4)	$ 11
Net income available to AHL shareholders – diluted		$ (4)	$ 11
Basic weighted average shares outstanding (in shares)		1	1
Dilutive effect of stock compensation plans (in shares)		0	0
Diluted weighted average shares outstanding (in shares)		1	1
Earnings per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 11.44
Class M-4
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income available to Athene Holding Ltd. common shareholders – basic and diluted		$ (9)	$ 26
Net income available to AHL shareholders – diluted		$ (9)	$ 26
Basic weighted average shares outstanding (in shares)		2.4	2.2
Dilutive effect of stock compensation plans (in shares)		0	0.3
Diluted weighted average shares outstanding (in shares)		2.4	2.5
Earnings per share
Basic (in USD per share)		$ (3.87)	$ 11.44
Diluted (in USD per share)		$ (3.87)	$ 9.94

Earnings Per Share - Shares Exc

Earnings Per Share - Shares Excluded from Dilutive Calculation (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Class A
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	0.8	1.8	31.9

Income Taxes - Components of In

Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Current Income Tax Expense (Benefit)	$ 410	$ 107	$ 53
Deferred income tax expense (benefit)	(24)	178	64
Income tax expense (benefit)	$ 386	$ 285	$ 117

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Before Income Tax (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Holiday [Line Items]
Income before income taxes	$ 4,186	$ 2,206	$ 2,302
Domestic Tax Authority [Member] | Office of the Tax Commissioner, Bermuda [Member]
Income Tax Holiday [Line Items]
Income before income taxes	2,780	903	1,895
Foreign Tax Authority [Member] | Internal Revenue Service (IRS)
Income Tax Holiday [Line Items]
Income before income taxes	1,559	1,083	528
Foreign Tax Authority [Member] | Her Majesty's Revenue and Customs (HMRC) [Member]
Income Tax Holiday [Line Items]
Income before income taxes	$ (153)	$ 220	$ (121)

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	$ 299	$ 268	$ 88
Increase (decrease) in income taxes resulting from:
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	(2)	8	16
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount	19	5	17
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount	4	(4)	2
Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount	52	(6)	(6)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount	2	0	2
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	12	14	(2)
Income tax expense (benefit)	$ 386	$ 285	$ 117
Effective Tax Rate	9.00%	13.00%	5.00%
Out-of-period Adjustment
Increase (decrease) in income taxes resulting from:
Income tax expense (benefit)	$ (63)
Domestic Tax Authority [Member] | Office of the Tax Commissioner, Bermuda [Member]
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	0.00%	0.00%	0.00%
Foreign Tax Authority [Member] | Internal Revenue Service (IRS)
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	21.00%	21.00%

Income Taxes - Schedule of In_2

Income Taxes - Schedule of Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income tax expense	$ 386	$ 285	$ 117
Income tax expense (benefit) related to other comprehensive income (loss)	(371)	413	698
Income Tax Expense (Benefit), Intraperiod Tax Allocation	$ 15	$ 698	$ 815

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Deferred Tax Assets, Gross
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Policyholder Liabilities	$ 2,169	$ 1,723
Deferred Tax Assets, Operating Loss Carryforwards	60	86
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation	22	20
Deferred Tax Assets, Other	39	36
Deferred Tax Assets, Gross	2,290	1,865
Deferred Tax Assets, Valuation Allowance	(66)	(74)
Deferred Tax Assets, Net of Valuation Allowance	2,224	1,791
Deferred Tax Liabilities, Gross [Abstract]
Deferred Tax Liabilities, Investments	974	998
Deferred Tax Liabilities, Other Comprehensive Income	626	997
Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost	1,026	767
Deferred Tax Liabilities, Other	174	1
Deferred Tax Liabilities, Gross	2,800	2,763
Deferred Tax Liabilities, Net	$ (576)	$ (972)

Income Taxes - Summary of Valua

Income Taxes - Summary of Valuation Allowance (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Valuation Allowance [Line Items]
Deferred Tax Assets, Valuation Allowance	$ 66	$ 74
United States Federal and State Net Operating Losses [Member]
Valuation Allowance [Line Items]
Deferred Tax Assets, Valuation Allowance	30	50
German Other Deferred Tax Assets [Member]
Valuation Allowance [Line Items]
Deferred Tax Assets, Valuation Allowance	$ 36	$ 24

Income Taxes - Schedule of Gros

Income Taxes - Schedule of Gross Current and Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Income Tax Assets and Liabilities [Line Items]
Income Taxes Receivable		$ 55
Deferred Tax Liabilities, Net	$ (576)	(972)
Taxes Payable	(167)
Other Assets [Member]
Income Tax Assets and Liabilities [Line Items]
Income Taxes Receivable	2	55
Deferred Tax Assets, Net	0	0
Other Liabilities [Member]
Income Tax Assets and Liabilities [Line Items]
Deferred Tax Liabilities, Net	(576)	(972)
Taxes Payable	$ (169)	$ 0

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Valuation Allowance [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards	$ 421
Effective Tax Rate	9.00%	13.00%	5.00%
Income Tax Expense (Benefit)	$ 386	$ 285	$ 117
Out-of-period Adjustment
Valuation Allowance [Line Items]
Income Tax Expense (Benefit)	$ (63)
Office of the Tax Commissioner, Bermuda [Member] | Domestic Tax Authority [Member]
Valuation Allowance [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	0.00%	0.00%	0.00%
Internal Revenue Service (IRS) | Foreign Tax Authority [Member]
Valuation Allowance [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	21.00%	21.00%
Her Majesty's Revenue and Customs (HMRC) [Member] | Foreign Tax Authority [Member]
Valuation Allowance [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	19.00%	19.00%	19.00%

Statutory Requirements - Statut

Statutory Requirements - Statutory EBS and BSCR (Details) - Bermuda - USD ($)	Dec. 31, 2021	Dec. 31, 2020
ALRe
Statutory Accounting Practices [Line Items]
EBS Capital and Surplus	$ 14,630,000,000	$ 17,168,000,000
BSCR ratio	209.00%	254.00%
Statutory Accounting Practices, Minimum Solvency Margin Required	$ 8,000,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets Threshold	2.00%
Statutory Accounting Practices, Minimum Solvency Margin, Assets Threshold	$ 500,000,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets In Excess of Threshold	1.50%
AARe
Statutory Accounting Practices [Line Items]
EBS Capital and Surplus	$ 6,632,000,000	$ 2,441,000,000
BSCR ratio	2460.00%	967.00%
Statutory Accounting Practices, Minimum Solvency Margin Required	$ 8,000,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets Threshold	2.00%
Statutory Accounting Practices, Minimum Solvency Margin, Assets Threshold	$ 500,000,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets In Excess of Threshold	1.50%
ACRA
Statutory Accounting Practices [Line Items]
EBS Capital and Surplus	$ 3,872,000,000	$ 2,945,000,000
BSCR ratio	183.00%	236.00%
Statutory Accounting Practices, Minimum Solvency Margin, Assets Threshold	$ 500,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets In Excess of Threshold	1.50%

Statutory Requirements - Narrat

Statutory Requirements - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
ALRe | Bermuda
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Minimum Solvency Margin Required	$ 8,000,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets Threshold	2.00%
Statutory Accounting Practices, Minimum Solvency Margin, Assets Threshold	$ 500,000,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets In Excess of Threshold	1.50%
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Capital And Surplus	$ 3,963,000,000
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Statutory Net Income	(635,000,000)
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval	7,122,000,000	$ 9,971,000,000
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	11,823,000,000	13,518,000,000
EBS Capital and Surplus	$ 14,630,000,000	$ 17,168,000,000
BSCR ratio	209.00%	254.00%
AARe | Bermuda
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Minimum Solvency Margin Required	$ 8,000,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets Threshold	2.00%
Statutory Accounting Practices, Minimum Solvency Margin, Assets Threshold	$ 500,000,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets In Excess of Threshold	1.50%
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Capital And Surplus	$ (4,979,000,000)
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Statutory Net Income	2,678,000,000
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval	165,000,000	$ 1,096,000,000
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	2,649,000,000	2,457,000,000
EBS Capital and Surplus	$ 6,632,000,000	$ 2,441,000,000
BSCR ratio	2460.00%	967.00%
AADE | Delaware
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval	$ 0	$ 170,000,000
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	1,605,000,000	1,700,000,000
AAIA | Iowa
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Permitted Practice, Amount	(91,000,000)	(84,000,000)
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	1,279,000,000	1,312,000,000
ACRA | Bermuda
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Minimum Solvency Margin, Assets Threshold	$ 500,000
Statutory Accounting Practices, Minimum Solvency Margin, Percentage of Assets In Excess of Threshold	1.50%
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Capital And Surplus	$ 980,000,000
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Statutory Net Income	599,000,000
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval	1,759,000,000	1,592,000,000
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	4,187,000,000	2,718,000,000
EBS Capital and Surplus	$ 3,872,000,000	$ 2,945,000,000
BSCR ratio	183.00%	236.00%
Line of Credit [Member] | Athene Re USA IV | Vermont
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Permitted Practice, Amount	$ 117,000,000	$ 134,000,000

Statutory Requirements - Stat_2

Statutory Requirements - Statutory Permitted Practices (Details) - Bermuda $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)
ALRe
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Capital And Surplus	$ 3,963
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Statutory Net Income	(635)
AARe
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Capital And Surplus	(4,979)
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Statutory Net Income	2,678
ACRA
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Capital And Surplus	980
Statutory Accounting Practices, Permitted Practice, Increase (Decrease) To Statutory Net Income	$ 599

Statutory Requirements - Stat_3

Statutory Requirements - Statutory Maximum Dividends (Details) - Bermuda - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
AARe
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval	$ 165	$ 1,096
ACRA
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval	$ 1,759	$ 1,592

Statutory Requirements - Stat_4

Statutory Requirements - Statutory Capital and Surplus and Net Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
ALRe | Bermuda
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	$ 11,823	$ 13,518
Statutory Accounting Practices, Statutory Net Income Amount	3,278	1,544	$ 1,247
AARe | Bermuda
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	2,649	2,457
Statutory Accounting Practices, Statutory Net Income Amount	(3,703)	92	248
ACRA | Bermuda
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	4,187	2,718
Statutory Accounting Practices, Statutory Net Income Amount	293	1,522	265
AADE | Delaware
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	1,605	1,700
Statutory Accounting Practices, Statutory Net Income Amount	(70)	54	(86)
AANY | New York
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	304	320
Statutory Accounting Practices, Statutory Net Income Amount	(8)	(25)	33
AAIA | Iowa
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	1,279	1,312
Statutory Accounting Practices, Statutory Net Income Amount	$ (182)	$ (8)	$ 241

Related Parties - Summary of Su

Related Parties - Summary of Sub-allocation assets (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Management Fees Associated with Investment Funds [Member] | Related Party
Related Party Transaction [Line Items]
Due to related parties	$ 59	$ 41

Related Parties - Narrative (De

Related Parties - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Related Party Transaction [Line Items]
Funds withheld liability	$ 439	$ 452
Payments to Acquire Investment Funds	3,807	1,536	$ 1,012
Fair Value	110,561	89,373
Investment funds	9,866	6,087
Related Party
Related Party Transaction [Line Items]
Payments to Acquire Investment Funds	3,140	1,372	838
Other investments	222	469
Fair Value	10,402	6,520
Investment funds	8,459	5,284
ABS | Related Party
Related Party Transaction [Line Items]
Fair Value	6,994	4,785
Investments [Member]
Related Party Transaction [Line Items]
Other Commitment	14,771	7,472
Private Equity Funds [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds	751	473
Differentiated Investments [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds	2,562	1,889
Management Fees Associated with Investment Funds [Member] | Related Party
Related Party Transaction [Line Items]
Management fees	592	490	426
MidCap | Related Party
Related Party Transaction [Line Items]
Fair Value	158	0
AmeriHome [Member] | ABS | Related Party
Related Party Transaction [Line Items]
Fair Value		360
Apollo | Other Fund [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds	$ 2,112	1,324
Apollo | Sub-allocated assets [Member] | Related Party
Related Party Transaction [Line Items]
Base Management Fee	0.225%
Backbook Value			103,400
Incremental Fee	0.15%
Athora Holding Ltd. [Member] | Investments [Member] | Related Party
Related Party Transaction [Line Items]
Other Commitment	$ 512
Athora Holding Ltd. [Member] | Differentiated Investments [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds	743	709
Venerable Holdings, Inc. | Differentiated Investments [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds	219	123
AmeriHome [Member] | Differentiated Investments [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds	26	444
AmeriHome [Member] | Purchase of Residential Mortgage Loans Under Agreement | Related Party
Related Party Transaction [Line Items]
Related Party Transaction, Purchases from Related Party	$ 0	$ 169	$ 411
Maximum | Apollo | Sub-allocated assets [Member] | Related Party
Related Party Transaction [Line Items]
Sub-allocation fee percentage	0.70%
Minimum | Apollo | Sub-allocated assets [Member] | Related Party
Related Party Transaction [Line Items]
Sub-allocation fee percentage	0.065%

Related Parties - Summary of As

Related Parties - Summary of Assets Sub-Advised by Affiliates (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Fair Value	$ 110,561	$ 89,373
Mortgage loans	24,148	15,938
Investment funds	9,866	6,087
Assets, Total	$ 235,149	$ 202,771

Related Parties - Other Related

Related Parties - Other Related Party Transactions (Details) - USD ($) $ in Millions	Feb. 16, 2021	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Feb. 28, 2020
Related Party Transaction [Line Items]
Other changes in equity of noncontrolling interests			$ 758	$ 240	$ 575
Investment funds			9,866	6,087
Proceeds from Issuance of Common Stock			11	351	0
Liabilities assumed			212,968	182,631
Funds withheld liability			439	452
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders				(46)
Fair Value			110,561	89,373
Proceeds from Investment Funds			1,823	788	429
Interest Sensitive Contract Liabilities			156,325	144,566
Related Party
Related Party Transaction [Line Items]
Investment funds			8,459	5,284
Trading securities			1,781	1,529
Other investments			222	469
Fair Value			10,402	6,520
Proceeds from Investment Funds			1,433	691	296
Equity Securities, FV-NI			284	72
Interest Sensitive Contract Liabilities			$ 12,948	14,150
ACRA
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners			63.45%
Noncontrolling Interest, Ownership Percentage by Parent			36.55%
MidCap | Related Party
Related Party Transaction [Line Items]
Fair Value			$ 158	0
MidCap Affiliates | Related Party
Related Party Transaction [Line Items]
Fair Value			897	630
Apollo Athene Strategic Partnership Advisors, LLC [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds			415	214
Strategic Partnership Capacity			$ 2,875
Venerable Holdings, Inc. | Related Party
Related Party Transaction [Line Items]
Interest rate			6.257%
AmeriHome [Member] | Purchase of Residential Mortgage Loans Under Agreement | Related Party
Related Party Transaction [Line Items]
Related party purchases			$ 0	169	411
MidCap | Related Party
Related Party Transaction [Line Items]
Other investments			0	328
Investments			800	939
Proceeds from Sale and Maturity of Other Investments		$ 330
Interest and Other Income			19
Apollo Operating Group | Related Party
Related Party Transaction [Line Items]
Investment Owned, Balance, Shares						29,154,519
Investment Owned, at Fair Value						$ 1,100
AA Infrastructure | Related Party
Related Party Transaction [Line Items]
Equity securities			113	72
Trading securities			586	420
Athora Holding Ltd. [Member] | Related Party
Related Party Transaction [Line Items]
Investments			914	709
Equity Securities, FV-NI			171	0
PK AirFinance [Member] | Related Party
Related Party Transaction [Line Items]
Debt Securities			1,401	1,373
Athene Freedom Holdings, LP | Related Party
Related Party Transaction [Line Items]
Investments			3,119
Fair Value			$ 2,419
Reinsurance agreement
Related Party Transaction [Line Items]
Liabilities assumed				27,439	791
Interest Sensitive Contract Liabilities				$ 1,366	0
Class A
Related Party Transaction [Line Items]
Common stock issued (in shares)			192,200,000	191,500,000
Class A | Apollo Operating Group | Related Party
Related Party Transaction [Line Items]
Proceeds from Issuance of Common Stock				$ 350
Common stock issued (in shares)						7,575,758
Exchange of stock [Member] | Class A | Apollo Operating Group | Related Party
Related Party Transaction [Line Items]
Common stock issued (in shares)						27,959,184
Dividend Paid [Member] | AA Infrastructure | Related Party
Related Party Transaction [Line Items]
Dividends					267
Investments [Member]
Related Party Transaction [Line Items]
Other Commitment			$ 14,771	7,472
Investments [Member] | AA Infrastructure | Related Party
Related Party Transaction [Line Items]
Other Commitment			0
Investments [Member] | Athora Holding Ltd. [Member] | Related Party
Related Party Transaction [Line Items]
Other Commitment			512
Investments [Member] | PK AirFinance [Member] | Related Party
Related Party Transaction [Line Items]
Other Commitment			1,224
Private Equity Funds [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds			751	473
Credit Funds [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds			1,198	375
Redeemable preferred stock | MidCap | Related Party
Related Party Transaction [Line Items]
Trading securities			7	77
Debt Securities [Member] | Venerable Holdings, Inc. | Related Party
Related Party Transaction [Line Items]
Other investments			222	145
Differentiated Investments [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds			2,562	1,889
Differentiated Investments [Member] | Venerable Holdings, Inc. | Related Party
Related Party Transaction [Line Items]
Investment funds			219	123
Proceeds from Investment Funds			124
Deferred Revenue			25
Differentiated Investments [Member] | AmeriHome [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds			26	444
Gain on Sale of Investments	$ 182
Differentiated Investments [Member] | Athora Holding Ltd. [Member] | Related Party
Related Party Transaction [Line Items]
Investment funds			743	709
Differentiated Investments [Member] | Athene Freedom Holdings, LP | Related Party
Related Party Transaction [Line Items]
Investment funds			700	0
ABS | Related Party
Related Party Transaction [Line Items]
Fair Value			6,994	4,785
ABS | MidCap | Related Party
Related Party Transaction [Line Items]
Trading securities			635	534
ABS | AmeriHome [Member] | Related Party
Related Party Transaction [Line Items]
Fair Value				360
Additional paid-in capital
Related Party Transaction [Line Items]
Other changes in equity of noncontrolling interests			0		(145)
Accumulated other comprehensive income (loss)
Related Party Transaction [Line Items]
Other changes in equity of noncontrolling interests			0		(34)
Noncontrolling interests
Related Party Transaction [Line Items]
Other changes in equity of noncontrolling interests			758	240	$ 754
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders			0	(46)
Funding Agreements | Athora Holding Ltd. [Member] | Related Party
Related Party Transaction [Line Items]
Interest Sensitive Contract Liabilities			$ 63	$ 122

Commitments and Contingencies -

Commitments and Contingencies - Pledged Assets and Funds in Trust (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Financial Instruments Owned and Pledged as Collateral [Line Items]
Debt Securities, Available-for-sale, Restricted	$ 9,111	$ 9,884
Debt Securities, Trading, Restricted	75	60
Equity Securities, FV-NI, Restricted	30	26
Investment funds	174	68
Derivative assets pledged as collateral	96	107
Mortgage loans	5,033	5,028
Short-term investments	0	52
Other Investments Pledged as Collateral	130	105
Restricted Cash and Cash Equivalents	796	738
Total restricted assets	$ 15,445	$ 16,068

Commitments and Contingencies_2

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Other Commitments [Line Items]
Letters of Credit Outstanding, Amount	$ 1,375
Advances from FHLB	2,751	$ 2,002
Interest Sensitive Contract Liabilities	156,325	144,566
Gain (Loss) Related to Litigation Settlement	53
Other Liabilities [Member]
Other Commitments [Line Items]
Gain (Loss) Related to Litigation Settlement	47
Funding Agreement Backed Repurchase Agreements [Member]
Other Commitments [Line Items]
Interest Sensitive Contract Liabilities	1,000	1,000
Athene Global Funding | Funding Agreements
Other Commitments [Line Items]
Maximum borrowing capacity	5,183
Interest Sensitive Contract Liabilities	$ 19,728	$ 8,822

Segment Information - Reconcili

Segment Information - Reconciliation of Segment Adjusted Operating Revenues to Consolidation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Total revenues	$ 26,320	$ 14,764	$ 16,258
Change in fair values of derivatives and embedded derivatives – index annuities, net of offsets	3,525	3,430	4,443
Investment gains (losses), net of offsets	4,188	3,309	4,719
Operating Segments | Retirement Services
Segment Reporting Information [Line Items]
Total revenues	14,903	10,681	11,460
Operating Segments | Corporate and Other
Segment Reporting Information [Line Items]
Total revenues	1,152	266	117
Non-operating adjustments
Segment Reporting Information [Line Items]
Change in fair values of derivatives and embedded derivatives – index annuities, net of offsets	2,507	868	2,346
Investment gains (losses), net of offsets	(6)	720	1,685
Noncontrolling interests, VIE expenses and other adjustments to revenues	$ 7,764	$ 2,229	$ 650

Segment Information - Reconci_2

Segment Information - Reconciliation of Segment Adjusted Operating Income to Consolidation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income tax expense – non-operating	$ (386)	$ (285)	$ (117)
Net income available to Athene Holding Ltd. common shareholders – basic and diluted	3,718	1,446	2,136
Operating Segments | Retirement Services
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income tax expense – non-operating	(89)	(164)	(117)
Net income available to Athene Holding Ltd. common shareholders – basic and diluted	2,423	1,266	1,322
Operating Segments | Corporate and Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income tax expense – non-operating	(182)	(60)	0
Net income available to Athene Holding Ltd. common shareholders – basic and diluted	643	(24)	(33)
Non-operating adjustments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Investment gains (losses), net of offsets	160	508	994
Loss on Derivative Instruments, Net of Expenses, Pretax	692	(235)	(65)
Integration, restructuring and other non-operating expenses	(124)	(10)	(70)
Stock-based compensation, excluding LTIP	(2)	(11)	(12)
Income tax expense – non-operating	$ (74)	$ (48)	$ 0

Segment Information - Reconci_3

Segment Information - Reconciliation of Segment Net Investment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net investment income	$ 7,177	$ 4,885	$ 4,596
Operating Segments | Retirement Services
Segment Reporting Information [Line Items]
Net investment income	6,791	5,287	5,062
Operating Segments | Corporate and Other
Segment Reporting Information [Line Items]
Net investment income	288	41	117
Non-operating adjustments
Segment Reporting Information [Line Items]
Reinsurance Embedded Derivative Gain (Loss)	(1,451)	(1,408)	(680)
Alternative Income Gain (Loss)	(144)	102	(1)
Noncontrolling interests	943	559	61
Apollo investment (gain) loss	864	225	0
Other Adjustment to Net Investment Income	$ (114)	$ 79	$ 37

Segment Information - Reconci_4

Segment Information - Reconciliation of Segment Income Tax Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting, Other Significant Reconciling Item [Line Items]
Income tax expense	$ 386	$ 285	$ 117
Non-operating adjustments
Segment Reporting, Other Significant Reconciling Item [Line Items]
Income tax expense	74	48	0
Noncontrolling interest tax expense	41	13	0
Retirement Services | Operating Segments
Segment Reporting, Other Significant Reconciling Item [Line Items]
Income tax expense	89	164	117
Corporate and Other | Operating Segments
Segment Reporting, Other Significant Reconciling Item [Line Items]
Income tax expense	$ 182	$ 60	$ 0

Segment Information - Assets by

Segment Information - Assets by Segment (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Total assets	$ 235,149	$ 202,771
Retirement Services
Revenues from External Customers and Long-Lived Assets [Line Items]
Total assets	228,835	197,295
Corporate and Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Total assets	$ 6,314	$ 5,476

Segment Information - Narrative

Segment Information - Narrative (Details)	12 Months Ended
	Dec. 31, 2021segment
Segment Reporting [Abstract]
Number of reportable segments	1

Segment Information - Premiums

Segment Information - Premiums and Deposits by Product (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Annuity Deposit Revenue, Gross	$ 23,466	$ 48,916	$ 12,125
Premiums	14,262	5,963	6,382
Premiums and Annuity Deposits	37,728	54,879	18,507
Fixed Indexed Annuity [Member]
Segment Reporting Information [Line Items]
Annuity Deposit Revenue, Gross	8,408	20,257	7,304
Fixed Rate Annuity [Member]
Segment Reporting Information [Line Items]
Annuity Deposit Revenue, Gross	2,662	20,433	3,192
Payouts Without Life Contingency [Member]
Segment Reporting Information [Line Items]
Annuity Deposit Revenue, Gross	542	545	341
Funding Agreements
Segment Reporting Information [Line Items]
Annuity Deposit Revenue, Gross	11,852	7,679	1,301
Life Insurance Product Line
Segment Reporting Information [Line Items]
Annuity Deposit Revenue, Gross	2	2	(13)
Premiums	45	52	50
Payouts With Life Contingency [Member]
Segment Reporting Information [Line Items]
Premiums	$ 14,217	$ 5,911	$ 6,332

Segment Information - Premium_2

Segment Information - Premiums and Deposits by Geographic Location (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Premiums and Annuity Deposits	$ 37,728	$ 54,879	$ 18,507
Total US region
Segment Reporting Information [Line Items]
Premiums and Annuity Deposits	25,380	19,187	16,614
Bermuda
Segment Reporting Information [Line Items]
Premiums and Annuity Deposits	$ 12,348	$ 35,692	$ 1,893

Schedule I Summary of Investm_2

Schedule I Summary of Investments - Other Than Investments in Related Parties (Details) $ in Millions	Dec. 31, 2021USD ($)
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	$ 173,362
Amount Shown on Consolidated Balance Sheet	177,567
Trading securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	1,824
Fair Value	2,056
Amount Shown on Consolidated Balance Sheet	2,056
Fixed Maturities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	98,282
Fair Value	102,215
Amount Shown on Consolidated Balance Sheet	102,215
Equity securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	955
Fair Value	1,170
Amount Shown on Consolidated Balance Sheet	1,170
Mortgage loans, net of allowances
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	22,555
Amount Shown on Consolidated Balance Sheet	22,557
Investment funds
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	1,392
Amount Shown on Consolidated Balance Sheet	1,407
Policy loans
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	312
Amount Shown on Consolidated Balance Sheet	312
Funds withheld at interest
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	43,907
Amount Shown on Consolidated Balance Sheet	43,907
Derivative
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	4,377
Amount Shown on Consolidated Balance Sheet	4,387
Short-term Investments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	139
Amount Shown on Consolidated Balance Sheet	139
Other investments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	1,443
Amount Shown on Consolidated Balance Sheet	1,473
US government and agencies | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	231
Fair Value	223
Amount Shown on Consolidated Balance Sheet	223
US state, municipal and political subdivisions | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	1,081
Fair Value	1,213
Amount Shown on Consolidated Balance Sheet	1,213
Foreign governments | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	1,110
Fair Value	1,128
Amount Shown on Consolidated Balance Sheet	1,128
Public utilities | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	6,680
Fair Value	7,180
Amount Shown on Consolidated Balance Sheet	7,180
Redeemable preferred stock | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	325
Fair Value	335
Amount Shown on Consolidated Balance Sheet	335
Other corporate | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	55,812
Fair Value	58,711
Amount Shown on Consolidated Balance Sheet	58,711
CLO | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	13,793
Fair Value	13,652
Amount Shown on Consolidated Balance Sheet	13,652
ABS | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	8,890
Fair Value	8,989
Amount Shown on Consolidated Balance Sheet	8,989
CMBS | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	2,764
Fair Value	2,758
Amount Shown on Consolidated Balance Sheet	2,758
RMBS | AFS securities – Foreign currency forwards
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	5,772
Fair Value	5,970
Amount Shown on Consolidated Balance Sheet	5,970
Industrial, miscellaneous and all other common stock | Equity securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	498
Fair Value	517
Amount Shown on Consolidated Balance Sheet	517
Nonredeemable preferred stocks | Equity securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	277
Fair Value	288
Amount Shown on Consolidated Balance Sheet	288
Financial Service | Equity securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost or Amortized Cost	180
Fair Value	365
Amount Shown on Consolidated Balance Sheet	$ 365

Schedule II - Condensed Finan_2

Schedule II - Condensed Financial Information of Registrant - Condensed Balance Sheet (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Condensed Financial Statements, Captions [Line Items]
Fair Value	$ 110,561	$ 89,373
Debt Securities, Available-for-sale, Amortized Cost	106,859	82,544
Accumulated other comprehensive income (loss)	2,430	3,971	$ 2,281	$ (472)
Cash and Cash Equivalents, at Carrying Value	9,633	7,704
Investment funds	9,866	6,087
Other Assets	1,283	1,249
Notes Receivable form Subsidiary	83	1,393
Assets, Total	235,149	202,771
Long-term Debt	2,964	1,976
Other Liabilities	2,997	2,040
Liabilities, Total	212,968	182,631
Additional Paid in Capital	6,667	6,613
Retained Earnings (Accumulated Deficit)	11,033	8,073
Stockholders' Equity Attributable to Parent, Total	20,130	18,657
Liabilities and Equity, Total	235,149	202,771
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Fair Value	78	52
Debt Securities, Available-for-sale, Amortized Cost	71	43
Accumulated other comprehensive income (loss)	2,430	3,971
Cash and Cash Equivalents, at Carrying Value	1,186	342	$ 171	$ 112
Other Assets	19	43
Intercompany Receivable	16	21
Intercompany Investments	21,773	18,133
Assets, Total	24,069	20,693
Long-term Debt	2,964	1,976
Notes Payable, Related Parties	158	0
Other Liabilities	811	57
Intercompany Payable	6	3
Liabilities, Total	3,939	2,036
Additional Paid in Capital	6,667	6,613
Retained Earnings (Accumulated Deficit)	11,033	8,073
Stockholders' Equity Attributable to Parent, Total	20,130	18,657
Liabilities and Equity, Total	24,069	20,693
Related Party
Condensed Financial Statements, Captions [Line Items]
Fair Value	10,402	6,520
Debt Securities, Available-for-sale, Amortized Cost	10,401	6,444
Equity Securities, FV-NI	284	72
Accumulated other comprehensive income (loss)	33	59
Investment funds	8,459	5,284
Other Liabilities	$ 936	$ 112
Series A Preferred Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Liquidation Preference, Value	$ 863	$ 863
Preferred Stock, Shares Authorized	34,500	0
Preferred Stock, Shares Issued	34,500	0
Preferred Stock, Shares Outstanding	34,500	0
Preferred Stock, Value, Outstanding	$ 0	$ 0
Series A Preferred Stock [Member] | Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Preferred Stock, Value, Outstanding	$ 0	$ 0
Series B Preferred Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Liquidation Preference, Value	$ 345	$ 345
Preferred Stock, Shares Authorized	13,800	0
Preferred Stock, Shares Issued	13,800	0
Preferred Stock, Shares Outstanding	13,800	0
Preferred Stock, Value, Outstanding	$ 0	$ 0
Series B Preferred Stock [Member] | Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Preferred Stock, Value, Outstanding	$ 0	$ 0
Class A
Condensed Financial Statements, Captions [Line Items]
Common stock issued (in shares)	192,200,000	191,500,000
Common stock, par value (in USD per share)	$ 0.001	$ 0.001
Common stock outstanding (in shares)	192,200,000	191,500,000	143,200,000	162,400,000
Common stock authorized (in shares)	425,000,000	425,000,000
Common Stock, Value, Issued	$ 0	$ 0
Class A | Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Common Stock, Value, Issued	$ 0	$ 0
Class B
Condensed Financial Statements, Captions [Line Items]
Common stock outstanding (in shares)	0	0	25,400,000	25,400,000
Class M-1
Condensed Financial Statements, Captions [Line Items]
Common stock outstanding (in shares)	0	0	3,300,000	3,400,000
Class M-2
Condensed Financial Statements, Captions [Line Items]
Common stock outstanding (in shares)	0	0	800,000	800,000
Class M-3
Condensed Financial Statements, Captions [Line Items]
Common stock outstanding (in shares)	0	0	1,000,000	1,000,000
Class M-4
Condensed Financial Statements, Captions [Line Items]
Common stock outstanding (in shares)	0	0	4,000,000	4,100,000
Series C Preferred Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Liquidation Preference, Value	$ 600	$ 600
Preferred Stock, Shares Authorized	24,000	0
Preferred Stock, Shares Issued	24,000	0
Preferred Stock, Shares Outstanding	24,000	0
Preferred Stock, Value, Outstanding	$ 0	$ 0
Series C Preferred Stock [Member] | Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Preferred Stock, Value, Outstanding	$ 0	$ 0
Series D Preferred Stock
Condensed Financial Statements, Captions [Line Items]
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Liquidation Preference, Value	$ 575	$ 575
Preferred Stock, Shares Authorized	23,000	0
Preferred Stock, Shares Issued	23,000	0
Preferred Stock, Shares Outstanding	23,000	0
Preferred Stock, Value, Outstanding	$ 0	$ 0
Series D Preferred Stock | Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Preferred Stock, Value, Outstanding	0	0
Related Party | Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Equity Securities, FV-NI	171	0
Investment funds	743	709
Other Liabilities	$ 754	$ 0

Schedule II - Condensed Finan_3

Schedule II - Condensed Financial Information of Registrant - Condensed Income Statement (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Condensed Financial Statements, Captions [Line Items]
Net investment income	$ 7,177	$ 4,885	$ 4,596
Gain (Loss) on Investments	4,188	3,309	4,719
Other Income	72	36	37
Revenues, Total	26,320	14,764	16,258
Policy and other operating expenses	1,101	855	744
Total benefits and expenses	22,134	12,558	13,956
Income tax expense	386	285	117
Net Income (Loss) Attributable to Parent	3,859	1,541	2,172
Less: Preferred stock dividends	141	95	36
Net income available to Athene Holding Ltd. common shareholders – basic and diluted	3,718	1,446	2,136
Comprehensive income (loss) available to Athene Holding Ltd. shareholders	2,318	3,237	4,959
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net investment income	39	147	15
Gain (Loss) on Investments	58	(50)	6
Other Income	7	0	0
Revenues, Total	104	97	21
Policy and other operating expenses	261	151	142
Total benefits and expenses	261	151	142
Income (Loss) from Continuing Operations before Income Taxes, Equity Earnings in Subsidiaries	(157)	(54)	(121)
Income tax expense	(2)	(2)	0
Income (Loss) from Subsidiaries, Net of Tax	4,014	1,593	2,293
Net Income (Loss) Attributable to Parent	3,859	1,541	2,172
Less: Preferred stock dividends	141	95	36
Net income available to Athene Holding Ltd. common shareholders – basic and diluted	3,718	1,446	2,136
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(1,541)	1,696	2,787
Comprehensive income (loss) available to Athene Holding Ltd. shareholders	2,318	3,237	4,959
Parent Company [Member] | Related Party
Condensed Financial Statements, Captions [Line Items]
Net investment income	44	146	8
Gain (Loss) on Investments	0	0	1
Policy and other operating expenses	$ 13	$ 13	$ 11

Schedule II - Condensed Finan_4

Schedule II - Condensed Financial Information of Registrant - Condensed Cash Flows (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Condensed Financial Statements, Captions [Line Items]
Net Investment Income	$ 10,292	$ 4,154	$ 2,656
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	28,620	11,384	12,762
Proceeds from Investment Funds	1,823	788	429
Short-term investments	3,125	883	398
Available-for-sale securities	(47,181)	(23,404)	(17,237)
Payments to Acquire Equity Securities, FV-NI	931	1,362	451
Payments to Acquire Investment Funds	(3,807)	(1,536)	(1,012)
Payments to Acquire Short-term Investments	3,045	617	802
Payments for (Proceeds from) Other Investing Activities	225	(299)	(45)
Net cash provided by (used in) investing activities	(27,932)	(14,817)	(9,956)
Proceeds from Issuance of Long-term Debt	997	992	0
Repayments of Notes Payable	0	(75)	0
Proceeds from Issuance of Preferred Stock and Preference Stock	0	1,140	1,172
Payments of Ordinary Dividends, Preferred Stock and Preference Stock	(141)	(95)	(36)
Payments for (Proceeds from) Derivative Instrument, Financing Activities	3,243	546	2,286
Payments for Repurchase of Common Stock	8	428	832
Proceeds from (Payments for) Other Financing Activities	373	122	(80)
Net cash provided by financing activities	19,629	14,489	8,537
Cash and Cash Equivalents, at Carrying Value	9,633	7,704
Cash paid for interest	125	99	49
Proceeds from Issuance of Common Stock	11	351	0
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net Investment Income	203	(145)	(106)
Payments to Acquire Additional Interest in Subsidiaries	(330)	(920)	(70)
Intercompany Receipts on Loans to Subsidiary	348	50	0
Intercompany Payments to Fund Loans to Subsidiary	(244)	(237)	0
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	2	17	4
Available-for-sale securities	(30)	(3)	(16)
Payments to Acquire Equity Securities, FV-NI	170	0	0
Transfer to Investments	0	1,206	0
Investment interests received in exchange for extinguishment of loan from subsidiary	1,206	0	0
Payments for (Proceeds from) Other Investing Activities	66	(51)	27
Net cash provided by (used in) investing activities	(364)	(1,599)	(74)
Proceeds from Issuance of Long-term Debt	997	992	0
Repayments of Notes Payable	(80)	(778)	(174)
Proceeds from Related Party Debt	238	740	108
Proceeds from Issuance of Preferred Stock and Preference Stock	0	1,140	1,172
Payments of Ordinary Dividends, Preferred Stock and Preference Stock	(141)	(95)	(36)
Payments for Repurchase of Common Stock	8	428	832
Proceeds from (Payments for) Other Financing Activities	(12)	(7)	1
Net cash provided by financing activities	1,005	1,915	239
Net increase (decrease) in cash and cash equivalents	844	171	59
Cash and Cash Equivalents, at Carrying Value	1,186	342	171	$ 112
Cash paid for interest	98	61	46
Proceeds from Issuance of Common Stock	11	351	0
Parent Company [Member] | Related Party
Condensed Financial Statements, Captions [Line Items]
Proceeds from Investment Funds	0	0	1
Payments to Acquire Investment Funds	$ (6)	$ (455)	$ (20)

Schedule II - Condensed Finan_5

Schedule II - Condensed Financial Information of Registrant - Condensed Footnotes of Parent (Details) - Parent Company [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Condensed Financial Statements, Captions [Line Items]
Contribution of Property	$ 330	$ 920	$ 70
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees	1,048	0	$ 3
ALRe
Condensed Financial Statements, Captions [Line Items]
Maximum borrowing capacity	$ 2,000
Line of Credit Facility, Interest Rate at Period End	2.29%
Long-term Line of Credit	$ 158	0
Notes Receivable, Related Parties		1,206
ALRe | Revolving Credit Facility
Condensed Financial Statements, Captions [Line Items]
Intercompany Note Receivable	$ 0	0
Intercompany Note Receivable Interest Rate	2.29%
Revolving note receivable, borrowing capacity	$ 2,000
Athene USA Corporation [Member] | Revolving Credit Facility
Condensed Financial Statements, Captions [Line Items]
Intercompany Note Receivable	83	187
Revolving note receivable, borrowing capacity	250
Athene Life Re International Ltd. [Member] | Revolving Credit Facility
Condensed Financial Statements, Captions [Line Items]
Intercompany Note Receivable	0	$ 0
Revolving note receivable, borrowing capacity	$ 100

Schedule III - Supplementary _2

Schedule III - Supplementary Insurance Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits	$ 5,362	$ 4,906	$ 5,008
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Liability for Future Policy Benefit, Loss, Claim and Loss Expense	198,813	173,824	126,075
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Policy Claim and Benefit Payable	138	130	138
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Revenue	14,262	5,963	6,382
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Net Investment Income	7,177	4,885	4,596
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Benefit, Claim, Loss and Settlement Expenses	20,401	11,182	12,254
Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Costs and Value of Business Acquired	632	521	958
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense	1,101	855	744
Retirement Services
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits	5,362	4,906	5,008
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Liability for Future Policy Benefit, Loss, Claim and Loss Expense	198,813	173,824	126,075
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Policy Claim and Benefit Payable	138	130	138
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Revenue	14,262	5,963	6,382
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Net Investment Income	6,025	4,619	4,479
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Benefit, Claim, Loss and Settlement Expenses	20,401	11,182	12,254
Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Costs and Value of Business Acquired	632	521	958
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense	841	705	599
Corporate and Other
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits	0	0	0
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Liability for Future Policy Benefit, Loss, Claim and Loss Expense	0	0	0
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Policy Claim and Benefit Payable	0	0	0
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Revenue	0	0	0
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Net Investment Income	1,152	266	117
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Benefit, Claim, Loss and Settlement Expenses	0	0	0
Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Costs and Value of Business Acquired	0	0	0
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense	$ 260	$ 150	$ 145

Schedule IV - Reinsurance (Deta

Schedule IV - Reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]
SEC Schedule, 12-17, Insurance Companies, Reinsurance, Life Insurance in Force, Gross	$ 26,858	$ 29,527	$ 33,221
SEC Schedule, 12-17, Insurance Companies, Reinsurance, Life Insurance in Force, Ceded	30,949	35,088	39,145
SEC Schedule, 12-17, Insurance Companies, Reinsurance, Life Insurance in Force, Assumed	5,518	6,863	7,317
SEC Schedule, 12-17, Insurance Companies, Reinsurance, Life Insurance in Force, Net	$ 1,427	$ 1,302	$ 1,393
SEC Schedule, 12-17, Insurance Companies, Reinsurance, Life Insurance in Force, Percentage Assumed to Net	386.70%	527.10%	525.30%
Direct	$ 13,989	$ 5,691	$ 5,449
Ceded Premiums Earned	115	141	159
Reinsurance assumed	388	413	1,092
Premiums	$ 14,262	$ 5,963	$ 6,382
SEC Schedule, 12-17, Insurance Companies, Reinsurance, Premium, Percentage Assumed to Net	2.70%	6.90%	17.10%

Schedule V - Valuation and Qu_2

Schedule V - Valuation and Qualifying Accounts (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount	$ 66	$ 74	$ 63	$ 52
SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense	12	11	31
SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired	0	0	0
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	$ (20)	$ 0	$ (20)